HADV OTC
Health Advance Inc.
1W: +0.0%
1M: -33.3%
3M: +0.0%
YTD: -41.2%
1Y: -55.6%
3Y: -96.1%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±14.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
#85
of 96
Medical - Pharmaceuticals
Technical Signal Map
32 Bullish
16 Neutral
189 Bearish
HADV
—
Health Advance Inc.
LEAN BEAR
-15
SDEV
$380M
Stablecoin Development Corp.
BULLISH
+100
SDEV
$380M
Stablecoin Development Corp.
BULLISH
+100
CSCIF
—
COSCIENS Biopharma Inc.
BULLISH
+82
CSCIF
—
COSCIENS Biopharma Inc.
BULLISH
+82
NSRX
$30M
Nasus Pharma Ltd.
BULLISH
+59
NSRX
$30M
Nasus Pharma Ltd.
BULLISH
+59
SCYX
$30M
SCYNEXIS, Inc.
BULLISH
+59
SCYX
$30M
SCYNEXIS, Inc.
BULLISH
+59
POM
$10M
POMDOCTOR Ltd
BULLISH
+58
POM
$10M
POMDOCTOR Ltd
BULLISH
+58
COSM
$20M
Cosmos Health Inc.
BULLISH
+53
COSM
$20M
Cosmos Health Inc.
BULLISH
+53
CTOR
$90M
Citius Oncology, Inc.
BULLISH
+43
CTOR
$90M
Citius Oncology, Inc.
BULLISH
+43
GCAN
—
Trafalgar International, Inc.
BULLISH
+43
GCAN
—
Trafalgar International, Inc.
BULLISH
+43
HITI
$230M
High Tide Inc.
BULLISH
+40
HITI
$230M
High Tide Inc.
BULLISH
+40
LGNDZ
—
Ligand Pharmaceuticals, Inc.
BULLISH
+40
LGNDZ
—
Ligand Pharmaceuticals, Inc.
BULLISH
+40
LPCUF
$110M
Lee's Pharmaceutical Holdings Limited
BULLISH
+35
LPCUF
$110M
Lee's Pharmaceutical Holdings Limited
BULLISH
+35
AJYG
—
AJ1G, Inc.
BULLISH
+31
AJYG
—
AJ1G, Inc.
BULLISH
+31
BIOYF
$130M
BioSyent Inc.
LEAN BULL
+27
BIOYF
$130M
BioSyent Inc.
LEAN BULL
+27
AIBT
—
Aibotics Inc.
LEAN BULL
+27
AIBT
—
Aibotics Inc.
LEAN BULL
+27
RMRK
—
Rimrock Gold Corp.
LEAN BULL
+16
RMRK
—
Rimrock Gold Corp.
LEAN BULL
+16
CTTH
—
CTT Pharmaceutical Holdings, Inc.
LEAN BULL
+16
CTTH
—
CTT Pharmaceutical Holdings, Inc.
LEAN BULL
+16
ERGO
—
Entia Biosciences, Inc.
NEUTRAL
+8
ERGO
—
Entia Biosciences, Inc.
NEUTRAL
+8
MNZO
—
Manzo Pharmaceuticals, Inc.
NEUTRAL
+2
MNZO
—
Manzo Pharmaceuticals, Inc.
NEUTRAL
+2
CBIA
—
Canopus Biopharma, Inc.
NEUTRAL
+2
CBIA
—
Canopus Biopharma, Inc.
NEUTRAL
+2
ETRA
$220M
Electra Therapeutics Inc.
N/A
0
ETRA
$220M
Electra Therapeutics Inc.
N/A
0
HYHY
—
Hydrogen Hybrid Technologies, Inc.
NEUTRAL
0
HYHY
—
Hydrogen Hybrid Technologies, Inc.
NEUTRAL
0
ITNS
—
Itonis, Inc.
NEUTRAL
-2
ITNS
—
Itonis, Inc.
NEUTRAL
-2
BGXXQ
—
Bright Green Corporation
NEUTRAL
-6
BGXXQ
—
Bright Green Corporation
NEUTRAL
-6
TNPH
—
Tian'an Pharmaceutical Co., Ltd.
NEUTRAL
-8
TNPH
—
Tian'an Pharmaceutical Co., Ltd.
NEUTRAL
-8
SGIPF
$1.8B
Sugi Holdings Co.,Ltd.
LEAN BEAR
-12
SGIPF
$1.8B
Sugi Holdings Co.,Ltd.
LEAN BEAR
-12
CELG-RI
$260M
Bristol-Myers Squibb Company Ce
LEAN BEAR
-14
CELG-RI
$260M
Bristol-Myers Squibb Company Ce
LEAN BEAR
-14
CLABF
—
Core One Labs Inc.
LEAN BEAR
-14
CLABF
—
Core One Labs Inc.
LEAN BEAR
-14
BIEI
—
Premier Biomedical, Inc.
LEAN BEAR
-15
BIEI
—
Premier Biomedical, Inc.
LEAN BEAR
-15
BDPT
—
BioAdaptives Inc.
LEAN BEAR
-15
BDPT
—
BioAdaptives Inc.
LEAN BEAR
-15
ETBI
—
Eastgate Biotech Corp.
LEAN BEAR
-15
ETBI
—
Eastgate Biotech Corp.
LEAN BEAR
-15
SKVI
—
Skinvisible, Inc.
LEAN BEAR
-15
SKVI
—
Skinvisible, Inc.
LEAN BEAR
-15
CXBS
—
Corix Bioscience, Inc.
LEAN BEAR
-15
CXBS
—
Corix Bioscience, Inc.
LEAN BEAR
-15
LTUS
—
Lotus Pharmaceuticals, Inc.
LEAN BEAR
-23
LTUS
—
Lotus Pharmaceuticals, Inc.
LEAN BEAR
-23
LJUIF
$1.2B
SSY Group Limited
LEAN BEAR
-24
LJUIF
$1.2B
SSY Group Limited
LEAN BEAR
-24
BGMS
—
Bio Green Med Solution, Inc.
LEAN BEAR
-26
BGMS
—
Bio Green Med Solution, Inc.
LEAN BEAR
-26
EOCN
—
Eocene Ltd.
LEAN BEAR
-29
EOCN
—
Eocene Ltd.
LEAN BEAR
-29
PKBFF
$540M
PeakBirch Commerce Inc.
BEARISH
-32
PKBFF
$540M
PeakBirch Commerce Inc.
BEARISH
-32
AOXG
—
Aoxing Pharmaceutical Company, Inc.
BEARISH
-32
AOXG
—
Aoxing Pharmaceutical Company, Inc.
BEARISH
-32
BJTRF
$540M
Beijing Tong Ren Tang Chinese Medicine Company Limited
BEARISH
-33
BJTRF
$540M
Beijing Tong Ren Tang Chinese Medicine Company Limited
BEARISH
-33
RBII
—
Rising Biosciences, Inc.
BEARISH
-39
RBII
—
Rising Biosciences, Inc.
BEARISH
-39
ROTH
—
PharmaRoth Labs, Inc.
BEARISH
-40
ROTH
—
PharmaRoth Labs, Inc.
BEARISH
-40
FSPM
—
FusionPharm, Inc.
BEARISH
-40
FSPM
—
FusionPharm, Inc.
BEARISH
-40
PXYN
—
Praxsyn Corporation
BEARISH
-40
PXYN
—
Praxsyn Corporation
BEARISH
-40
PRPH
—
ProPhase Labs, Inc.
BEARISH
-40
PRPH
—
ProPhase Labs, Inc.
BEARISH
-40
MDIN
—
MedGen, Inc.
BEARISH
-40
MDIN
—
MedGen, Inc.
BEARISH
-40
CNNXF
—
CannAmerica Brands Corp.
BEARISH
-40
CNNXF
—
CannAmerica Brands Corp.
BEARISH
-40
SNNC
—
Sibannac, Inc.
BEARISH
-41
SNNC
—
Sibannac, Inc.
BEARISH
-41
BHCCF
$230M
Benchmark Holdings plc
BEARISH
-42
BHCCF
$230M
Benchmark Holdings plc
BEARISH
-42
AEGY
—
Alternative Energy Partners, Inc.
BEARISH
-42
AEGY
—
Alternative Energy Partners, Inc.
BEARISH
-42
ALST
—
AllStar Health Brands Inc
BEARISH
-43
ALST
—
AllStar Health Brands Inc
BEARISH
-43
BLMS
—
Bloomios, Inc.
BEARISH
-43
BLMS
—
Bloomios, Inc.
BEARISH
-43
FITX
—
Creative Edge Nutrition, Inc.
BEARISH
-48
FITX
—
Creative Edge Nutrition, Inc.
BEARISH
-48
RSCI
—
Redwood Scientific Technologies, Inc.
BEARISH
-49
RSCI
—
Redwood Scientific Technologies, Inc.
BEARISH
-49
GEATF
—
Radiko Holdings Corp
BEARISH
-49
GEATF
—
Radiko Holdings Corp
BEARISH
-49
LRSV
—
Link Reservations Inc.
BEARISH
-49
LRSV
—
Link Reservations Inc.
BEARISH
-49
MDVLQ
—
MedAvail Holdings, Inc.
BEARISH
-49
MDVLQ
—
MedAvail Holdings, Inc.
BEARISH
-49
UPPR
—
Upper Street Marketing Inc.
BEARISH
-49
UPPR
—
Upper Street Marketing Inc.
BEARISH
-49
SPPH
—
Spencer Pharmaceutical Inc.
BEARISH
-49
SPPH
—
Spencer Pharmaceutical Inc.
BEARISH
-49
MDCN
—
Medican Enterprises, Inc.
BEARISH
-50
MDCN
—
Medican Enterprises, Inc.
BEARISH
-50
MDRM
—
Modern Mobility Aids, Inc.
BEARISH
-50
MDRM
—
Modern Mobility Aids, Inc.
BEARISH
-50
RTSL
—
Rapid Therapeutic Science Laboratories, Inc.
BEARISH
-52
RTSL
—
Rapid Therapeutic Science Laboratories, Inc.
BEARISH
-52
GWLL
$70M
Goldenwell Biotech, Inc.
BEARISH
-53
GWLL
$70M
Goldenwell Biotech, Inc.
BEARISH
-53
INBP
$10M
Integrated BioPharma, Inc.
BEARISH
-56
INBP
$10M
Integrated BioPharma, Inc.
BEARISH
-56
BZYR
—
Burzynski Research Institute, Inc.
BEARISH
-58
BZYR
—
Burzynski Research Institute, Inc.
BEARISH
-58
VIAP
—
VIA Pharmaceuticals, Inc.
BEARISH
-58
VIAP
—
VIA Pharmaceuticals, Inc.
BEARISH
-58
MBCI
—
MabCure Inc.
BEARISH
-58
MBCI
—
MabCure Inc.
BEARISH
-58
PLWY
—
Peoplesway.com Inc.
BEARISH
-58
PLWY
—
Peoplesway.com Inc.
BEARISH
-58
RLLVF
—
Relevium Technologies Inc.
BEARISH
-58
RLLVF
—
Relevium Technologies Inc.
BEARISH
-58
SHMN
—
SOHM, Inc.
BEARISH
-58
SHMN
—
SOHM, Inc.
BEARISH
-58
IYXI
—
Inyx, Inc.
BEARISH
-58
IYXI
—
Inyx, Inc.
BEARISH
-58
SYDRF
—
Delota Corp.
BEARISH
-60
SYDRF
—
Delota Corp.
BEARISH
-60
ACBM
—
Acro Biomedical Co., Ltd.
BEARISH
-60
ACBM
—
Acro Biomedical Co., Ltd.
BEARISH
-60
NEXI
—
NexImmune, Inc.
BEARISH
-66
NEXI
—
NexImmune, Inc.
BEARISH
-66
WPHM
—
Winston Pharmaceuticals, Inc.
BEARISH
-66
WPHM
—
Winston Pharmaceuticals, Inc.
BEARISH
-66
DECN
—
Decision Diagnostics Corp.
BEARISH
-66
DECN
—
Decision Diagnostics Corp.
BEARISH
-66
QMDT
—
Quick-Med Technologies, Inc.
BEARISH
-66
QMDT
—
Quick-Med Technologies, Inc.
BEARISH
-66
CDXQ
—
China De Xiao Quan Care Group Co., Ltd
BEARISH
-66
CDXQ
—
China De Xiao Quan Care Group Co., Ltd
BEARISH
-66
PNPL
—
Pineapple, Inc.
BEARISH
-66
PNPL
—
Pineapple, Inc.
BEARISH
-66
RTEZ
$1.9B
Rest Ez Inc.
BEARISH
-75
RTEZ
$1.9B
Rest Ez Inc.
BEARISH
-75
HTPRF
—
HTC Purenergy Inc.
BEARISH
-75
HTPRF
—
HTC Purenergy Inc.
BEARISH
-75
CHME
—
China Medicine Corp.
BEARISH
-75
CHME
—
China Medicine Corp.
BEARISH
-75
GSAC
—
GelStat Corporation
BEARISH
-75
GSAC
—
GelStat Corporation
BEARISH
-75
OXIHF
—
Oxford Investments Holdings Inc.
BEARISH
-75
OXIHF
—
Oxford Investments Holdings Inc.
BEARISH
-75
HELP
$730M
Cybin Inc. Common Stock
BEARISH
-80
HELP
$730M
Cybin Inc. Common Stock
BEARISH
-80
ADVT
—
Advantis Corp.
BEARISH
-82
ADVT
—
Advantis Corp.
BEARISH
-82
OVIT
—
OncoVista Innovative Therapies, Inc.
BEARISH
-82
OVIT
—
OncoVista Innovative Therapies, Inc.
BEARISH
-82
DOSEF
—
Doseology Sciences Inc.
BEARISH
-82
DOSEF
—
Doseology Sciences Inc.
BEARISH
-82
ECGS
—
Eco-Growth Strategies Inc.
BEARISH
-82
ECGS
—
Eco-Growth Strategies Inc.
BEARISH
-82
IPAH
—
Interpharm Holdings, Inc.
BEARISH
-82
IPAH
—
Interpharm Holdings, Inc.
BEARISH
-82
MEDXF
$110M
Medexus Pharmaceuticals Inc.
BEARISH
-84
MEDXF
$110M
Medexus Pharmaceuticals Inc.
BEARISH
-84
ADIA
$10M
Adia Med Inc.
BEARISH
-84
ADIA
$10M
Adia Med Inc.
BEARISH
-84
PAVS
—
Paranovus Entertainment Technology Ltd.
BEARISH
-84
PAVS
—
Paranovus Entertainment Technology Ltd.
BEARISH
-84
MAYNF
$160M
Mayne Pharma Group Limited
BEARISH
-87
MAYNF
$160M
Mayne Pharma Group Limited
BEARISH
-87
BFRI
$10M
Biofrontera Inc.
BEARISH
-87
BFRI
$10M
Biofrontera Inc.
BEARISH
-87
CMOPF
$1.1B
Cosmo Pharmaceuticals N.V.
BEARISH
-91
CMOPF
$1.1B
Cosmo Pharmaceuticals N.V.
BEARISH
-91
ORXOF
$50M
Orexo AB (publ)
BEARISH
-91
ORXOF
$50M
Orexo AB (publ)
BEARISH
-91
MYCOF
$40M
Noveris Health Sciences Inc.
BEARISH
-91
MYCOF
$40M
Noveris Health Sciences Inc.
BEARISH
-91
SYMQY
$30M
SymBio Pharmaceuticals Limited
BEARISH
-91
SYMQY
$30M
SymBio Pharmaceuticals Limited
BEARISH
-91
CNSY
$10M
Cerenome, Inc.
BEARISH
-91
CNSY
$10M
Cerenome, Inc.
BEARISH
-91
AREVF
—
AREV Life Sciences Global Corp
BEARISH
-91
AREVF
—
AREV Life Sciences Global Corp
BEARISH
-91
RPGLF
—
Regent Pacific Group Limited
BEARISH
-91
RPGLF
—
Regent Pacific Group Limited
BEARISH
-91
NUNZ
—
Nunzia Pharmaceutical Company
BEARISH
-91
NUNZ
—
Nunzia Pharmaceutical Company
BEARISH
-91
ISHI
—
Islet Holdings, Inc.
BEARISH
-91
ISHI
—
Islet Holdings, Inc.
BEARISH
-91
AJOY
—
Ayujoy Herbals Ltd.
BEARISH
-91
AJOY
—
Ayujoy Herbals Ltd.
BEARISH
-91
OMHE
—
OMNI Health, Inc.
BEARISH
-91
OMHE
—
OMNI Health, Inc.
BEARISH
-91
PNDHF
—
Pond Technologies Holdings Inc.
BEARISH
-91
PNDHF
—
Pond Technologies Holdings Inc.
BEARISH
-91
TRGM
—
Targeted Medical Pharma, Inc.
BEARISH
-91
TRGM
—
Targeted Medical Pharma, Inc.
BEARISH
-91
NEUN
—
Neurogenesis, Inc.
BEARISH
-91
NEUN
—
Neurogenesis, Inc.
BEARISH
-91
GRCU
—
Global Roundtable Corporation
BEARISH
-91
GRCU
—
Global Roundtable Corporation
BEARISH
-91
GRPI
—
Grupo International Inc.
BEARISH
-91
GRPI
—
Grupo International Inc.
BEARISH
-91
LTGO
$960M
Latigo Biotherapeutics Inc.
BEARISH
-100
LTGO
$960M
Latigo Biotherapeutics Inc.
BEARISH
-100
CUVL
$300M
Clinuvel Pharmaceuticals Ltd.
BEARISH
-100
CUVL
$300M
Clinuvel Pharmaceuticals Ltd.
BEARISH
-100
SCNX
$10M
Scienture Holdings, Inc.
BEARISH
-100
SCNX
$10M
Scienture Holdings, Inc.
BEARISH
-100
INNPF
$10M
INNOCAN PHARMA Corp
BEARISH
-100
INNPF
$10M
INNOCAN PHARMA Corp
BEARISH
-100
HEWA
—
HealthWarehouse.com, Inc.
BEARISH
-100
HEWA
—
HealthWarehouse.com, Inc.
BEARISH
-100
EVAHF
—
EGF Theramed Health Corp.
BEARISH
-100
EVAHF
—
EGF Theramed Health Corp.
BEARISH
-100
WUHN
—
Wuhan General Group (China), Inc.
BEARISH
-100
WUHN
—
Wuhan General Group (China), Inc.
BEARISH
-100
ATTBF
—
Abattis Bioceuticals Corp.
BEARISH
-100
ATTBF
—
Abattis Bioceuticals Corp.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| HADV Health Advance Inc. | — | -2.9 | 60.0 | -29.9 | — | — | 1 | LEAN BEAR | -55.6 |
| SDEV Stablecoin Development Corp. | $380M | — | — | — | — | — | — | BULLISH | — |
| SDEV Stablecoin Development Corp. | $380M | — | — | — | — | — | — | BULLISH | — |
| CSCIF COSCIENS Biopharma Inc. | — | -0.5 | -19.9 | -18.7 | -6.4 | — | 1 | BULLISH | — |
| CSCIF COSCIENS Biopharma Inc. | — | -0.5 | -19.9 | -18.7 | -6.4 | — | 1 | BULLISH | — |
| NSRX Nasus Pharma Ltd. | $30M | — | — | — | — | — | — | BULLISH | -34.7 |
| NSRX Nasus Pharma Ltd. | $30M | — | — | — | — | — | — | BULLISH | -34.7 |
| SCYX SCYNEXIS, Inc. | $30M | -2.8 | -18.4 | -120.7 | 3147.7 | 489.8 | 5 | BULLISH | 533.4 |
| SCYX SCYNEXIS, Inc. | $30M | -2.8 | -18.4 | -120.7 | 3147.7 | 489.8 | 5 | BULLISH | 533.4 |
| POM POMDOCTOR Ltd | $10M | — | — | — | — | — | — | BULLISH | — |
| POM POMDOCTOR Ltd | $10M | — | — | — | — | — | — | BULLISH | — |
| COSM Cosmos Health Inc. | $20M | -0.6 | -104.0 | -41.2 | -32.1 | 33.8 | 4 | BULLISH | -65.5 |
| COSM Cosmos Health Inc. | $20M | -0.6 | -104.0 | -41.2 | -32.1 | 33.8 | 4 | BULLISH | -65.5 |
| CTOR Citius Oncology, Inc. | $90M | -2.0 | -126.6 | -109.8 | -597.4 | — | 3 | BULLISH | -51.8 |
| CTOR Citius Oncology, Inc. | $90M | -2.0 | -126.6 | -109.8 | -597.4 | — | 3 | BULLISH | -51.8 |
| GCAN Trafalgar International, Inc. | — | 0.4 | -162.2 | 1112.4 | — | -100.0 | 4 | BULLISH | -28.0 |
| GCAN Trafalgar International, Inc. | — | 0.4 | -162.2 | 1112.4 | — | -100.0 | 4 | BULLISH | -28.0 |
| HITI High Tide Inc. | $230M | -9.9 | -26.9 | 1.6 | 5.7 | 27.2 | 3 | BULLISH | -27.1 |
| HITI High Tide Inc. | $230M | -9.9 | -26.9 | 1.6 | 5.7 | 27.2 | 3 | BULLISH | -27.1 |
| LGNDZ Ligand Pharmaceuticals, Inc. | — | 0.0 | 20.4 | 11.3 | 76.2 | — | 3 | BULLISH | — |
| LGNDZ Ligand Pharmaceuticals, Inc. | — | 0.0 | 20.4 | 11.3 | 76.2 | — | 3 | BULLISH | — |
| LPCUF Lee's Pharmaceutical Holdings Limited | $110M | 4.1 | 9.9 | 0.2 | 11.9 | 81.2 | 8 | BULLISH | -1.3 |
| LPCUF Lee's Pharmaceutical Holdings Limited | $110M | 4.1 | 9.9 | 0.2 | 11.9 | 81.2 | 8 | BULLISH | -1.3 |
| AJYG AJ1G, Inc. | — | — | — | — | — | — | — | BULLISH | 380.1 |
| AJYG AJ1G, Inc. | — | — | — | — | — | — | — | BULLISH | 380.1 |
| BIOYF BioSyent Inc. | $130M | 19.0 | 23.7 | 23.8 | 14.3 | 41.0 | 5 | LEAN BULL | 35.0 |
| BIOYF BioSyent Inc. | $130M | 19.0 | 23.7 | 23.8 | 14.3 | 41.0 | 5 | LEAN BULL | 35.0 |
| AIBT Aibotics Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| AIBT Aibotics Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| RMRK Rimrock Gold Corp. | — | 5.7 | 8.6 | 6.4 | — | -100.0 | 2 | LEAN BULL | 0.0 |
| RMRK Rimrock Gold Corp. | — | 5.7 | 8.6 | 6.4 | — | -100.0 | 2 | LEAN BULL | 0.0 |
| CTTH CTT Pharmaceutical Holdings, Inc. | — | -42.3 | -272.8 | -210.7 | — | — | 2 | LEAN BULL | -5.0 |
| CTTH CTT Pharmaceutical Holdings, Inc. | — | -42.3 | -272.8 | -210.7 | — | — | 2 | LEAN BULL | -5.0 |
| ERGO Entia Biosciences, Inc. | — | -0.0 | 106.8 | 92.5 | -1021.5 | -23.5 | 5 | NEUTRAL | 900.0 |
| ERGO Entia Biosciences, Inc. | — | -0.0 | 106.8 | 92.5 | -1021.5 | -23.5 | 5 | NEUTRAL | 900.0 |
| MNZO Manzo Pharmaceuticals, Inc. | — | -1.0 | 4.6 | 4.1 | — | — | 2 | NEUTRAL | 0.0 |
| MNZO Manzo Pharmaceuticals, Inc. | — | -1.0 | 4.6 | 4.1 | — | — | 2 | NEUTRAL | 0.0 |
| CBIA Canopus Biopharma, Inc. | — | -0.0 | 1457.1 | 15327.7 | — | — | 1 | NEUTRAL | 0.0 |
| CBIA Canopus Biopharma, Inc. | — | -0.0 | 1457.1 | 15327.7 | — | — | 1 | NEUTRAL | 0.0 |
| ETRA Electra Therapeutics Inc. | $220M | — | — | — | — | — | — | N/A | — |
| ETRA Electra Therapeutics Inc. | $220M | — | — | — | — | — | — | N/A | — |
| HYHY Hydrogen Hybrid Technologies, Inc. | — | -0.0 | -138.6 | -342.9 | — | 16.1 | 4 | NEUTRAL | 0.0 |
| HYHY Hydrogen Hybrid Technologies, Inc. | — | -0.0 | -138.6 | -342.9 | — | 16.1 | 4 | NEUTRAL | 0.0 |
| ITNS Itonis, Inc. | — | -53.9 | 2.9 | 16.1 | -299.0 | -55.8 | 3 | NEUTRAL | 33.3 |
| ITNS Itonis, Inc. | — | -53.9 | 2.9 | 16.1 | -299.0 | -55.8 | 3 | NEUTRAL | 33.3 |
| BGXXQ Bright Green Corporation | — | — | — | — | — | — | — | NEUTRAL | — |
| BGXXQ Bright Green Corporation | — | — | — | — | — | — | — | NEUTRAL | — |
| TNPH Tian'an Pharmaceutical Co., Ltd. | — | -1699.6 | 0.3 | 33.0 | — | -100.0 | 3 | NEUTRAL | 983.3 |
| TNPH Tian'an Pharmaceutical Co., Ltd. | — | -1699.6 | 0.3 | 33.0 | — | -100.0 | 3 | NEUTRAL | 983.3 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 14.6 | 8.8 | 9.6 | 3.6 | -12.7 | 5 | LEAN BEAR | -41.7 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 14.6 | 8.8 | 9.6 | 3.6 | -12.7 | 5 | LEAN BEAR | -41.7 |
| CELG-RI Bristol-Myers Squibb Company Ce | $260M | 0.0 | 38.8 | 20.8 | 23.3 | 1.8 | 8 | LEAN BEAR | 289.2 |
| CELG-RI Bristol-Myers Squibb Company Ce | $260M | 0.0 | 38.8 | 20.8 | 23.3 | 1.8 | 8 | LEAN BEAR | 289.2 |
| CLABF Core One Labs Inc. | — | -0.3 | -233.7 | -70.3 | -897.6 | -69.3 | 3 | LEAN BEAR | -100.0 |
| CLABF Core One Labs Inc. | — | -0.3 | -233.7 | -70.3 | -897.6 | -69.3 | 3 | LEAN BEAR | -100.0 |
| BIEI Premier Biomedical, Inc. | — | -18.9 | 9.8 | 7.4 | — | -100.0 | 5 | LEAN BEAR | -31.2 |
| BIEI Premier Biomedical, Inc. | — | -18.9 | 9.8 | 7.4 | — | -100.0 | 5 | LEAN BEAR | -31.2 |
| BDPT BioAdaptives Inc. | — | -0.0 | 80.2 | 56.3 | 3009.0 | 169.7 | 3 | LEAN BEAR | -96.9 |
| BDPT BioAdaptives Inc. | — | -0.0 | 80.2 | 56.3 | 3009.0 | 169.7 | 3 | LEAN BEAR | -96.9 |
| ETBI Eastgate Biotech Corp. | — | -2.6 | 93.4 | 134.9 | -7057.2 | -53.0 | 3 | LEAN BEAR | -10.0 |
| ETBI Eastgate Biotech Corp. | — | -2.6 | 93.4 | 134.9 | -7057.2 | -53.0 | 3 | LEAN BEAR | -10.0 |
| SKVI Skinvisible, Inc. | — | -1.0 | 10.0 | 7.2 | -5110.7 | 0.0 | 2 | LEAN BEAR | -6.8 |
| SKVI Skinvisible, Inc. | — | -1.0 | 10.0 | 7.2 | -5110.7 | 0.0 | 2 | LEAN BEAR | -6.8 |
| CXBS Corix Bioscience, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| CXBS Corix Bioscience, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| LTUS Lotus Pharmaceuticals, Inc. | — | -385.1 | 14.7 | -340.1 | — | — | 3 | LEAN BEAR | 29.1 |
| LTUS Lotus Pharmaceuticals, Inc. | — | -385.1 | 14.7 | -340.1 | — | — | 3 | LEAN BEAR | 29.1 |
| LJUIF SSY Group Limited | $1.2B | 16.1 | 15.5 | 11.9 | 13.6 | -30.2 | 4 | LEAN BEAR | 0.0 |
| LJUIF SSY Group Limited | $1.2B | 16.1 | 15.5 | 11.9 | 13.6 | -30.2 | 4 | LEAN BEAR | 0.0 |
| BGMS Bio Green Med Solution, Inc. | — | -0.2 | -30.7 | -64.2 | -120.5 | — | 2 | LEAN BEAR | -82.2 |
| BGMS Bio Green Med Solution, Inc. | — | -0.2 | -30.7 | -64.2 | -120.5 | — | 2 | LEAN BEAR | -82.2 |
| EOCN Eocene Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| EOCN Eocene Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| AOXG Aoxing Pharmaceutical Company, Inc. | — | -35.9 | -0.2 | -13.9 | -405.2 | -99.8 | 1 | BEARISH | -68.6 |
| AOXG Aoxing Pharmaceutical Company, Inc. | — | -35.9 | -0.2 | -13.9 | -405.2 | -99.8 | 1 | BEARISH | -68.6 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.0 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | BEARISH | 0.0 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.0 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | BEARISH | 0.0 |
| RBII Rising Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RBII Rising Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ROTH PharmaRoth Labs, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| ROTH PharmaRoth Labs, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| FSPM FusionPharm, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| FSPM FusionPharm, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PXYN Praxsyn Corporation | — | -0.0 | 159.9 | 101.7 | 14.5 | 14.7 | 4 | BEARISH | 0.0 |
| PXYN Praxsyn Corporation | — | -0.0 | 159.9 | 101.7 | 14.5 | 14.7 | 4 | BEARISH | 0.0 |
| PRPH ProPhase Labs, Inc. | — | -0.0 | -544.0 | -207.6 | -301.8 | -5.5 | 3 | BEARISH | -99.7 |
| PRPH ProPhase Labs, Inc. | — | -0.0 | -544.0 | -207.6 | -301.8 | -5.5 | 3 | BEARISH | -99.7 |
| MDIN MedGen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MDIN MedGen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CNNXF CannAmerica Brands Corp. | — | -0.0 | 53.3 | 23.6 | -127.3 | -16.8 | 4 | BEARISH | 0.0 |
| CNNXF CannAmerica Brands Corp. | — | -0.0 | 53.3 | 23.6 | -127.3 | -16.8 | 4 | BEARISH | 0.0 |
| SNNC Sibannac, Inc. | — | -1.7 | 44.4 | 105.9 | — | -14.2 | 3 | BEARISH | -72.4 |
| SNNC Sibannac, Inc. | — | -1.7 | 44.4 | 105.9 | — | -14.2 | 3 | BEARISH | -72.4 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| AEGY Alternative Energy Partners, Inc. | — | -0.0 | 190.5 | 67.0 | — | -165.0 | 4 | BEARISH | -80.0 |
| AEGY Alternative Energy Partners, Inc. | — | -0.0 | 190.5 | 67.0 | — | -165.0 | 4 | BEARISH | -80.0 |
| ALST AllStar Health Brands Inc | — | -0.4 | 12.9 | 2.5 | — | — | 4 | BEARISH | -20.0 |
| ALST AllStar Health Brands Inc | — | -0.4 | 12.9 | 2.5 | — | — | 4 | BEARISH | -20.0 |
| BLMS Bloomios, Inc. | — | -0.0 | 221.4 | 58.3 | -3817.0 | 46.5 | 2 | BEARISH | 200.0 |
| BLMS Bloomios, Inc. | — | -0.0 | 221.4 | 58.3 | -3817.0 | 46.5 | 2 | BEARISH | 200.0 |
| FITX Creative Edge Nutrition, Inc. | — | -0.0 | 242.9 | 120.2 | -98.6 | — | 3 | BEARISH | 0.0 |
| FITX Creative Edge Nutrition, Inc. | — | -0.0 | 242.9 | 120.2 | -98.6 | — | 3 | BEARISH | 0.0 |
| RSCI Redwood Scientific Technologies, Inc. | — | -0.0 | 2488.8 | 821.0 | — | — | 2 | BEARISH | -99.9 |
| RSCI Redwood Scientific Technologies, Inc. | — | -0.0 | 2488.8 | 821.0 | — | — | 2 | BEARISH | -99.9 |
| GEATF Radiko Holdings Corp | — | -0.0 | 178.7 | -374.3 | -40.1 | -30.5 | 3 | BEARISH | 0.0 |
| GEATF Radiko Holdings Corp | — | -0.0 | 178.7 | -374.3 | -40.1 | -30.5 | 3 | BEARISH | 0.0 |
| LRSV Link Reservations Inc. | — | -7.6 | 103.3 | 152.0 | -20.7 | 73995.4 | 5 | BEARISH | -50.0 |
| LRSV Link Reservations Inc. | — | -7.6 | 103.3 | 152.0 | -20.7 | 73995.4 | 5 | BEARISH | -50.0 |
| MDVLQ MedAvail Holdings, Inc. | — | -0.0 | -164.8 | -243.8 | -1429.9 | -28.6 | 4 | BEARISH | 0.0 |
| MDVLQ MedAvail Holdings, Inc. | — | -0.0 | -164.8 | -243.8 | -1429.9 | -28.6 | 4 | BEARISH | 0.0 |
| UPPR Upper Street Marketing Inc. | — | -0.0 | 228.5 | -53.9 | -715.0 | — | 1 | BEARISH | 42.9 |
| UPPR Upper Street Marketing Inc. | — | -0.0 | 228.5 | -53.9 | -715.0 | — | 1 | BEARISH | 42.9 |
| SPPH Spencer Pharmaceutical Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SPPH Spencer Pharmaceutical Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MDCN Medican Enterprises, Inc. | — | -3.4 | 40.4 | -2.1 | — | -38.5 | 3 | BEARISH | 0.0 |
| MDCN Medican Enterprises, Inc. | — | -3.4 | 40.4 | -2.1 | — | -38.5 | 3 | BEARISH | 0.0 |
| MDRM Modern Mobility Aids, Inc. | — | -63.9 | 146.1 | 120.5 | — | — | 2 | BEARISH | 42.9 |
| MDRM Modern Mobility Aids, Inc. | — | -63.9 | 146.1 | 120.5 | — | — | 2 | BEARISH | 42.9 |
| RTSL Rapid Therapeutic Science Laboratories, Inc. | — | -0.0 | -3.4 | 35.5 | — | -100.0 | 2 | BEARISH | -86.7 |
| RTSL Rapid Therapeutic Science Laboratories, Inc. | — | -0.0 | -3.4 | 35.5 | — | -100.0 | 2 | BEARISH | -86.7 |
| GWLL Goldenwell Biotech, Inc. | $70M | -255.4 | 31.8 | 137.0 | — | 319257.9 | 5 | BEARISH | 244.8 |
| GWLL Goldenwell Biotech, Inc. | $70M | -255.4 | 31.8 | 137.0 | — | 319257.9 | 5 | BEARISH | 244.8 |
| INBP Integrated BioPharma, Inc. | $10M | -2.0 | -15.0 | -13.1 | -13.9 | -19.3 | 2 | BEARISH | -37.2 |
| INBP Integrated BioPharma, Inc. | $10M | -2.0 | -15.0 | -13.1 | -13.9 | -19.3 | 2 | BEARISH | -37.2 |
| BZYR Burzynski Research Institute, Inc. | — | -0.3 | 2902.9 | 1462.7 | — | — | 4 | BEARISH | -94.9 |
| BZYR Burzynski Research Institute, Inc. | — | -0.3 | 2902.9 | 1462.7 | — | — | 4 | BEARISH | -94.9 |
| VIAP VIA Pharmaceuticals, Inc. | — | -0.0 | 64.7 | 103.9 | — | — | 2 | BEARISH | 0.0 |
| VIAP VIA Pharmaceuticals, Inc. | — | -0.0 | 64.7 | 103.9 | — | — | 2 | BEARISH | 0.0 |
| MBCI MabCure Inc. | — | -0.0 | -127.0 | -14.0 | -2239.0 | — | 3 | BEARISH | -80.0 |
| MBCI MabCure Inc. | — | -0.0 | -127.0 | -14.0 | -2239.0 | — | 3 | BEARISH | -80.0 |
| PLWY Peoplesway.com Inc. | — | -0.0 | -6.5 | -4001.9 | -1.4 | -22.7 | 5 | BEARISH | 0.0 |
| PLWY Peoplesway.com Inc. | — | -0.0 | -6.5 | -4001.9 | -1.4 | -22.7 | 5 | BEARISH | 0.0 |
| RLLVF Relevium Technologies Inc. | — | -0.3 | 969.5 | 2839.9 | -218.6 | — | 1 | BEARISH | 0.0 |
| RLLVF Relevium Technologies Inc. | — | -0.3 | 969.5 | 2839.9 | -218.6 | — | 1 | BEARISH | 0.0 |
| SHMN SOHM, Inc. | — | 9.0 | -15.3 | -2.9 | -130.8 | -3.6 | 4 | BEARISH | -18.2 |
| SHMN SOHM, Inc. | — | 9.0 | -15.3 | -2.9 | -130.8 | -3.6 | 4 | BEARISH | -18.2 |
| IYXI Inyx, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| IYXI Inyx, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SYDRF Delota Corp. | — | -3.8 | -52.9 | -6.1 | -4.8 | 7.8 | 6 | BEARISH | 25.0 |
| SYDRF Delota Corp. | — | -3.8 | -52.9 | -6.1 | -4.8 | 7.8 | 6 | BEARISH | 25.0 |
| ACBM Acro Biomedical Co., Ltd. | — | -10.8 | 36.8 | 262.2 | — | 100.0 | 3 | BEARISH | 3614.3 |
| ACBM Acro Biomedical Co., Ltd. | — | -10.8 | 36.8 | 262.2 | — | 100.0 | 3 | BEARISH | 3614.3 |
| NEXI NexImmune, Inc. | — | -0.0 | -230.1 | 1048.5 | — | — | 4 | BEARISH | -50.0 |
| NEXI NexImmune, Inc. | — | -0.0 | -230.1 | 1048.5 | — | — | 4 | BEARISH | -50.0 |
| WPHM Winston Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | -66.7 |
| WPHM Winston Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | -66.7 |
| DECN Decision Diagnostics Corp. | — | -0.0 | -8643.1 | -51.3 | -107.0 | -2.7 | 4 | BEARISH | -99.0 |
| DECN Decision Diagnostics Corp. | — | -0.0 | -8643.1 | -51.3 | -107.0 | -2.7 | 4 | BEARISH | -99.0 |
| QMDT Quick-Med Technologies, Inc. | — | -0.0 | 8.3 | 3.4 | -78.6 | -6.9 | 5 | BEARISH | 400.0 |
| QMDT Quick-Med Technologies, Inc. | — | -0.0 | 8.3 | 3.4 | -78.6 | -6.9 | 5 | BEARISH | 400.0 |
| CDXQ China De Xiao Quan Care Group Co., Ltd | — | 0.0 | -136.1 | -277.5 | — | — | 4 | BEARISH | 300.0 |
| CDXQ China De Xiao Quan Care Group Co., Ltd | — | 0.0 | -136.1 | -277.5 | — | — | 4 | BEARISH | 300.0 |
| PNPL Pineapple, Inc. | — | -6.5 | 63.1 | -28.2 | -276.2 | 943.8 | 7 | BEARISH | -99.6 |
| PNPL Pineapple, Inc. | — | -6.5 | 63.1 | -28.2 | -276.2 | 943.8 | 7 | BEARISH | -99.6 |
| RTEZ Rest Ez Inc. | $1.9B | — | — | — | — | — | — | BEARISH | 0.0 |
| RTEZ Rest Ez Inc. | $1.9B | — | — | — | — | — | — | BEARISH | 0.0 |
| HTPRF HTC Purenergy Inc. | — | -0.1 | 13.4 | -6.6 | — | 100.0 | 5 | BEARISH | -99.8 |
| HTPRF HTC Purenergy Inc. | — | -0.1 | 13.4 | -6.6 | — | 100.0 | 5 | BEARISH | -99.8 |
| CHME China Medicine Corp. | — | -196.6 | 9.7 | 9.7 | 12.7 | -4.3 | 6 | BEARISH | 2483.3 |
| CHME China Medicine Corp. | — | -196.6 | 9.7 | 9.7 | 12.7 | -4.3 | 6 | BEARISH | 2483.3 |
| GSAC GelStat Corporation | — | -2.8 | 25.1 | 80.4 | -124.9 | 62.9 | 6 | BEARISH | -14.3 |
| GSAC GelStat Corporation | — | -2.8 | 25.1 | 80.4 | -124.9 | 62.9 | 6 | BEARISH | -14.3 |
| OXIHF Oxford Investments Holdings Inc. | — | -0.2 | 19.5 | 9.8 | 6887.8 | -90.6 | 2 | BEARISH | 0.0 |
| OXIHF Oxford Investments Holdings Inc. | — | -0.2 | 19.5 | 9.8 | 6887.8 | -90.6 | 2 | BEARISH | 0.0 |
| HELP Cybin Inc. Common Stock | $730M | -2.8 | -38.6 | -94.5 | — | — | 2 | BEARISH | — |
| HELP Cybin Inc. Common Stock | $730M | -2.8 | -38.6 | -94.5 | — | — | 2 | BEARISH | — |
| ADVT Advantis Corp. | — | -0.4 | -8.4 | -3.2 | -1775.1 | — | 1 | BEARISH | 0.0 |
| ADVT Advantis Corp. | — | -0.4 | -8.4 | -3.2 | -1775.1 | — | 1 | BEARISH | 0.0 |
| OVIT OncoVista Innovative Therapies, Inc. | — | -0.0 | 61.2 | 43.6 | — | — | 1 | BEARISH | 0.0 |
| OVIT OncoVista Innovative Therapies, Inc. | — | -0.0 | 61.2 | 43.6 | — | — | 1 | BEARISH | 0.0 |
| DOSEF Doseology Sciences Inc. | — | -0.9 | -95.4 | -103.8 | -1609.9 | 161.1 | 1 | BEARISH | -88.9 |
| DOSEF Doseology Sciences Inc. | — | -0.9 | -95.4 | -103.8 | -1609.9 | 161.1 | 1 | BEARISH | -88.9 |
| ECGS Eco-Growth Strategies Inc. | — | -2.0 | 19.5 | 55.1 | — | — | 2 | BEARISH | -76.5 |
| ECGS Eco-Growth Strategies Inc. | — | -2.0 | 19.5 | 55.1 | — | — | 2 | BEARISH | -76.5 |
| IPAH Interpharm Holdings, Inc. | — | -0.0 | -342.5 | -47.0 | -67.2 | -5.1 | 1 | BEARISH | -99.8 |
| IPAH Interpharm Holdings, Inc. | — | -0.0 | -342.5 | -47.0 | -67.2 | -5.1 | 1 | BEARISH | -99.8 |
| MEDXF Medexus Pharmaceuticals Inc. | $110M | -43.4 | -4.7 | 7.1 | -10.9 | -8.3 | 5 | BEARISH | 80.5 |
| MEDXF Medexus Pharmaceuticals Inc. | $110M | -43.4 | -4.7 | 7.1 | -10.9 | -8.3 | 5 | BEARISH | 80.5 |
| ADIA Adia Med Inc. | $10M | -0.1 | 32.2 | -16.3 | 8.3 | — | 1 | BEARISH | 145.7 |
| ADIA Adia Med Inc. | $10M | -0.1 | 32.2 | -16.3 | 8.3 | — | 1 | BEARISH | 145.7 |
| PAVS Paranovus Entertainment Technology Ltd. | — | -0.0 | -157.0 | -4.3 | -5.5 | -82.4 | 3 | BEARISH | -96.3 |
| PAVS Paranovus Entertainment Technology Ltd. | — | -0.0 | -157.0 | -4.3 | -5.5 | -82.4 | 3 | BEARISH | -96.3 |
| MAYNF Mayne Pharma Group Limited | $160M | 9.2 | -16.4 | -17.8 | 23.0 | 38.4 | 5 | BEARISH | -41.2 |
| MAYNF Mayne Pharma Group Limited | $160M | 9.2 | -16.4 | -17.8 | 23.0 | 38.4 | 5 | BEARISH | -41.2 |
| BFRI Biofrontera Inc. | $10M | -1.7 | -988.4 | -39.2 | -5.0 | 17.8 | 4 | BEARISH | -1.0 |
| BFRI Biofrontera Inc. | $10M | -1.7 | -988.4 | -39.2 | -5.0 | 17.8 | 4 | BEARISH | -1.0 |
| CMOPF Cosmo Pharmaceuticals N.V. | $1.1B | -148.1 | 9.2 | 10.2 | -9.5 | -1.7 | 3 | BEARISH | -22.4 |
| CMOPF Cosmo Pharmaceuticals N.V. | $1.1B | -148.1 | 9.2 | 10.2 | -9.5 | -1.7 | 3 | BEARISH | -22.4 |
| ORXOF Orexo AB (publ) | $50M | -1.5 | -578.7 | -5591.3 | -2868.6 | -78.2 | 4 | BEARISH | -43.5 |
| ORXOF Orexo AB (publ) | $50M | -1.5 | -578.7 | -5591.3 | -2868.6 | -78.2 | 4 | BEARISH | -43.5 |
| MYCOF Noveris Health Sciences Inc. | $40M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 12066.7 |
| MYCOF Noveris Health Sciences Inc. | $40M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 12066.7 |
| SYMQY SymBio Pharmaceuticals Limited | $30M | -0.6 | -334.3 | 639.4 | -515.2 | -54.2 | 1 | BEARISH | -41.5 |
| SYMQY SymBio Pharmaceuticals Limited | $30M | -0.6 | -334.3 | 639.4 | -515.2 | -54.2 | 1 | BEARISH | -41.5 |
| CNSY Cerenome, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| CNSY Cerenome, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| AREVF AREV Life Sciences Global Corp | — | -1.9 | 23.9 | 15.1 | — | -96.1 | 2 | BEARISH | -95.0 |
| AREVF AREV Life Sciences Global Corp | — | -1.9 | 23.9 | 15.1 | — | -96.1 | 2 | BEARISH | -95.0 |
| RPGLF Regent Pacific Group Limited | — | -16.1 | 119.2 | -279.5 | 10.3 | 1351.3 | 6 | BEARISH | -94.1 |
| RPGLF Regent Pacific Group Limited | — | -16.1 | 119.2 | -279.5 | 10.3 | 1351.3 | 6 | BEARISH | -94.1 |
| NUNZ Nunzia Pharmaceutical Company | — | -0.0 | 69398.6 | 176728.6 | — | — | 2 | BEARISH | 0.0 |
| NUNZ Nunzia Pharmaceutical Company | — | -0.0 | 69398.6 | 176728.6 | — | — | 2 | BEARISH | 0.0 |
| ISHI Islet Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ISHI Islet Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AJOY Ayujoy Herbals Ltd. | — | -1.0 | -54.8 | 142.7 | — | -100.0 | 3 | BEARISH | -70.7 |
| AJOY Ayujoy Herbals Ltd. | — | -1.0 | -54.8 | 142.7 | — | -100.0 | 3 | BEARISH | -70.7 |
| OMHE OMNI Health, Inc. | — | 0.0 | 30.4 | -8.8 | -6.1 | 2046.4 | 4 | BEARISH | -95.0 |
| OMHE OMNI Health, Inc. | — | 0.0 | 30.4 | -8.8 | -6.1 | 2046.4 | 4 | BEARISH | -95.0 |
| PNDHF Pond Technologies Holdings Inc. | — | -0.4 | 43.2 | 90.7 | -114.9 | -47.3 | 2 | BEARISH | 23.1 |
| PNDHF Pond Technologies Holdings Inc. | — | -0.4 | 43.2 | 90.7 | -114.9 | -47.3 | 2 | BEARISH | 23.1 |
| TRGM Targeted Medical Pharma, Inc. | — | -0.0 | 26.6 | 20.9 | -45.1 | -26.0 | 4 | BEARISH | -90.0 |
| TRGM Targeted Medical Pharma, Inc. | — | -0.0 | 26.6 | 20.9 | -45.1 | -26.0 | 4 | BEARISH | -90.0 |
| NEUN Neurogenesis, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NEUN Neurogenesis, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GRCU Global Roundtable Corporation | — | -2.9 | 28.1 | 25.5 | -673.8 | 35.7 | 7 | BEARISH | -99.0 |
| GRCU Global Roundtable Corporation | — | -2.9 | 28.1 | 25.5 | -673.8 | 35.7 | 7 | BEARISH | -99.0 |
| GRPI Grupo International Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GRPI Grupo International Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LTGO Latigo Biotherapeutics Inc. | $960M | — | — | — | — | — | — | BEARISH | — |
| LTGO Latigo Biotherapeutics Inc. | $960M | — | — | — | — | — | — | BEARISH | — |
| CUVL Clinuvel Pharmaceuticals Ltd. | $300M | — | — | — | — | — | — | BEARISH | — |
| CUVL Clinuvel Pharmaceuticals Ltd. | $300M | — | — | — | — | — | — | BEARISH | — |
| SCNX Scienture Holdings, Inc. | $10M | -0.1 | -53.5 | -15.4 | -821.3 | 540.6 | 3 | BEARISH | -82.5 |
| SCNX Scienture Holdings, Inc. | $10M | -0.1 | -53.5 | -15.4 | -821.3 | 540.6 | 3 | BEARISH | -82.5 |
| INNPF INNOCAN PHARMA Corp | $10M | -7.4 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -80.8 |
| INNPF INNOCAN PHARMA Corp | $10M | -7.4 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -80.8 |
| HEWA HealthWarehouse.com, Inc. | — | -3.3 | 24.7 | 44.2 | -6.8 | -42.5 | 3 | BEARISH | -36.4 |
| HEWA HealthWarehouse.com, Inc. | — | -3.3 | 24.7 | 44.2 | -6.8 | -42.5 | 3 | BEARISH | -36.4 |
| EVAHF EGF Theramed Health Corp. | — | -0.2 | 102.2 | 4.7 | — | — | 2 | BEARISH | -65.1 |
| EVAHF EGF Theramed Health Corp. | — | -0.2 | 102.2 | 4.7 | — | — | 2 | BEARISH | -65.1 |
| WUHN Wuhan General Group (China), Inc. | — | -0.0 | 106.5 | 1.0 | -155074.0 | — | 2 | BEARISH | 100.0 |
| WUHN Wuhan General Group (China), Inc. | — | -0.0 | 106.5 | 1.0 | -155074.0 | — | 2 | BEARISH | 100.0 |
| ATTBF Abattis Bioceuticals Corp. | — | -0.0 | -27.0 | -30.2 | -400.9 | 4163.2 | 4 | BEARISH | -96.7 |
| ATTBF Abattis Bioceuticals Corp. | — | -0.0 | -27.0 | -30.2 | -400.9 | 4163.2 | 4 | BEARISH | -96.7 |
| HADV Health Advance Inc. | — | -2.9 | 60.0 | -29.9 | — | — | 1 | LEAN BEAR | -55.6 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | BULLISH | -90.0 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | BULLISH | -90.0 |
| NYMXF Nymox Pharmaceutical Corporation | — | -0.7 | 193.9 | 89.4 | — | — | 2 | LEAN BULL | -44.4 |
| NYMXF Nymox Pharmaceutical Corporation | — | -0.7 | 193.9 | 89.4 | — | — | 2 | LEAN BULL | -44.4 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -57.9 |
| BIOCQ Biocept, Inc. | — | -0.0 | -13593.8 | -631.8 | -616.5 | — | 2 | BEARISH | 100.0 |
| LPTI Longport, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LPTI Longport, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NEPTF Neptune Wellness Solutions Inc. | — | -2.7 | 606.5 | 1351.5 | -233.6 | -24.7 | 2 | BEARISH | -100.0 |
| SILO Silo Pharma, Inc. | — | -0.3 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 113.0 |
| CCM Concord Medical Services Holdings Limited | — | -0.0 | 7.5 | -26.9 | -13.5 | -22.5 | 2 | BEARISH | -51.0 |
| CCM Concord Medical Services Holdings Limited | — | -0.0 | 7.5 | -26.9 | -13.5 | -22.5 | 2 | BEARISH | -51.0 |
| FBLG FibroBiologics, Inc. Common Stock | — | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -88.2 |
| FBLG FibroBiologics, Inc. Common Stock | — | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -88.2 |
| PMSNF Proteome Sciences plc | — | -2.0 | 75.0 | -73.3 | -74.6 | -100.0 | 1 | BEARISH | -80.0 |
| PMSNF Proteome Sciences plc | — | -2.0 | 75.0 | -73.3 | -74.6 | -100.0 | 1 | BEARISH | -80.0 |
| ADGM Adagio Medical Holdings, Inc. | — | -0.1 | -657.8 | -87.8 | — | -100.0 | 2 | BEARISH | -92.3 |
| ADGM Adagio Medical Holdings, Inc. | — | -0.1 | -657.8 | -87.8 | — | -100.0 | 2 | BEARISH | -92.3 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| HADV Health Advance Inc. | — | -2.9 | 60.0 | -29.9 | — | — | 1 | LEAN BEAR | -55.6 |
| ABSI Absci Corporation | $1.9B | -13.8 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BULLISH | 253.7 |
| ABSI Absci Corporation | $1.9B | -13.8 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BULLISH | 253.7 |
| AMN AMN Healthcare Services, Inc. | $1.4B | 13.6 | 15.6 | 8.9 | 3.1 | 24.0 | 8 | BULLISH | 83.6 |
| AMN AMN Healthcare Services, Inc. | $1.4B | 13.6 | 15.6 | 8.9 | 3.1 | 24.0 | 8 | BULLISH | 83.6 |
| HSTM HealthStream, Inc. | $900M | 43.1 | 6.0 | 6.5 | 8.0 | 8.8 | 8 | BULLISH | 12.3 |
| HSTM HealthStream, Inc. | $900M | 43.1 | 6.0 | 6.5 | 8.0 | 8.8 | 8 | BULLISH | 12.3 |
| SDEV Stablecoin Development Corp. | $380M | — | — | — | — | — | — | BULLISH | — |
| SDEV Stablecoin Development Corp. | $380M | — | — | — | — | — | — | BULLISH | — |
| INFU InfuSystem Holdings, Inc. | $270M | 31.3 | 15.0 | 11.4 | 8.7 | 2.5 | 9 | BULLISH | 28.1 |
| INFU InfuSystem Holdings, Inc. | $270M | 31.3 | 15.0 | 11.4 | 8.7 | 2.5 | 9 | BULLISH | 28.1 |
| OSUR OraSure Technologies, Inc. | $270M | -5.7 | -14.1 | -23.5 | 20.4 | -18.9 | 4 | BULLISH | 26.0 |
| OSUR OraSure Technologies, Inc. | $270M | -5.7 | -14.1 | -23.5 | 20.4 | -18.9 | 4 | BULLISH | 26.0 |
| PMVP PMV Pharmaceuticals, Inc. | $100M | -1.3 | -70.9 | 815.8 | — | — | 2 | BULLISH | 31.6 |
| PMVP PMV Pharmaceuticals, Inc. | $100M | -1.3 | -70.9 | 815.8 | — | — | 2 | BULLISH | 31.6 |
| MYO Myomo, Inc. | $60M | -4.8 | -123.8 | -74.2 | -34.4 | 6.1 | 3 | BULLISH | 75.9 |
| MYO Myomo, Inc. | $60M | -4.8 | -123.8 | -74.2 | -34.4 | 6.1 | 3 | BULLISH | 75.9 |
| ICU SeaStar Medical Holding Corporation | $10M | -1.2 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BULLISH | -24.8 |
| ICU SeaStar Medical Holding Corporation | $10M | -1.2 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BULLISH | -24.8 |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | — | -0.1 | -90.1 | -46.0 | — | — | 4 | BULLISH | -6.9 |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | — | -0.1 | -90.1 | -46.0 | — | — | 4 | BULLISH | -6.9 |
| FTRE Fortrea Holdings Inc. | $1.9B | -21.5 | -15.3 | 0.6 | -1.9 | -2.1 | 6 | BULLISH | 110.1 |
| FTRE Fortrea Holdings Inc. | $1.9B | -21.5 | -15.3 | 0.6 | -1.9 | -2.1 | 6 | BULLISH | 110.1 |
| AZTA Azenta, Inc. | $1.8B | -14.1 | -7.7 | -1.4 | 1.5 | 1.5 | 4 | BULLISH | 22.7 |
| AZTA Azenta, Inc. | $1.8B | -14.1 | -7.7 | -1.4 | 1.5 | 1.5 | 4 | BULLISH | 22.7 |
| NVAX Novavax, Inc. | $1.7B | -6.9 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BULLISH | 10.1 |
| NVAX Novavax, Inc. | $1.7B | -6.9 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BULLISH | 10.1 |
| NUTX Nutex Health, Inc. | $1.5B | 8.3 | 49.2 | 53.9 | 31.2 | 6.9 | 7 | BULLISH | 107.4 |
| NUTX Nutex Health, Inc. | $1.5B | 8.3 | 49.2 | 53.9 | 31.2 | 6.9 | 7 | BULLISH | 107.4 |
| CERT Certara, Inc. | $1.5B | -21.1 | -6.7 | 0.6 | -59.3 | 0.7 | 6 | BULLISH | -30.0 |
| CERT Certara, Inc. | $1.5B | -21.1 | -6.7 | 0.6 | -59.3 | 0.7 | 6 | BULLISH | -30.0 |
| USPH U.S. Physical Therapy, Inc. | $1.3B | 492.5 | -1.3 | 7.7 | 0.7 | 17.1 | 5 | BULLISH | -2.1 |
| USPH U.S. Physical Therapy, Inc. | $1.3B | 492.5 | -1.3 | 7.7 | 0.7 | 17.1 | 5 | BULLISH | -2.1 |
| CTKB Cytek Biosciences, Inc. | $760M | -9.4 | -23.0 | -40.8 | -25.3 | 5.4 | 3 | BULLISH | 62.6 |
| CTKB Cytek Biosciences, Inc. | $760M | -9.4 | -23.0 | -40.8 | -25.3 | 5.4 | 3 | BULLISH | 62.6 |
| KHTRF Knight Therapeutics Inc. | $730M | 70.2 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 69.0 |
| KHTRF Knight Therapeutics Inc. | $730M | 70.2 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 69.0 |
| MASS 908 Devices Inc. | $520M | -13.6 | -25.1 | -103.8 | -74.0 | 4.6 | 5 | BULLISH | 41.2 |
| MASS 908 Devices Inc. | $520M | -13.6 | -25.1 | -103.8 | -74.0 | 4.6 | 5 | BULLISH | 41.2 |
| TKNO Alpha Teknova, Inc. | $480M | -28.5 | -24.2 | -17.2 | -26.0 | 12.3 | 4 | BULLISH | 41.1 |
| TKNO Alpha Teknova, Inc. | $480M | -28.5 | -24.2 | -17.2 | -26.0 | 12.3 | 4 | BULLISH | 41.1 |
| RCEL Avita Medical Inc. | $320M | -8.8 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 142.3 |
| RCEL Avita Medical Inc. | $320M | -8.8 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 142.3 |
| SEER Seer, Inc. | $120M | -1.8 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BULLISH | 2.3 |
| SEER Seer, Inc. | $120M | -1.8 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BULLISH | 2.3 |
| HBIO Harvard Bioscience, Inc. | $40M | -3.6 | -89.9 | 1.8 | -12.8 | -1.1 | 7 | BULLISH | 86.2 |
| HBIO Harvard Bioscience, Inc. | $40M | -3.6 | -89.9 | 1.8 | -12.8 | -1.1 | 7 | BULLISH | 86.2 |
| AHG Akso Health Group | $980M | -4.4 | -50.1 | -44.9 | -546.5 | 22.7 | 4 | BULLISH | -31.6 |
| AHG Akso Health Group | $980M | -4.4 | -50.1 | -44.9 | -546.5 | 22.7 | 4 | BULLISH | -31.6 |
| PACB Pacific Biosciences of California, Inc. | $790M | -5.9 | -929.3 | -29.4 | -114.7 | 2.0 | 2 | BULLISH | 84.1 |
| PACB Pacific Biosciences of California, Inc. | $790M | -5.9 | -929.3 | -29.4 | -114.7 | 2.0 | 2 | BULLISH | 84.1 |
| QSI Quantum-Si incorporated | $310M | -3.3 | -49.1 | -121.8 | -6841.3 | -53.0 | 3 | BULLISH | 6.2 |
| QSI Quantum-Si incorporated | $310M | -3.3 | -49.1 | -121.8 | -6841.3 | -53.0 | 3 | BULLISH | 6.2 |
| NAUT Nautilus Biotechnolgy, Inc. | $250M | -4.4 | -36.2 | -66.2 | -7615.3 | — | 3 | BULLISH | 134.7 |
| NAUT Nautilus Biotechnolgy, Inc. | $250M | -4.4 | -36.2 | -66.2 | -7615.3 | — | 3 | BULLISH | 134.7 |
| ZCMD Zhongchao Inc. | — | -0.0 | -38.0 | -109.0 | -92.6 | -18.9 | 5 | BULLISH | 62.3 |
| ZCMD Zhongchao Inc. | — | -0.0 | -38.0 | -109.0 | -92.6 | -18.9 | 5 | BULLISH | 62.3 |
| OPRX OptimizeRx Corp. | $160M | 35.2 | 3.7 | 6.1 | -3.4 | -5.8 | 8 | BULLISH | -54.9 |
| OPRX OptimizeRx Corp. | $160M | 35.2 | 3.7 | 6.1 | -3.4 | -5.8 | 8 | BULLISH | -54.9 |
| TLSA Tiziana Life Sciences Ltd | $70M | -4.1 | -1250.8 | 978.2 | — | — | 1 | BULLISH | -42.6 |
| TLSA Tiziana Life Sciences Ltd | $70M | -4.1 | -1250.8 | 978.2 | — | — | 1 | BULLISH | -42.6 |
| CSTL Castle Biosciences, Inc. | $1.1B | -53.9 | -4.2 | -10.6 | -2.0 | 3.2 | 4 | BULLISH | 54.5 |
| CSTL Castle Biosciences, Inc. | $1.1B | -53.9 | -4.2 | -10.6 | -2.0 | 3.2 | 4 | BULLISH | 54.5 |
| AGEN Agenus Inc. | $350M | 3.1 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | BULLISH | 114.4 |
| AGEN Agenus Inc. | $350M | 3.1 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | BULLISH | 114.4 |
| UTMD Utah Medical Products, Inc. | $240M | 22.6 | 8.8 | 24.1 | 31.5 | -7.0 | 7 | BULLISH | 17.0 |
| UTMD Utah Medical Products, Inc. | $240M | 22.6 | 8.8 | 24.1 | 31.5 | -7.0 | 7 | BULLISH | 17.0 |
| RMTI Rockwell Medical, Inc. | $30M | -6.2 | -15.5 | -14.8 | -6.6 | -21.1 | 6 | BULLISH | 626.9 |
| RMTI Rockwell Medical, Inc. | $30M | -6.2 | -15.5 | -14.8 | -6.6 | -21.1 | 6 | BULLISH | 626.9 |
| EXHI Exlites Holdings International, Inc. | $20M | -750.0 | -66.7 | -65.8 | -35.4 | 283.9 | 4 | BULLISH | 246.2 |
| EXHI Exlites Holdings International, Inc. | $20M | -750.0 | -66.7 | -65.8 | -35.4 | 283.9 | 4 | BULLISH | 246.2 |
| CSCIF COSCIENS Biopharma Inc. | — | -0.5 | -19.9 | -18.7 | -6.4 | — | 1 | BULLISH | — |
| CSCIF COSCIENS Biopharma Inc. | — | -0.5 | -19.9 | -18.7 | -6.4 | — | 1 | BULLISH | — |
| DNA Ginkgo Bioworks Holdings, Inc. | $810M | -2.5 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BULLISH | -15.9 |
| DNA Ginkgo Bioworks Holdings, Inc. | $810M | -2.5 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BULLISH | -15.9 |
| YDES YD Bio Limited Ordinary Shares | $570M | — | — | — | — | — | — | BULLISH | -54.7 |
| YDES YD Bio Limited Ordinary Shares | $570M | — | — | — | — | — | — | BULLISH | -54.7 |
| DMAC DiaMedica Therapeutics Inc. | $440M | -11.4 | -114.6 | 616.3 | — | — | 2 | BULLISH | 20.0 |
| DMAC DiaMedica Therapeutics Inc. | $440M | -11.4 | -114.6 | 616.3 | — | — | 2 | BULLISH | 20.0 |
| MYGN Myriad Genetics, Inc. | $430M | -3.8 | -32.5 | -19.5 | -22.7 | -3.2 | 4 | BULLISH | -41.3 |
| MYGN Myriad Genetics, Inc. | $430M | -3.8 | -32.5 | -19.5 | -22.7 | -3.2 | 4 | BULLISH | -41.3 |
| SRZN Surrozen, Inc. | $220M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | BULLISH | 114.6 |
| SRZN Surrozen, Inc. | $220M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | BULLISH | 114.6 |
| MREO Mereo BioPharma Group plc | $60M | -2.1 | -67.8 | 6194.3 | — | -100.0 | 2 | BULLISH | -81.5 |
| MREO Mereo BioPharma Group plc | $60M | -2.1 | -67.8 | 6194.3 | — | -100.0 | 2 | BULLISH | -81.5 |
| CVM CEL-SCI Corporation | $20M | -0.9 | -252.5 | -142.9 | — | -100.0 | 4 | BULLISH | -76.8 |
| CVM CEL-SCI Corporation | $20M | -0.9 | -252.5 | -142.9 | — | -100.0 | 4 | BULLISH | -76.8 |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.2 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BULLISH | -5.4 |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.2 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BULLISH | -5.4 |
| DGWPF Drägerwerk AG & Co. KGaA | $1.9B | 12.8 | 10.9 | 9.8 | 3.4 | 6.5 | 9 | BULLISH | 79.5 |
| DGWPF Drägerwerk AG & Co. KGaA | $1.9B | 12.8 | 10.9 | 9.8 | 3.4 | 6.5 | 9 | BULLISH | 79.5 |
| COGZF Cogstate Limited | $400M | 32.9 | 49.6 | 94.6 | 22.4 | 3.7 | 6 | BULLISH | 85.7 |
| COGZF Cogstate Limited | $400M | 32.9 | 49.6 | 94.6 | 22.4 | 3.7 | 6 | BULLISH | 85.7 |
| SPHRF Starpharma Holdings Limited | $240M | -46.8 | -83.3 | -941.6 | -725.1 | 50.8 | 5 | BULLISH | 480.0 |
| SPHRF Starpharma Holdings Limited | $240M | -46.8 | -83.3 | -941.6 | -725.1 | 50.8 | 5 | BULLISH | 480.0 |
| SIGA SIGA Technologies, Inc. | $240M | -77.5 | -1.5 | -18.3 | 30.4 | -70.1 | 1 | BULLISH | -63.4 |
| SIGA SIGA Technologies, Inc. | $240M | -77.5 | -1.5 | -18.3 | 30.4 | -70.1 | 1 | BULLISH | -63.4 |
| SPOK Spok Holdings, Inc. | $230M | 18.3 | 8.4 | 10.0 | 11.8 | -3.4 | 5 | BULLISH | -32.7 |
| SPOK Spok Holdings, Inc. | $230M | 18.3 | 8.4 | 10.0 | 11.8 | -3.4 | 5 | BULLISH | -32.7 |
| DIUXF Diaceutics PLC | $200M | -609.4 | -4.7 | -7.3 | -15.9 | 58.0 | 4 | BULLISH | 68.6 |
| DIUXF Diaceutics PLC | $200M | -609.4 | -4.7 | -7.3 | -15.9 | 58.0 | 4 | BULLISH | 68.6 |
| QTRX Quanterix Corporation | $170M | -1.4 | -46.5 | -59.0 | -148.7 | 23.4 | 2 | BULLISH | -34.3 |
| QTRX Quanterix Corporation | $170M | -1.4 | -46.5 | -59.0 | -148.7 | 23.4 | 2 | BULLISH | -34.3 |
| INKT MiNK Therapeutics, Inc. | $60M | -5.2 | 57.9 | 42.8 | — | — | 3 | BULLISH | -14.1 |
| INKT MiNK Therapeutics, Inc. | $60M | -5.2 | 57.9 | 42.8 | — | — | 3 | BULLISH | -14.1 |
| VRHI Veri Medtech Holdings Inc. | $40M | — | — | — | — | — | — | BULLISH | — |
| VRHI Veri Medtech Holdings Inc. | $40M | — | — | — | — | — | — | BULLISH | — |
| CRVO CervoMed Inc. | $30M | -0.9 | -107.6 | 1244.8 | — | — | 2 | BULLISH | -62.4 |
| CRVO CervoMed Inc. | $30M | -0.9 | -107.6 | 1244.8 | — | — | 2 | BULLISH | -62.4 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | BULLISH | -60.5 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | BULLISH | -60.5 |
| BLFS BioLife Solutions, Inc. | $1.8B | 36.1 | 13.2 | 13.2 | 158.4 | 34.4 | 6 | BULLISH | 42.8 |
| BLFS BioLife Solutions, Inc. | $1.8B | 36.1 | 13.2 | 13.2 | 158.4 | 34.4 | 6 | BULLISH | 42.8 |
| OM Outset Medical, Inc. | $70M | -1.0 | -59.2 | -97.3 | -56.8 | -1.3 | 4 | BULLISH | -71.8 |
| OM Outset Medical, Inc. | $70M | -1.0 | -59.2 | -97.3 | -56.8 | -1.3 | 4 | BULLISH | -71.8 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BULLISH | 39.8 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BULLISH | 39.8 |
| SENS Senseonics Holdings, Inc. | $410M | -4.4 | -118.2 | -901.4 | -253.4 | 79.0 | 3 | BULLISH | 19.6 |
| SENS Senseonics Holdings, Inc. | $410M | -4.4 | -118.2 | -901.4 | -253.4 | 79.0 | 3 | BULLISH | 19.6 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $10M | -1.3 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | BULLISH | -58.1 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $10M | -1.3 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | BULLISH | -58.1 |
| MBXBF Microbix Biosystems Inc. | $30M | -8.5 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | BULLISH | 18.5 |
| MBXBF Microbix Biosystems Inc. | $30M | -8.5 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | BULLISH | 18.5 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -2.9 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -67.5 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -2.9 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -67.5 |
| SAEYY Redcare Pharmacy N.V. | $1.6B | -33.6 | -8.7 | -1.2 | 0.6 | 20.5 | 2 | BULLISH | -4.7 |
| SAEYY Redcare Pharmacy N.V. | $1.6B | -33.6 | -8.7 | -1.2 | 0.6 | 20.5 | 2 | BULLISH | -4.7 |
| KMTS Kestra Medical Technologies, Ltd. | $1.6B | -10.3 | -56.6 | -96.8 | -135.6 | 452.0 | 4 | BULLISH | 13.6 |
| KMTS Kestra Medical Technologies, Ltd. | $1.6B | -10.3 | -56.6 | -96.8 | -135.6 | 452.0 | 4 | BULLISH | 13.6 |
| SLGL Sol-Gel Technologies Ltd. | $240M | -12.8 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | BULLISH | 144.1 |
| SLGL Sol-Gel Technologies Ltd. | $240M | -12.8 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | BULLISH | 144.1 |
| FRNM Freenome, Inc. | $130M | — | — | — | — | — | — | BULLISH | — |
| FRNM Freenome, Inc. | $130M | — | — | — | — | — | — | BULLISH | — |
| INCR InterCure Ltd. | $60M | -4.8 | -15.9 | -10.2 | -1.3 | -10.8 | 2 | BULLISH | -34.3 |
| INCR InterCure Ltd. | $60M | -4.8 | -15.9 | -10.2 | -1.3 | -10.8 | 2 | BULLISH | -34.3 |
| BYSI BeyondSpring Inc. | $30M | -4.8 | 20.3 | 15.7 | — | 100.0 | 2 | BULLISH | -56.0 |
| BYSI BeyondSpring Inc. | $30M | -4.8 | 20.3 | 15.7 | — | 100.0 | 2 | BULLISH | -56.0 |
| NDRA ENDRA Life Sciences Inc. | $10M | -1.0 | -152.0 | -105.1 | — | — | 4 | BULLISH | 5.4 |
| NDRA ENDRA Life Sciences Inc. | $10M | -1.0 | -152.0 | -105.1 | — | — | 4 | BULLISH | 5.4 |
| PULM Pulmatrix, Inc. | $10M | -1.4 | -98.3 | -835.1 | — | -100.0 | 3 | BULLISH | -68.0 |
| PULM Pulmatrix, Inc. | $10M | -1.4 | -98.3 | -835.1 | — | -100.0 | 3 | BULLISH | -68.0 |
| NXL Nexalin Technology, Inc. | — | -0.4 | -240.3 | -1401.4 | -18412.7 | 24.2 | 4 | BULLISH | 551.3 |
| NXL Nexalin Technology, Inc. | — | -0.4 | -240.3 | -1401.4 | -18412.7 | 24.2 | 4 | BULLISH | 551.3 |
| DRTSW Alpha Tau Medical Ltd. | $1.6B | -14.2 | -141.7 | -17.1 | — | — | 3 | BULLISH | 1253.3 |
| DRTSW Alpha Tau Medical Ltd. | $1.6B | -14.2 | -141.7 | -17.1 | — | — | 3 | BULLISH | 1253.3 |
| MDRX Veradigm Inc. | $830M | -7.3 | 4.3 | 7.0 | 6.2 | -39.7 | 5 | BULLISH | 4.3 |
| MDRX Veradigm Inc. | $830M | -7.3 | 4.3 | 7.0 | 6.2 | -39.7 | 5 | BULLISH | 4.3 |
| TTRX Turn Therapeutics Inc. | $400M | -45.7 | -952.4 | 115.0 | — | — | 2 | BULLISH | — |
| TTRX Turn Therapeutics Inc. | $400M | -45.7 | -952.4 | 115.0 | — | — | 2 | BULLISH | — |
| OBIO Orchestra BioMed Holdings, Inc. | $360M | -6.0 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | BULLISH | 133.3 |
| OBIO Orchestra BioMed Holdings, Inc. | $360M | -6.0 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | BULLISH | 133.3 |
| EMBC Embecta Corp. | $340M | 3.8 | -13.6 | 26.3 | 7.8 | -7.6 | 5 | BULLISH | -61.1 |
| EMBC Embecta Corp. | $340M | 3.8 | -13.6 | 26.3 | 7.8 | -7.6 | 5 | BULLISH | -61.1 |
| CPIX Cumberland Pharmaceuticals Inc. | $110M | -10.3 | -46.7 | -41.6 | -2472.5 | -25.7 | 3 | BULLISH | 136.9 |
| CPIX Cumberland Pharmaceuticals Inc. | $110M | -10.3 | -46.7 | -41.6 | -2472.5 | -25.7 | 3 | BULLISH | 136.9 |
| NTRB Nutriband Inc. | $90M | -12.7 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | BULLISH | 0.1 |
| NTRB Nutriband Inc. | $90M | -12.7 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | BULLISH | 0.1 |
| TELA TELA Bio, Inc. | $50M | -1.5 | 1232.5 | -260.3 | -58.4 | 6.1 | 3 | BULLISH | -24.0 |
| TELA TELA Bio, Inc. | $50M | -1.5 | 1232.5 | -260.3 | -58.4 | 6.1 | 3 | BULLISH | -24.0 |
| NEGXF NexgenRx Inc. | $30M | 18.8 | 30.1 | -9.7 | 19.7 | 12.0 | 4 | BULLISH | 120.0 |
| NEGXF NexgenRx Inc. | $30M | 18.8 | 30.1 | -9.7 | 19.7 | 12.0 | 4 | BULLISH | 120.0 |
| JCRRF JCR Pharmaceuticals Co., Ltd. | $440M | 72.0 | 4.7 | 0.9 | 4.4 | -3.1 | 4 | BULLISH | inf |
| JCRRF JCR Pharmaceuticals Co., Ltd. | $440M | 72.0 | 4.7 | 0.9 | 4.4 | -3.1 | 4 | BULLISH | inf |
| ATGGF Actinogen Medical Limited | $220M | -11.2 | -146.7 | -361.2 | — | -63.0 | 1 | BULLISH | 140.0 |
| ATGGF Actinogen Medical Limited | $220M | -11.2 | -146.7 | -361.2 | — | -63.0 | 1 | BULLISH | 140.0 |
| INGN Inogen, Inc. | $160M | -6.6 | -13.1 | -27.8 | -4.0 | 3.2 | 5 | BULLISH | -29.1 |
| INGN Inogen, Inc. | $160M | -6.6 | -13.1 | -27.8 | -4.0 | 3.2 | 5 | BULLISH | -29.1 |
| AEMD Aethlon Medical, Inc. | — | -0.6 | -142.9 | -2931.8 | — | — | 4 | BULLISH | -82.3 |
| AEMD Aethlon Medical, Inc. | — | -0.6 | -142.9 | -2931.8 | — | — | 4 | BULLISH | -82.3 |
| CVALF Covalon Technologies Ltd. | $70M | 25.3 | 14.3 | 28.5 | 28.0 | 4.2 | 8 | BULLISH | 95.7 |
| CVALF Covalon Technologies Ltd. | $70M | 25.3 | 14.3 | 28.5 | 28.0 | 4.2 | 8 | BULLISH | 95.7 |
| XCRT Xcelerate Inc. | $10M | -11.4 | 71.8 | 24.0 | — | -142.3 | 2 | BULLISH | 61.8 |
| XCRT Xcelerate Inc. | $10M | -11.4 | 71.8 | 24.0 | — | -142.3 | 2 | BULLISH | 61.8 |
| CVGRF City View Green Holdings Inc. | — | -2.3 | 75.6 | 105.0 | — | — | 4 | BULLISH | -42.7 |
| CVGRF City View Green Holdings Inc. | — | -2.3 | 75.6 | 105.0 | — | — | 4 | BULLISH | -42.7 |
| DMTRF 3-D Matrix, Ltd. | $350M | 13.8 | 92.3 | 29.3 | 50.9 | 56.9 | 5 | BULLISH | 80.0 |
| DMTRF 3-D Matrix, Ltd. | $350M | 13.8 | 92.3 | 29.3 | 50.9 | 56.9 | 5 | BULLISH | 80.0 |
| VMD Viemed Healthcare, Inc. | $350M | 24.2 | 10.2 | 11.8 | 3.5 | 25.2 | 4 | BULLISH | 31.8 |
| VMD Viemed Healthcare, Inc. | $350M | 24.2 | 10.2 | 11.8 | 3.5 | 25.2 | 4 | BULLISH | 31.8 |
| BGM BGM Group Ltd. | $120M | -1.9 | -0.5 | -0.2 | -8.7 | — | 3 | BULLISH | -97.0 |
| BGM BGM Group Ltd. | $120M | -1.9 | -0.5 | -0.2 | -8.7 | — | 3 | BULLISH | -97.0 |
| LITS Lite Strategy, Inc. | $50M | -0.2 | -170.9 | -28.2 | — | — | 2 | BULLISH | -46.1 |
| LITS Lite Strategy, Inc. | $50M | -0.2 | -170.9 | -28.2 | — | — | 2 | BULLISH | -46.1 |
| NSRX Nasus Pharma Ltd. | $30M | — | — | — | — | — | — | BULLISH | -34.7 |
| NSRX Nasus Pharma Ltd. | $30M | — | — | — | — | — | — | BULLISH | -34.7 |
| GRDX GridAI Technologies Corp. | $30M | -0.9 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | -11.2 |
| GRDX GridAI Technologies Corp. | $30M | -0.9 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | -11.2 |
| SCYX SCYNEXIS, Inc. | $30M | -2.8 | -18.4 | -120.7 | 3147.7 | 489.8 | 5 | BULLISH | 533.4 |
| SCYX SCYNEXIS, Inc. | $30M | -2.8 | -18.4 | -120.7 | 3147.7 | 489.8 | 5 | BULLISH | 533.4 |
| PMI Picard Medical, Inc. | $10M | -0.3 | -1631.2 | -469.0 | -191.6 | — | 2 | BULLISH | -36.3 |
| PMI Picard Medical, Inc. | $10M | -0.3 | -1631.2 | -469.0 | -191.6 | — | 2 | BULLISH | -36.3 |
| LKFT Lakefront Biotherapeutics N.V. | $1.9B | — | — | — | — | — | — | BULLISH | — |
| LKFT Lakefront Biotherapeutics N.V. | $1.9B | — | — | — | — | — | — | BULLISH | — |
| XERS Xeris Biopharma Holdings, Inc. | $1.6B | -93.5 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 13.4 |
| XERS Xeris Biopharma Holdings, Inc. | $1.6B | -93.5 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 13.4 |
| RIGL Rigel Pharmaceuticals, Inc. | $870M | 2.7 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 67.4 |
| RIGL Rigel Pharmaceuticals, Inc. | $870M | 2.7 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 67.4 |
| GYRE Gyre Therapeutics, Inc. | $790M | -35.7 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BULLISH | -6.2 |
| GYRE Gyre Therapeutics, Inc. | $790M | -35.7 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BULLISH | -6.2 |
| ENGN enGene Holdings Inc. | $130M | -6.9 | -2.3 | 134.1 | — | -100.0 | 2 | BULLISH | -74.5 |
| ENGN enGene Holdings Inc. | $130M | -6.9 | -2.3 | 134.1 | — | -100.0 | 2 | BULLISH | -74.5 |
| MRAI Marpai, Inc. | $90M | -4.5 | 47.4 | 28.0 | -110.0 | -29.7 | 3 | BULLISH | 150.4 |
| MRAI Marpai, Inc. | $90M | -4.5 | 47.4 | 28.0 | -110.0 | -29.7 | 3 | BULLISH | 150.4 |
| NRXS NeurAxis, Inc. | $90M | -9.2 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 128.6 |
| NRXS NeurAxis, Inc. | $90M | -9.2 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 128.6 |
| RLYB Rallybio Corporation | $90M | 2.2 | 64.9 | -1399.7 | — | -15.1 | 6 | BULLISH | 3191.6 |
| RLYB Rallybio Corporation | $90M | 2.2 | 64.9 | -1399.7 | — | -15.1 | 6 | BULLISH | 3191.6 |
| MCUJF Medicure Inc. | $20M | -4.1 | -49.9 | -54.9 | -19.2 | 38.3 | 4 | BULLISH | 186.2 |
| MCUJF Medicure Inc. | $20M | -4.1 | -49.9 | -54.9 | -19.2 | 38.3 | 4 | BULLISH | 186.2 |
| POM POMDOCTOR Ltd | $10M | — | — | — | — | — | — | BULLISH | — |
| POM POMDOCTOR Ltd | $10M | — | — | — | — | — | — | BULLISH | — |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | BULLISH | — |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | BULLISH | — |
| SY So-Young International Inc. | $360M | -10.0 | -15.7 | -22.3 | -11.4 | 14.1 | 4 | BULLISH | -27.8 |
| SY So-Young International Inc. | $360M | -10.0 | -15.7 | -22.3 | -11.4 | 14.1 | 4 | BULLISH | -27.8 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | BULLISH | — |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | BULLISH | — |
| PPTDF PeptiDream Inc. | $940M | -38.3 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BULLISH | -34.3 |
| PPTDF PeptiDream Inc. | $940M | -38.3 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BULLISH | -34.3 |
| LFCR Lifecore Biomedical, Inc. | $250M | -5.9 | 227.6 | -2.0 | -18.0 | -4.8 | 4 | BULLISH | -8.8 |
| LFCR Lifecore Biomedical, Inc. | $250M | -5.9 | 227.6 | -2.0 | -18.0 | -4.8 | 4 | BULLISH | -8.8 |
| CELU Celularity Inc. | $50M | -0.6 | 349.7 | -195.2 | 17.6 | -62.8 | 2 | BULLISH | -21.6 |
| CELU Celularity Inc. | $50M | -0.6 | 349.7 | -195.2 | 17.6 | -62.8 | 2 | BULLISH | -21.6 |
| COSM Cosmos Health Inc. | $20M | -0.6 | -104.0 | -41.2 | -32.1 | 33.8 | 4 | BULLISH | -65.5 |
| COSM Cosmos Health Inc. | $20M | -0.6 | -104.0 | -41.2 | -32.1 | 33.8 | 4 | BULLISH | -65.5 |
| BNR Burning Rock Biotech Limited | $20M | -1.7 | -12.8 | -41.7 | -13.7 | -6.6 | 2 | BULLISH | 89.0 |
| BNR Burning Rock Biotech Limited | $20M | -1.7 | -12.8 | -41.7 | -13.7 | -6.6 | 2 | BULLISH | 89.0 |
| VSEE VSee Health, Inc. | — | -0.1 | -1488.9 | -87.7 | -197.2 | -9.3 | 5 | BULLISH | -95.7 |
| VSEE VSee Health, Inc. | — | -0.1 | -1488.9 | -87.7 | -197.2 | -9.3 | 5 | BULLISH | -95.7 |
| SOPH SOPHiA GENETICS S.A. | $680M | -7.0 | -101.2 | -155.2 | -95.9 | 23.6 | 3 | BULLISH | 81.3 |
| SOPH SOPHiA GENETICS S.A. | $680M | -7.0 | -101.2 | -155.2 | -95.9 | 23.6 | 3 | BULLISH | 81.3 |
| FLGT Fulgent Genetics, Inc. | $610M | -7.6 | -8.0 | -12.6 | -34.6 | 6.8 | 4 | BULLISH | -8.6 |
| FLGT Fulgent Genetics, Inc. | $610M | -7.6 | -8.0 | -12.6 | -34.6 | 6.8 | 4 | BULLISH | -8.6 |
| ANTX AN2 Therapeutics, Inc. | $210M | -5.3 | -50.1 | 1243.3 | — | — | 2 | BULLISH | 342.6 |
| ANTX AN2 Therapeutics, Inc. | $210M | -5.3 | -50.1 | 1243.3 | — | — | 2 | BULLISH | 342.6 |
| ESMC Escalon Medical Corp. | — | 1.7 | 57.5 | 0.0 | 91.0 | -11.6 | 5 | BULLISH | 8.4 |
| ESMC Escalon Medical Corp. | — | 1.7 | 57.5 | 0.0 | 91.0 | -11.6 | 5 | BULLISH | 8.4 |
| SHWGF Shandong Weigao Group Medical Polymer Company Limited | $1.9B | 9.2 | 14.0 | 15.7 | 11.3 | -0.2 | 4 | BULLISH | -44.7 |
| SHWGF Shandong Weigao Group Medical Polymer Company Limited | $1.9B | 9.2 | 14.0 | 15.7 | 11.3 | -0.2 | 4 | BULLISH | -44.7 |
| CASBF CanSino Biologics Inc. | $1.6B | 523.4 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -29.6 |
| CASBF CanSino Biologics Inc. | $1.6B | 523.4 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -29.6 |
| UMCN UMC, Inc. | $30M | -66.9 | -840.4 | -95.6 | -590.7 | 2325.0 | 4 | BULLISH | 79.2 |
| UMCN UMC, Inc. | $30M | -66.9 | -840.4 | -95.6 | -590.7 | 2325.0 | 4 | BULLISH | 79.2 |
| FZMD Fuse Medical, Inc. | — | 15.0 | -177.1 | -13.7 | 6.2 | -5.8 | 5 | BULLISH | -45.0 |
| FZMD Fuse Medical, Inc. | — | 15.0 | -177.1 | -13.7 | 6.2 | -5.8 | 5 | BULLISH | -45.0 |
| FLNA Filana Therapeutics, Inc. | $40M | -1.1 | -13.5 | 38.9 | — | — | 2 | BULLISH | — |
| FLNA Filana Therapeutics, Inc. | $40M | -1.1 | -13.5 | 38.9 | — | — | 2 | BULLISH | — |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $40M | -5.5 | 239.0 | 256.6 | -409.4 | — | 2 | BULLISH | — |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $40M | -5.5 | 239.0 | 256.6 | -409.4 | — | 2 | BULLISH | — |
| INAB IN8bio, Inc. | $10M | -0.7 | -111.1 | -576.1 | — | — | 4 | BULLISH | -39.4 |
| INAB IN8bio, Inc. | $10M | -0.7 | -111.1 | -576.1 | — | — | 4 | BULLISH | -39.4 |
| VCNX Vaccinex, Inc. | — | -0.5 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BULLISH | 62.9 |
| VCNX Vaccinex, Inc. | — | -0.5 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BULLISH | 62.9 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.3 | -125.6 | 710.2 | — | — | 3 | BULLISH | 76.1 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.3 | -125.6 | 710.2 | — | — | 3 | BULLISH | 76.1 |
| SGHT Sight Sciences, Inc. | $460M | -15.3 | -48.4 | -145.7 | -19.0 | 9.3 | 4 | BULLISH | 154.6 |
| SGHT Sight Sciences, Inc. | $460M | -15.3 | -48.4 | -145.7 | -19.0 | 9.3 | 4 | BULLISH | 154.6 |
| XGN Exagen Inc. | $200M | -10.0 | -113.8 | -79.2 | -16.0 | 20.8 | 3 | BULLISH | -25.6 |
| XGN Exagen Inc. | $200M | -10.0 | -113.8 | -79.2 | -16.0 | 20.8 | 3 | BULLISH | -25.6 |
| BCTX BriaCell Therapeutics Corp. | $40M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BULLISH | -67.9 |
| BCTX BriaCell Therapeutics Corp. | $40M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BULLISH | -67.9 |
| PDSB PDS Biotechnology Corporation | $40M | -1.2 | -544.0 | 456.9 | — | — | 1 | BULLISH | -26.6 |
| PDSB PDS Biotechnology Corporation | $40M | -1.2 | -544.0 | 456.9 | — | — | 1 | BULLISH | -26.6 |
| FDMDF 4DMedical Limited | $1.8B | -11.0 | -194.6 | 65.5 | -1194.8 | 188.6 | 5 | BULLISH | 129.0 |
| FDMDF 4DMedical Limited | $1.8B | -11.0 | -194.6 | 65.5 | -1194.8 | 188.6 | 5 | BULLISH | 129.0 |
| CTOR Citius Oncology, Inc. | $90M | -2.0 | -126.6 | -109.8 | -597.4 | — | 3 | BULLISH | -51.8 |
| CTOR Citius Oncology, Inc. | $90M | -2.0 | -126.6 | -109.8 | -597.4 | — | 3 | BULLISH | -51.8 |
| SNWV SANUWAVE Health Inc. | $40M | 2.9 | -238.8 | 4.8 | -7.0 | 12.0 | 7 | BULLISH | -87.1 |
| SNWV SANUWAVE Health Inc. | $40M | 2.9 | -238.8 | 4.8 | -7.0 | 12.0 | 7 | BULLISH | -87.1 |
| GCAN Trafalgar International, Inc. | — | 0.4 | -162.2 | 1112.4 | — | -100.0 | 4 | BULLISH | -28.0 |
| GCAN Trafalgar International, Inc. | — | 0.4 | -162.2 | 1112.4 | — | -100.0 | 4 | BULLISH | -28.0 |
| KROS Keros Therapeutics, Inc. | $230M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | BULLISH | -25.6 |
| KROS Keros Therapeutics, Inc. | $230M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | BULLISH | -25.6 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | BULLISH | -27.9 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | BULLISH | -27.9 |
| MEDS DataMEDS AI, Inc. | $10M | -0.1 | -142327.8 | -322403.1 | -1031.7 | 339160.3 | 4 | BULLISH | 18.7 |
| MEDS DataMEDS AI, Inc. | $10M | -0.1 | -142327.8 | -322403.1 | -1031.7 | 339160.3 | 4 | BULLISH | 18.7 |
| BMNDF Biomind Labs Inc. | $40M | -24.5 | 85.8 | 101.7 | — | — | 2 | BULLISH | 2811.4 |
| BMNDF Biomind Labs Inc. | $40M | -24.5 | 85.8 | 101.7 | — | — | 2 | BULLISH | 2811.4 |
| DRTS Alpha Tau Medical Ltd | $1.3B | -14.2 | -141.7 | -17.1 | — | — | 3 | BULLISH | 238.0 |
| DRTS Alpha Tau Medical Ltd | $1.3B | -14.2 | -141.7 | -17.1 | — | — | 3 | BULLISH | 238.0 |
| CSSPF NIOX Group Plc | $380M | 40.0 | 16.6 | 23.1 | 24.6 | 27.2 | 6 | BULLISH | -2.3 |
| CSSPF NIOX Group Plc | $380M | 40.0 | 16.6 | 23.1 | 24.6 | 27.2 | 6 | BULLISH | -2.3 |
| HITI High Tide Inc. | $230M | -9.9 | -26.9 | 1.6 | 5.7 | 27.2 | 3 | BULLISH | -27.1 |
| HITI High Tide Inc. | $230M | -9.9 | -26.9 | 1.6 | 5.7 | 27.2 | 3 | BULLISH | -27.1 |
| BITRF Biotron Limited | $20M | -3.6 | -137.4 | -107.4 | -113.4 | -24.0 | 3 | BULLISH | 219.2 |
| BITRF Biotron Limited | $20M | -3.6 | -137.4 | -107.4 | -113.4 | -24.0 | 3 | BULLISH | 219.2 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.6 | -218.7 | -392.2 | — | — | 1 | BULLISH | -69.5 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.6 | -218.7 | -392.2 | — | — | 1 | BULLISH | -69.5 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | BULLISH | 125.6 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | BULLISH | 125.6 |
| LGNDZ Ligand Pharmaceuticals, Inc. | — | 0.0 | 20.4 | 11.3 | 76.2 | — | 3 | BULLISH | — |
| LGNDZ Ligand Pharmaceuticals, Inc. | — | 0.0 | 20.4 | 11.3 | 76.2 | — | 3 | BULLISH | — |
| EKTAF Elekta AB (publ) | $2.0B | -54.7 | -6.5 | 6.2 | -18.2 | -7.5 | 2 | BULLISH | 3.5 |
| EKTAF Elekta AB (publ) | $2.0B | -54.7 | -6.5 | 6.2 | -18.2 | -7.5 | 2 | BULLISH | 3.5 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | BULLISH | -69.5 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | BULLISH | -69.5 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | BULLISH | -90.0 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | BULLISH | -90.0 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BULLISH | 0.0 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BULLISH | 0.0 |
| ALRTF ALR Technologies Inc. | $10M | -1.4 | 54.2 | 8.3 | -151734.7 | — | 2 | BULLISH | 30.9 |
| ALRTF ALR Technologies Inc. | $10M | -1.4 | 54.2 | 8.3 | -151734.7 | — | 2 | BULLISH | 30.9 |
| AIMLF AI/ML Innovations Inc. | $10M | -1.9 | -702.6 | 6389.8 | — | -50.4 | 1 | BULLISH | -2.7 |
| AIMLF AI/ML Innovations Inc. | $10M | -1.9 | -702.6 | 6389.8 | — | -50.4 | 1 | BULLISH | -2.7 |
| CBIH Cannabis Bioscience International Holdings, Inc. | — | -0.0 | 48.2 | 34.0 | -341.5 | -58.2 | 1 | BULLISH | -60.0 |
| CBIH Cannabis Bioscience International Holdings, Inc. | — | -0.0 | 48.2 | 34.0 | -341.5 | -58.2 | 1 | BULLISH | -60.0 |
| HALB Halberd Corporation | — | -31.8 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -13.0 |
| HALB Halberd Corporation | — | -31.8 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -13.0 |
| AAWH Ascend Wellness Holdings, Inc. | $110M | -1.0 | 388.6 | 3.1 | -7.8 | -8.4 | 3 | BULLISH | -21.9 |
| AAWH Ascend Wellness Holdings, Inc. | $110M | -1.0 | 388.6 | 3.1 | -7.8 | -8.4 | 3 | BULLISH | -21.9 |
| LPCUF Lee's Pharmaceutical Holdings Limited | $110M | 4.1 | 9.9 | 0.2 | 11.9 | 81.2 | 8 | BULLISH | -1.3 |
| LPCUF Lee's Pharmaceutical Holdings Limited | $110M | 4.1 | 9.9 | 0.2 | 11.9 | 81.2 | 8 | BULLISH | -1.3 |
| HYPR Hyperfine, Inc. | $80M | -2.3 | -97.0 | -395.6 | -238.2 | 53.2 | 5 | BULLISH | -37.1 |
| HYPR Hyperfine, Inc. | $80M | -2.3 | -97.0 | -395.6 | -238.2 | 53.2 | 5 | BULLISH | -37.1 |
| EUDA EUDA Health Holdings Limited | $30M | -7.7 | -5.5 | 104.7 | -39.4 | 30.1 | 6 | BULLISH | -57.3 |
| EUDA EUDA Health Holdings Limited | $30M | -7.7 | -5.5 | 104.7 | -39.4 | 30.1 | 6 | BULLISH | -57.3 |
| REZNF Street Capital Inc. | — | -3.3 | 20.7 | 15.0 | — | -44.3 | 5 | BULLISH | 74.5 |
| REZNF Street Capital Inc. | — | -3.3 | 20.7 | 15.0 | — | -44.3 | 5 | BULLISH | 74.5 |
| STTK Shattuck Labs, Inc. | $610M | -13.2 | -39.2 | -29.3 | — | -66.6 | 4 | BULLISH | 182.8 |
| STTK Shattuck Labs, Inc. | $610M | -13.2 | -39.2 | -29.3 | — | -66.6 | 4 | BULLISH | 182.8 |
| ACIU AC Immune S.A. | $280M | -5.2 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BULLISH | -10.2 |
| ACIU AC Immune S.A. | $280M | -5.2 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BULLISH | -10.2 |
| MGRX Mangoceuticals, Inc. | $10M | -0.4 | -95.1 | -82.6 | -1909.1 | -38.9 | 4 | BULLISH | -79.3 |
| MGRX Mangoceuticals, Inc. | $10M | -0.4 | -95.1 | -82.6 | -1909.1 | -38.9 | 4 | BULLISH | -79.3 |
| LIANY LianMedical | $10M | 1.3 | 74.7 | -612.1 | — | — | 6 | BULLISH | 7.9 |
| LIANY LianMedical | $10M | 1.3 | 74.7 | -612.1 | — | — | 6 | BULLISH | 7.9 |
| CYBQY CYBERDYNE Inc. | $270M | 170.0 | 0.4 | -0.8 | -3.9 | -11.1 | 2 | BULLISH | 11.8 |
| CYBQY CYBERDYNE Inc. | $270M | 170.0 | 0.4 | -0.8 | -3.9 | -11.1 | 2 | BULLISH | 11.8 |
| ANIX Anixa Biosciences, Inc. | $100M | -9.7 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -13.0 |
| ANIX Anixa Biosciences, Inc. | $100M | -9.7 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -13.0 |
| INIS Radnostix, Inc. | $30M | -0.0 | -29489557.0 | -23.1 | -33.0 | -23.7 | 1 | BULLISH | 5.0 |
| INIS Radnostix, Inc. | $30M | -0.0 | -29489557.0 | -23.1 | -33.0 | -23.7 | 1 | BULLISH | 5.0 |
| TXTM ProText Mobility, Inc. | $10M | 58.0 | -0.4 | -0.3 | — | -100.0 | 1 | BULLISH | 87.1 |
| TXTM ProText Mobility, Inc. | $10M | 58.0 | -0.4 | -0.3 | — | -100.0 | 1 | BULLISH | 87.1 |
| MLAB Mesa Laboratories, Inc. | $740M | 154.1 | 3.9 | 3.2 | -6.5 | 3.4 | 8 | BULLISH | 88.5 |
| MLAB Mesa Laboratories, Inc. | $740M | 154.1 | 3.9 | 3.2 | -6.5 | 3.4 | 8 | BULLISH | 88.5 |
| BDSX Biodesix, Inc. | $230M | -8.7 | -540.0 | -31.9 | -27.1 | 34.5 | 6 | BULLISH | 261.4 |
| BDSX Biodesix, Inc. | $230M | -8.7 | -540.0 | -31.9 | -27.1 | 34.5 | 6 | BULLISH | 261.4 |
| LOVFF Cannara Biotech Inc. | $150M | 18.8 | 11.4 | 12.2 | 15.2 | 15.4 | 7 | BULLISH | 15.6 |
| LOVFF Cannara Biotech Inc. | $150M | 18.8 | 11.4 | 12.2 | 15.2 | 15.4 | 7 | BULLISH | 15.6 |
| BNGO Bionano Genomics, Inc. | $20M | -0.4 | -83.6 | -89.6 | -90.8 | 10.0 | 6 | BULLISH | -21.9 |
| BNGO Bionano Genomics, Inc. | $20M | -0.4 | -83.6 | -89.6 | -90.8 | 10.0 | 6 | BULLISH | -21.9 |
| AJYG AJ1G, Inc. | — | — | — | — | — | — | — | BULLISH | 380.1 |
| AJYG AJ1G, Inc. | — | — | — | — | — | — | — | BULLISH | 380.1 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BULLISH | 75.1 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BULLISH | 75.1 |
| STSN Stemsation International, Inc. | — | -11.0 | -2.8 | -1.6 | — | — | 3 | LEAN BULL | 185.2 |
| STSN Stemsation International, Inc. | — | -11.0 | -2.8 | -1.6 | — | — | 3 | LEAN BULL | 185.2 |
| PRGO Perrigo Company plc | $2.0B | -1.1 | -49.6 | 3.1 | 7.3 | -4.2 | 4 | LEAN BULL | -35.2 |
| PRGO Perrigo Company plc | $2.0B | -1.1 | -49.6 | 3.1 | 7.3 | -4.2 | 4 | LEAN BULL | -35.2 |
| NTLA Intellia Therapeutics, Inc. | $1.7B | -3.6 | -55.4 | -92.1 | -1392.3 | 12.6 | 4 | LEAN BULL | -34.6 |
| NTLA Intellia Therapeutics, Inc. | $1.7B | -3.6 | -55.4 | -92.1 | -1392.3 | 12.6 | 4 | LEAN BULL | -34.6 |
| PAHC Phibro Animal Health Corporation | $1.5B | 15.1 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | LEAN BULL | -8.5 |
| PAHC Phibro Animal Health Corporation | $1.5B | 15.1 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | LEAN BULL | -8.5 |
| SI Shoulder Innovations, Inc. | $390M | -11.1 | -28.2 | -69.1 | -59.1 | — | 1 | LEAN BULL | 58.1 |
| SI Shoulder Innovations, Inc. | $390M | -11.1 | -28.2 | -69.1 | -59.1 | — | 1 | LEAN BULL | 58.1 |
| ENTA Enanta Pharmaceuticals, Inc. | $380M | -5.4 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BULL | 22.1 |
| ENTA Enanta Pharmaceuticals, Inc. | $380M | -5.4 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BULL | 22.1 |
| LAB Standard BioTools Inc. | $290M | -3.2 | -18.1 | -69.4 | -133.1 | -45.2 | 5 | LEAN BULL | -41.8 |
| LAB Standard BioTools Inc. | $290M | -3.2 | -18.1 | -69.4 | -133.1 | -45.2 | 5 | LEAN BULL | -41.8 |
| PLX Protalix BioTherapeutics, Inc. | $220M | 11.2 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | LEAN BULL | 14.8 |
| PLX Protalix BioTherapeutics, Inc. | $220M | 11.2 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | LEAN BULL | 14.8 |
| CBUS Cibus, Inc. | $130M | -1.0 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | LEAN BULL | 27.6 |
| CBUS Cibus, Inc. | $130M | -1.0 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | LEAN BULL | 27.6 |
| CORBF Global Cord Blood Corporation | $130M | 1.5 | 104.3 | -167.2 | 35.9 | — | 4 | LEAN BULL | -4.9 |
| CORBF Global Cord Blood Corporation | $130M | 1.5 | 104.3 | -167.2 | 35.9 | — | 4 | LEAN BULL | -4.9 |
| BIOYF BioSyent Inc. | $130M | 19.0 | 23.7 | 23.8 | 14.3 | 41.0 | 5 | LEAN BULL | 35.0 |
| BIOYF BioSyent Inc. | $130M | 19.0 | 23.7 | 23.8 | 14.3 | 41.0 | 5 | LEAN BULL | 35.0 |
| MDAI Spectral AI, Inc. | $50M | -4.8 | 99.0 | 97.9 | -118.5 | -45.0 | 2 | LEAN BULL | -27.5 |
| MDAI Spectral AI, Inc. | $50M | -4.8 | 99.0 | 97.9 | -118.5 | -45.0 | 2 | LEAN BULL | -27.5 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.3 | -119.9 | 354.7 | 17.5 | — | 4 | LEAN BULL | -52.4 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.3 | -119.9 | 354.7 | 17.5 | — | 4 | LEAN BULL | -52.4 |
| RMSL REMSleep Holdings, Inc. | — | -0.0 | 4286484750.6 | 1769.6 | -702.2 | -27.1 | 2 | LEAN BULL | -51.5 |
| RMSL REMSleep Holdings, Inc. | — | -0.0 | 4286484750.6 | 1769.6 | -702.2 | -27.1 | 2 | LEAN BULL | -51.5 |
| AIBT Aibotics Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| AIBT Aibotics Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| ACOG Alpha Cognition Inc | $140M | -8.3 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | LEAN BULL | 14.8 |
| ACOG Alpha Cognition Inc | $140M | -8.3 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | LEAN BULL | 14.8 |
| ACIXF Acarix AB (publ) | $30M | -6.2 | -86.1 | -207.4 | -410.8 | 65.2 | 4 | LEAN BULL | -30.7 |
| ACIXF Acarix AB (publ) | $30M | -6.2 | -86.1 | -207.4 | -410.8 | 65.2 | 4 | LEAN BULL | -30.7 |
| CPIVF Captiva Verde Wellness Corp. | $20M | -32.8 | -48.9 | -123.3 | — | — | 2 | LEAN BULL | 384.6 |
| CPIVF Captiva Verde Wellness Corp. | $20M | -32.8 | -48.9 | -123.3 | — | — | 2 | LEAN BULL | 384.6 |
| ZHCLF Zenith Capital Corp. | $20M | -0.0 | 35107.2 | 37766.2 | -360.0 | — | 3 | LEAN BULL | 42.9 |
| ZHCLF Zenith Capital Corp. | $20M | -0.0 | 35107.2 | 37766.2 | -360.0 | — | 3 | LEAN BULL | 42.9 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | LEAN BULL | -5.3 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | LEAN BULL | -5.3 |
| PCYN Procyon Corporation | — | 117.4 | -13.9 | -10.8 | 2.7 | 6.4 | 3 | LEAN BULL | 145.4 |
| PCYN Procyon Corporation | — | 117.4 | -13.9 | -10.8 | 2.7 | 6.4 | 3 | LEAN BULL | 145.4 |
| VIR Vir Biotechnology, Inc. | $1.9B | -6.0 | -26.1 | -38.9 | 33.5 | 1495.9 | 4 | LEAN BULL | 96.0 |
| VIR Vir Biotechnology, Inc. | $1.9B | -6.0 | -26.1 | -38.9 | 33.5 | 1495.9 | 4 | LEAN BULL | 96.0 |
| NYMXF Nymox Pharmaceutical Corporation | — | -0.7 | 193.9 | 89.4 | — | — | 2 | LEAN BULL | -44.4 |
| NYMXF Nymox Pharmaceutical Corporation | — | -0.7 | 193.9 | 89.4 | — | — | 2 | LEAN BULL | -44.4 |
| LUCY Lucyd, Inc | $10M | -0.7 | -84.6 | -209.4 | -165.3 | 72.5 | 4 | LEAN BULL | -54.5 |
| LUCY Lucyd, Inc | $10M | -0.7 | -84.6 | -209.4 | -165.3 | 72.5 | 4 | LEAN BULL | -54.5 |
| CV CapsoVision, Inc. | $310M | -9.8 | -226.6 | -73.0 | -205.4 | — | 2 | LEAN BULL | 31.3 |
| CV CapsoVision, Inc. | $310M | -9.8 | -226.6 | -73.0 | -205.4 | — | 2 | LEAN BULL | 31.3 |
| SMTI Sanara MedTech Inc. | $320M | -9.4 | -147.7 | 19.8 | -1.6 | 12.9 | 5 | LEAN BULL | 13.2 |
| SMTI Sanara MedTech Inc. | $320M | -9.4 | -147.7 | 19.8 | -1.6 | 12.9 | 5 | LEAN BULL | 13.2 |
| NNVC NanoViricides, Inc. | $30M | -3.1 | -189.3 | -0.0 | — | — | 2 | LEAN BULL | -11.1 |
| NNVC NanoViricides, Inc. | $30M | -3.1 | -189.3 | -0.0 | — | — | 2 | LEAN BULL | -11.1 |
| TGIFF 1933 Industries Inc. | — | 6.2 | -14.6 | -33.1 | 8.9 | -11.8 | 5 | LEAN BULL | 1.4 |
| TGIFF 1933 Industries Inc. | — | 6.2 | -14.6 | -33.1 | 8.9 | -11.8 | 5 | LEAN BULL | 1.4 |
| ELMD Electromed, Inc. | $230M | 20.5 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | LEAN BULL | 14.8 |
| ELMD Electromed, Inc. | $230M | 20.5 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | LEAN BULL | 14.8 |
| DBCCF Decibel Cannabis Company Inc. | $50M | -105.6 | -1.0 | -3.0 | 11.7 | 26.5 | 3 | LEAN BULL | -23.4 |
| DBCCF Decibel Cannabis Company Inc. | $50M | -105.6 | -1.0 | -3.0 | 11.7 | 26.5 | 3 | LEAN BULL | -23.4 |
| RVVTF Revive Therapeutics Ltd. | $10M | -1.0 | -1114.6 | 25.7 | — | — | 2 | LEAN BULL | 97.2 |
| RVVTF Revive Therapeutics Ltd. | $10M | -1.0 | -1114.6 | 25.7 | — | — | 2 | LEAN BULL | 97.2 |
| PHRRF PharmaTher Holdings Ltd. | — | -8.3 | -125.3 | 309.7 | — | — | 2 | LEAN BULL | -71.8 |
| PHRRF PharmaTher Holdings Ltd. | — | -8.3 | -125.3 | 309.7 | — | — | 2 | LEAN BULL | -71.8 |
| KRSA Korsana Biosciences, Inc. | $140M | — | — | — | — | — | — | LEAN BULL | — |
| KRSA Korsana Biosciences, Inc. | $140M | — | — | — | — | — | — | LEAN BULL | — |
| SINT Sintx Technologies, Inc. | $10M | -0.4 | -408.3 | -216.8 | -598.7 | 0.2 | 3 | LEAN BULL | -45.7 |
| SINT Sintx Technologies, Inc. | $10M | -0.4 | -408.3 | -216.8 | -598.7 | 0.2 | 3 | LEAN BULL | -45.7 |
| PSNL Personalis, Inc. | $1.7B | -14.9 | -50.3 | -149.3 | -141.7 | -13.3 | 2 | LEAN BULL | 135.6 |
| PSNL Personalis, Inc. | $1.7B | -14.9 | -50.3 | -149.3 | -141.7 | -13.3 | 2 | LEAN BULL | 135.6 |
| NWKHY Netcare Limited | $1.2B | 11.8 | 31.4 | 23.7 | 6.7 | 12.6 | 7 | LEAN BULL | 45.8 |
| NWKHY Netcare Limited | $1.2B | 11.8 | 31.4 | 23.7 | 6.7 | 12.6 | 7 | LEAN BULL | 45.8 |
| MNKD MannKind Corporation | $1.2B | -27.2 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | LEAN BULL | -29.4 |
| MNKD MannKind Corporation | $1.2B | -27.2 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | LEAN BULL | -29.4 |
| DGNOF DIAGNOS Inc. | $40M | -11.6 | -988.8 | -2061.6 | -7539.8 | -36.9 | 3 | LEAN BULL | 58.5 |
| DGNOF DIAGNOS Inc. | $40M | -11.6 | -988.8 | -2061.6 | -7539.8 | -36.9 | 3 | LEAN BULL | 58.5 |
| ATNM Actinium Pharmaceuticals, Inc. | $40M | 3.2 | 45.9 | -197.8 | 79.7 | — | 3 | LEAN BULL | -26.9 |
| ATNM Actinium Pharmaceuticals, Inc. | $40M | 3.2 | 45.9 | -197.8 | 79.7 | — | 3 | LEAN BULL | -26.9 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.2 | -131.6 | 644.6 | -3499.8 | 161.3 | 2 | LEAN BULL | -92.1 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.2 | -131.6 | 644.6 | -3499.8 | 161.3 | 2 | LEAN BULL | -92.1 |
| TRAW Traws Pharma, Inc. | $10M | -1.1 | 35.4 | 225.5 | — | 606.3 | 3 | LEAN BULL | -69.9 |
| TRAW Traws Pharma, Inc. | $10M | -1.1 | 35.4 | 225.5 | — | 606.3 | 3 | LEAN BULL | -69.9 |
| HLYK HealthLynked Corp. | $10M | -1.7 | 63.5 | -580.7 | -328.1 | -46.7 | 3 | LEAN BULL | 24.0 |
| HLYK HealthLynked Corp. | $10M | -1.7 | 63.5 | -580.7 | -328.1 | -46.7 | 3 | LEAN BULL | 24.0 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| CBDD CBD of Denver, Inc. | — | -12.3 | -0.1 | -28.9 | -2.7 | 19.0 | 3 | LEAN BULL | -33.3 |
| CBDD CBD of Denver, Inc. | — | -12.3 | -0.1 | -28.9 | -2.7 | 19.0 | 3 | LEAN BULL | -33.3 |
| ASBP Aspire Biopharma Holdings, Inc. | — | -1.1 | -1032.1 | 1368.4 | -2009.6 | — | 6 | LEAN BULL | -96.6 |
| ASBP Aspire Biopharma Holdings, Inc. | — | -1.1 | -1032.1 | 1368.4 | -2009.6 | — | 6 | LEAN BULL | -96.6 |
| BFRGW Bullfrog AI Holdings, Inc. Warrants | — | -1.3 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | LEAN BULL | -89.6 |
| BFRGW Bullfrog AI Holdings, Inc. Warrants | — | -1.3 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | LEAN BULL | -89.6 |
| CLCFF Christina Lake Cannabis Corp. | — | -1.9 | -37.8 | -14.8 | -10.0 | -18.1 | 2 | LEAN BULL | -39.8 |
| CLCFF Christina Lake Cannabis Corp. | — | -1.9 | -37.8 | -14.8 | -10.0 | -18.1 | 2 | LEAN BULL | -39.8 |
| OWLT Owlet, Inc. | $90M | -11.8 | 180.6 | -50.5 | -1.8 | 28.0 | 6 | LEAN BULL | -39.5 |
| OWLT Owlet, Inc. | $90M | -11.8 | 180.6 | -50.5 | -1.8 | 28.0 | 6 | LEAN BULL | -39.5 |
| SERA Sera Prognostics, Inc. | $80M | -3.1 | -45.0 | -184.9 | -30463.3 | -35.2 | 3 | LEAN BULL | -29.8 |
| SERA Sera Prognostics, Inc. | $80M | -3.1 | -45.0 | -184.9 | -30463.3 | -35.2 | 3 | LEAN BULL | -29.8 |
| HYFT MindWalk Holdings Corp. | $60M | -5.2 | -78.4 | -298.7 | -93.9 | -16.9 | 5 | LEAN BULL | -24.7 |
| HYFT MindWalk Holdings Corp. | $60M | -5.2 | -78.4 | -298.7 | -93.9 | -16.9 | 5 | LEAN BULL | -24.7 |
| VERU Veru Inc. | $40M | -4.2 | -62.3 | -211.2 | — | -100.0 | 3 | LEAN BULL | -35.5 |
| VERU Veru Inc. | $40M | -4.2 | -62.3 | -211.2 | — | -100.0 | 3 | LEAN BULL | -35.5 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | LEAN BULL | -38.9 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | LEAN BULL | -38.9 |
| EBS Emergent BioSolutions Inc. | $330M | -1.8 | -40.3 | -5.5 | -76.9 | -9.6 | 5 | LEAN BULL | -31.0 |
| EBS Emergent BioSolutions Inc. | $330M | -1.8 | -40.3 | -5.5 | -76.9 | -9.6 | 5 | LEAN BULL | -31.0 |
| BMKDF BioMark Diagnostics Inc. | $40M | -41.5 | -142.6 | -2900.2 | -2846.3 | -61.2 | 2 | LEAN BULL | 60.8 |
| BMKDF BioMark Diagnostics Inc. | $40M | -41.5 | -142.6 | -2900.2 | -2846.3 | -61.2 | 2 | LEAN BULL | 60.8 |
| CUBT Curative Biotechnology, Inc. | $10M | -2.3 | 31.0 | 15.3 | — | — | 4 | LEAN BULL | -27.4 |
| CUBT Curative Biotechnology, Inc. | $10M | -2.3 | 31.0 | 15.3 | — | — | 4 | LEAN BULL | -27.4 |
| RMRK Rimrock Gold Corp. | — | 5.7 | 8.6 | 6.4 | — | -100.0 | 2 | LEAN BULL | 0.0 |
| RMRK Rimrock Gold Corp. | — | 5.7 | 8.6 | 6.4 | — | -100.0 | 2 | LEAN BULL | 0.0 |
| ADMT ADM Tronics Unlimited, Inc. | — | -8.6 | -16.2 | -11.9 | -29.1 | 4.7 | 4 | LEAN BULL | -49.0 |
| ADMT ADM Tronics Unlimited, Inc. | — | -8.6 | -16.2 | -11.9 | -29.1 | 4.7 | 4 | LEAN BULL | -49.0 |
| CTTH CTT Pharmaceutical Holdings, Inc. | — | -42.3 | -272.8 | -210.7 | — | — | 2 | LEAN BULL | -5.0 |
| CTTH CTT Pharmaceutical Holdings, Inc. | — | -42.3 | -272.8 | -210.7 | — | — | 2 | LEAN BULL | -5.0 |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 14.6 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | LEAN BULL | -5.8 |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 14.6 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | LEAN BULL | -5.8 |
| WHTCF WELL Health Technologies Corp. | $790M | 170.4 | 0.5 | 5.4 | -2.7 | 38.6 | 6 | LEAN BULL | -20.0 |
| WHTCF WELL Health Technologies Corp. | $790M | 170.4 | 0.5 | 5.4 | -2.7 | 38.6 | 6 | LEAN BULL | -20.0 |
| HSCS HeartSciences Inc. | $10M | -1.3 | -639.9 | 0.2 | — | -0.7 | 4 | LEAN BULL | 20.4 |
| HSCS HeartSciences Inc. | $10M | -1.3 | -639.9 | 0.2 | — | -0.7 | 4 | LEAN BULL | 20.4 |
| CBWTF Auxly Cannabis Group Inc. | $250M | 10.3 | 16.6 | 2.2 | 16.8 | 10.8 | 7 | LEAN BULL | 64.4 |
| CBWTF Auxly Cannabis Group Inc. | $250M | 10.3 | 16.6 | 2.2 | 16.8 | 10.8 | 7 | LEAN BULL | 64.4 |
| ECOR electroCore, Inc. | $90M | -6.0 | 1761.5 | 336.0 | -32.4 | 33.5 | 3 | LEAN BULL | 105.3 |
| ECOR electroCore, Inc. | $90M | -6.0 | 1761.5 | 336.0 | -32.4 | 33.5 | 3 | LEAN BULL | 105.3 |
| NNCSF Nanosonics Limited | $610M | 48.9 | 19.3 | 35.7 | 8.1 | 19.0 | 7 | LEAN BULL | -28.4 |
| NNCSF Nanosonics Limited | $610M | 48.9 | 19.3 | 35.7 | 8.1 | 19.0 | 7 | LEAN BULL | -28.4 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | LEAN BULL | -81.2 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | LEAN BULL | -81.2 |
| CNNA Cann American Corp. | — | 0.4 | -312.1 | -287.6 | -7986.6 | -64.9 | 3 | LEAN BULL | 96.0 |
| CNNA Cann American Corp. | — | 0.4 | -312.1 | -287.6 | -7986.6 | -64.9 | 3 | LEAN BULL | 96.0 |
| GNLX Genelux Corporation | $110M | -2.9 | -168.9 | 20537.7 | — | — | 2 | LEAN BULL | -41.8 |
| GNLX Genelux Corporation | $110M | -2.9 | -168.9 | 20537.7 | — | — | 2 | LEAN BULL | -41.8 |
| HSTC HST Global, Inc. | $100M | -27.8 | -5.0 | -2.1 | 2.7 | — | 3 | LEAN BULL | 349900.0 |
| HSTC HST Global, Inc. | $100M | -27.8 | -5.0 | -2.1 | 2.7 | — | 3 | LEAN BULL | 349900.0 |
| RNTX Rein Therapeutics Inc. | $20M | -0.4 | -753.6 | 53.9 | — | — | 3 | LEAN BULL | -32.1 |
| RNTX Rein Therapeutics Inc. | $20M | -0.4 | -753.6 | 53.9 | — | — | 3 | LEAN BULL | -32.1 |
| BEAT HeartBeam, Inc. | $20M | -0.8 | -328.4 | 2958.2 | — | — | 3 | LEAN BULL | -73.7 |
| BEAT HeartBeam, Inc. | $20M | -0.8 | -328.4 | 2958.2 | — | — | 3 | LEAN BULL | -73.7 |
| STEK Stemtech Corporation | — | -0.0 | 58.2 | 37.1 | -46.5 | -38.6 | 2 | LEAN BULL | -99.2 |
| STEK Stemtech Corporation | — | -0.0 | 58.2 | 37.1 | -46.5 | -38.6 | 2 | LEAN BULL | -99.2 |
| EWLL eWellness Healthcare Corp. | — | -0.2 | 69.3 | 46.3 | — | -99.2 | 1 | LEAN BULL | 900.0 |
| EWLL eWellness Healthcare Corp. | — | -0.2 | 69.3 | 46.3 | — | -99.2 | 1 | LEAN BULL | 900.0 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | LEAN BULL | -92.2 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | LEAN BULL | -92.2 |
| NMLSF Restart Life Sciences Corp. | — | -1.8 | -214.3 | -153.9 | -307.0 | — | 2 | LEAN BULL | 83.8 |
| NMLSF Restart Life Sciences Corp. | — | -1.8 | -214.3 | -153.9 | -307.0 | — | 2 | LEAN BULL | 83.8 |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | LEAN BULL | -66.3 |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | LEAN BULL | -66.3 |
| SLDX Stella Diagnostics Inc. | — | -0.7 | 18.1 | 21.7 | -195.2 | — | 4 | LEAN BULL | -50.0 |
| SLDX Stella Diagnostics Inc. | — | -0.7 | 18.1 | 21.7 | -195.2 | — | 4 | LEAN BULL | -50.0 |
| HRTX Heron Therapeutics, Inc. | $70M | -1.9 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | LEAN BULL | -72.2 |
| HRTX Heron Therapeutics, Inc. | $70M | -1.9 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | LEAN BULL | -72.2 |
| NVYTF Novacyt S.A. | $40M | -0.8 | -97.2 | -129.7 | -161.6 | 181.0 | 5 | LEAN BULL | 14.0 |
| NVYTF Novacyt S.A. | $40M | -0.8 | -97.2 | -129.7 | -161.6 | 181.0 | 5 | LEAN BULL | 14.0 |
| ARAY Accuray Incorporated | $30M | -0.7 | -80.1 | -11.3 | -1.9 | -12.3 | 2 | LEAN BULL | -83.0 |
| ARAY Accuray Incorporated | $30M | -0.7 | -80.1 | -11.3 | -1.9 | -12.3 | 2 | LEAN BULL | -83.0 |
| MAZE Maze Therapeutics, Inc. | $1.5B | -9.6 | -37.3 | -112.3 | — | — | 3 | NEUTRAL | 2.4 |
| MAZE Maze Therapeutics, Inc. | $1.5B | -9.6 | -37.3 | -112.3 | — | — | 3 | NEUTRAL | 2.4 |
| SPRO Spero Therapeutics, Inc. | $70M | 8.5 | 19.2 | -128.5 | — | -7.0 | 7 | NEUTRAL | -39.3 |
| SPRO Spero Therapeutics, Inc. | $70M | 8.5 | 19.2 | -128.5 | — | -7.0 | 7 | NEUTRAL | -39.3 |
| ORGS Orgenesis Inc. | $10M | -0.3 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | NEUTRAL | -26.6 |
| ORGS Orgenesis Inc. | $10M | -0.3 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | NEUTRAL | -26.6 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | NEUTRAL | -67.1 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | NEUTRAL | -67.1 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -1.2 | 9.2 | 7.5 | — | — | 2 | NEUTRAL | -84.9 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -1.2 | 9.2 | 7.5 | — | — | 2 | NEUTRAL | -84.9 |
| FOXO FOXO Technologies Inc. | — | 0.0 | -62.5 | -3.2 | 172.6 | 44.0 | 3 | NEUTRAL | 2182.2 |
| FOXO FOXO Technologies Inc. | — | 0.0 | -62.5 | -3.2 | 172.6 | 44.0 | 3 | NEUTRAL | 2182.2 |
| IOBCF Ion Beam Applications S.A. | $530M | 18.3 | 39.6 | 26.8 | 2.9 | 41.2 | 5 | NEUTRAL | 43.7 |
| IOBCF Ion Beam Applications S.A. | $530M | 18.3 | 39.6 | 26.8 | 2.9 | 41.2 | 5 | NEUTRAL | 43.7 |
| CAPR Capricor Therapeutics, Inc. | $510M | -3.7 | -73.7 | -107.5 | — | -100.0 | 3 | NEUTRAL | 14.4 |
| CAPR Capricor Therapeutics, Inc. | $510M | -3.7 | -73.7 | -107.5 | — | -100.0 | 3 | NEUTRAL | 14.4 |
| PBYI Puma Biotechnology, Inc. | $480M | 17.7 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | NEUTRAL | 80.5 |
| PBYI Puma Biotechnology, Inc. | $480M | 17.7 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | NEUTRAL | 80.5 |
| GRUSF Grown Rogue International Inc. | $110M | -25.4 | -20.2 | 12.8 | -8.8 | 58.1 | 5 | NEUTRAL | 6.5 |
| GRUSF Grown Rogue International Inc. | $110M | -25.4 | -20.2 | 12.8 | -8.8 | 58.1 | 5 | NEUTRAL | 6.5 |
| DARE Dare Bioscience, Inc. | $10M | -1.1 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | NEUTRAL | -60.8 |
| DARE Dare Bioscience, Inc. | $10M | -1.1 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | NEUTRAL | -60.8 |
| ERGO Entia Biosciences, Inc. | — | -0.0 | 106.8 | 92.5 | -1021.5 | -23.5 | 5 | NEUTRAL | 900.0 |
| ERGO Entia Biosciences, Inc. | — | -0.0 | 106.8 | 92.5 | -1021.5 | -23.5 | 5 | NEUTRAL | 900.0 |
| KAYS Kaya Holdings, Inc. | — | -0.0 | 141.1 | -11929.1 | -158865.8 | -102.0 | 3 | NEUTRAL | -97.2 |
| KAYS Kaya Holdings, Inc. | — | -0.0 | 141.1 | -11929.1 | -158865.8 | -102.0 | 3 | NEUTRAL | -97.2 |
| HIGR Hi-Great Group Holding Company | — | -19.3 | 30.7 | 30.8 | -177.4 | -40.3 | 1 | NEUTRAL | -91.3 |
| HIGR Hi-Great Group Holding Company | — | -19.3 | 30.7 | 30.8 | -177.4 | -40.3 | 1 | NEUTRAL | -91.3 |
| PBFFF Planet Based Foods Global Inc. | — | -0.9 | 69.6 | 63.1 | — | 100.0 | 2 | NEUTRAL | -78.1 |
| PBFFF Planet Based Foods Global Inc. | — | -0.9 | 69.6 | 63.1 | — | 100.0 | 2 | NEUTRAL | -78.1 |
| SYRA Syra Health Corp. Class A Common Stock | $10M | 91.7 | 5.2 | 11.3 | 10.5 | 0.3 | 4 | NEUTRAL | 927.8 |
| SYRA Syra Health Corp. Class A Common Stock | $10M | 91.7 | 5.2 | 11.3 | 10.5 | 0.3 | 4 | NEUTRAL | 927.8 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -1.0 | -56.4 | -2884.1 | — | — | 2 | NEUTRAL | -9.5 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -1.0 | -56.4 | -2884.1 | — | — | 2 | NEUTRAL | -9.5 |
| SAGD South American Gold Corp. | — | -0.5 | 106.5 | 49.7 | — | — | 1 | NEUTRAL | 900.0 |
| SAGD South American Gold Corp. | — | -0.5 | 106.5 | 49.7 | — | — | 1 | NEUTRAL | 900.0 |
| HBRM Herborium Group, Inc. | — | -4.7 | 0.6 | 0.6 | 0.7 | -2.7 | 5 | NEUTRAL | 0.0 |
| HBRM Herborium Group, Inc. | — | -4.7 | 0.6 | 0.6 | 0.7 | -2.7 | 5 | NEUTRAL | 0.0 |
| VYCO Vycor Medical, Inc. | — | -37.2 | 1.5 | -1.1 | -5.3 | 1.6 | 6 | NEUTRAL | -61.7 |
| VYCO Vycor Medical, Inc. | — | -37.2 | 1.5 | -1.1 | -5.3 | 1.6 | 6 | NEUTRAL | -61.7 |
| ATEC Alphatec Holdings, Inc. | $1.5B | -13.9 | -623.1 | -7.6 | -12.1 | 19.5 | 5 | NEUTRAL | -28.2 |
| ATEC Alphatec Holdings, Inc. | $1.5B | -13.9 | -623.1 | -7.6 | -12.1 | 19.5 | 5 | NEUTRAL | -28.2 |
| NEO NeoGenomics, Inc. | $470M | -9.3 | -6.3 | -4.8 | 1.1 | 11.2 | 5 | NEUTRAL | 111.8 |
| NEO NeoGenomics, Inc. | $470M | -9.3 | -6.3 | -4.8 | 1.1 | 11.2 | 5 | NEUTRAL | 111.8 |
| COYA Coya Therapeutics, Inc. | $110M | -4.5 | -0.1 | -18.8 | -2723.4 | 1793.8 | 3 | NEUTRAL | -17.8 |
| COYA Coya Therapeutics, Inc. | $110M | -4.5 | -0.1 | -18.8 | -2723.4 | 1793.8 | 3 | NEUTRAL | -17.8 |
| BIAFW bioAffinity Technologies, Inc. | $10M | -0.1 | -1860.2 | -352.6 | -222.8 | -23.2 | 4 | NEUTRAL | 175.2 |
| BIAFW bioAffinity Technologies, Inc. | $10M | -0.1 | -1860.2 | -352.6 | -222.8 | -23.2 | 4 | NEUTRAL | 175.2 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | NEUTRAL | — |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | NEUTRAL | — |
| PNTG The Pennant Group, Inc. | $1.4B | 41.7 | 9.6 | 5.5 | 3.0 | 37.9 | 6 | NEUTRAL | 61.7 |
| PNTG The Pennant Group, Inc. | $1.4B | 41.7 | 9.6 | 5.5 | 3.0 | 37.9 | 6 | NEUTRAL | 61.7 |
| ANL Adlai Nortye Ltd. | $800M | -7.7 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | NEUTRAL | 738.3 |
| ANL Adlai Nortye Ltd. | $800M | -7.7 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | NEUTRAL | 738.3 |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.7 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | NEUTRAL | -54.0 |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.7 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | NEUTRAL | -54.0 |
| VASO Vaso Corporation | $50M | 18.5 | 10.0 | -3055.8 | 7.5 | -8.0 | 8 | NEUTRAL | 153.9 |
| VASO Vaso Corporation | $50M | 18.5 | 10.0 | -3055.8 | 7.5 | -8.0 | 8 | NEUTRAL | 153.9 |
| PETV PetVivo Holdings, Inc. | $30M | -2.4 | -326.3 | -286.3 | -1163.4 | 0.8 | 4 | NEUTRAL | -37.0 |
| PETV PetVivo Holdings, Inc. | $30M | -2.4 | -326.3 | -286.3 | -1163.4 | 0.8 | 4 | NEUTRAL | -37.0 |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | NEUTRAL | -86.5 |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | NEUTRAL | -86.5 |
| SAFLY Safilo Group S.p.A. | $1.4B | 14.3 | 22.4 | 19.9 | 8.7 | -4.8 | 7 | NEUTRAL | 40.1 |
| SAFLY Safilo Group S.p.A. | $1.4B | 14.3 | 22.4 | 19.9 | 8.7 | -4.8 | 7 | NEUTRAL | 40.1 |
| OMER Omeros Corporation | $1.4B | 9.7 | -89.2 | 71.8 | 46.4 | — | 5 | NEUTRAL | 349.5 |
| OMER Omeros Corporation | $1.4B | 9.7 | -89.2 | 71.8 | 46.4 | — | 5 | NEUTRAL | 349.5 |
| CAIHF CPBIO Holding Company Limited | $830M | 10.5 | 10.0 | 8.1 | 3.4 | 73.4 | 8 | NEUTRAL | 282.1 |
| CAIHF CPBIO Holding Company Limited | $830M | 10.5 | 10.0 | 8.1 | 3.4 | 73.4 | 8 | NEUTRAL | 282.1 |
| VREX Varex Imaging Corporation | $780M | 35.2 | 4.6 | 7.6 | 7.5 | 5.3 | 6 | NEUTRAL | 50.9 |
| VREX Varex Imaging Corporation | $780M | 35.2 | 4.6 | 7.6 | 7.5 | 5.3 | 6 | NEUTRAL | 50.9 |
| SOLTF Nxera Pharma Co., Ltd. | $720M | -14.1 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | NEUTRAL | 22.2 |
| SOLTF Nxera Pharma Co., Ltd. | $720M | -14.1 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | NEUTRAL | 22.2 |
| SUSRF Surgical Science Sweden AB | $270M | 27.3 | 2.1 | 2.7 | 8.2 | 8.1 | 6 | NEUTRAL | -46.5 |
| SUSRF Surgical Science Sweden AB | $270M | 27.3 | 2.1 | 2.7 | 8.2 | 8.1 | 6 | NEUTRAL | -46.5 |
| HWAIF Healwell AI Inc. | $170M | -6.1 | -21.9 | -10.8 | 19.4 | 54.1 | 5 | NEUTRAL | -47.0 |
| HWAIF Healwell AI Inc. | $170M | -6.1 | -21.9 | -10.8 | 19.4 | 54.1 | 5 | NEUTRAL | -47.0 |
| MLLCF Molecular Partners AG | $150M | -2.4 | -62.1 | 650.3 | — | -100.0 | 2 | NEUTRAL | 14.6 |
| MLLCF Molecular Partners AG | $150M | -2.4 | -62.1 | 650.3 | — | -100.0 | 2 | NEUTRAL | 14.6 |
| PRNAF Alterity Therapeutics Limited | $90M | -3.4 | -117.0 | -556.9 | — | -41.1 | 4 | NEUTRAL | 13233.3 |
| PRNAF Alterity Therapeutics Limited | $90M | -3.4 | -117.0 | -556.9 | — | -41.1 | 4 | NEUTRAL | 13233.3 |
| OKYO OKYO Pharma Limited | $60M | -6.1 | -213.7 | 128.1 | — | — | 3 | NEUTRAL | -26.9 |
| OKYO OKYO Pharma Limited | $60M | -6.1 | -213.7 | 128.1 | — | — | 3 | NEUTRAL | -26.9 |
| PRCNF Pure Global Cannabis Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| PRCNF Pure Global Cannabis Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| EDXC Endexx Corporation | — | -0.0 | 51.8 | 0.5 | — | -125.6 | 2 | NEUTRAL | -95.8 |
| EDXC Endexx Corporation | — | -0.0 | 51.8 | 0.5 | — | -125.6 | 2 | NEUTRAL | -95.8 |
| SETO SETO Holdings, Inc. | — | -7.5 | -22.5 | -8.5 | -32.2 | 9760.2 | 6 | NEUTRAL | 17.6 |
| SETO SETO Holdings, Inc. | — | -7.5 | -22.5 | -8.5 | -32.2 | 9760.2 | 6 | NEUTRAL | 17.6 |
| YBGJ Yubo International Biotech Limited | — | -0.8 | 28.2 | 30.1 | — | 9417.8 | 5 | NEUTRAL | -19.4 |
| YBGJ Yubo International Biotech Limited | — | -0.8 | 28.2 | 30.1 | — | 9417.8 | 5 | NEUTRAL | -19.4 |
| LVRLF CordovaCann Corp. | — | -1.0 | 47.4 | -18.4 | -6.5 | -2.8 | 4 | NEUTRAL | -35.2 |
| LVRLF CordovaCann Corp. | — | -1.0 | 47.4 | -18.4 | -6.5 | -2.8 | 4 | NEUTRAL | -35.2 |
| MNZO Manzo Pharmaceuticals, Inc. | — | -1.0 | 4.6 | 4.1 | — | — | 2 | NEUTRAL | 0.0 |
| MNZO Manzo Pharmaceuticals, Inc. | — | -1.0 | 4.6 | 4.1 | — | — | 2 | NEUTRAL | 0.0 |
| NSRS North Springs Resources Corp. | — | -0.0 | -92.1 | -21.1 | — | — | 2 | NEUTRAL | 0.0 |
| NSRS North Springs Resources Corp. | — | -0.0 | -92.1 | -21.1 | — | — | 2 | NEUTRAL | 0.0 |
| XBRAF Xebra Brands Ltd. | — | -0.1 | -542.1 | -2373.1 | — | -100.0 | 1 | NEUTRAL | -98.5 |
| XBRAF Xebra Brands Ltd. | — | -0.1 | -542.1 | -2373.1 | — | -100.0 | 1 | NEUTRAL | -98.5 |
| HRAL Hear AtLast Holdings, Inc. | — | -0.3 | 16.3 | 89.4 | — | — | 3 | NEUTRAL | -20.0 |
| HRAL Hear AtLast Holdings, Inc. | — | -0.3 | 16.3 | 89.4 | — | — | 3 | NEUTRAL | -20.0 |
| CBIA Canopus Biopharma, Inc. | — | -0.0 | 1457.1 | 15327.7 | — | — | 1 | NEUTRAL | 0.0 |
| CBIA Canopus Biopharma, Inc. | — | -0.0 | 1457.1 | 15327.7 | — | — | 1 | NEUTRAL | 0.0 |
| CLNN Clene Inc. | $50M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | NEUTRAL | -40.5 |
| CLNN Clene Inc. | $50M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | NEUTRAL | -40.5 |
| SXTC China SXT Pharmaceuticals, Inc. | — | -0.3 | -32.7 | -254.3 | 13.7 | 42.5 | 6 | NEUTRAL | 47.0 |
| SXTC China SXT Pharmaceuticals, Inc. | — | -0.3 | -32.7 | -254.3 | 13.7 | 42.5 | 6 | NEUTRAL | 47.0 |
| MOTS Motus GI Holdings, Inc. | — | -0.0 | -1069.0 | -1348.2 | -3301.6 | -47.9 | 4 | NEUTRAL | 1900.0 |
| MOTS Motus GI Holdings, Inc. | — | -0.0 | -1069.0 | -1348.2 | -3301.6 | -47.9 | 4 | NEUTRAL | 1900.0 |
| ANIP ANI Pharmaceuticals, Inc. | $1.6B | 14.9 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | NEUTRAL | -20.0 |
| ANIP ANI Pharmaceuticals, Inc. | $1.6B | 14.9 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | NEUTRAL | -20.0 |
| ARRJF Arjo AB (publ) | $790M | 19.0 | 5.0 | 4.3 | 4.5 | -3.5 | 6 | NEUTRAL | -16.9 |
| ARRJF Arjo AB (publ) | $790M | 19.0 | 5.0 | 4.3 | 4.5 | -3.5 | 6 | NEUTRAL | -16.9 |
| ACB Aurora Cannabis Inc. | $240M | -2.9 | -13.9 | -0.4 | -149.7 | -9.4 | 5 | NEUTRAL | -31.6 |
| ACB Aurora Cannabis Inc. | $240M | -2.9 | -13.9 | -0.4 | -149.7 | -9.4 | 5 | NEUTRAL | -31.6 |
| ETRA Electra Therapeutics Inc. | $220M | — | — | — | — | — | — | N/A | — |
| ETRA Electra Therapeutics Inc. | $220M | — | — | — | — | — | — | N/A | — |
| KNTPF Kintor Pharmaceutical Limited | $110M | -3.7 | -111.3 | -105.7 | -145.6 | 3136.1 | 3 | NEUTRAL | -6.7 |
| KNTPF Kintor Pharmaceutical Limited | $110M | -3.7 | -111.3 | -105.7 | -145.6 | 3136.1 | 3 | NEUTRAL | -6.7 |
| POSC Positron Corporation | $60M | -5.7 | 1961.0 | -1406.8 | -734.6 | -22.9 | 2 | NEUTRAL | 26.4 |
| POSC Positron Corporation | $60M | -5.7 | 1961.0 | -1406.8 | -734.6 | -22.9 | 2 | NEUTRAL | 26.4 |
| BXPHF Botanix Pharmaceuticals Limited | $40M | -0.6 | -181.3 | -285.1 | -203.1 | 1249.3 | 2 | NEUTRAL | -88.1 |
| BXPHF Botanix Pharmaceuticals Limited | $40M | -0.6 | -181.3 | -285.1 | -203.1 | 1249.3 | 2 | NEUTRAL | -88.1 |
| MMIRF MedMira Inc. | $30M | -13.6 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | NEUTRAL | -55.8 |
| MMIRF MedMira Inc. | $30M | -13.6 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | NEUTRAL | -55.8 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -1.0 | 119.2 | 76.7 | — | -100.0 | 1 | NEUTRAL | 31.0 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -1.0 | 119.2 | 76.7 | — | -100.0 | 1 | NEUTRAL | 31.0 |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | NEUTRAL | -81.4 |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | NEUTRAL | -81.4 |
| CLRD Clearday, Inc. | — | -0.0 | 41.6 | 33.3 | -296.5 | -39.1 | 3 | NEUTRAL | 108.3 |
| CLRD Clearday, Inc. | — | -0.0 | 41.6 | 33.3 | -296.5 | -39.1 | 3 | NEUTRAL | 108.3 |
| HYHY Hydrogen Hybrid Technologies, Inc. | — | -0.0 | -138.6 | -342.9 | — | 16.1 | 4 | NEUTRAL | 0.0 |
| HYHY Hydrogen Hybrid Technologies, Inc. | — | -0.0 | -138.6 | -342.9 | — | 16.1 | 4 | NEUTRAL | 0.0 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | N/A | — |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | N/A | — |
| CENBF CEN Biotech, Inc. | — | -0.0 | 32.0 | -64.0 | 569.4 | -54.9 | 5 | NEUTRAL | 200.0 |
| CENBF CEN Biotech, Inc. | — | -0.0 | 32.0 | -64.0 | 569.4 | -54.9 | 5 | NEUTRAL | 200.0 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | NEUTRAL | -96.5 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | NEUTRAL | -96.5 |
| CNGGF Cann Group Limited | — | 0.3 | -9.6 | -35.6 | -150.3 | -32.1 | 4 | NEUTRAL | -43.5 |
| CNGGF Cann Group Limited | — | 0.3 | -9.6 | -35.6 | -150.3 | -32.1 | 4 | NEUTRAL | -43.5 |
| SVSO SheerVision, Inc. | — | -0.0 | 31.8 | -24.5 | 42.2 | -32.8 | 3 | NEUTRAL | 0.0 |
| SVSO SheerVision, Inc. | — | -0.0 | 31.8 | -24.5 | 42.2 | -32.8 | 3 | NEUTRAL | 0.0 |
| ERUC ER Urgent Care Holdings, Inc. | — | — | — | — | — | — | — | N/A | -99.0 |
| ERUC ER Urgent Care Holdings, Inc. | — | — | — | — | — | — | — | N/A | -99.0 |
| GBCS Selectis Health, Inc. | $20M | 1.2 | 1850.1 | -22.2 | 171.7 | -21.3 | 4 | NEUTRAL | 154.7 |
| GBCS Selectis Health, Inc. | $20M | 1.2 | 1850.1 | -22.2 | 171.7 | -21.3 | 4 | NEUTRAL | 154.7 |
| QNTM Quantum BioPharma Ltd. | $20M | -0.6 | -425.3 | 175.1 | — | — | 4 | NEUTRAL | -79.1 |
| QNTM Quantum BioPharma Ltd. | $20M | -0.6 | -425.3 | 175.1 | — | — | 4 | NEUTRAL | -79.1 |
| ACAI Safeplus International Holdings Limited | — | -0.4 | -205.0 | -617.4 | -224.7 | -94.2 | 1 | NEUTRAL | 200.0 |
| ACAI Safeplus International Holdings Limited | — | -0.4 | -205.0 | -617.4 | -224.7 | -94.2 | 1 | NEUTRAL | 200.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | NEUTRAL | -99.1 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | NEUTRAL | -99.1 |
| ITNS Itonis, Inc. | — | -53.9 | 2.9 | 16.1 | -299.0 | -55.8 | 3 | NEUTRAL | 33.3 |
| ITNS Itonis, Inc. | — | -53.9 | 2.9 | 16.1 | -299.0 | -55.8 | 3 | NEUTRAL | 33.3 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.9 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | -7.5 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.9 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | -7.5 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | NEUTRAL | -31.5 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | NEUTRAL | -31.5 |
| XLO Xilio Therapeutics, Inc. | $60M | -6.0 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | NEUTRAL | 982.1 |
| XLO Xilio Therapeutics, Inc. | $60M | -6.0 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | NEUTRAL | 982.1 |
| CNVIF Conavi Medical Corp. | $10M | 13.2 | 57.4 | 363.8 | -4867.7 | — | 2 | NEUTRAL | — |
| CNVIF Conavi Medical Corp. | $10M | 13.2 | 57.4 | 363.8 | -4867.7 | — | 2 | NEUTRAL | — |
| DVLP Golden Developing Solutions, Inc. | — | -0.0 | 450.9 | 46.1 | -166.7 | — | 6 | NEUTRAL | -90.0 |
| DVLP Golden Developing Solutions, Inc. | — | -0.0 | 450.9 | 46.1 | -166.7 | — | 6 | NEUTRAL | -90.0 |
| OMCL Omnicell, Inc. | $1.5B | 39.3 | 3.1 | 3.2 | 7.8 | 8.5 | 9 | NEUTRAL | 12.2 |
| OMCL Omnicell, Inc. | $1.5B | 39.3 | 3.1 | 3.2 | 7.8 | 8.5 | 9 | NEUTRAL | 12.2 |
| PCRX Pacira BioSciences, Inc. | $990M | 71.6 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | NEUTRAL | -0.2 |
| PCRX Pacira BioSciences, Inc. | $990M | 71.6 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | NEUTRAL | -0.2 |
| CNTN Canton Strategic Holdings Inc | $170M | -1.4 | -14.6 | -7.2 | -1287.2 | — | 2 | NEUTRAL | — |
| CNTN Canton Strategic Holdings Inc | $170M | -1.4 | -14.6 | -7.2 | -1287.2 | — | 2 | NEUTRAL | — |
| BGXXQ Bright Green Corporation | — | — | — | — | — | — | — | NEUTRAL | — |
| BGXXQ Bright Green Corporation | — | — | — | — | — | — | — | NEUTRAL | — |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | NEUTRAL | 1900.0 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | NEUTRAL | 1900.0 |
| PASO Patient Access Solutions, Inc. | — | -0.0 | 540.4 | 691.6 | 0.6 | — | 2 | NEUTRAL | 9900.0 |
| PASO Patient Access Solutions, Inc. | — | -0.0 | 540.4 | 691.6 | 0.6 | — | 2 | NEUTRAL | 9900.0 |
| ISCNF Isracann Biosciences Inc. | — | -0.5 | -252.3 | 2640.8 | — | — | 2 | NEUTRAL | 0.0 |
| ISCNF Isracann Biosciences Inc. | — | -0.5 | -252.3 | 2640.8 | — | — | 2 | NEUTRAL | 0.0 |
| OCLG Oncologix Tech Inc. | — | -0.0 | 255.0 | — | — | -20.4 | 2 | NEUTRAL | 0.0 |
| OCLG Oncologix Tech Inc. | — | -0.0 | 255.0 | — | — | -20.4 | 2 | NEUTRAL | 0.0 |
| FCHS First Choice Healthcare Solutions, Inc. | — | -0.0 | 61.1 | 51.6 | — | 140.3 | 4 | NEUTRAL | -38.5 |
| FCHS First Choice Healthcare Solutions, Inc. | — | -0.0 | 61.1 | 51.6 | — | 140.3 | 4 | NEUTRAL | -38.5 |
| FORZ Forza Innovations Inc. | — | -0.0 | 91.9 | 0.0 | 11330.0 | 8.7 | 3 | NEUTRAL | 0.0 |
| FORZ Forza Innovations Inc. | — | -0.0 | 91.9 | 0.0 | 11330.0 | 8.7 | 3 | NEUTRAL | 0.0 |
| GMVDF G Medical Innovations Holdings Ltd | — | -0.0 | 662.5 | 718.7 | -585.5 | — | 1 | NEUTRAL | 0.0 |
| GMVDF G Medical Innovations Holdings Ltd | — | -0.0 | 662.5 | 718.7 | -585.5 | — | 1 | NEUTRAL | 0.0 |
| VPHIF Valeo Pharma Inc. | — | -0.0 | 65.5 | 19863.3 | -65.0 | -0.2 | 2 | NEUTRAL | -99.8 |
| VPHIF Valeo Pharma Inc. | — | -0.0 | 65.5 | 19863.3 | -65.0 | -0.2 | 2 | NEUTRAL | -99.8 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.2 | -4165.9 | 252.1 | — | — | 2 | NEUTRAL | -85.8 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.2 | -4165.9 | 252.1 | — | — | 2 | NEUTRAL | -85.8 |
| FRLI Frélii, Inc. | — | -0.0 | -671.6 | -265.5 | -10546.4 | 378.8 | 4 | NEUTRAL | 0.0 |
| FRLI Frélii, Inc. | — | -0.0 | -671.6 | -265.5 | -10546.4 | 378.8 | 4 | NEUTRAL | 0.0 |
| CBDG THC Farmaceuticals, Inc. | — | -41.9 | 2.0 | -0.9 | — | 28.1 | 5 | NEUTRAL | 83.2 |
| CBDG THC Farmaceuticals, Inc. | — | -41.9 | 2.0 | -0.9 | — | 28.1 | 5 | NEUTRAL | 83.2 |
| RLBD Real Brands, Inc. | — | -0.0 | 62.2 | 111.8 | — | 204.2 | 5 | NEUTRAL | -90.0 |
| RLBD Real Brands, Inc. | — | -0.0 | 62.2 | 111.8 | — | 204.2 | 5 | NEUTRAL | -90.0 |
| DRWN Quantum Medical Transport, Inc. | — | 0.3 | 25.7 | 20.8 | 2.2 | -96.3 | 4 | NEUTRAL | 0.0 |
| DRWN Quantum Medical Transport, Inc. | — | 0.3 | 25.7 | 20.8 | 2.2 | -96.3 | 4 | NEUTRAL | 0.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | NEUTRAL | 0.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | NEUTRAL | 0.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | NEUTRAL | 0.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | NEUTRAL | 0.0 |
| BBBT Black Bird Biotech, Inc. | — | -0.0 | 129.1 | 137.7 | -3333.2 | -61.0 | 2 | NEUTRAL | 0.0 |
| BBBT Black Bird Biotech, Inc. | — | -0.0 | 129.1 | 137.7 | -3333.2 | -61.0 | 2 | NEUTRAL | 0.0 |
| VSTM Verastem, Inc. | $680M | -3.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | NEUTRAL | -12.5 |
| VSTM Verastem, Inc. | $680M | -3.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | NEUTRAL | -12.5 |
| ASTH Astrana Health, Inc. | $1.8B | 43.4 | 5.1 | 4.7 | 2.0 | 58.9 | 5 | NEUTRAL | 27.4 |
| ASTH Astrana Health, Inc. | $1.8B | 43.4 | 5.1 | 4.7 | 2.0 | 58.9 | 5 | NEUTRAL | 27.4 |
| EVOTF Evotec SE | $1.2B | -2.6 | -26.1 | -14.9 | -32.5 | -7.7 | 2 | NEUTRAL | -8.1 |
| EVOTF Evotec SE | $1.2B | -2.6 | -26.1 | -14.9 | -32.5 | -7.7 | 2 | NEUTRAL | -8.1 |
| OPK OPKO Health, Inc. | $1.2B | -16.4 | -5.9 | -3.0 | -5.1 | -11.5 | 2 | NEUTRAL | 0.7 |
| OPK OPKO Health, Inc. | $1.2B | -16.4 | -5.9 | -3.0 | -5.1 | -11.5 | 2 | NEUTRAL | 0.7 |
| CSWYF China Shineway Pharmaceutical Group Limited | $760M | 5.9 | 21.7 | 50.7 | 21.6 | 277.6 | 4 | NEUTRAL | -12.7 |
| CSWYF China Shineway Pharmaceutical Group Limited | $760M | 5.9 | 21.7 | 50.7 | 21.6 | 277.6 | 4 | NEUTRAL | -12.7 |
| INTI Inhibitor Therapeutics, Inc. | $20M | -5.1 | 358.8 | 88.0 | — | — | 1 | NEUTRAL | 96.0 |
| INTI Inhibitor Therapeutics, Inc. | $20M | -5.1 | 358.8 | 88.0 | — | — | 1 | NEUTRAL | 96.0 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | $10M | -0.2 | 294.4 | 252.1 | — | — | 4 | NEUTRAL | -95.5 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | $10M | -0.2 | 294.4 | 252.1 | — | — | 4 | NEUTRAL | -95.5 |
| VBIO Valion Bio, Inc. | $10M | -0.0 | -122.7 | -45.5 | — | — | 2 | NEUTRAL | — |
| VBIO Valion Bio, Inc. | $10M | -0.0 | -122.7 | -45.5 | — | — | 2 | NEUTRAL | — |
| IDTA IDenta Corp. | — | 8.7 | 13.8 | 25.0 | -9.1 | 57.3 | 8 | NEUTRAL | 72.2 |
| IDTA IDenta Corp. | — | 8.7 | 13.8 | 25.0 | -9.1 | 57.3 | 8 | NEUTRAL | 72.2 |
| TNPH Tian'an Pharmaceutical Co., Ltd. | — | -1699.6 | 0.3 | 33.0 | — | -100.0 | 3 | NEUTRAL | 983.3 |
| TNPH Tian'an Pharmaceutical Co., Ltd. | — | -1699.6 | 0.3 | 33.0 | — | -100.0 | 3 | NEUTRAL | 983.3 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | NEUTRAL | -90.6 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | NEUTRAL | -90.6 |
| VVOS Vivos Therapeutics, Inc. | — | -0.1 | -6663.0 | -267.4 | -106.4 | 45.2 | 3 | NEUTRAL | -95.2 |
| VVOS Vivos Therapeutics, Inc. | — | -0.1 | -6663.0 | -267.4 | -106.4 | 45.2 | 3 | NEUTRAL | -95.2 |
| UPC Universe Pharmaceuticals Inc. | — | -1.3 | -2.1 | -23.4 | -17.2 | -39.4 | 3 | NEUTRAL | 2.3 |
| UPC Universe Pharmaceuticals Inc. | — | -1.3 | -2.1 | -23.4 | -17.2 | -39.4 | 3 | NEUTRAL | 2.3 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.6 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | NEUTRAL | -49.2 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.6 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | NEUTRAL | -49.2 |
| EBRCZ EBR Systems, Inc. | $140M | -1.9 | -102.2 | 22812.5 | -661.9 | 305113.7 | 3 | NEUTRAL | -75.0 |
| EBRCZ EBR Systems, Inc. | $140M | -1.9 | -102.2 | 22812.5 | -661.9 | 305113.7 | 3 | NEUTRAL | -75.0 |
| HCAT Health Catalyst, Inc. | $130M | -0.5 | -118.1 | -27.1 | -57.5 | -7.5 | 5 | NEUTRAL | -37.7 |
| HCAT Health Catalyst, Inc. | $130M | -0.5 | -118.1 | -27.1 | -57.5 | -7.5 | 5 | NEUTRAL | -37.7 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.3 | -59.8 | 1235.8 | — | — | 1 | NEUTRAL | -74.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.3 | -59.8 | 1235.8 | — | — | 1 | NEUTRAL | -74.0 |
| ACON Aclarion, Inc. | $10M | -0.3 | -59.0 | -1069.5 | -10899.5 | 33.1 | 3 | NEUTRAL | -68.6 |
| ACON Aclarion, Inc. | $10M | -0.3 | -59.0 | -1069.5 | -10899.5 | 33.1 | 3 | NEUTRAL | -68.6 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | NEUTRAL | 0.0 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | NEUTRAL | 0.0 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | NEUTRAL | -75.7 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | NEUTRAL | -75.7 |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | NEUTRAL | -77.1 |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | NEUTRAL | -77.1 |
| HENC Hero Technologies Inc. | — | -0.1 | -10112.1 | 3310.9 | — | 100.0 | 4 | NEUTRAL | 0.0 |
| HENC Hero Technologies Inc. | — | -0.1 | -10112.1 | 3310.9 | — | 100.0 | 4 | NEUTRAL | 0.0 |
| BTTX Better Therapeutics, Inc. | — | -0.0 | 2351.8 | 1050.0 | — | -100.0 | 1 | NEUTRAL | -0.0 |
| BTTX Better Therapeutics, Inc. | — | -0.0 | 2351.8 | 1050.0 | — | -100.0 | 1 | NEUTRAL | -0.0 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | NEUTRAL | -55.6 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | NEUTRAL | -55.6 |
| KHRNF Khiron Life Sciences Corp. | — | -0.2 | -74.7 | -41.4 | -105.6 | 76.2 | 2 | NEUTRAL | 0.0 |
| KHRNF Khiron Life Sciences Corp. | — | -0.2 | -74.7 | -41.4 | -105.6 | 76.2 | 2 | NEUTRAL | 0.0 |
| LTGHY Life Healthcare Group Holdings Limited | $1.0B | 2.4 | 52.6 | 6.9 | 6.2 | 19.4 | 7 | LEAN BEAR | 3.7 |
| LTGHY Life Healthcare Group Holdings Limited | $1.0B | 2.4 | 52.6 | 6.9 | 6.2 | 19.4 | 7 | LEAN BEAR | 3.7 |
| GLSI Greenwich LifeSciences, Inc. | $250M | -11.0 | -951.6 | 299.9 | — | — | 2 | LEAN BEAR | 68.0 |
| GLSI Greenwich LifeSciences, Inc. | $250M | -11.0 | -951.6 | 299.9 | — | — | 2 | LEAN BEAR | 68.0 |
| MDWD MediWound Ltd. | $170M | -8.4 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | LEAN BEAR | -22.7 |
| MDWD MediWound Ltd. | $170M | -8.4 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | LEAN BEAR | -22.7 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $90M | -1.1 | -64.6 | 5251.5 | — | — | 1 | LEAN BEAR | 9.9 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $90M | -1.1 | -64.6 | 5251.5 | — | — | 1 | LEAN BEAR | 9.9 |
| AURX Nuo Therapeutics, Inc. | $60M | -29.9 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | LEAN BEAR | -35.9 |
| AURX Nuo Therapeutics, Inc. | $60M | -29.9 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | LEAN BEAR | -35.9 |
| STLN Starling Oncology, Inc. | $630M | — | — | — | — | — | — | LEAN BEAR | — |
| STLN Starling Oncology, Inc. | $630M | — | — | — | — | — | — | LEAN BEAR | — |
| SGMOQ Sangamo Therapeutics, Inc. | $60M | — | — | — | — | — | — | LEAN BEAR | — |
| SGMOQ Sangamo Therapeutics, Inc. | $60M | — | — | — | — | — | — | LEAN BEAR | — |
| OSSFF Embla Medical hf. | $1.9B | 18.9 | 10.7 | 7.7 | 11.3 | 11.7 | 7 | LEAN BEAR | -5.6 |
| OSSFF Embla Medical hf. | $1.9B | 18.9 | 10.7 | 7.7 | 11.3 | 11.7 | 7 | LEAN BEAR | -5.6 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 14.6 | 8.8 | 9.6 | 3.6 | -12.7 | 5 | LEAN BEAR | -41.7 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 14.6 | 8.8 | 9.6 | 3.6 | -12.7 | 5 | LEAN BEAR | -41.7 |
| GWIN Glorywin Entertainment Group, Inc. | $230M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 254.3 |
| GWIN Glorywin Entertainment Group, Inc. | $230M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 254.3 |
| BIOQ Bioqual, Inc. | $30M | -7.1 | -2.8 | -4.3 | -0.8 | -16.6 | 3 | LEAN BEAR | -17.5 |
| BIOQ Bioqual, Inc. | $30M | -7.1 | -2.8 | -4.3 | -0.8 | -16.6 | 3 | LEAN BEAR | -17.5 |
| MILFF 1CM Inc. | $30M | 7.4 | 15.1 | 7.4 | 2.5 | 7.3 | 7 | LEAN BEAR | -28.8 |
| MILFF 1CM Inc. | $30M | 7.4 | 15.1 | 7.4 | 2.5 | 7.3 | 7 | LEAN BEAR | -28.8 |
| CLYYF Celyad Oncology S.A. | $10M | 2.7 | -114.9 | -1433.2 | 64360.6 | 102.9 | 4 | LEAN BEAR | -31.7 |
| CLYYF Celyad Oncology S.A. | $10M | 2.7 | -114.9 | -1433.2 | 64360.6 | 102.9 | 4 | LEAN BEAR | -31.7 |
| RBOT Vicarious Surgical Inc. | — | -0.0 | -223.8 | -476.5 | — | — | 1 | LEAN BEAR | -99.0 |
| RBOT Vicarious Surgical Inc. | — | -0.0 | -223.8 | -476.5 | — | — | 1 | LEAN BEAR | -99.0 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | LEAN BEAR | -77.8 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | LEAN BEAR | -77.8 |
| MNOV MediciNova, Inc. | $90M | -8.2 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | LEAN BEAR | 42.4 |
| MNOV MediciNova, Inc. | $90M | -8.2 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | LEAN BEAR | 42.4 |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | LEAN BEAR | 0.0 |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | LEAN BEAR | 0.0 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.3 | -485.4 | -367.8 | — | 100.0 | 6 | LEAN BEAR | -77.1 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.3 | -485.4 | -367.8 | — | 100.0 | 6 | LEAN BEAR | -77.1 |
| CELG-RI Bristol-Myers Squibb Company Ce | $260M | 0.0 | 38.8 | 20.8 | 23.3 | 1.8 | 8 | LEAN BEAR | 289.2 |
| CELG-RI Bristol-Myers Squibb Company Ce | $260M | 0.0 | 38.8 | 20.8 | 23.3 | 1.8 | 8 | LEAN BEAR | 289.2 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $170M | — | — | — | — | — | — | LEAN BEAR | -95.5 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $170M | — | — | — | — | — | — | LEAN BEAR | -95.5 |
| RNVA Rennova Health, Inc. | — | -0.5 | 23.5 | -4.3 | -241.1 | 43.3 | 5 | LEAN BEAR | 9900.0 |
| RNVA Rennova Health, Inc. | — | -0.5 | 23.5 | -4.3 | -241.1 | 43.3 | 5 | LEAN BEAR | 9900.0 |
| FFNTF 4Front Ventures Corp. | — | -0.0 | 73.3 | -15.3 | -37.4 | -34.7 | 3 | LEAN BEAR | -90.0 |
| FFNTF 4Front Ventures Corp. | — | -0.0 | 73.3 | -15.3 | -37.4 | -34.7 | 3 | LEAN BEAR | -90.0 |
| NNRX Nutranomics, Inc. | — | -0.1 | 58.6 | -70.9 | -150.9 | 46.4 | 4 | LEAN BEAR | 0.0 |
| NNRX Nutranomics, Inc. | — | -0.1 | 58.6 | -70.9 | -150.9 | 46.4 | 4 | LEAN BEAR | 0.0 |
| CLABF Core One Labs Inc. | — | -0.3 | -233.7 | -70.3 | -897.6 | -69.3 | 3 | LEAN BEAR | -100.0 |
| CLABF Core One Labs Inc. | — | -0.3 | -233.7 | -70.3 | -897.6 | -69.3 | 3 | LEAN BEAR | -100.0 |
| OWCP OWC Pharmaceutical Research Corp. | — | -0.0 | -34.4 | 1662.7 | — | — | 2 | LEAN BEAR | 0.0 |
| OWCP OWC Pharmaceutical Research Corp. | — | -0.0 | -34.4 | 1662.7 | — | — | 2 | LEAN BEAR | 0.0 |
| AYRWF Ayr Wellness Inc. | — | -0.0 | -65.7 | -16.1 | -53.2 | -2.4 | 3 | LEAN BEAR | -84.9 |
| AYRWF Ayr Wellness Inc. | — | -0.0 | -65.7 | -16.1 | -53.2 | -2.4 | 3 | LEAN BEAR | -84.9 |
| TRCNF Transnational Cannabis Ltd. | — | -0.0 | -178.2 | -75.5 | — | — | 1 | LEAN BEAR | -96.0 |
| TRCNF Transnational Cannabis Ltd. | — | -0.0 | -178.2 | -75.5 | — | — | 1 | LEAN BEAR | -96.0 |
| NVCT Nuvectis Pharma, Inc. | $580M | -16.7 | -214.6 | 174.4 | — | — | 1 | LEAN BEAR | 261.7 |
| NVCT Nuvectis Pharma, Inc. | $580M | -16.7 | -214.6 | 174.4 | — | — | 1 | LEAN BEAR | 261.7 |
| INDP Indaptus Therapeutics, Inc. | $270M | -0.3 | -318.0 | 6437.4 | — | — | 4 | LEAN BEAR | -32.0 |
| INDP Indaptus Therapeutics, Inc. | $270M | -0.3 | -318.0 | 6437.4 | — | — | 4 | LEAN BEAR | -32.0 |
| TRLFF Maven Brands Inc. | — | -0.3 | 54.0 | -28.1 | — | -200.0 | 3 | LEAN BEAR | 9900.0 |
| TRLFF Maven Brands Inc. | — | -0.3 | 54.0 | -28.1 | — | -200.0 | 3 | LEAN BEAR | 9900.0 |
| HDVY Health Discovery Corporation | — | -0.1 | -3852.6 | 357.6 | — | -100.0 | 1 | LEAN BEAR | 0.0 |
| HDVY Health Discovery Corporation | — | -0.1 | -3852.6 | 357.6 | — | -100.0 | 1 | LEAN BEAR | 0.0 |
| BIEI Premier Biomedical, Inc. | — | -18.9 | 9.8 | 7.4 | — | -100.0 | 5 | LEAN BEAR | -31.2 |
| BIEI Premier Biomedical, Inc. | — | -18.9 | 9.8 | 7.4 | — | -100.0 | 5 | LEAN BEAR | -31.2 |
| WMGR Wellness Matrix Group, Inc. | — | -0.0 | 24.4 | 19.3 | — | — | 2 | LEAN BEAR | 0.0 |
| WMGR Wellness Matrix Group, Inc. | — | -0.0 | 24.4 | 19.3 | — | — | 2 | LEAN BEAR | 0.0 |
| BDPT BioAdaptives Inc. | — | -0.0 | 80.2 | 56.3 | 3009.0 | 169.7 | 3 | LEAN BEAR | -96.9 |
| BDPT BioAdaptives Inc. | — | -0.0 | 80.2 | 56.3 | 3009.0 | 169.7 | 3 | LEAN BEAR | -96.9 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | LEAN BEAR | -99.6 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | LEAN BEAR | -99.6 |
| MSPR MSP Recovery, Inc. | — | -0.0 | 127.6 | -506.2 | -84750.5 | — | 2 | LEAN BEAR | -100.0 |
| MSPR MSP Recovery, Inc. | — | -0.0 | 127.6 | -506.2 | -84750.5 | — | 2 | LEAN BEAR | -100.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | LEAN BEAR | 0.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | LEAN BEAR | 0.0 |
| FLWPF The Flowr Corporation | — | — | -335.3 | 207.1 | -1827.8 | 38.5 | 3 | LEAN BEAR | -100.0 |
| FLWPF The Flowr Corporation | — | — | -335.3 | 207.1 | -1827.8 | 38.5 | 3 | LEAN BEAR | -100.0 |
| RDDTF Radient Technologies Inc. | — | — | 98.9 | 263.2 | -131.7 | -20.4 | 3 | LEAN BEAR | 0.0 |
| RDDTF Radient Technologies Inc. | — | — | 98.9 | 263.2 | -131.7 | -20.4 | 3 | LEAN BEAR | 0.0 |
| ETBI Eastgate Biotech Corp. | — | -2.6 | 93.4 | 134.9 | -7057.2 | -53.0 | 3 | LEAN BEAR | -10.0 |
| ETBI Eastgate Biotech Corp. | — | -2.6 | 93.4 | 134.9 | -7057.2 | -53.0 | 3 | LEAN BEAR | -10.0 |
| SESI SES Solar Inc. | — | -0.5 | 16.7 | 1.7 | 28.0 | 324.6 | 7 | LEAN BEAR | 0.0 |
| SESI SES Solar Inc. | — | -0.5 | 16.7 | 1.7 | 28.0 | 324.6 | 7 | LEAN BEAR | 0.0 |
| FLOOF Flower One Holdings Inc. | — | -0.0 | 111.5 | -21.8 | -15.4 | -19.8 | 2 | LEAN BEAR | 0.0 |
| FLOOF Flower One Holdings Inc. | — | -0.0 | 111.5 | -21.8 | -15.4 | -19.8 | 2 | LEAN BEAR | 0.0 |
| CWWBF Plant-Based Investment Corp. | — | -0.0 | -95.9 | -3827.0 | 167.3 | -218.9 | 3 | LEAN BEAR | 0.0 |
| CWWBF Plant-Based Investment Corp. | — | -0.0 | -95.9 | -3827.0 | 167.3 | -218.9 | 3 | LEAN BEAR | 0.0 |
| OMRX Orthometrix, Inc. | — | 0.0 | 30.7 | -48.6 | -238.0 | -29.6 | 2 | LEAN BEAR | 0.0 |
| OMRX Orthometrix, Inc. | — | 0.0 | 30.7 | -48.6 | -238.0 | -29.6 | 2 | LEAN BEAR | 0.0 |
| SPLM Sentry Petroleum Ltd | — | -0.1 | -184.2 | -129.4 | — | — | 1 | LEAN BEAR | 0.0 |
| SPLM Sentry Petroleum Ltd | — | -0.1 | -184.2 | -129.4 | — | — | 1 | LEAN BEAR | 0.0 |
| CYPS Cyclo3pss Corporation | — | — | — | — | — | — | — | LEAN BEAR | 400.0 |
| CYPS Cyclo3pss Corporation | — | — | — | — | — | — | — | LEAN BEAR | 400.0 |
| SKVI Skinvisible, Inc. | — | -1.0 | 10.0 | 7.2 | -5110.7 | 0.0 | 2 | LEAN BEAR | -6.8 |
| SKVI Skinvisible, Inc. | — | -1.0 | 10.0 | 7.2 | -5110.7 | 0.0 | 2 | LEAN BEAR | -6.8 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -72.2 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -72.2 |
| CXBS Corix Bioscience, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| CXBS Corix Bioscience, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| IMRSQ IMRIS Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| IMRSQ IMRIS Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| UTRS Minerva Surgical, Inc. | — | -0.0 | -170.1 | -43.9 | -60.0 | 3.1 | 1 | LEAN BEAR | 0.0 |
| UTRS Minerva Surgical, Inc. | — | -0.0 | -170.1 | -43.9 | -60.0 | 3.1 | 1 | LEAN BEAR | 0.0 |
| XNCR Xencor, Inc. | $1.8B | -11.4 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | LEAN BEAR | 110.0 |
| XNCR Xencor, Inc. | $1.8B | -11.4 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | LEAN BEAR | 110.0 |
| PROK ProKidney Corp. | $580M | -3.0 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | LEAN BEAR | -33.9 |
| PROK ProKidney Corp. | $580M | -3.0 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | LEAN BEAR | -33.9 |
| MEDIF MediPharm Labs Corp. | $20M | -6.0 | -13.2 | -15.4 | 0.0 | -6.7 | 4 | LEAN BEAR | -8.4 |
| MEDIF MediPharm Labs Corp. | $20M | -6.0 | -13.2 | -15.4 | 0.0 | -6.7 | 4 | LEAN BEAR | -8.4 |
| KTTA Pasithea Therapeutics Corp. | $20M | -0.2 | -65.5 | 0.0 | — | — | 4 | LEAN BEAR | -35.8 |
| KTTA Pasithea Therapeutics Corp. | $20M | -0.2 | -65.5 | 0.0 | — | — | 4 | LEAN BEAR | -35.8 |
| BIEL Bioelectronics Corporation | $10M | -13.9 | 6.3 | 24.0 | -132.4 | -63.1 | 1 | LEAN BEAR | 100.0 |
| BIEL Bioelectronics Corporation | $10M | -13.9 | 6.3 | 24.0 | -132.4 | -63.1 | 1 | LEAN BEAR | 100.0 |
| XAIR Beyond Air, Inc. | — | -0.1 | -337.4 | -128.4 | -539.2 | 107.3 | 5 | LEAN BEAR | 16.1 |
| XAIR Beyond Air, Inc. | — | -0.1 | -337.4 | -128.4 | -539.2 | 107.3 | 5 | LEAN BEAR | 16.1 |
| BJDX Bluejay Diagnostics, Inc. | — | -0.1 | -98.9 | 5625.8 | — | — | 4 | LEAN BEAR | -86.3 |
| BJDX Bluejay Diagnostics, Inc. | — | -0.1 | -98.9 | 5625.8 | — | — | 4 | LEAN BEAR | -86.3 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.5 | -78.0 | 8335.2 | — | -50.0 | 2 | LEAN BEAR | -71.7 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.5 | -78.0 | 8335.2 | — | -50.0 | 2 | LEAN BEAR | -71.7 |
| LFMDP LifeMD, Inc. | $160M | -5.4 | -687.6 | 135.4 | -15.0 | -16.7 | 4 | LEAN BEAR | -2.8 |
| LFMDP LifeMD, Inc. | $160M | -5.4 | -687.6 | 135.4 | -15.0 | -16.7 | 4 | LEAN BEAR | -2.8 |
| MDXG MiMedx Group, Inc. | $670M | 114.8 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | LEAN BEAR | -32.8 |
| MDXG MiMedx Group, Inc. | $670M | 114.8 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | LEAN BEAR | -32.8 |
| EKDHF EKF Diagnostics Holdings plc | $150M | 42.4 | 12.4 | 17.0 | 9.3 | -4.9 | 7 | LEAN BEAR | -19.6 |
| EKDHF EKF Diagnostics Holdings plc | $150M | 42.4 | 12.4 | 17.0 | 9.3 | -4.9 | 7 | LEAN BEAR | -19.6 |
| DXR Daxor Corporation | $60M | 8.6 | 19.0 | 17.7 | -14382.9 | 161.9 | 4 | LEAN BEAR | -21.9 |
| DXR Daxor Corporation | $60M | 8.6 | 19.0 | 17.7 | -14382.9 | 161.9 | 4 | LEAN BEAR | -21.9 |
| LEEEF Leef Brands Inc. | $40M | -2.0 | 222.4 | -39.5 | -17.9 | 8.4 | 5 | LEAN BEAR | -22.7 |
| LEEEF Leef Brands Inc. | $40M | -2.0 | 222.4 | -39.5 | -17.9 | 8.4 | 5 | LEAN BEAR | -22.7 |
| VDRM ViaDerma, Inc. | — | 28.7 | 133.1 | -25.3 | -214.1 | 5.3 | 3 | LEAN BEAR | 0.0 |
| VDRM ViaDerma, Inc. | — | 28.7 | 133.1 | -25.3 | -214.1 | 5.3 | 3 | LEAN BEAR | 0.0 |
| SLNX Solanbridge Group, Inc. | — | -7.0 | 149.0 | 74.1 | — | — | 2 | LEAN BEAR | 400.0 |
| SLNX Solanbridge Group, Inc. | — | -7.0 | 149.0 | 74.1 | — | — | 2 | LEAN BEAR | 400.0 |
| REMI Remedent, Inc. | — | -0.1 | -11.3 | -4.3 | -86.4 | 14.2 | 6 | LEAN BEAR | 300.0 |
| REMI Remedent, Inc. | — | -0.1 | -11.3 | -4.3 | -86.4 | 14.2 | 6 | LEAN BEAR | 300.0 |
| XRTX XORTX Therapeutics Inc. | — | -0.3 | -99.1 | -68.5 | — | — | 3 | LEAN BEAR | 108.3 |
| XRTX XORTX Therapeutics Inc. | — | -0.3 | -99.1 | -68.5 | — | — | 3 | LEAN BEAR | 108.3 |
| TNON Tenon Medical, Inc. | — | -0.1 | -549.9 | -452.2 | -316.7 | 80.9 | 4 | LEAN BEAR | 203.3 |
| TNON Tenon Medical, Inc. | — | -0.1 | -549.9 | -452.2 | -316.7 | 80.9 | 4 | LEAN BEAR | 203.3 |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | LEAN BEAR | — |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | LEAN BEAR | — |
| VIVE Viveve Medical, Inc. | — | -0.0 | -222.0 | -1442.3 | -314.1 | 2.4 | 3 | LEAN BEAR | 0.0 |
| VIVE Viveve Medical, Inc. | — | -0.0 | -222.0 | -1442.3 | -314.1 | 2.4 | 3 | LEAN BEAR | 0.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | LEAN BEAR | -50.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | LEAN BEAR | -50.0 |
| XSVT Xsovt Brands, Inc. | — | -0.0 | 241.0 | 189.8 | -134.3 | 300584.1 | 4 | LEAN BEAR | -99.5 |
| XSVT Xsovt Brands, Inc. | — | -0.0 | 241.0 | 189.8 | -134.3 | 300584.1 | 4 | LEAN BEAR | -99.5 |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | LEAN BEAR | 100.0 |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | LEAN BEAR | 100.0 |
| CSPHF CStone Pharmaceuticals | $1.2B | -17.9 | -74.4 | -553.0 | -123.0 | -36.4 | 4 | LEAN BEAR | -24.5 |
| CSPHF CStone Pharmaceuticals | $1.2B | -17.9 | -74.4 | -553.0 | -123.0 | -36.4 | 4 | LEAN BEAR | -24.5 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BEAR | -98.4 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BEAR | -98.4 |
| BDRX Biodexa Pharmaceuticals Plc | — | -0.0 | -116.7 | -229.9 | — | -100.0 | 4 | LEAN BEAR | -98.1 |
| BDRX Biodexa Pharmaceuticals Plc | — | -0.0 | -116.7 | -229.9 | — | -100.0 | 4 | LEAN BEAR | -98.1 |
| GNFTF Genfit S.a. | $790M | -4.5 | -575.3 | -453.0 | -124.0 | 1.4 | 4 | LEAN BEAR | 323.4 |
| GNFTF Genfit S.a. | $790M | -4.5 | -575.3 | -453.0 | -124.0 | 1.4 | 4 | LEAN BEAR | 323.4 |
| DH Definitive Healthcare Corp. | $100M | -0.6 | -75.0 | 96.7 | -9.8 | -5.0 | 6 | LEAN BEAR | -73.8 |
| DH Definitive Healthcare Corp. | $100M | -0.6 | -75.0 | 96.7 | -9.8 | -5.0 | 6 | LEAN BEAR | -73.8 |
| BOEUF Bonesupport Holding AB (publ) | $1.5B | 68.7 | 24.6 | 42.3 | 23.0 | 20.8 | 6 | LEAN BEAR | -26.5 |
| BOEUF Bonesupport Holding AB (publ) | $1.5B | 68.7 | 24.6 | 42.3 | 23.0 | 20.8 | 6 | LEAN BEAR | -26.5 |
| ITHUF iAnthus Capital Holdings, Inc. | $30M | -0.6 | 53.1 | -9.2 | -40.8 | -9.9 | 1 | LEAN BEAR | -46.7 |
| ITHUF iAnthus Capital Holdings, Inc. | $30M | -0.6 | 53.1 | -9.2 | -40.8 | -9.9 | 1 | LEAN BEAR | -46.7 |
| ATOS Atossa Therapeutics, Inc. | $20M | -0.5 | -89.2 | -4213.1 | — | — | 2 | LEAN BEAR | -83.0 |
| ATOS Atossa Therapeutics, Inc. | $20M | -0.5 | -89.2 | -4213.1 | — | — | 2 | LEAN BEAR | -83.0 |
| HCTI Healthcare Triangle, Inc. | $10M | -0.0 | -57.4 | -19.3 | -48.0 | 116.4 | 3 | LEAN BEAR | -99.6 |
| HCTI Healthcare Triangle, Inc. | $10M | -0.0 | -57.4 | -19.3 | -48.0 | 116.4 | 3 | LEAN BEAR | -99.6 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | LEAN BEAR | -66.7 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | LEAN BEAR | -66.7 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | LEAN BEAR | -29.7 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | LEAN BEAR | -29.7 |
| DKSC Dakshidin Corporation | — | -45.8 | -113.2 | -9.1 | — | — | 2 | LEAN BEAR | 300.0 |
| DKSC Dakshidin Corporation | — | -45.8 | -113.2 | -9.1 | — | — | 2 | LEAN BEAR | 300.0 |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | LEAN BEAR | 0.0 |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | LEAN BEAR | 0.0 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | LEAN BEAR | -99.7 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | LEAN BEAR | -99.7 |
| NMRD Nemaura Medical Inc. | — | -0.0 | 45.5 | -457.0 | — | -491.0 | 1 | LEAN BEAR | 0.0 |
| NMRD Nemaura Medical Inc. | — | -0.0 | 45.5 | -457.0 | — | -491.0 | 1 | LEAN BEAR | 0.0 |
| IONKF Ionic Brands Corp. | — | -0.0 | -395.1 | -29.9 | -53.6 | 179.4 | 4 | LEAN BEAR | 0.0 |
| IONKF Ionic Brands Corp. | — | -0.0 | -395.1 | -29.9 | -53.6 | 179.4 | 4 | LEAN BEAR | 0.0 |
| STAA STAAR Surgical Company | $1.1B | 280.9 | 1.1 | 3.5 | 8.6 | 51.3 | 5 | LEAN BEAR | -17.3 |
| STAA STAAR Surgical Company | $1.1B | 280.9 | 1.1 | 3.5 | 8.6 | 51.3 | 5 | LEAN BEAR | -17.3 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | LEAN BEAR | 0.0 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | LEAN BEAR | 0.0 |
| LTUS Lotus Pharmaceuticals, Inc. | — | -385.1 | 14.7 | -340.1 | — | — | 3 | LEAN BEAR | 29.1 |
| LTUS Lotus Pharmaceuticals, Inc. | — | -385.1 | 14.7 | -340.1 | — | — | 3 | LEAN BEAR | 29.1 |
| CHOOF Choom Holdings Inc. | — | -0.0 | 3772.9 | -35.1 | -140.0 | 4.6 | 4 | LEAN BEAR | 0.0 |
| CHOOF Choom Holdings Inc. | — | -0.0 | 3772.9 | -35.1 | -140.0 | 4.6 | 4 | LEAN BEAR | 0.0 |
| CSTF CuraScientific Corp | — | -0.0 | -72.1 | 17.4 | -2482.5 | 954.6 | 5 | LEAN BEAR | 0.0 |
| CSTF CuraScientific Corp | — | -0.0 | -72.1 | 17.4 | -2482.5 | 954.6 | 5 | LEAN BEAR | 0.0 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | LEAN BEAR | 0.0 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | LEAN BEAR | 0.0 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BEAR | 100.0 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BEAR | 100.0 |
| NPRRF Nipro Corporation | $1.5B | — | — | — | — | — | — | LEAN BEAR | 9.7 |
| NPRRF Nipro Corporation | $1.5B | — | — | — | — | — | — | LEAN BEAR | 9.7 |
| LJUIF SSY Group Limited | $1.2B | 16.1 | 15.5 | 11.9 | 13.6 | -30.2 | 4 | LEAN BEAR | 0.0 |
| LJUIF SSY Group Limited | $1.2B | 16.1 | 15.5 | 11.9 | 13.6 | -30.2 | 4 | LEAN BEAR | 0.0 |
| AONC American Oncology Network, Inc. | $320M | -15.9 | 5.6 | -14.7 | 0.3 | 37.5 | 6 | LEAN BEAR | 29.4 |
| AONC American Oncology Network, Inc. | $320M | -15.9 | 5.6 | -14.7 | 0.3 | 37.5 | 6 | LEAN BEAR | 29.4 |
| EDTXF Spectral Medical Inc | $240M | -9.1 | 64.9 | 19.4 | 53.3 | 1.5 | 2 | LEAN BEAR | -23.1 |
| EDTXF Spectral Medical Inc | $240M | -9.1 | 64.9 | 19.4 | 53.3 | 1.5 | 2 | LEAN BEAR | -23.1 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -8.0 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | LEAN BEAR | -34.4 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -8.0 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | LEAN BEAR | -34.4 |
| XBIT XBiotech Inc. | $70M | -1.5 | -29.9 | -201.2 | — | — | 2 | LEAN BEAR | -17.1 |
| XBIT XBiotech Inc. | $70M | -1.5 | -29.9 | -201.2 | — | — | 2 | LEAN BEAR | -17.1 |
| VTIAF FamiCord AG | $50M | -7.1 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | LEAN BEAR | 16.0 |
| VTIAF FamiCord AG | $50M | -7.1 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | LEAN BEAR | 16.0 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.8 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | LEAN BEAR | -46.2 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.8 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | LEAN BEAR | -46.2 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $10M | — | — | — | — | — | — | LEAN BEAR | -71.2 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $10M | — | — | — | — | — | — | LEAN BEAR | -71.2 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -57.9 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -57.9 |
| ARYC Arrayit Corporation | — | -0.0 | 116.8 | 89.8 | -513.1 | -30.5 | 2 | LEAN BEAR | -90.0 |
| ARYC Arrayit Corporation | — | -0.0 | 116.8 | 89.8 | -513.1 | -30.5 | 2 | LEAN BEAR | -90.0 |
| THMO ThermoGenesis Holdings, Inc. | — | -0.0 | -417.9 | -71.5 | -67.8 | -7.5 | 3 | LEAN BEAR | 0.0 |
| THMO ThermoGenesis Holdings, Inc. | — | -0.0 | -417.9 | -71.5 | -67.8 | -7.5 | 3 | LEAN BEAR | 0.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | LEAN BEAR | 0.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | LEAN BEAR | 0.0 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | LEAN BEAR | -99.6 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | LEAN BEAR | -99.6 |
| ENMI DH Enchantment Inc. | — | -0.5 | 52.9 | -49.5 | -32.2 | 26.9 | 5 | LEAN BEAR | -75.0 |
| ENMI DH Enchantment Inc. | — | -0.5 | 52.9 | -49.5 | -32.2 | 26.9 | 5 | LEAN BEAR | -75.0 |
| UPDC UPD Holding Corp. | — | -0.0 | 198.3 | 1243.8 | -858.8 | — | 2 | LEAN BEAR | 200.0 |
| UPDC UPD Holding Corp. | — | -0.0 | 198.3 | 1243.8 | -858.8 | — | 2 | LEAN BEAR | 200.0 |
| PBIO Pressure BioSciences, Inc. | — | -0.0 | 100.6 | 84.5 | -1687.2 | -25.3 | 3 | LEAN BEAR | -60.0 |
| PBIO Pressure BioSciences, Inc. | — | -0.0 | 100.6 | 84.5 | -1687.2 | -25.3 | 3 | LEAN BEAR | -60.0 |
| AQSZF Aequus Pharmaceuticals Inc. | — | 3.1 | 10.0 | 17.6 | 147.2 | 122.3 | 5 | LEAN BEAR | -66.7 |
| AQSZF Aequus Pharmaceuticals Inc. | — | 3.1 | 10.0 | 17.6 | 147.2 | 122.3 | 5 | LEAN BEAR | -66.7 |
| BIOGY BioGaia AB (publ) | $1.3B | 33.2 | 30.7 | 52.8 | 23.4 | 9.5 | 6 | LEAN BEAR | 10.7 |
| BIOGY BioGaia AB (publ) | $1.3B | 33.2 | 30.7 | 52.8 | 23.4 | 9.5 | 6 | LEAN BEAR | 10.7 |
| TBPH Theravance Biopharma Inc | $880M | 16.0 | 20.9 | -7.2 | -28.5 | 35.1 | 7 | LEAN BEAR | 21.2 |
| TBPH Theravance Biopharma Inc | $880M | 16.0 | 20.9 | -7.2 | -28.5 | 35.1 | 7 | LEAN BEAR | 21.2 |
| KIDS OrthoPediatrics Corp. | $570M | -13.2 | -11.4 | -4.6 | -10.2 | 14.5 | 6 | LEAN BEAR | 20.3 |
| KIDS OrthoPediatrics Corp. | $570M | -13.2 | -11.4 | -4.6 | -10.2 | 14.5 | 6 | LEAN BEAR | 20.3 |
| CLVSF CellaVision AB (publ) | $330M | 31.2 | 15.1 | 17.1 | 16.3 | -1.9 | 6 | LEAN BEAR | -27.4 |
| CLVSF CellaVision AB (publ) | $330M | 31.2 | 15.1 | 17.1 | 16.3 | -1.9 | 6 | LEAN BEAR | -27.4 |
| EQ Equillium, Inc. | $90M | -5.5 | -59.0 | 2703.6 | — | -100.0 | 3 | LEAN BEAR | -4.7 |
| EQ Equillium, Inc. | $90M | -5.5 | -59.0 | 2703.6 | — | -100.0 | 3 | LEAN BEAR | -4.7 |
| MRMD MariMed Inc. | $30M | -1.8 | -28.4 | -0.9 | -8.6 | 4.2 | 4 | LEAN BEAR | -57.1 |
| MRMD MariMed Inc. | $30M | -1.8 | -28.4 | -0.9 | -8.6 | 4.2 | 4 | LEAN BEAR | -57.1 |
| PTN Palatin Technologies, Inc. | $20M | -1.8 | -877.5 | 1176.9 | -1449.1 | — | 5 | LEAN BEAR | 18.9 |
| PTN Palatin Technologies, Inc. | $20M | -1.8 | -877.5 | 1176.9 | -1449.1 | — | 5 | LEAN BEAR | 18.9 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.2 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | LEAN BEAR | -39.0 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.2 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | LEAN BEAR | -39.0 |
| EBYH Strainsforpains, Inc. | — | -18.9 | -3.4 | 16.3 | -603.3 | 1679.9 | 5 | LEAN BEAR | 24.6 |
| EBYH Strainsforpains, Inc. | — | -18.9 | -3.4 | 16.3 | -603.3 | 1679.9 | 5 | LEAN BEAR | 24.6 |
| SDCCQ SmileDirectClub Inc Class A | — | -0.0 | -72.6 | -19.0 | -17.5 | -23.4 | 3 | LEAN BEAR | 0.0 |
| SDCCQ SmileDirectClub Inc Class A | — | -0.0 | -72.6 | -19.0 | -17.5 | -23.4 | 3 | LEAN BEAR | 0.0 |
| ESVNF Apptly Health Technologies Corp. | — | -2.5 | -22.3 | -40.4 | — | — | 2 | LEAN BEAR | -22.5 |
| ESVNF Apptly Health Technologies Corp. | — | -2.5 | -22.3 | -40.4 | — | — | 2 | LEAN BEAR | -22.5 |
| BVS Bioventus Inc. | $890M | 16.3 | 28.0 | 21.3 | 21.8 | 3.1 | 7 | LEAN BEAR | 95.7 |
| BVS Bioventus Inc. | $890M | 16.3 | 28.0 | 21.3 | 21.8 | 3.1 | 7 | LEAN BEAR | 95.7 |
| BBNX Beta Bionics, Inc. | $850M | -11.3 | -26.2 | -79.6 | -73.1 | 191.1 | 3 | LEAN BEAR | -6.2 |
| BBNX Beta Bionics, Inc. | $850M | -11.3 | -26.2 | -79.6 | -73.1 | 191.1 | 3 | LEAN BEAR | -6.2 |
| LDXHF Lumos Diagnostics Holdings Ltd. | $70M | -10.7 | -81.7 | -123.2 | -1.0 | 19.5 | 4 | LEAN BEAR | -39.1 |
| LDXHF Lumos Diagnostics Holdings Ltd. | $70M | -10.7 | -81.7 | -123.2 | -1.0 | 19.5 | 4 | LEAN BEAR | -39.1 |
| CPHI China Pharma Holdings, Inc. | $30M | -0.7 | -21.0 | -8.7 | -153.8 | -11.0 | 4 | LEAN BEAR | -67.0 |
| CPHI China Pharma Holdings, Inc. | $30M | -0.7 | -21.0 | -8.7 | -153.8 | -11.0 | 4 | LEAN BEAR | -67.0 |
| NSYS Nortech Systems Incorporated | $30M | 31.5 | 3.0 | 3.2 | 0.9 | 6.0 | 7 | LEAN BEAR | 20.4 |
| NSYS Nortech Systems Incorporated | $30M | 31.5 | 3.0 | 3.2 | 0.9 | 6.0 | 7 | LEAN BEAR | 20.4 |
| RGNT Regentis Biomaterials Ltd. | $10M | — | — | — | — | — | — | LEAN BEAR | — |
| RGNT Regentis Biomaterials Ltd. | $10M | — | — | — | — | — | — | LEAN BEAR | — |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.9 | -99.9 | 590.1 | — | -90.7 | 2 | LEAN BEAR | -40.0 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.9 | -99.9 | 590.1 | — | -90.7 | 2 | LEAN BEAR | -40.0 |
| SKYE Skye Bioscience, Inc. | $10M | -0.2 | -233.9 | 389.5 | — | — | 3 | LEAN BEAR | -60.6 |
| SKYE Skye Bioscience, Inc. | $10M | -0.2 | -233.9 | 389.5 | — | — | 3 | LEAN BEAR | -60.6 |
| NUGS Cannabis Strategic Ventures | — | -0.3 | 115.4 | -142.7 | -3106.7 | -29.3 | 2 | LEAN BEAR | 7000.0 |
| NUGS Cannabis Strategic Ventures | — | -0.3 | 115.4 | -142.7 | -3106.7 | -29.3 | 2 | LEAN BEAR | 7000.0 |
| PFSA Profusa, Inc. Common Stock | — | -0.0 | 158.4 | 181.7 | — | — | 2 | LEAN BEAR | 448.0 |
| PFSA Profusa, Inc. Common Stock | — | -0.0 | 158.4 | 181.7 | — | — | 2 | LEAN BEAR | 448.0 |
| ITOC iTonic Holdings Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| ITOC iTonic Holdings Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| PTPI Petros Pharmaceuticals, Inc. | — | 0.0 | -124.4 | 96.3 | — | -100.0 | 1 | LEAN BEAR | -85.0 |
| PTPI Petros Pharmaceuticals, Inc. | — | 0.0 | -124.4 | 96.3 | — | -100.0 | 1 | LEAN BEAR | -85.0 |
| BGMS Bio Green Med Solution, Inc. | — | -0.2 | -30.7 | -64.2 | -120.5 | — | 2 | LEAN BEAR | -82.2 |
| BGMS Bio Green Med Solution, Inc. | — | -0.2 | -30.7 | -64.2 | -120.5 | — | 2 | LEAN BEAR | -82.2 |
| CBLL CeriBell, Inc. | $900M | -13.5 | -43.9 | -263.7 | -68.6 | 69.3 | 3 | LEAN BEAR | 104.9 |
| CBLL CeriBell, Inc. | $900M | -13.5 | -43.9 | -263.7 | -68.6 | 69.3 | 3 | LEAN BEAR | 104.9 |
| PYPD PolyPid Ltd. | $100M | -3.5 | -1913.8 | 231.6 | — | — | 3 | LEAN BEAR | 54.0 |
| PYPD PolyPid Ltd. | $100M | -3.5 | -1913.8 | 231.6 | — | — | 3 | LEAN BEAR | 54.0 |
| BIIO Bionovate Technologies Corp | — | -0.0 | 47.5 | 16.6 | — | — | 3 | LEAN BEAR | 0.0 |
| BIIO Bionovate Technologies Corp | — | -0.0 | 47.5 | 16.6 | — | — | 3 | LEAN BEAR | 0.0 |
| ABMT Advanced BioMedical Technologies Inc. | — | -0.1 | 6.0 | 9.6 | 3842.6 | 264.3 | 3 | LEAN BEAR | 400.0 |
| ABMT Advanced BioMedical Technologies Inc. | — | -0.1 | 6.0 | 9.6 | 3842.6 | 264.3 | 3 | LEAN BEAR | 400.0 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| NWCI NewCardio, Inc. | — | -0.0 | 258.3 | 352.6 | -23059.8 | 40.9 | 2 | LEAN BEAR | 0.0 |
| NWCI NewCardio, Inc. | — | -0.0 | 258.3 | 352.6 | -23059.8 | 40.9 | 2 | LEAN BEAR | 0.0 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.2 | 235.3 | 244.1 | — | — | 5 | LEAN BEAR | 710.5 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.2 | 235.3 | 244.1 | — | — | 5 | LEAN BEAR | 710.5 |
| ALZN Alzamend Neuro Inc | $10M | -0.6 | -373.2 | -30751.3 | — | — | 1 | LEAN BEAR | -44.1 |
| ALZN Alzamend Neuro Inc | $10M | -0.6 | -373.2 | -30751.3 | — | — | 1 | LEAN BEAR | -44.1 |
| ODYY Odyssey Health, Inc. | — | -0.2 | 43.4 | 10.0 | — | -100.0 | 4 | LEAN BEAR | -81.2 |
| ODYY Odyssey Health, Inc. | — | -0.2 | 43.4 | 10.0 | — | -100.0 | 4 | LEAN BEAR | -81.2 |
| EGRX Eagle Pharmaceuticals, Inc. | — | 0.1 | 6.4 | 3.6 | 8.0 | -5.4 | 3 | LEAN BEAR | -92.2 |
| EGRX Eagle Pharmaceuticals, Inc. | — | 0.1 | 6.4 | 3.6 | 8.0 | -5.4 | 3 | LEAN BEAR | -92.2 |
| BPMUF Basilea Pharmaceutica AG | $940M | 15.7 | 140.1 | 185.7 | 23.5 | 49.5 | 9 | LEAN BEAR | 12.6 |
| BPMUF Basilea Pharmaceutica AG | $940M | 15.7 | 140.1 | 185.7 | 23.5 | 49.5 | 9 | LEAN BEAR | 12.6 |
| AVHHL AVITA Medical, Inc. | $270M | -8.8 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | LEAN BEAR | 56.8 |
| AVHHL AVITA Medical, Inc. | $270M | -8.8 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | LEAN BEAR | 56.8 |
| QUCY Quantum Cyber N.V. | $30M | — | — | — | — | — | — | LEAN BEAR | — |
| QUCY Quantum Cyber N.V. | $30M | — | — | — | — | — | — | LEAN BEAR | — |
| PLSM Pulsenmore Ltd. Ordinary Shares | $10M | — | — | — | — | — | — | LEAN BEAR | — |
| PLSM Pulsenmore Ltd. Ordinary Shares | $10M | — | — | — | — | — | — | LEAN BEAR | — |
| EOCN Eocene Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| EOCN Eocene Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| RKAGY RHÃN-KLINIKUM Aktiengesellschaft | $1.1B | 22.5 | 2.8 | 3.1 | 2.1 | 2.5 | 6 | BEARISH | 10.7 |
| RKAGY RHÃN-KLINIKUM Aktiengesellschaft | $1.1B | 22.5 | 2.8 | 3.1 | 2.1 | 2.5 | 6 | BEARISH | 10.7 |
| SHIEF Shield Therapeutics plc | $90M | -8.0 | 262.0 | 1974.0 | -7.4 | 547.4 | 5 | BEARISH | -15.8 |
| SHIEF Shield Therapeutics plc | $90M | -8.0 | 262.0 | 1974.0 | -7.4 | 547.4 | 5 | BEARISH | -15.8 |
| ANNX Annexon, Inc. | $690M | -3.6 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 38.3 |
| ANNX Annexon, Inc. | $690M | -3.6 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 38.3 |
| CODX Co-Diagnostics, Inc. | $10M | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -89.8 |
| CODX Co-Diagnostics, Inc. | $10M | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -89.8 |
| BBRRF Blueberries Medical Corp. | $10M | -7.1 | -218.7 | -2675.7 | -588.1 | -36.9 | 4 | BEARISH | 8.2 |
| BBRRF Blueberries Medical Corp. | $10M | -7.1 | -218.7 | -2675.7 | -588.1 | -36.9 | 4 | BEARISH | 8.2 |
| SNTI Senti Biosciences, Inc. | $10M | -0.2 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -77.6 |
| SNTI Senti Biosciences, Inc. | $10M | -0.2 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -77.6 |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.0 | -115.7 | -377.9 | — | -133.3 | 3 | BEARISH | -93.3 |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.0 | -115.7 | -377.9 | — | -133.3 | 3 | BEARISH | -93.3 |
| ARTL Artelo Biosciences, Inc. | — | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -91.4 |
| ARTL Artelo Biosciences, Inc. | — | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -91.4 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -64.8 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -64.8 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| IMCC IM Cannabis Corp. | — | -1062.5 | 1556.1 | -129.3 | -57.5 | -21.1 | 1 | BEARISH | -96.4 |
| IMCC IM Cannabis Corp. | — | -1062.5 | 1556.1 | -129.3 | -57.5 | -21.1 | 1 | BEARISH | -96.4 |
| GGBXF Green Growth Brands Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GGBXF Green Growth Brands Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NSTM NovelStem International Corp. | — | -1.5 | 15.3 | 31.5 | — | -100.0 | 3 | BEARISH | -66.7 |
| NSTM NovelStem International Corp. | — | -1.5 | 15.3 | 31.5 | — | -100.0 | 3 | BEARISH | -66.7 |
| USAQ QHSLab, Inc. | — | 6.8 | 114.6 | 6.2 | 4.5 | 24.6 | 6 | BEARISH | 60.0 |
| USAQ QHSLab, Inc. | — | 6.8 | 114.6 | 6.2 | 4.5 | 24.6 | 6 | BEARISH | 60.0 |
| PRFX PRF Technologies Ltd. | — | -0.1 | -57.8 | -88.3 | -19978.6 | 137249010644668.4 | 6 | BEARISH | -33.3 |
| PRFX PRF Technologies Ltd. | — | -0.1 | -57.8 | -88.3 | -19978.6 | 137249010644668.4 | 6 | BEARISH | -33.3 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -93.1 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -93.1 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| CHHHF CareRx Corporation | $150M | 7.6 | 27.3 | 40.1 | 0.4 | 3.0 | 6 | BEARISH | -8.8 |
| CHHHF CareRx Corporation | $150M | 7.6 | 27.3 | 40.1 | 0.4 | 3.0 | 6 | BEARISH | -8.8 |
| CSBR Champions Oncology, Inc. | $70M | -62.5 | -30.5 | -25.2 | -5.3 | 4.4 | 4 | BEARISH | -22.8 |
| CSBR Champions Oncology, Inc. | $70M | -62.5 | -30.5 | -25.2 | -5.3 | 4.4 | 4 | BEARISH | -22.8 |
| ELUT Elutia Inc | $30M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | BEARISH | -12.0 |
| ELUT Elutia Inc | $30M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | BEARISH | -12.0 |
| ONMD OneMedNet Corporation | $30M | -3.2 | 231.2 | 252.1 | -743.8 | 216.5 | 3 | BEARISH | -47.7 |
| ONMD OneMedNet Corporation | $30M | -3.2 | 231.2 | 252.1 | -743.8 | 216.5 | 3 | BEARISH | -47.7 |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | BEARISH | — |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | BEARISH | — |
| PTKFY PT Kalbe Farma Tbk | $10M | 9.1 | 15.5 | 17.8 | 9.1 | 13.6 | 6 | BEARISH | -42.4 |
| PTKFY PT Kalbe Farma Tbk | $10M | 9.1 | 15.5 | 17.8 | 9.1 | 13.6 | 6 | BEARISH | -42.4 |
| BICX BioCorRx Inc. | $10M | -1.6 | 25.4 | 84.3 | -1096.7 | 151.2 | 3 | BEARISH | -5.2 |
| BICX BioCorRx Inc. | $10M | -1.6 | 25.4 | 84.3 | -1096.7 | 151.2 | 3 | BEARISH | -5.2 |
| LUFFF Herbal Dispatch Inc. | $10M | -1.6 | -124.8 | -42.8 | -26.7 | 4.6 | 6 | BEARISH | 134.3 |
| LUFFF Herbal Dispatch Inc. | $10M | -1.6 | -124.8 | -42.8 | -26.7 | 4.6 | 6 | BEARISH | 134.3 |
| VNRX VolitionRX Ltd | — | -0.1 | 80.1 | 66.5 | -1837.7 | 86.3 | 3 | BEARISH | -62.2 |
| VNRX VolitionRX Ltd | — | -0.1 | 80.1 | 66.5 | -1837.7 | 86.3 | 3 | BEARISH | -62.2 |
| MRDH Meridian Holdings, Inc. | — | -0.9 | 29.2 | -2410.8 | — | -100.0 | 1 | BEARISH | 9.1 |
| MRDH Meridian Holdings, Inc. | — | -0.9 | 29.2 | -2410.8 | — | -100.0 | 1 | BEARISH | 9.1 |
| RQHTF Reliq Health Technologies Inc. | — | -5.4 | -4.5 | -8.2 | 15.4 | 119.4 | 5 | BEARISH | 0.0 |
| RQHTF Reliq Health Technologies Inc. | — | -5.4 | -4.5 | -8.2 | 15.4 | 119.4 | 5 | BEARISH | 0.0 |
| GRST Ethema Health Corporation | — | -0.5 | 18.3 | 0.0 | 1.2 | 171.7 | 6 | BEARISH | -66.7 |
| GRST Ethema Health Corporation | — | -0.5 | 18.3 | 0.0 | 1.2 | 171.7 | 6 | BEARISH | -66.7 |
| SHOM Southern Home Medical, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SHOM Southern Home Medical, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| UAHC United American Healthcare Corporation | — | 180.0 | 4.6 | -10.0 | — | -100.0 | 6 | BEARISH | -14.3 |
| UAHC United American Healthcare Corporation | — | 180.0 | 4.6 | -10.0 | — | -100.0 | 6 | BEARISH | -14.3 |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -92.9 |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -92.9 |
| WHSI Wearable Health Solutions, Inc. | — | -0.1 | 37.4 | 155.3 | 98.4 | -29.7 | 2 | BEARISH | 0.0 |
| WHSI Wearable Health Solutions, Inc. | — | -0.1 | 37.4 | 155.3 | 98.4 | -29.7 | 2 | BEARISH | 0.0 |
| AOXG Aoxing Pharmaceutical Company, Inc. | — | -35.9 | -0.2 | -13.9 | -405.2 | -99.8 | 1 | BEARISH | -68.6 |
| AOXG Aoxing Pharmaceutical Company, Inc. | — | -35.9 | -0.2 | -13.9 | -405.2 | -99.8 | 1 | BEARISH | -68.6 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | BEARISH | -20.0 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | BEARISH | -20.0 |
| ISOLF Isodiol International Inc. | — | -0.0 | -220.6 | -602.3 | -73.2 | -17.7 | 4 | BEARISH | 900.0 |
| ISOLF Isodiol International Inc. | — | -0.0 | -220.6 | -602.3 | -73.2 | -17.7 | 4 | BEARISH | 900.0 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | BEARISH | 0.0 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | BEARISH | 0.0 |
| PAOG PAO Group, Inc. | — | -3.9 | -20.2 | 11.2 | — | — | 4 | BEARISH | 0.0 |
| PAOG PAO Group, Inc. | — | -3.9 | -20.2 | 11.2 | — | — | 4 | BEARISH | 0.0 |
| SNBIF SanBio Company Limited | $1.3B | -19.7 | -50.0 | 1250.3 | — | — | 4 | BEARISH | 0.0 |
| SNBIF SanBio Company Limited | $1.3B | -19.7 | -50.0 | 1250.3 | — | — | 4 | BEARISH | 0.0 |
| REPL Replimune Group, Inc. | $1.1B | -4.1 | -107.9 | -2853.5 | — | — | 1 | BEARISH | 210.4 |
| REPL Replimune Group, Inc. | $1.1B | -4.1 | -107.9 | -2853.5 | — | — | 1 | BEARISH | 210.4 |
| IRMD IRadimed Corporation | $1.1B | 46.9 | 23.5 | 50.1 | 25.5 | 11.2 | 6 | BEARISH | 22.2 |
| IRMD IRadimed Corporation | $1.1B | 46.9 | 23.5 | 50.1 | 25.5 | 11.2 | 6 | BEARISH | 22.2 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.0 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | BEARISH | 0.0 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.0 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | BEARISH | 0.0 |
| TSNLF Tristel PLC | $280M | 24.9 | 43.3 | 53.7 | 15.4 | 25.1 | 6 | BEARISH | 8.5 |
| TSNLF Tristel PLC | $280M | 24.9 | 43.3 | 53.7 | 15.4 | 25.1 | 6 | BEARISH | 8.5 |
| GALT Galectin Therapeutics Inc. | $260M | -9.1 | 21.9 | 99.4 | — | — | 2 | BEARISH | -6.7 |
| GALT Galectin Therapeutics Inc. | $260M | -9.1 | 21.9 | 99.4 | — | — | 2 | BEARISH | -6.7 |
| KJFI Comjoyful International Company | $210M | -98.4 | 56.8 | 51.4 | -1397.6 | — | 2 | BEARISH | 441.1 |
| KJFI Comjoyful International Company | $210M | -98.4 | 56.8 | 51.4 | -1397.6 | — | 2 | BEARISH | 441.1 |
| SCNLF Scancell Holdings plc | $150M | -17.9 | 254.8 | 3518.0 | — | -10.6 | 1 | BEARISH | 5.9 |
| SCNLF Scancell Holdings plc | $150M | -17.9 | 254.8 | 3518.0 | — | -10.6 | 1 | BEARISH | 5.9 |
| RANI Rani Therapeutics Holdings, Inc. | $50M | -3.0 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | 59.3 |
| RANI Rani Therapeutics Holdings, Inc. | $50M | -3.0 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | 59.3 |
| RAPH Raphael Pharmaceutical Inc. | $30M | -28.5 | 59.9 | 47.0 | — | — | 2 | BEARISH | 536.4 |
| RAPH Raphael Pharmaceutical Inc. | $30M | -28.5 | 59.9 | 47.0 | — | — | 2 | BEARISH | 536.4 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| PLSH Panacea Life Sciences Holdings, Inc. | — | -0.8 | 128.5 | -48.4 | -1581.6 | -90.2 | 5 | BEARISH | 14.9 |
| PLSH Panacea Life Sciences Holdings, Inc. | — | -0.8 | 128.5 | -48.4 | -1581.6 | -90.2 | 5 | BEARISH | 14.9 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | BEARISH | 0.0 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | BEARISH | 0.0 |
| SSKN STRATA Skin Sciences, Inc. | — | -0.0 | -164.6 | -42.5 | 0.6 | -8.5 | 4 | BEARISH | -99.7 |
| SSKN STRATA Skin Sciences, Inc. | — | -0.0 | -164.6 | -42.5 | 0.6 | -8.5 | 4 | BEARISH | -99.7 |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | BEARISH | -98.0 |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | BEARISH | -98.0 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.0 | 6.3 | -1.4 | 11.2 | 10.9 | 6 | BEARISH | -19.1 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.0 | 6.3 | -1.4 | 11.2 | 10.9 | 6 | BEARISH | -19.1 |
| BOIRF Boiron S.A. | $550M | 13.3 | 7.2 | 7.8 | 2.0 | -5.4 | 4 | BEARISH | 10.5 |
| BOIRF Boiron S.A. | $550M | 13.3 | 7.2 | 7.8 | 2.0 | -5.4 | 4 | BEARISH | 10.5 |
| AUNA Auna S.A. | $370M | -17.9 | 0.8 | 4.5 | 2.4 | 9.2 | 7 | BEARISH | -25.0 |
| AUNA Auna S.A. | $370M | -17.9 | 0.8 | 4.5 | 2.4 | 9.2 | 7 | BEARISH | -25.0 |
| FATE Fate Therapeutics, Inc. | $270M | -2.2 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | BEARISH | 109.0 |
| FATE Fate Therapeutics, Inc. | $270M | -2.2 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | BEARISH | 109.0 |
| ALEC Alector, Inc. | $200M | -1.6 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | BEARISH | -39.7 |
| ALEC Alector, Inc. | $200M | -1.6 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | BEARISH | -39.7 |
| PARK Park Dental Partners, Inc. Common Stock | $90M | -23.9 | -16.0 | 0.0 | 2.0 | — | 3 | BEARISH | — |
| PARK Park Dental Partners, Inc. Common Stock | $90M | -23.9 | -16.0 | 0.0 | 2.0 | — | 3 | BEARISH | — |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $80M | -0.8 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -15.1 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $80M | -0.8 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -15.1 |
| XTNT Xtant Medical Holdings, Inc. | $50M | -4.1 | -25.2 | -14.8 | -40.9 | -14.3 | 4 | BEARISH | -45.5 |
| XTNT Xtant Medical Holdings, Inc. | $50M | -4.1 | -25.2 | -14.8 | -40.9 | -14.3 | 4 | BEARISH | -45.5 |
| ELOX Eloxx Pharmaceuticals, Inc. | $50M | -10.2 | -107.5 | 81.5 | — | — | 4 | BEARISH | 15509900.5 |
| ELOX Eloxx Pharmaceuticals, Inc. | $50M | -10.2 | -107.5 | 81.5 | — | — | 4 | BEARISH | 15509900.5 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| ABVC ABVC BioPharma, Inc. | $30M | -3.4 | -82.2 | -43.0 | — | -100.0 | 2 | BEARISH | -66.2 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.4 | -82.2 | -43.0 | — | -100.0 | 2 | BEARISH | -66.2 |
| CABR Caring Brands, Inc. | $10M | — | — | — | — | — | — | BEARISH | -69.1 |
| CABR Caring Brands, Inc. | $10M | — | — | — | — | — | — | BEARISH | -69.1 |
| BIOCQ Biocept, Inc. | — | -0.0 | -13593.8 | -631.8 | -616.5 | — | 2 | BEARISH | 100.0 |
| BIOCQ Biocept, Inc. | — | -0.0 | -13593.8 | -631.8 | -616.5 | — | 2 | BEARISH | 100.0 |
| CGNH CardioGenics Holdings Inc | — | -0.0 | 58.8 | 40.3 | — | — | 3 | BEARISH | 0.0 |
| CGNH CardioGenics Holdings Inc | — | -0.0 | 58.8 | 40.3 | — | — | 3 | BEARISH | 0.0 |
| MILC Millennium Sustainable Ventures Corp. | — | -0.0 | 763.2 | -36.7 | — | 584982.1 | 2 | BEARISH | 100.0 |
| MILC Millennium Sustainable Ventures Corp. | — | -0.0 | 763.2 | -36.7 | — | 584982.1 | 2 | BEARISH | 100.0 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | BEARISH | 423.8 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | BEARISH | 423.8 |
| GNMLF Genomma Lab Internacional, S.A.B. de C.V. | $710M | 7.8 | 14.1 | 14.1 | 8.5 | 18.2 | 5 | BEARISH | -37.6 |
| GNMLF Genomma Lab Internacional, S.A.B. de C.V. | $710M | 7.8 | 14.1 | 14.1 | 8.5 | 18.2 | 5 | BEARISH | -37.6 |
| CTNM Contineum Therapeutics, Inc. | $490M | -7.6 | -28.0 | -541.6 | — | — | 4 | BEARISH | 19.2 |
| CTNM Contineum Therapeutics, Inc. | $490M | -7.6 | -28.0 | -541.6 | — | — | 4 | BEARISH | 19.2 |
| ANVS Annovis Bio, Inc. | $50M | -0.7 | -703.7 | 170.2 | — | — | 1 | BEARISH | -44.6 |
| ANVS Annovis Bio, Inc. | $50M | -0.7 | -703.7 | 170.2 | — | — | 1 | BEARISH | -44.6 |
| ICBU iMD Companies, Inc. | — | -16.3 | 27.7 | 30.0 | — | -100.0 | 3 | BEARISH | -62.1 |
| ICBU iMD Companies, Inc. | — | -16.3 | 27.7 | 30.0 | — | -100.0 | 3 | BEARISH | -62.1 |
| SYUP Anbc, Inc. | — | — | — | — | — | — | — | BEARISH | 200.0 |
| SYUP Anbc, Inc. | — | — | — | — | — | — | — | BEARISH | 200.0 |
| IGEX Indo Global Exchange(s) PTE, Ltd. | — | -20.1 | -12.1 | -3.5 | — | -100.0 | 5 | BEARISH | 25.0 |
| IGEX Indo Global Exchange(s) PTE, Ltd. | — | -20.1 | -12.1 | -3.5 | — | -100.0 | 5 | BEARISH | 25.0 |
| TSMRF Tsumura & Co. | $1.7B | 9.1 | 9.1 | 7.0 | 10.5 | 6.9 | 3 | BEARISH | inf |
| TSMRF Tsumura & Co. | $1.7B | 9.1 | 9.1 | 7.0 | 10.5 | 6.9 | 3 | BEARISH | inf |
| STSEY Stratec SE | $1.7B | -542.5 | -0.2 | -0.2 | 7.0 | -4.8 | 4 | BEARISH | -17.8 |
| STSEY Stratec SE | $1.7B | -542.5 | -0.2 | -0.2 | 7.0 | -4.8 | 4 | BEARISH | -17.8 |
| MDCLF MedinCell S.A. | $1.2B | -24.4 | 264.0 | 116.8 | -152.1 | 129.2 | 6 | BEARISH | 392.7 |
| MDCLF MedinCell S.A. | $1.2B | -24.4 | 264.0 | 116.8 | -152.1 | 129.2 | 6 | BEARISH | 392.7 |
| AGYTF Allergy Therapeutics plc | $760M | -4.8 | -550.7 | -218.7 | -54.9 | 4.4 | 2 | BEARISH | 76.5 |
| AGYTF Allergy Therapeutics plc | $760M | -4.8 | -550.7 | -218.7 | -54.9 | 4.4 | 2 | BEARISH | 76.5 |
| CLHLF COLTENE Holding AG | $370M | 18.9 | 30.1 | 25.6 | 3.6 | -5.4 | 4 | BEARISH | 0.0 |
| CLHLF COLTENE Holding AG | $370M | 18.9 | 30.1 | 25.6 | 3.6 | -5.4 | 4 | BEARISH | 0.0 |
| JMDMF Japan Medical Dynamic Marketing, Inc. | $130M | — | — | — | — | — | — | BEARISH | 49.7 |
| JMDMF Japan Medical Dynamic Marketing, Inc. | $130M | — | — | — | — | — | — | BEARISH | 49.7 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $100M | -17.1 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $100M | -17.1 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| POLBF Poolbeg Pharma PLC | $70M | -9.2 | -117.0 | -516.5 | — | — | 1 | BEARISH | 125.4 |
| POLBF Poolbeg Pharma PLC | $70M | -9.2 | -117.0 | -516.5 | — | — | 1 | BEARISH | 125.4 |
| POCI Precision Optics Corporation, Inc. | $50M | -9.6 | -22.3 | -19.0 | -1.2 | 65.2 | 5 | BEARISH | 2.8 |
| POCI Precision Optics Corporation, Inc. | $50M | -9.6 | -22.3 | -19.0 | -1.2 | 65.2 | 5 | BEARISH | 2.8 |
| CLIFF Cordlife Group Limited | $40M | -2.9 | -9.9 | -15.8 | -11.3 | 11.3 | 5 | BEARISH | 20.3 |
| CLIFF Cordlife Group Limited | $40M | -2.9 | -9.9 | -15.8 | -11.3 | 11.3 | 5 | BEARISH | 20.3 |
| NASC Nascent Pharma Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NASC Nascent Pharma Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| PAIOF Paion AG | — | -4.4 | -385.3 | -130.5 | -98.8 | -18.0 | 1 | BEARISH | 600.0 |
| PAIOF Paion AG | — | -4.4 | -385.3 | -130.5 | -98.8 | -18.0 | 1 | BEARISH | 600.0 |
| YUKA Yuka Group, Inc. | — | -2.4 | 24.0 | 81.8 | -50.7 | -8.2 | 5 | BEARISH | 192.4 |
| YUKA Yuka Group, Inc. | — | -2.4 | 24.0 | 81.8 | -50.7 | -8.2 | 5 | BEARISH | 192.4 |
| MRRCF Wayland Group Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MRRCF Wayland Group Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RBII Rising Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RBII Rising Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | $690M | 70.6 | 2.8 | 2.7 | 7.0 | -0.3 | 6 | BEARISH | 0.0 |
| SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | $690M | 70.6 | 2.8 | 2.7 | 7.0 | -0.3 | 6 | BEARISH | 0.0 |
| KMDA Kamada Ltd. | $480M | 21.7 | 8.4 | 11.0 | 16.9 | 13.2 | 7 | BEARISH | 21.5 |
| KMDA Kamada Ltd. | $480M | 21.7 | 8.4 | 11.0 | 16.9 | 13.2 | 7 | BEARISH | 21.5 |
| CBSC Cardiac Biotech Solutions Inc. | $10M | -8.0 | 87.3 | 51.1 | -341.6 | 78.5 | 3 | BEARISH | -30.0 |
| CBSC Cardiac Biotech Solutions Inc. | $10M | -8.0 | 87.3 | 51.1 | -341.6 | 78.5 | 3 | BEARISH | -30.0 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | 38.5 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | 38.5 |
| PUMD ProUroCare Medical Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| PUMD ProUroCare Medical Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| CBDHF Hempfusion Wellness Inc. | — | 0.0 | -82.5 | -84.6 | -190.5 | — | 1 | BEARISH | 0.0 |
| CBDHF Hempfusion Wellness Inc. | — | 0.0 | -82.5 | -84.6 | -190.5 | — | 1 | BEARISH | 0.0 |
| CLVR Clever Leaves Holdings Inc. | — | -0.0 | -55.4 | -63.3 | -109.6 | 3.6 | 4 | BEARISH | -0.0 |
| CLVR Clever Leaves Holdings Inc. | — | -0.0 | -55.4 | -63.3 | -109.6 | 3.6 | 4 | BEARISH | -0.0 |
| WLDFF Wildflower Brands Inc. | — | -0.0 | -27.7 | -4.7 | 1.9 | 319.8 | 7 | BEARISH | 0.0 |
| WLDFF Wildflower Brands Inc. | — | -0.0 | -27.7 | -4.7 | 1.9 | 319.8 | 7 | BEARISH | 0.0 |
| ASFX American Scientific Resources, Incorporated | — | — | — | — | — | — | — | BEARISH | -25.0 |
| ASFX American Scientific Resources, Incorporated | — | — | — | — | — | — | — | BEARISH | -25.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | BEARISH | 0.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | BEARISH | 0.0 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | BEARISH | -92.3 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | BEARISH | -92.3 |
| ROTH PharmaRoth Labs, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| ROTH PharmaRoth Labs, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| SKTO SK3 Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SKTO SK3 Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| FSPM FusionPharm, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| FSPM FusionPharm, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NPHC Nutra Pharma Corp. | — | -0.1 | 23.1 | 4.7 | -11458.0 | 55.8 | 3 | BEARISH | 0.0 |
| NPHC Nutra Pharma Corp. | — | -0.1 | 23.1 | 4.7 | -11458.0 | 55.8 | 3 | BEARISH | 0.0 |
| GELS Gelteq Limited Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -59.6 |
| GELS Gelteq Limited Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -59.6 |
| PXYN Praxsyn Corporation | — | -0.0 | 159.9 | 101.7 | 14.5 | 14.7 | 4 | BEARISH | 0.0 |
| PXYN Praxsyn Corporation | — | -0.0 | 159.9 | 101.7 | 14.5 | 14.7 | 4 | BEARISH | 0.0 |
| IONM Assure Holdings Corp. | — | -0.0 | 237.0 | 462.9 | -25500.0 | -64.6 | 1 | BEARISH | -99.0 |
| IONM Assure Holdings Corp. | — | -0.0 | 237.0 | 462.9 | -25500.0 | -64.6 | 1 | BEARISH | -99.0 |
| CSDX CS Diagnostics Corp. | — | — | — | — | — | — | — | BEARISH | — |
| CSDX CS Diagnostics Corp. | — | — | — | — | — | — | — | BEARISH | — |
| HTGMQ HTG Molecular Diagnostics, Inc. | — | -0.0 | -343.2 | 734.2 | -489.6 | -28.2 | 2 | BEARISH | 0.0 |
| HTGMQ HTG Molecular Diagnostics, Inc. | — | -0.0 | -343.2 | 734.2 | -489.6 | -28.2 | 2 | BEARISH | 0.0 |
| EVRRF Molecule Holdings Inc. | — | -0.1 | 97.7 | -3110.1 | -110.2 | 11.6 | 4 | BEARISH | 0.0 |
| EVRRF Molecule Holdings Inc. | — | -0.1 | 97.7 | -3110.1 | -110.2 | 11.6 | 4 | BEARISH | 0.0 |
| SNNVF Sunniva Inc. | — | -0.2 | -85.4 | -22.5 | -381.7 | 126.7 | 3 | BEARISH | 900.0 |
| SNNVF Sunniva Inc. | — | -0.2 | -85.4 | -22.5 | -381.7 | 126.7 | 3 | BEARISH | 900.0 |
| TCNAF TransCanna Holdings Inc. | — | -0.0 | -246.6 | -38.8 | -338.7 | 90.3 | 3 | BEARISH | 0.0 |
| TCNAF TransCanna Holdings Inc. | — | -0.0 | -246.6 | -38.8 | -338.7 | 90.3 | 3 | BEARISH | 0.0 |
| CAAOF INDVR Brands Inc. | — | -0.0 | -111.6 | -22.0 | -159.3 | 22.0 | 4 | BEARISH | 0.0 |
| CAAOF INDVR Brands Inc. | — | -0.0 | -111.6 | -22.0 | -159.3 | 22.0 | 4 | BEARISH | 0.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | BEARISH | 0.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | BEARISH | 0.0 |
| PRPH ProPhase Labs, Inc. | — | -0.0 | -544.0 | -207.6 | -301.8 | -5.5 | 3 | BEARISH | -99.7 |
| PRPH ProPhase Labs, Inc. | — | -0.0 | -544.0 | -207.6 | -301.8 | -5.5 | 3 | BEARISH | -99.7 |
| FIORF Fiore Cannabis Ltd. | — | -0.0 | -417.3 | -33.3 | -383.4 | -6.2 | 2 | BEARISH | 0.0 |
| FIORF Fiore Cannabis Ltd. | — | -0.0 | -417.3 | -33.3 | -383.4 | -6.2 | 2 | BEARISH | 0.0 |
| MCIC Multicorp International, Inc. | — | -31.5 | -1.1 | -0.2 | — | — | 3 | BEARISH | 100.0 |
| MCIC Multicorp International, Inc. | — | -31.5 | -1.1 | -0.2 | — | — | 3 | BEARISH | 100.0 |
| AVTI Avitar, Inc. | — | -0.0 | 26.0 | -62.7 | -263.1 | -47.4 | 2 | BEARISH | 0.0 |
| AVTI Avitar, Inc. | — | -0.0 | 26.0 | -62.7 | -263.1 | -47.4 | 2 | BEARISH | 0.0 |
| LITH BioELife Corp. | — | -0.0 | -598.1 | 467.7 | — | — | 2 | BEARISH | 0.0 |
| LITH BioELife Corp. | — | -0.0 | -598.1 | 467.7 | — | — | 2 | BEARISH | 0.0 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | BEARISH | 1900.0 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | BEARISH | 1900.0 |
| AUSAF Australis Capital Inc. | — | -0.0 | -52.8 | -42.1 | -1022.3 | 1388076.3 | 3 | BEARISH | -90.0 |
| AUSAF Australis Capital Inc. | — | -0.0 | -52.8 | -42.1 | -1022.3 | 1388076.3 | 3 | BEARISH | -90.0 |
| IGRW Interactive Health Network | — | 0.2 | 1090.1 | 947.6 | -29882.2 | — | 2 | BEARISH | 900.0 |
| IGRW Interactive Health Network | — | 0.2 | 1090.1 | 947.6 | -29882.2 | — | 2 | BEARISH | 900.0 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | BEARISH | 900.0 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | BEARISH | 900.0 |
| VRTHF Indigenous Bloom Hemp Corp. | — | -0.3 | 77.3 | 21.2 | — | — | 3 | BEARISH | 0.0 |
| VRTHF Indigenous Bloom Hemp Corp. | — | -0.3 | 77.3 | 21.2 | — | — | 3 | BEARISH | 0.0 |
| MDIN MedGen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MDIN MedGen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| JUVAF Juva Life Inc. | — | -0.0 | -105.0 | -21.4 | -24.6 | 43.5 | 4 | BEARISH | 0.0 |
| JUVAF Juva Life Inc. | — | -0.0 | -105.0 | -21.4 | -24.6 | 43.5 | 4 | BEARISH | 0.0 |
| ALID Allied Corp. | — | -0.0 | 266.4 | 484.7 | -207842.5 | -53.9 | 2 | BEARISH | -95.5 |
| ALID Allied Corp. | — | -0.0 | 266.4 | 484.7 | -207842.5 | -53.9 | 2 | BEARISH | -95.5 |
| CNNXF CannAmerica Brands Corp. | — | -0.0 | 53.3 | 23.6 | -127.3 | -16.8 | 4 | BEARISH | 0.0 |
| CNNXF CannAmerica Brands Corp. | — | -0.0 | 53.3 | 23.6 | -127.3 | -16.8 | 4 | BEARISH | 0.0 |
| DXBRF BellRock Brands Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| DXBRF BellRock Brands Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| WIBFF West Island Brands Inc. | — | -0.3 | -99.5 | -95.1 | -40.3 | 165.1 | 4 | BEARISH | 0.0 |
| WIBFF West Island Brands Inc. | — | -0.3 | -99.5 | -95.1 | -40.3 | 165.1 | 4 | BEARISH | 0.0 |
| MIRA MIRA Pharmaceuticals, Inc. | $30M | -0.5 | -710.9 | -15187.8 | — | — | 3 | BEARISH | -44.7 |
| MIRA MIRA Pharmaceuticals, Inc. | $30M | -0.5 | -710.9 | -15187.8 | — | — | 3 | BEARISH | -44.7 |
| SNANF Sona Nanotech Inc. | $30M | -15.4 | 526.4 | 236.5 | — | — | 1 | BEARISH | -47.3 |
| SNANF Sona Nanotech Inc. | $30M | -15.4 | 526.4 | 236.5 | — | — | 1 | BEARISH | -47.3 |
| RDGL Vivos Inc. | $20M | -5.9 | -132.5 | -427.2 | -2280.7 | 91.5 | 3 | BEARISH | -49.0 |
| RDGL Vivos Inc. | $20M | -5.9 | -132.5 | -427.2 | -2280.7 | 91.5 | 3 | BEARISH | -49.0 |
| AIMD Ainos, Inc. | $10M | -0.5 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -61.2 |
| AIMD Ainos, Inc. | $10M | -0.5 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -61.2 |
| IVRO InVitro International | — | 17.1 | 3.7 | 4.6 | 4.8 | -14.0 | 5 | BEARISH | 0.0 |
| IVRO InVitro International | — | 17.1 | 3.7 | 4.6 | 4.8 | -14.0 | 5 | BEARISH | 0.0 |
| SNNC Sibannac, Inc. | — | -1.7 | 44.4 | 105.9 | — | -14.2 | 3 | BEARISH | -72.4 |
| SNNC Sibannac, Inc. | — | -1.7 | 44.4 | 105.9 | — | -14.2 | 3 | BEARISH | -72.4 |
| CNBX CNBX Pharmaceuticals Inc. | — | -0.5 | 17.8 | 13.3 | — | 100.0 | 3 | BEARISH | -71.4 |
| CNBX CNBX Pharmaceuticals Inc. | — | -0.5 | 17.8 | 13.3 | — | 100.0 | 3 | BEARISH | -71.4 |
| STME Stimcell Energetics, Inc. | — | -6.2 | 17.7 | 20.7 | — | — | 2 | BEARISH | — |
| STME Stimcell Energetics, Inc. | — | -6.2 | 17.7 | 20.7 | — | — | 2 | BEARISH | — |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | BEARISH | -99.8 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | BEARISH | -99.8 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | 77.8 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | 77.8 |
| SKYI Sky Century Investment, Inc. | — | -2.5 | 26.2 | 21.6 | -11.3 | 180.9 | 4 | BEARISH | 3448.8 |
| SKYI Sky Century Investment, Inc. | — | -2.5 | 26.2 | 21.6 | -11.3 | 180.9 | 4 | BEARISH | 3448.8 |
| FUNI Hypha Labs, Inc. | — | -0.4 | 26.8 | 31.4 | — | — | 2 | BEARISH | — |
| FUNI Hypha Labs, Inc. | — | -0.4 | 26.8 | 31.4 | — | — | 2 | BEARISH | — |
| ACUR Acura Pharmaceuticals, Inc. | — | -0.0 | 30.8 | -306.4 | 80.6 | -56.2 | 4 | BEARISH | -75.0 |
| ACUR Acura Pharmaceuticals, Inc. | — | -0.0 | 30.8 | -306.4 | 80.6 | -56.2 | 4 | BEARISH | -75.0 |
| CBDL CBD Life Sciences Inc. | — | 75.9 | -92.8 | -98.4 | -234.9 | -30.0 | 2 | BEARISH | -83.3 |
| CBDL CBD Life Sciences Inc. | — | 75.9 | -92.8 | -98.4 | -234.9 | -30.0 | 2 | BEARISH | -83.3 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 128.1 | 61.3 | 282.5 | 14.6 | 7.2 | 5 | BEARISH | 19.0 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 128.1 | 61.3 | 282.5 | 14.6 | 7.2 | 5 | BEARISH | 19.0 |
| AVBP ArriVent BioPharma, Inc. | $1.3B | -7.7 | -53.1 | 2345.1 | — | — | 3 | BEARISH | 53.1 |
| AVBP ArriVent BioPharma, Inc. | $1.3B | -7.7 | -53.1 | 2345.1 | — | — | 3 | BEARISH | 53.1 |
| OMDA Omada Health | $1.2B | 300.0 | 1.8 | -1.5 | 6.0 | 404.7 | 7 | BEARISH | -9.2 |
| OMDA Omada Health | $1.2B | 300.0 | 1.8 | -1.5 | 6.0 | 404.7 | 7 | BEARISH | -9.2 |
| SLNCF Silence Therapeutics plc | $570M | -2.8 | -90.4 | 137.0 | — | -97.6 | 1 | BEARISH | 175.9 |
| SLNCF Silence Therapeutics plc | $570M | -2.8 | -90.4 | 137.0 | — | -97.6 | 1 | BEARISH | 175.9 |
| ZRSEF DocMorris AG | $500M | -8.1 | -65.3 | -43.0 | -8.9 | -0.4 | 4 | BEARISH | 0.0 |
| ZRSEF DocMorris AG | $500M | -8.1 | -65.3 | -43.0 | -8.9 | -0.4 | 4 | BEARISH | 0.0 |
| AVIR Atea Pharmaceuticals, Inc. | $410M | -2.5 | -58.1 | 974.6 | — | — | 3 | BEARISH | 78.1 |
| AVIR Atea Pharmaceuticals, Inc. | $410M | -2.5 | -58.1 | 974.6 | — | — | 3 | BEARISH | 78.1 |
| CARL Carlsmed, Inc. | $390M | -10.5 | -43.8 | -122.7 | -55.5 | — | 2 | BEARISH | 7.1 |
| CARL Carlsmed, Inc. | $390M | -10.5 | -43.8 | -122.7 | -55.5 | — | 2 | BEARISH | 7.1 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| WHWK Whitehawk Therapeutics Inc | $210M | -3.3 | -45.0 | 963.4 | — | -100.0 | 1 | BEARISH | 93.7 |
| WHWK Whitehawk Therapeutics Inc | $210M | -3.3 | -45.0 | 963.4 | — | -100.0 | 1 | BEARISH | 93.7 |
| CLLKF BICO Group AB (publ) | $150M | -1.9 | -41.7 | -8.4 | -11.1 | -16.1 | 7 | BEARISH | -6.1 |
| CLLKF BICO Group AB (publ) | $150M | -1.9 | -41.7 | -8.4 | -11.1 | -16.1 | 7 | BEARISH | -6.1 |
| VTVT vTv Therapeutics Inc. | $80M | -277.9 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 27.4 |
| VTVT vTv Therapeutics Inc. | $80M | -277.9 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 27.4 |
| CNTB Connect Biopharma Holdings Limited | $60M | -1.1 | -128.0 | 1785.6 | -1249.0 | -79.7 | 2 | BEARISH | -38.2 |
| CNTB Connect Biopharma Holdings Limited | $60M | -1.1 | -128.0 | 1785.6 | -1249.0 | -79.7 | 2 | BEARISH | -38.2 |
| QTI QT Imaging Holdings, Inc. | $40M | -2.3 | -1915.2 | 88.4 | -148.9 | -99.4 | 5 | BEARISH | 372.6 |
| QTI QT Imaging Holdings, Inc. | $40M | -2.3 | -1915.2 | 88.4 | -148.9 | -99.4 | 5 | BEARISH | 372.6 |
| HYEX Healthy Extracts Inc. | $20M | -6.6 | -7.7 | -2.8 | -6.3 | 84.1 | 5 | BEARISH | -38.6 |
| HYEX Healthy Extracts Inc. | $20M | -6.6 | -7.7 | -2.8 | -6.3 | 84.1 | 5 | BEARISH | -38.6 |
| VYYRF Voyageur Pharmaceuticals Ltd. | $20M | -6.5 | -527.9 | -47345.4 | -6124.5 | — | 3 | BEARISH | -16.7 |
| VYYRF Voyageur Pharmaceuticals Ltd. | $20M | -6.5 | -527.9 | -47345.4 | -6124.5 | — | 3 | BEARISH | -16.7 |
| AYTU Aytu BioPharma, Inc. | $20M | -1.5 | -52.6 | -24.3 | -0.1 | -13.3 | 4 | BEARISH | 10.7 |
| AYTU Aytu BioPharma, Inc. | $20M | -1.5 | -52.6 | -24.3 | -0.1 | -13.3 | 4 | BEARISH | 10.7 |
| FNCHQ Finch Therapeutics Group, Inc. | $20M | — | — | — | — | — | — | BEARISH | — |
| FNCHQ Finch Therapeutics Group, Inc. | $20M | — | — | — | — | — | — | BEARISH | — |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $20M | -10.5 | 64.4 | 131.0 | — | — | 4 | BEARISH | 269.5 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $20M | -10.5 | 64.4 | 131.0 | — | — | 4 | BEARISH | 269.5 |
| INM InMed Pharmaceuticals Inc. | $10M | -0.4 | -129.6 | 732.1 | -0.2 | 37942.8 | 3 | BEARISH | -40.1 |
| INM InMed Pharmaceuticals Inc. | $10M | -0.4 | -129.6 | 732.1 | -0.2 | 37942.8 | 3 | BEARISH | -40.1 |
| ASAPF Aurora Spine Corporation | $10M | -6.4 | -35.3 | -14.8 | -22.8 | -4.5 | 5 | BEARISH | -51.2 |
| ASAPF Aurora Spine Corporation | $10M | -6.4 | -35.3 | -14.8 | -22.8 | -4.5 | 5 | BEARISH | -51.2 |
| TUTH Standard Dental Labs Inc. | — | -4.5 | 26.7 | 318.1 | -228.2 | -27.6 | 2 | BEARISH | -48.8 |
| TUTH Standard Dental Labs Inc. | — | -4.5 | 26.7 | 318.1 | -228.2 | -27.6 | 2 | BEARISH | -48.8 |
| AZFL Amazonas Florestal, Ltd | — | 3.3 | 19.8 | 13.9 | 13.6 | — | 5 | BEARISH | 0.0 |
| AZFL Amazonas Florestal, Ltd | — | 3.3 | 19.8 | 13.9 | 13.6 | — | 5 | BEARISH | 0.0 |
| TDSGF Telo Genomics Corp. | — | -2.4 | -2858.5 | 258.3 | — | — | 2 | BEARISH | -37.3 |
| TDSGF Telo Genomics Corp. | — | -2.4 | -2858.5 | 258.3 | — | — | 2 | BEARISH | -37.3 |
| ATXI Avenue Therapeutics, Inc. | — | -0.5 | -120.0 | 178.4 | — | -100.0 | 2 | BEARISH | -43.4 |
| ATXI Avenue Therapeutics, Inc. | — | -0.5 | -120.0 | 178.4 | — | -100.0 | 2 | BEARISH | -43.4 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -4.3 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -4.3 |
| AEGY Alternative Energy Partners, Inc. | — | -0.0 | 190.5 | 67.0 | — | -165.0 | 4 | BEARISH | -80.0 |
| AEGY Alternative Energy Partners, Inc. | — | -0.0 | 190.5 | 67.0 | — | -165.0 | 4 | BEARISH | -80.0 |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | 10.8 |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | 10.8 |
| NUWE Nuwellis, Inc. | — | -0.0 | 202.0 | 173.3 | -245.2 | 8.4 | 5 | BEARISH | -78.4 |
| NUWE Nuwellis, Inc. | — | -0.0 | 202.0 | 173.3 | -245.2 | 8.4 | 5 | BEARISH | -78.4 |
| EMYSF Easy Technologies Inc. | — | -0.3 | 192.7 | 227.8 | — | -100.0 | 1 | BEARISH | 0.0 |
| EMYSF Easy Technologies Inc. | — | -0.3 | 192.7 | 227.8 | — | -100.0 | 1 | BEARISH | 0.0 |
| PANHF Ping An Healthcare and Technology Company Limited | $1.7B | 23.9 | 5.3 | 6.9 | 8.8 | 4.4 | 7 | BEARISH | -56.5 |
| PANHF Ping An Healthcare and Technology Company Limited | $1.7B | 23.9 | 5.3 | 6.9 | 8.8 | 4.4 | 7 | BEARISH | -56.5 |
| ARDT Ardent Health Inc. | $1.5B | 18.8 | 6.0 | 13.5 | 1.0 | 3.3 | 5 | BEARISH | -20.9 |
| ARDT Ardent Health Inc. | $1.5B | 18.8 | 6.0 | 13.5 | 1.0 | 3.3 | 5 | BEARISH | -20.9 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.3B | -9.0 | -39.8 | -102.9 | — | — | 3 | BEARISH | 4.3 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.3B | -9.0 | -39.8 | -102.9 | — | — | 3 | BEARISH | 4.3 |
| ANGO AngioDynamics, Inc. | $620M | -17.2 | -20.8 | -27.0 | -13.2 | 9.5 | 4 | BEARISH | 36.5 |
| ANGO AngioDynamics, Inc. | $620M | -17.2 | -20.8 | -27.0 | -13.2 | 9.5 | 4 | BEARISH | 36.5 |
| DCTH Delcath Systems, Inc. | $520M | 1375.5 | 0.5 | -2.7 | 9.2 | 35.8 | 6 | BEARISH | 40.7 |
| DCTH Delcath Systems, Inc. | $520M | 1375.5 | 0.5 | -2.7 | 9.2 | 35.8 | 6 | BEARISH | 40.7 |
| IVVD Invivyd, Inc. | $240M | -2.1 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -31.8 |
| IVVD Invivyd, Inc. | $240M | -2.1 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -31.8 |
| PDEX Pro-Dex, Inc. | $200M | 15.2 | 32.4 | 17.5 | 14.0 | 16.4 | 8 | BEARISH | 89.6 |
| PDEX Pro-Dex, Inc. | $200M | 15.2 | 32.4 | 17.5 | 14.0 | 16.4 | 8 | BEARISH | 89.6 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | BEARISH | 9900.0 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | BEARISH | 9900.0 |
| LFPI LifePoint, Inc. | — | -0.0 | -288.4 | -229.2 | -52133.6 | 161.6 | 3 | BEARISH | 1400.0 |
| LFPI LifePoint, Inc. | — | -0.0 | -288.4 | -229.2 | -52133.6 | 161.6 | 3 | BEARISH | 1400.0 |
| ONSS Onassis Holdings Corp. | — | -0.2 | 202.8 | 38.2 | — | -100.0 | 2 | BEARISH | 200.0 |
| ONSS Onassis Holdings Corp. | — | -0.2 | 202.8 | 38.2 | — | -100.0 | 2 | BEARISH | 200.0 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | BEARISH | 100.0 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | BEARISH | 100.0 |
| ALST AllStar Health Brands Inc | — | -0.4 | 12.9 | 2.5 | — | — | 4 | BEARISH | -20.0 |
| ALST AllStar Health Brands Inc | — | -0.4 | 12.9 | 2.5 | — | — | 4 | BEARISH | -20.0 |
| BLMS Bloomios, Inc. | — | -0.0 | 221.4 | 58.3 | -3817.0 | 46.5 | 2 | BEARISH | 200.0 |
| BLMS Bloomios, Inc. | — | -0.0 | 221.4 | 58.3 | -3817.0 | 46.5 | 2 | BEARISH | 200.0 |
| BRSF Brain Scientific Inc. | — | -0.0 | -633.9 | -94.8 | -77714.6 | -19.3 | 3 | BEARISH | -99.9 |
| BRSF Brain Scientific Inc. | — | -0.0 | -633.9 | -94.8 | -77714.6 | -19.3 | 3 | BEARISH | -99.9 |
| ALPS Alps Group Inc | $70M | — | — | — | — | — | — | BEARISH | — |
| ALPS Alps Group Inc | $70M | — | — | — | — | — | — | BEARISH | — |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -2.1 | -69.7 | 650.7 | — | — | 1 | BEARISH | -86.7 |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -2.1 | -69.7 | 650.7 | — | — | 1 | BEARISH | -86.7 |
| MDRSF Medartis Holding AG | $1.4B | 68.4 | 5.2 | 3.9 | 3.2 | 29.8 | 7 | BEARISH | 72.5 |
| MDRSF Medartis Holding AG | $1.4B | 68.4 | 5.2 | 3.9 | 3.2 | 29.8 | 7 | BEARISH | 72.5 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 13.9 | 1.4 | -0.8 | 3.9 | -17.8 | 5 | BEARISH | -7.5 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 13.9 | 1.4 | -0.8 | 3.9 | -17.8 | 5 | BEARISH | -7.5 |
| IRD Opus Genetics, Inc. | $380M | -3.6 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 154.4 |
| IRD Opus Genetics, Inc. | $380M | -3.6 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 154.4 |
| VMTHF Venus Medtech (Hangzhou), Inc. Class H | $190M | -1.0 | -51.9 | -31.5 | -141.2 | -25.9 | 4 | BEARISH | -18.8 |
| VMTHF Venus Medtech (Hangzhou), Inc. Class H | $190M | -1.0 | -51.9 | -31.5 | -141.2 | -25.9 | 4 | BEARISH | -18.8 |
| TCLIF Theraclion S.A. | $40M | -6.4 | -342.1 | 1171.9 | -543.9 | 7.1 | 2 | BEARISH | 312841.2 |
| TCLIF Theraclion S.A. | $40M | -6.4 | -342.1 | 1171.9 | -543.9 | 7.1 | 2 | BEARISH | 312841.2 |
| ETST Earth Science Tech, Inc. | $30M | 6.8 | 66.8 | 212.2 | 8.0 | 8.0 | 6 | BEARISH | -47.9 |
| ETST Earth Science Tech, Inc. | $30M | 6.8 | 66.8 | 212.2 | 8.0 | 8.0 | 6 | BEARISH | -47.9 |
| LANZ Lancer Orthodontics, Inc. | — | 4.0 | 3.3 | 2.5 | -4.3 | 4.5 | 4 | BEARISH | 2566.7 |
| LANZ Lancer Orthodontics, Inc. | — | 4.0 | 3.3 | 2.5 | -4.3 | 4.5 | 4 | BEARISH | 2566.7 |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | BEARISH | 1081.8 |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | BEARISH | 1081.8 |
| HDRPF Epsilon Healthcare Limited | — | 86.7 | -33.3 | -22.6 | -9.6 | 161.1 | 5 | BEARISH | 614.3 |
| HDRPF Epsilon Healthcare Limited | — | 86.7 | -33.3 | -22.6 | -9.6 | 161.1 | 5 | BEARISH | 614.3 |
| NDATF nDatalyze Corp. | — | -16.7 | -49.3 | 2580.1 | — | -100.0 | 3 | BEARISH | 633.9 |
| NDATF nDatalyze Corp. | — | -16.7 | -49.3 | 2580.1 | — | -100.0 | 3 | BEARISH | 633.9 |
| DYAI Dyadic International, Inc. | $20M | -2.1 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -64.1 |
| DYAI Dyadic International, Inc. | $20M | -2.1 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -64.1 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -40.8 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -40.8 |
| BMRA Biomerica, Inc. | $10M | -1.7 | -112.1 | -113.5 | -130.9 | -16.2 | 4 | BEARISH | -21.3 |
| BMRA Biomerica, Inc. | $10M | -1.7 | -112.1 | -113.5 | -130.9 | -16.2 | 4 | BEARISH | -21.3 |
| PZOO Pazoo, Inc. | — | -0.0 | 49.0 | 21.1 | -972321.6 | -100.0 | 4 | BEARISH | 0.0 |
| PZOO Pazoo, Inc. | — | -0.0 | 49.0 | 21.1 | -972321.6 | -100.0 | 4 | BEARISH | 0.0 |
| CHALF Chalice Brands Ltd | — | 0.0 | -51.3 | -9.0 | 9.4 | 36.2 | 5 | BEARISH | 0.0 |
| CHALF Chalice Brands Ltd | — | 0.0 | -51.3 | -9.0 | 9.4 | 36.2 | 5 | BEARISH | 0.0 |
| KGET CaliPharms, Inc. | — | -0.4 | 72.6 | 7.6 | -6979.1 | — | 2 | BEARISH | 3900.0 |
| KGET CaliPharms, Inc. | — | -0.4 | 72.6 | 7.6 | -6979.1 | — | 2 | BEARISH | 3900.0 |
| FITX Creative Edge Nutrition, Inc. | — | -0.0 | 242.9 | 120.2 | -98.6 | — | 3 | BEARISH | 0.0 |
| FITX Creative Edge Nutrition, Inc. | — | -0.0 | 242.9 | 120.2 | -98.6 | — | 3 | BEARISH | 0.0 |
| KALY Kali, Inc. | — | -8.6 | 32.3 | 47.0 | 20.9 | 28.1 | 4 | BEARISH | 100.0 |
| KALY Kali, Inc. | — | -8.6 | 32.3 | 47.0 | 20.9 | 28.1 | 4 | BEARISH | 100.0 |
| TOMDF Todos Medical Ltd. | — | -0.0 | 89.6 | -253.6 | -355.9 | -37.1 | 3 | BEARISH | 0.0 |
| TOMDF Todos Medical Ltd. | — | -0.0 | 89.6 | -253.6 | -355.9 | -37.1 | 3 | BEARISH | 0.0 |
| KLYG Kelyniam Global, Inc. | — | -30.2 | -26.9 | 10.0 | -16.7 | 2.0 | 5 | BEARISH | 62.6 |
| KLYG Kelyniam Global, Inc. | — | -30.2 | -26.9 | 10.0 | -16.7 | 2.0 | 5 | BEARISH | 62.6 |
| WLSI Wellstar International, Inc. | — | -0.0 | 24.2 | 35.0 | — | — | 3 | BEARISH | 0.0 |
| WLSI Wellstar International, Inc. | — | -0.0 | 24.2 | 35.0 | — | — | 3 | BEARISH | 0.0 |
| AFIB Acutus Medical, Inc. | — | -0.0 | 153.1 | -0.4 | -19.7 | 375.7 | 2 | BEARISH | -88.9 |
| AFIB Acutus Medical, Inc. | — | -0.0 | 153.1 | -0.4 | -19.7 | 375.7 | 2 | BEARISH | -88.9 |
| CATV Opus Holdings, Inc. | — | -16.9 | -0.8 | -1.4 | 91.7 | 47.8 | 5 | BEARISH | -50.0 |
| CATV Opus Holdings, Inc. | — | -16.9 | -0.8 | -1.4 | 91.7 | 47.8 | 5 | BEARISH | -50.0 |
| MAHN Mid-Atlantic Home Health Network, Inc. | — | — | — | — | — | — | — | BEARISH | -88.0 |
| MAHN Mid-Atlantic Home Health Network, Inc. | — | — | — | — | — | — | — | BEARISH | -88.0 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -920.3 | -356.4 | -649.8 | 131.0 | 4 | BEARISH | -85.1 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -920.3 | -356.4 | -649.8 | 131.0 | 4 | BEARISH | -85.1 |
| CVSGF CVS Group plc | $1.1B | 45.6 | 16.0 | 17.2 | 2.7 | 49.6 | 6 | BEARISH | 1.8 |
| CVSGF CVS Group plc | $1.1B | 45.6 | 16.0 | 17.2 | 2.7 | 49.6 | 6 | BEARISH | 1.8 |
| PHGUF Pharming Group N.V. | $780M | 66.6 | 3.7 | 5.8 | 1.7 | 7.8 | 7 | BEARISH | -26.0 |
| PHGUF Pharming Group N.V. | $780M | 66.6 | 3.7 | 5.8 | 1.7 | 7.8 | 7 | BEARISH | -26.0 |
| OFIX Orthofix Medical Inc. | $370M | -5.9 | -13.9 | -3.6 | -7.5 | 3.0 | 6 | BEARISH | -36.6 |
| OFIX Orthofix Medical Inc. | $370M | -5.9 | -13.9 | -3.6 | -7.5 | 3.0 | 6 | BEARISH | -36.6 |
| VHIBF Vitalhub Corp. | $340M | 63.2 | 3.3 | 10.7 | 6.1 | 53.9 | 7 | BEARISH | -32.0 |
| VHIBF Vitalhub Corp. | $340M | 63.2 | 3.3 | 10.7 | 6.1 | 53.9 | 7 | BEARISH | -32.0 |
| CATX Perspective Therapeutics, Inc. | $310M | -1.8 | -39.5 | -108.8 | -33069.1 | -35.3 | 3 | BEARISH | -19.8 |
| CATX Perspective Therapeutics, Inc. | $310M | -1.8 | -39.5 | -108.8 | -33069.1 | -35.3 | 3 | BEARISH | -19.8 |
| PROF Profound Medical Corp. | $210M | -6.1 | -73.1 | -148.0 | -384.2 | 35.5 | 3 | BEARISH | 18.2 |
| PROF Profound Medical Corp. | $210M | -6.1 | -73.1 | -148.0 | -384.2 | 35.5 | 3 | BEARISH | 18.2 |
| CDXS Codexis, Inc. | $150M | -4.0 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -45.6 |
| CDXS Codexis, Inc. | $150M | -4.0 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -45.6 |
| GTHP Guided Therapeutics, Inc. | $20M | -5.5 | 66.3 | 57.9 | — | 450.8 | 3 | BEARISH | -18.5 |
| GTHP Guided Therapeutics, Inc. | $20M | -5.5 | 66.3 | 57.9 | — | 450.8 | 3 | BEARISH | -18.5 |
| LPTI Longport, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LPTI Longport, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RSCI Redwood Scientific Technologies, Inc. | — | -0.0 | 2488.8 | 821.0 | — | — | 2 | BEARISH | -99.9 |
| RSCI Redwood Scientific Technologies, Inc. | — | -0.0 | 2488.8 | 821.0 | — | — | 2 | BEARISH | -99.9 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | 0.0 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | 0.0 |
| LLBO Lifeline Biotechnologies, Inc. | — | — | — | — | — | — | — | BEARISH | -60.0 |
| LLBO Lifeline Biotechnologies, Inc. | — | — | — | — | — | — | — | BEARISH | -60.0 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| JWCAF James E. Wagner Cultivation Corporation | — | -0.0 | -50.3 | -16.2 | -493.1 | 315.1 | 2 | BEARISH | 9900.0 |
| JWCAF James E. Wagner Cultivation Corporation | — | -0.0 | -50.3 | -16.2 | -493.1 | 315.1 | 2 | BEARISH | 9900.0 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | BEARISH | 0.0 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | BEARISH | 0.0 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| GEATF Radiko Holdings Corp | — | -0.0 | 178.7 | -374.3 | -40.1 | -30.5 | 3 | BEARISH | 0.0 |
| GEATF Radiko Holdings Corp | — | -0.0 | 178.7 | -374.3 | -40.1 | -30.5 | 3 | BEARISH | 0.0 |
| BMGP Biomagnetics Diagnostics Corp. | — | — | — | — | — | — | — | BEARISH | -28.6 |
| BMGP Biomagnetics Diagnostics Corp. | — | — | — | — | — | — | — | BEARISH | -28.6 |
| OMDD Ormand Industries Inc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| OMDD Ormand Industries Inc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LFCOF Lift & Co. Corp. | — | -0.0 | 149.0 | -666.2 | -170.0 | — | 2 | BEARISH | 0.0 |
| LFCOF Lift & Co. Corp. | — | -0.0 | 149.0 | -666.2 | -170.0 | — | 2 | BEARISH | 0.0 |
| LRSV Link Reservations Inc. | — | -7.6 | 103.3 | 152.0 | -20.7 | 73995.4 | 5 | BEARISH | -50.0 |
| LRSV Link Reservations Inc. | — | -7.6 | 103.3 | 152.0 | -20.7 | 73995.4 | 5 | BEARISH | -50.0 |
| DGEN Deltagen Inc. | — | 0.0 | 19.8 | 182.7 | -27.2 | -65.8 | 4 | BEARISH | 0.0 |
| DGEN Deltagen Inc. | — | 0.0 | 19.8 | 182.7 | -27.2 | -65.8 | 4 | BEARISH | 0.0 |
| VRSEF Verisante Technology Inc. | — | 0.7 | 124.9 | 102.2 | — | — | 3 | BEARISH | -88.0 |
| VRSEF Verisante Technology Inc. | — | 0.7 | 124.9 | 102.2 | — | — | 3 | BEARISH | -88.0 |
| CGNSF Cognetivity Neurosciences Ltd. | — | -0.1 | 78.7 | 25.2 | -6985.2 | — | 2 | BEARISH | 0.0 |
| CGNSF Cognetivity Neurosciences Ltd. | — | -0.1 | 78.7 | 25.2 | -6985.2 | — | 2 | BEARISH | 0.0 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| IMEXF Imagin Medical Inc. | — | -0.0 | 31.8 | 185.9 | — | — | 3 | BEARISH | 0.0 |
| IMEXF Imagin Medical Inc. | — | -0.0 | 31.8 | 185.9 | — | — | 3 | BEARISH | 0.0 |
| RGDXQ Response Genetics, Inc | — | -0.0 | 1186.4 | -243.6 | -110.9 | -8.1 | 3 | BEARISH | 0.0 |
| RGDXQ Response Genetics, Inc | — | -0.0 | 1186.4 | -243.6 | -110.9 | -8.1 | 3 | BEARISH | 0.0 |
| DMSI Dermisonics, Inc. | — | -0.0 | -392.2 | 1105.0 | — | — | 1 | BEARISH | 0.0 |
| DMSI Dermisonics, Inc. | — | -0.0 | -392.2 | 1105.0 | — | — | 1 | BEARISH | 0.0 |
| EWPI Emerging World Pharma, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| EWPI Emerging World Pharma, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BNVIF Binovi Technologies Corp. | — | -0.0 | -433.7 | 182.0 | 17056.9 | -74.4 | 1 | BEARISH | 400.0 |
| BNVIF Binovi Technologies Corp. | — | -0.0 | -433.7 | 182.0 | 17056.9 | -74.4 | 1 | BEARISH | 400.0 |
| BSPK Bespoke Extracts, Inc. | — | -0.0 | 37.1 | 45.4 | -16.7 | 284.5 | 4 | BEARISH | -99.4 |
| BSPK Bespoke Extracts, Inc. | — | -0.0 | 37.1 | 45.4 | -16.7 | 284.5 | 4 | BEARISH | -99.4 |
| THCBF THC Biomed Intl Ltd. | — | -1.1 | -56.5 | -34.0 | -196.4 | -17.5 | 2 | BEARISH | 0.0 |
| THCBF THC Biomed Intl Ltd. | — | -1.1 | -56.5 | -34.0 | -196.4 | -17.5 | 2 | BEARISH | 0.0 |
| CBGL Cannabis Global Inc. | — | -0.5 | 5.4 | 17.3 | — | 520.3 | 3 | BEARISH | 900.0 |
| CBGL Cannabis Global Inc. | — | -0.5 | 5.4 | 17.3 | — | 520.3 | 3 | BEARISH | 900.0 |
| MDVLQ MedAvail Holdings, Inc. | — | -0.0 | -164.8 | -243.8 | -1429.9 | -28.6 | 4 | BEARISH | 0.0 |
| MDVLQ MedAvail Holdings, Inc. | — | -0.0 | -164.8 | -243.8 | -1429.9 | -28.6 | 4 | BEARISH | 0.0 |
| NSVGF Nass Valley Gateway Ltd. | — | -3.7 | 12.1 | 2.9 | — | -95.8 | 1 | BEARISH | 0.0 |
| NSVGF Nass Valley Gateway Ltd. | — | -3.7 | 12.1 | 2.9 | — | -95.8 | 1 | BEARISH | 0.0 |
| INSD Instadose Pharma Corp. | — | -0.0 | -9.7 | -3.7 | — | — | 4 | BEARISH | -90.9 |
| INSD Instadose Pharma Corp. | — | -0.0 | -9.7 | -3.7 | — | — | 4 | BEARISH | -90.9 |
| WCUI Wellness Center USA, Inc. | — | -0.0 | 44.8 | 1728.1 | -86.5 | 140.9 | 5 | BEARISH | 0.0 |
| WCUI Wellness Center USA, Inc. | — | -0.0 | 44.8 | 1728.1 | -86.5 | 140.9 | 5 | BEARISH | 0.0 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 6681.5 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 6681.5 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | BEARISH | 0.0 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | BEARISH | 0.0 |
| UPPR Upper Street Marketing Inc. | — | -0.0 | 228.5 | -53.9 | -715.0 | — | 1 | BEARISH | 42.9 |
| UPPR Upper Street Marketing Inc. | — | -0.0 | 228.5 | -53.9 | -715.0 | — | 1 | BEARISH | 42.9 |
| BHNGF Bhang Inc. | — | -0.0 | 782.7 | 270.1 | -248.2 | 78.7 | 3 | BEARISH | 0.0 |
| BHNGF Bhang Inc. | — | -0.0 | 782.7 | 270.1 | -248.2 | 78.7 | 3 | BEARISH | 0.0 |
| DSOL Drug Free Solution, Inc. | — | -16.9 | 255.8 | 197.9 | — | — | 2 | BEARISH | -63.6 |
| DSOL Drug Free Solution, Inc. | — | -16.9 | 255.8 | 197.9 | — | — | 2 | BEARISH | -63.6 |
| ACNV Accelera Innovations, Inc | — | -0.0 | 197.1 | 28.9 | — | -97.0 | 1 | BEARISH | 0.0 |
| ACNV Accelera Innovations, Inc | — | -0.0 | 197.1 | 28.9 | — | -97.0 | 1 | BEARISH | 0.0 |
| BMCS BioTech Medics, Inc. | — | -13.9 | -0.0 | -0.0 | — | — | 5 | BEARISH | -97.7 |
| BMCS BioTech Medics, Inc. | — | -13.9 | -0.0 | -0.0 | — | — | 5 | BEARISH | -97.7 |
| SCRCQ ScripsAmerica, Inc. | — | -0.0 | 168.2 | 144.2 | -17.6 | 3510.5 | 5 | BEARISH | 0.0 |
| SCRCQ ScripsAmerica, Inc. | — | -0.0 | 168.2 | 144.2 | -17.6 | 3510.5 | 5 | BEARISH | 0.0 |
| IBXG iBX Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| IBXG iBX Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PEMTF Thoughtful Brands Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PEMTF Thoughtful Brands Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MJARF MJardin Group, Inc. | — | -0.0 | 59.5 | -11.0 | -1614.6 | -42.3 | 3 | BEARISH | 0.0 |
| MJARF MJardin Group, Inc. | — | -0.0 | 59.5 | -11.0 | -1614.6 | -42.3 | 3 | BEARISH | 0.0 |
| OTRKQ Ontrak, Inc. | — | -0.0 | -215.7 | -149.5 | -341.6 | -21.0 | 1 | BEARISH | -99.8 |
| OTRKQ Ontrak, Inc. | — | -0.0 | -215.7 | -149.5 | -341.6 | -21.0 | 1 | BEARISH | -99.8 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| ROSGQ Rosetta Genomics Ltd. | — | -0.0 | -44.3 | -306.4 | 136.0 | — | 1 | BEARISH | 0.0 |
| ROSGQ Rosetta Genomics Ltd. | — | -0.0 | -44.3 | -306.4 | 136.0 | — | 1 | BEARISH | 0.0 |
| SPPH Spencer Pharmaceutical Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SPPH Spencer Pharmaceutical Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 29900.0 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 29900.0 |
| CRRVF CVR Medical Corp. | — | -0.0 | 49.0 | 11.5 | — | — | 1 | BEARISH | 0.0 |
| CRRVF CVR Medical Corp. | — | -0.0 | 49.0 | 11.5 | — | — | 1 | BEARISH | 0.0 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.9 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | BEARISH | 27.9 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.9 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | BEARISH | 27.9 |
| ETON Eton Pharmaceuticals, Inc. | $1.5B | 119.1 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 173.2 |
| ETON Eton Pharmaceuticals, Inc. | $1.5B | 119.1 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 173.2 |
| HCSG Healthcare Services Group, Inc. | $1.4B | 12.1 | 24.7 | 31.7 | 4.8 | 5.2 | 8 | BEARISH | 28.4 |
| HCSG Healthcare Services Group, Inc. | $1.4B | 12.1 | 24.7 | 31.7 | 4.8 | 5.2 | 8 | BEARISH | 28.4 |
| SGP SpyGlass Pharma, Inc. Common Stock | $830M | — | — | — | — | — | — | BEARISH | — |
| SGP SpyGlass Pharma, Inc. Common Stock | $830M | — | — | — | — | — | — | BEARISH | — |
| ACHV Achieve Life Sciences, Inc. | $740M | -4.7 | -845.0 | 24.6 | — | — | 2 | BEARISH | 133.6 |
| ACHV Achieve Life Sciences, Inc. | $740M | -4.7 | -845.0 | 24.6 | — | — | 2 | BEARISH | 133.6 |
| TLSI TriSalus Life Sciences, Inc. | $270M | -3.3 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -5.3 |
| TLSI TriSalus Life Sciences, Inc. | $270M | -3.3 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -5.3 |
| ORMP Oramed Pharmaceuticals Inc. | $180M | 1.1 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 76.1 |
| ORMP Oramed Pharmaceuticals Inc. | $180M | 1.1 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 76.1 |
| ENTX Entera Bio Ltd. | $140M | -8.2 | -138.9 | 314.4 | — | -100.0 | 1 | BEARISH | 54.6 |
| ENTX Entera Bio Ltd. | $140M | -8.2 | -138.9 | 314.4 | — | -100.0 | 1 | BEARISH | 54.6 |
| ADCT ADC Therapeutics S.A. | $140M | -1.7 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BEARISH | -72.0 |
| ADCT ADC Therapeutics S.A. | $140M | -1.7 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BEARISH | -72.0 |
| OTLK Outlook Therapeutics, Inc. | $110M | -0.3 | 256.9 | 1372.0 | -225766.7 | -169.4 | 4 | BEARISH | -43.0 |
| OTLK Outlook Therapeutics, Inc. | $110M | -0.3 | 256.9 | 1372.0 | -225766.7 | -169.4 | 4 | BEARISH | -43.0 |
| ICCC ImmuCell Corporation | $90M | 115.2 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BEARISH | 47.7 |
| ICCC ImmuCell Corporation | $90M | 115.2 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BEARISH | 47.7 |
| LUNG Pulmonx Corporation | $80M | -1.6 | -88.9 | -92.5 | -44.3 | -3.4 | 4 | BEARISH | 10.2 |
| LUNG Pulmonx Corporation | $80M | -1.6 | -88.9 | -92.5 | -44.3 | -3.4 | 4 | BEARISH | 10.2 |
| DRIO DarioHealth Corp. | $50M | 9.4 | 113.8 | -93.8 | -153.1 | -22.6 | 3 | BEARISH | -62.4 |
| DRIO DarioHealth Corp. | $50M | 9.4 | 113.8 | -93.8 | -153.1 | -22.6 | 3 | BEARISH | -62.4 |
| ABDXF Abingdon Health Plc | $40M | -13.1 | -143.7 | -145.6 | -55.4 | 212.2 | 6 | BEARISH | 105.0 |
| ABDXF Abingdon Health Plc | $40M | -13.1 | -143.7 | -145.6 | -55.4 | 212.2 | 6 | BEARISH | 105.0 |
| YI 111, Inc. | $30M | -1.8 | 30.0 | 15.9 | -1.7 | -20.9 | 2 | BEARISH | -29.6 |
| YI 111, Inc. | $30M | -1.8 | 30.0 | 15.9 | -1.7 | -20.9 | 2 | BEARISH | -29.6 |
| AIMV AI Maverick Intel, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| AIMV AI Maverick Intel, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| ADVB Advanced Biomed Inc. Common Stock | $10M | -31.6 | -10.2 | -11.8 | — | — | 3 | BEARISH | -24.9 |
| ADVB Advanced Biomed Inc. Common Stock | $10M | -31.6 | -10.2 | -11.8 | — | — | 3 | BEARISH | -24.9 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.2 | -931.1 | -564.2 | — | — | 1 | BEARISH | -92.0 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.2 | -931.1 | -564.2 | — | — | 1 | BEARISH | -92.0 |
| RHEPB Regional Health Properties, Inc. | $10M | 0.5 | -328.8 | -0.6 | -3.2 | 200.4 | 6 | BEARISH | -0.8 |
| RHEPB Regional Health Properties, Inc. | $10M | 0.5 | -328.8 | -0.6 | -3.2 | 200.4 | 6 | BEARISH | -0.8 |
| MTVA MetaVia Inc. | $10M | -0.4 | -175.7 | 209.3 | — | — | 0 | BEARISH | -86.4 |
| MTVA MetaVia Inc. | $10M | -0.4 | -175.7 | 209.3 | — | — | 0 | BEARISH | -86.4 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | BEARISH | 9.5 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | BEARISH | 9.5 |
| PMHS Polomar Health Services, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| PMHS Polomar Health Services, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | BEARISH | -98.0 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | BEARISH | -98.0 |
| MDCN Medican Enterprises, Inc. | — | -3.4 | 40.4 | -2.1 | — | -38.5 | 3 | BEARISH | 0.0 |
| MDCN Medican Enterprises, Inc. | — | -3.4 | 40.4 | -2.1 | — | -38.5 | 3 | BEARISH | 0.0 |
| MDRM Modern Mobility Aids, Inc. | — | -63.9 | 146.1 | 120.5 | — | — | 2 | BEARISH | 42.9 |
| MDRM Modern Mobility Aids, Inc. | — | -63.9 | 146.1 | 120.5 | — | — | 2 | BEARISH | 42.9 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -92.6 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -92.6 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -97.1 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -97.1 |
| LVVV LiveWire Ergogenics, Inc. | — | -0.6 | -188.5 | -4.0 | -2585.3 | -89.5 | 3 | BEARISH | -0.0 |
| LVVV LiveWire Ergogenics, Inc. | — | -0.6 | -188.5 | -4.0 | -2585.3 | -89.5 | 3 | BEARISH | -0.0 |
| SPRC SciSparc Ltd. | — | -0.0 | -311.5 | -90652.5 | -721.8 | -48.8 | 3 | BEARISH | -25.2 |
| SPRC SciSparc Ltd. | — | -0.0 | -311.5 | -90652.5 | -721.8 | -48.8 | 3 | BEARISH | -25.2 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | BEARISH | -99.0 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | BEARISH | -99.0 |
| UDOCF Unidoc Health Corp. | — | -1.9 | -399.0 | 358.8 | -256.4 | — | 3 | BEARISH | -66.7 |
| UDOCF Unidoc Health Corp. | — | -1.9 | -399.0 | 358.8 | -256.4 | — | 3 | BEARISH | -66.7 |
| ZYBT Zhengye Biotechnology Holding Limited | $60M | — | — | — | — | — | — | BEARISH | -49.8 |
| ZYBT Zhengye Biotechnology Holding Limited | $60M | — | — | — | — | — | — | BEARISH | -49.8 |
| EXOZ eXoZymes, Inc. | $50M | -4.8 | -187.2 | 913.0 | — | — | 2 | BEARISH | -58.8 |
| EXOZ eXoZymes, Inc. | $50M | -4.8 | -187.2 | 913.0 | — | — | 2 | BEARISH | -58.8 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| JXFGF Jinxin Fertility Group Limited | $740M | 25.5 | -8.2 | 3.3 | 7.8 | -2.0 | 5 | BEARISH | 3.6 |
| JXFGF Jinxin Fertility Group Limited | $740M | 25.5 | -8.2 | 3.3 | 7.8 | -2.0 | 5 | BEARISH | 3.6 |
| VBIZF Viva Biotech Holdings | $400M | 15.4 | 9.0 | 8.9 | 8.0 | -15.5 | 5 | BEARISH | -31.6 |
| VBIZF Viva Biotech Holdings | $400M | 15.4 | 9.0 | 8.9 | 8.0 | -15.5 | 5 | BEARISH | -31.6 |
| AMWL American Well Corporation | $210M | -2.6 | -31.0 | -215.3 | -19.1 | -19.0 | 4 | BEARISH | 100.7 |
| AMWL American Well Corporation | $210M | -2.6 | -31.0 | -215.3 | -19.1 | -19.0 | 4 | BEARISH | 100.7 |
| OPORF hVIVO plc | $80M | -3.3 | -20.1 | -21.3 | -39.7 | -28.1 | 2 | BEARISH | -54.3 |
| OPORF hVIVO plc | $80M | -3.3 | -20.1 | -21.3 | -39.7 | -28.1 | 2 | BEARISH | -54.3 |
| BBIXF Bonus Biogroup Ltd. | $50M | -17.8 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | -42.9 |
| BBIXF Bonus Biogroup Ltd. | $50M | -17.8 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | -42.9 |
| NICXF Nicox S.A. | $30M | -7.0 | -243.6 | -114.4 | -302.5 | — | 2 | BEARISH | 0.0 |
| NICXF Nicox S.A. | $30M | -7.0 | -243.6 | -114.4 | -302.5 | — | 2 | BEARISH | 0.0 |
| HSTI High Sierra Technologies, Inc. | $30M | -22.8 | 225.7 | 189.7 | — | — | 4 | BEARISH | 0.0 |
| HSTI High Sierra Technologies, Inc. | $30M | -22.8 | 225.7 | 189.7 | — | — | 4 | BEARISH | 0.0 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -4.7 | -83.9 | -39069.8 | — | 451.3 | 3 | BEARISH | 51.6 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -4.7 | -83.9 | -39069.8 | — | 451.3 | 3 | BEARISH | 51.6 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.6 | -647.5 | -822.2 | — | — | 2 | BEARISH | 0.0 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.6 | -647.5 | -822.2 | — | — | 2 | BEARISH | 0.0 |
| ANPCF Cellbxhealth PLC | $20M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -58.3 |
| ANPCF Cellbxhealth PLC | $20M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -58.3 |
| BIVI BioVie Inc. | $10M | -0.5 | -0.0 | -0.0 | — | — | 3 | BEARISH | -26.6 |
| BIVI BioVie Inc. | $10M | -0.5 | -0.0 | -0.0 | — | — | 3 | BEARISH | -26.6 |
| PLLWF Polarean Imaging plc | $10M | -0.1 | -181.7 | -1444.2 | -852.0 | 157.0 | 3 | BEARISH | -40.0 |
| PLLWF Polarean Imaging plc | $10M | -0.1 | -181.7 | -1444.2 | -852.0 | 157.0 | 3 | BEARISH | -40.0 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | BEARISH | 100.0 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | BEARISH | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | BEARISH | 48.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | BEARISH | 48.0 |
| ELXMF Nova Eye Medical Limited | — | -8.6 | -75.3 | -44.7 | -5.3 | 58.9 | 4 | BEARISH | -85.7 |
| ELXMF Nova Eye Medical Limited | — | -8.6 | -75.3 | -44.7 | -5.3 | 58.9 | 4 | BEARISH | -85.7 |
| PSIQ Profile Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PSIQ Profile Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| OMWS Omnia Wellness Inc. | — | -0.0 | 91.7 | -520.4 | -2231.0 | -14.0 | 1 | BEARISH | 100.0 |
| OMWS Omnia Wellness Inc. | — | -0.0 | 91.7 | -520.4 | -2231.0 | -14.0 | 1 | BEARISH | 100.0 |
| AOLS Aeolus Pharmaceuticals, Inc. | — | -0.0 | -186.4 | 1650.1 | -7300.0 | -68.7 | 1 | BEARISH | 0.0 |
| AOLS Aeolus Pharmaceuticals, Inc. | — | -0.0 | -186.4 | 1650.1 | -7300.0 | -68.7 | 1 | BEARISH | 0.0 |
| NMSCA Nutrition Management Services Company | — | 0.0 | 4.0 | 6.5 | -0.5 | -7.8 | 5 | BEARISH | 200.0 |
| NMSCA Nutrition Management Services Company | — | 0.0 | 4.0 | 6.5 | -0.5 | -7.8 | 5 | BEARISH | 200.0 |
| AIDA Aida Pharmaceuticals, Inc. | — | 0.0 | -20.7 | 25.4 | 19.3 | 40.9 | 6 | BEARISH | 50.0 |
| AIDA Aida Pharmaceuticals, Inc. | — | 0.0 | -20.7 | 25.4 | 19.3 | 40.9 | 6 | BEARISH | 50.0 |
| CANQF CanaQuest Medical Corp. | — | -0.0 | 177.1 | 159.9 | -1515.1 | 102.7 | 4 | BEARISH | -99.3 |
| CANQF CanaQuest Medical Corp. | — | -0.0 | 177.1 | 159.9 | -1515.1 | 102.7 | 4 | BEARISH | -99.3 |
| LXGTF Registered Plan Private Investments Inc. | — | -0.0 | 7.6 | 5.5 | — | — | 1 | BEARISH | 0.0 |
| LXGTF Registered Plan Private Investments Inc. | — | -0.0 | 7.6 | 5.5 | — | — | 1 | BEARISH | 0.0 |
| NSHSF NanoSphere Health Sciences Inc. | — | -1.8 | 4.6 | 11.1 | — | — | 1 | BEARISH | -50.0 |
| NSHSF NanoSphere Health Sciences Inc. | — | -1.8 | 4.6 | 11.1 | — | — | 1 | BEARISH | -50.0 |
| ELIXF Elixxer Ltd. | — | -0.2 | 27.1 | 280.4 | — | — | 2 | BEARISH | -55.4 |
| ELIXF Elixxer Ltd. | — | -0.2 | 27.1 | 280.4 | — | — | 2 | BEARISH | -55.4 |
| IAGX Imagenetix, Inc. | — | -0.2 | -88.3 | -8.5 | -12.9 | -69.1 | 4 | BEARISH | 100.0 |
| IAGX Imagenetix, Inc. | — | -0.2 | -88.3 | -8.5 | -12.9 | -69.1 | 4 | BEARISH | 100.0 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | -33.3 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | -33.3 |
| BGMD BG Medicine, Inc. | — | -0.0 | 747.3 | 104.5 | -311.0 | -43.8 | 5 | BEARISH | 0.0 |
| BGMD BG Medicine, Inc. | — | -0.0 | 747.3 | 104.5 | -311.0 | -43.8 | 5 | BEARISH | 0.0 |
| RTSL Rapid Therapeutic Science Laboratories, Inc. | — | -0.0 | -3.4 | 35.5 | — | -100.0 | 2 | BEARISH | -86.7 |
| RTSL Rapid Therapeutic Science Laboratories, Inc. | — | -0.0 | -3.4 | 35.5 | — | -100.0 | 2 | BEARISH | -86.7 |
| EXETF Extendicare Inc. | $1.9B | 21.4 | 43.8 | 14.1 | 5.0 | 31.2 | 3 | BEARISH | 84.2 |
| EXETF Extendicare Inc. | $1.9B | 21.4 | 43.8 | 14.1 | 5.0 | 31.2 | 3 | BEARISH | 84.2 |
| MRCHF H.U. Group Holdings, Inc. | $1.2B | 20.0 | 5.0 | 2.3 | 2.0 | 2.3 | 9 | BEARISH | -11.6 |
| MRCHF H.U. Group Holdings, Inc. | $1.2B | 20.0 | 5.0 | 2.3 | 2.0 | 2.3 | 9 | BEARISH | -11.6 |
| CSBTF Kuros Biosciences AG | $950M | 102.9 | 2.4 | 3.5 | 4.8 | 236.5 | 4 | BEARISH | -15.2 |
| CSBTF Kuros Biosciences AG | $950M | 102.9 | 2.4 | 3.5 | 4.8 | 236.5 | 4 | BEARISH | -15.2 |
| AVCTF Avacta Group Plc | $440M | -7.9 | -553.3 | -1587.8 | -33970.3 | -65.3 | 2 | BEARISH | 25.6 |
| AVCTF Avacta Group Plc | $440M | -7.9 | -553.3 | -1587.8 | -33970.3 | -65.3 | 2 | BEARISH | 25.6 |
| HNSBF Hansa Biopharma AB | $330M | -4.2 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | 9.7 |
| HNSBF Hansa Biopharma AB | $330M | -4.2 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | 9.7 |
| PFGTF Pacific Edge Limited | $170M | -6.5 | -201.2 | -1550.5 | -299.7 | -21.3 | 2 | BEARISH | 36.9 |
| PFGTF Pacific Edge Limited | $170M | -6.5 | -201.2 | -1550.5 | -299.7 | -21.3 | 2 | BEARISH | 36.9 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 124.5 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 124.5 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.0 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | BEARISH | -59.0 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.0 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | BEARISH | -59.0 |
| GWLL Goldenwell Biotech, Inc. | $70M | -255.4 | 31.8 | 137.0 | — | 319257.9 | 5 | BEARISH | 244.8 |
| GWLL Goldenwell Biotech, Inc. | $70M | -255.4 | 31.8 | 137.0 | — | 319257.9 | 5 | BEARISH | 244.8 |
| CWBHF Charlotte's Web Holdings, Inc. | $70M | -1.3 | -97.1 | -27.9 | -38.0 | -6.9 | 5 | BEARISH | 70.9 |
| CWBHF Charlotte's Web Holdings, Inc. | $70M | -1.3 | -97.1 | -27.9 | -38.0 | -6.9 | 5 | BEARISH | 70.9 |
| SNZZF Senzime AB (publ) | $40M | -3.7 | -35.1 | -36.2 | -86.6 | 27.1 | 3 | BEARISH | -59.3 |
| SNZZF Senzime AB (publ) | $40M | -3.7 | -35.1 | -36.2 | -86.6 | 27.1 | 3 | BEARISH | -59.3 |
| VICP Vicapsys Life Sciences, Inc. | $20M | -80.2 | 31.3 | 17.6 | — | — | 5 | BEARISH | -63.3 |
| VICP Vicapsys Life Sciences, Inc. | $20M | -80.2 | 31.3 | 17.6 | — | — | 5 | BEARISH | -63.3 |
| PCLOF PharmaCielo Ltd. | $10M | -2.9 | 39.6 | -31.4 | -103.5 | 11.2 | 4 | BEARISH | 51.1 |
| PCLOF PharmaCielo Ltd. | $10M | -2.9 | 39.6 | -31.4 | -103.5 | 11.2 | 4 | BEARISH | 51.1 |
| IZOZF Izotropic Corporation | $10M | -5.8 | 41.7 | 41.4 | — | — | 2 | BEARISH | -54.1 |
| IZOZF Izotropic Corporation | $10M | -5.8 | 41.7 | 41.4 | — | — | 2 | BEARISH | -54.1 |
| BIOE Bio Essence Corporation | $10M | 4.9 | -392.9 | 38.8 | 34.0 | 416.6 | 5 | BEARISH | 114.1 |
| BIOE Bio Essence Corporation | $10M | 4.9 | -392.9 | 38.8 | 34.0 | 416.6 | 5 | BEARISH | 114.1 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -2.1 | -66.6 | -70.4 | -1182.3 | -71.4 | 3 | BEARISH | -94.0 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -2.1 | -66.6 | -70.4 | -1182.3 | -71.4 | 3 | BEARISH | -94.0 |
| MJNA Medical Marijuana, Inc. | — | -1.3 | -1.3 | -2.2 | -0.9 | -22.1 | 2 | BEARISH | -66.7 |
| MJNA Medical Marijuana, Inc. | — | -1.3 | -1.3 | -2.2 | -0.9 | -22.1 | 2 | BEARISH | -66.7 |
| SONX Sonendo, Inc. | — | -0.3 | -166.8 | -185.6 | -76.7 | -27.7 | 5 | BEARISH | 183.3 |
| SONX Sonendo, Inc. | — | -0.3 | -166.8 | -185.6 | -76.7 | -27.7 | 5 | BEARISH | 183.3 |
| ERBB American Green, Inc. | — | 0.1 | 33.3 | -15.0 | -629.5 | 17.7 | 3 | BEARISH | -33.3 |
| ERBB American Green, Inc. | — | 0.1 | 33.3 | -15.0 | -629.5 | 17.7 | 3 | BEARISH | -33.3 |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 9.1 | 7.6 | 13.0 | 13.0 | -1.2 | 4 | BEARISH | 0.8 |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 9.1 | 7.6 | 13.0 | 13.0 | -1.2 | 4 | BEARISH | 0.8 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.9 | -774.6 | 2147.3 | — | — | 4 | BEARISH | -82.5 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.9 | -774.6 | 2147.3 | — | — | 4 | BEARISH | -82.5 |
| SEOVF Sernova Corp. | $30M | -3.6 | 57.0 | 76.3 | — | — | 3 | BEARISH | -34.1 |
| SEOVF Sernova Corp. | $30M | -3.6 | 57.0 | 76.3 | — | — | 3 | BEARISH | -34.1 |
| INBP Integrated BioPharma, Inc. | $10M | -2.0 | -15.0 | -13.1 | -13.9 | -19.3 | 2 | BEARISH | -37.2 |
| INBP Integrated BioPharma, Inc. | $10M | -2.0 | -15.0 | -13.1 | -13.9 | -19.3 | 2 | BEARISH | -37.2 |
| RDGT Ridgetech, Inc. | — | -0.0 | 27.5 | -1.8 | -1.7 | — | 2 | BEARISH | -32.3 |
| RDGT Ridgetech, Inc. | — | -0.0 | 27.5 | -1.8 | -1.7 | — | 2 | BEARISH | -32.3 |
| PJET Priority Aviation, Inc. | — | -0.1 | 19.5 | 31.9 | — | -83.3 | 2 | BEARISH | 0.0 |
| PJET Priority Aviation, Inc. | — | -0.1 | 19.5 | 31.9 | — | -83.3 | 2 | BEARISH | 0.0 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | BEARISH | 0.0 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | BEARISH | 0.0 |
| IDCN Indocan Resources Inc. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| IDCN Indocan Resources Inc. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| PHRX Pharmagen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PHRX Pharmagen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| INND InnerScope Hearing Technologies, Inc. | — | -0.0 | -1.4 | -0.4 | — | -56.8 | 4 | BEARISH | -96.0 |
| INND InnerScope Hearing Technologies, Inc. | — | -0.0 | -1.4 | -0.4 | — | -56.8 | 4 | BEARISH | -96.0 |
| YOURF YourWay Cannabis Brands Inc. | — | -0.0 | 19.0 | 18.4 | 3.3 | 253.3 | 8 | BEARISH | 0.0 |
| YOURF YourWay Cannabis Brands Inc. | — | -0.0 | 19.0 | 18.4 | 3.3 | 253.3 | 8 | BEARISH | 0.0 |
| LMAT LeMaitre Vascular, Inc. | $1.8B | 27.2 | 16.8 | 25.6 | 24.2 | 11.8 | 8 | BEARISH | -8.7 |
| LMAT LeMaitre Vascular, Inc. | $1.8B | 27.2 | 16.8 | 25.6 | 24.2 | 11.8 | 8 | BEARISH | -8.7 |
| CNMD CONMED Corporation | $1.4B | 25.0 | 5.5 | 5.2 | 6.7 | 3.4 | 7 | BEARISH | -1.8 |
| CNMD CONMED Corporation | $1.4B | 25.0 | 5.5 | 5.2 | 6.7 | 3.4 | 7 | BEARISH | -1.8 |
| RAFLF Raffles Medical Group Ltd | $1.2B | 22.4 | 5.8 | 7.3 | 8.2 | -2.8 | 7 | BEARISH | -20.0 |
| RAFLF Raffles Medical Group Ltd | $1.2B | 22.4 | 5.8 | 7.3 | 8.2 | -2.8 | 7 | BEARISH | -20.0 |
| TNDM Tandem Diabetes Care, Inc. | $1.1B | -17.8 | -48.0 | -8.2 | -8.3 | -7.1 | 4 | BEARISH | 33.0 |
| TNDM Tandem Diabetes Care, Inc. | $1.1B | -17.8 | -48.0 | -8.2 | -8.3 | -7.1 | 4 | BEARISH | 33.0 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.3 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | BEARISH | -28.6 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.3 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | BEARISH | -28.6 |
| IUSDF AS ONE Corporation | $1.0B | 18.0 | 12.2 | 13.4 | 8.1 | 5.7 | 6 | BEARISH | -40.4 |
| IUSDF AS ONE Corporation | $1.0B | 18.0 | 12.2 | 13.4 | 8.1 | 5.7 | 6 | BEARISH | -40.4 |
| TDVXF Tobii Dynavox AB (publ) | $790M | 36.5 | 37.3 | 16.1 | 11.0 | 12.6 | 8 | BEARISH | -41.6 |
| TDVXF Tobii Dynavox AB (publ) | $790M | 36.5 | 37.3 | 16.1 | 11.0 | 12.6 | 8 | BEARISH | -41.6 |
| COLL Collegium Pharmaceutical, Inc. | $710M | 14.4 | 17.6 | 9.4 | -7.5 | 14.3 | 6 | BEARISH | -37.4 |
| COLL Collegium Pharmaceutical, Inc. | $710M | 14.4 | 17.6 | 9.4 | -7.5 | 14.3 | 6 | BEARISH | -37.4 |
| SMSZF SMS Co., Ltd. | $700M | -14.6 | -38.9 | 25.5 | -109.1 | 6.8 | 4 | BEARISH | 0.0 |
| SMSZF SMS Co., Ltd. | $700M | -14.6 | -38.9 | 25.5 | -109.1 | 6.8 | 4 | BEARISH | 0.0 |
| TGRNF Tong Ren Tang Technologies Co. Ltd. | $510M | 11.1 | 10.2 | 30.0 | 8.2 | -8.5 | 6 | BEARISH | -43.0 |
| TGRNF Tong Ren Tang Technologies Co. Ltd. | $510M | 11.1 | 10.2 | 30.0 | 8.2 | -8.5 | 6 | BEARISH | -43.0 |
| ELTP Elite Pharmaceuticals, Inc. | $250M | 4.6 | 58.9 | -0.1 | 45.3 | 77.1 | 6 | BEARISH | -65.6 |
| ELTP Elite Pharmaceuticals, Inc. | $250M | 4.6 | 58.9 | -0.1 | 45.3 | 77.1 | 6 | BEARISH | -65.6 |
| NNNN Anbio Biotechnology Class A Ordinary Shares | $240M | — | — | — | — | — | — | BEARISH | -84.1 |
| NNNN Anbio Biotechnology Class A Ordinary Shares | $240M | — | — | — | — | — | — | BEARISH | -84.1 |
| FOCL EDAP TMS S.A. American Depositary Shares | $160M | — | — | — | — | — | — | BEARISH | — |
| FOCL EDAP TMS S.A. American Depositary Shares | $160M | — | — | — | — | — | — | BEARISH | — |
| STRO Sutro Biopharma, Inc. | $150M | -0.9 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | 70.0 |
| STRO Sutro Biopharma, Inc. | $150M | -0.9 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | 70.0 |
| KRMD KORU Medical Systems, Inc. | $140M | -75.5 | -10.5 | -8.8 | 2.1 | 22.4 | 6 | BEARISH | -22.3 |
| KRMD KORU Medical Systems, Inc. | $140M | -75.5 | -10.5 | -8.8 | 2.1 | 22.4 | 6 | BEARISH | -22.3 |
| IMDX Insight Molecular Diagnostics Inc. | $110M | -2.3 | 488.7 | 92.7 | -4711.3 | -60.8 | 2 | BEARISH | 4.6 |
| IMDX Insight Molecular Diagnostics Inc. | $110M | -2.3 | 488.7 | 92.7 | -4711.3 | -60.8 | 2 | BEARISH | 4.6 |
| UNHLF EC Healthcare | $100M | -1.7 | -34.1 | 6.2 | -21.3 | -2.2 | 5 | BEARISH | 0.0 |
| UNHLF EC Healthcare | $100M | -1.7 | -34.1 | 6.2 | -21.3 | -2.2 | 5 | BEARISH | 0.0 |
| IBIO iBio, Inc. | $70M | -3.5 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | 37.2 |
| IBIO iBio, Inc. | $70M | -3.5 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | 37.2 |
| TIL Instil Bio, Inc. | $50M | -1.6 | -25.3 | -69.1 | — | — | 4 | BEARISH | -62.2 |
| TIL Instil Bio, Inc. | $50M | -1.6 | -25.3 | -69.1 | — | — | 4 | BEARISH | -62.2 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $40M | 118.8 | 228.3 | 11.8 | -21.1 | 6.2 | 3 | BEARISH | 0.0 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $40M | 118.8 | 228.3 | 11.8 | -21.1 | 6.2 | 3 | BEARISH | 0.0 |
| AIRDF Rocket Doctor AI Inc. | $40M | -2.2 | -6105.0 | -2497.4 | -909.1 | — | 2 | BEARISH | -13.3 |
| AIRDF Rocket Doctor AI Inc. | $40M | -2.2 | -6105.0 | -2497.4 | -909.1 | — | 2 | BEARISH | -13.3 |
| IGC IGC Pharma, Inc. | $30M | -3.3 | -105.2 | -118.3 | -757.7 | -6.7 | 2 | BEARISH | -33.2 |
| IGC IGC Pharma, Inc. | $30M | -3.3 | -105.2 | -118.3 | -757.7 | -6.7 | 2 | BEARISH | -33.2 |
| TCRX TScan Therapeutics, Inc. | $20M | -0.4 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -84.7 |
| ACTU Actuate Therapeutics Inc | $20M | -0.9 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -88.2 |
| ACTU Actuate Therapeutics Inc | $20M | -0.9 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -88.2 |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -4.8 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -38.4 |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -4.8 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -38.4 |
| TCRX TScan Therapeutics, Inc. | $20M | -0.4 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -84.7 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -77.6 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -77.6 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.6 | -90.6 | -106.7 | -1125.6 | 62.6 | 1 | BEARISH | -56.2 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.6 | -90.6 | -106.7 | -1125.6 | 62.6 | 1 | BEARISH | -56.2 |
| BIOIF Biome Grow Inc. | — | -0.0 | 56.7 | 86.9 | — | — | 3 | BEARISH | 0.0 |
| BIOIF Biome Grow Inc. | — | -0.0 | 56.7 | 86.9 | — | — | 3 | BEARISH | 0.0 |
| SECI Sector 10, Inc. | — | 0.0 | 0.5 | 0.3 | — | — | 3 | BEARISH | 0.0 |
| SECI Sector 10, Inc. | — | 0.0 | 0.5 | 0.3 | — | — | 3 | BEARISH | 0.0 |
| BBLNF Babylon Holdings Limited | — | -0.0 | 348.4 | -1412.2 | -20.3 | 198.9 | 3 | BEARISH | 0.0 |
| BBLNF Babylon Holdings Limited | — | -0.0 | 348.4 | -1412.2 | -20.3 | 198.9 | 3 | BEARISH | 0.0 |
| ADLI American Medical Technologies Inc. | — | -0.0 | -34.0 | 1108.3 | -19.7 | -21.7 | 3 | BEARISH | 0.0 |
| ADLI American Medical Technologies Inc. | — | -0.0 | -34.0 | 1108.3 | -19.7 | -21.7 | 3 | BEARISH | 0.0 |
| NOBDF North Bud Farms Inc. | — | -0.0 | -30.5 | -29.8 | — | — | 2 | BEARISH | 0.0 |
| NOBDF North Bud Farms Inc. | — | -0.0 | -30.5 | -29.8 | — | — | 2 | BEARISH | 0.0 |
| BZYR Burzynski Research Institute, Inc. | — | -0.3 | 2902.9 | 1462.7 | — | — | 4 | BEARISH | -94.9 |
| BZYR Burzynski Research Institute, Inc. | — | -0.3 | 2902.9 | 1462.7 | — | — | 4 | BEARISH | -94.9 |
| VIAP VIA Pharmaceuticals, Inc. | — | -0.0 | 64.7 | 103.9 | — | — | 2 | BEARISH | 0.0 |
| VIAP VIA Pharmaceuticals, Inc. | — | -0.0 | 64.7 | 103.9 | — | — | 2 | BEARISH | 0.0 |
| SPDE Speedus Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SPDE Speedus Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MBCI MabCure Inc. | — | -0.0 | -127.0 | -14.0 | -2239.0 | — | 3 | BEARISH | -80.0 |
| MBCI MabCure Inc. | — | -0.0 | -127.0 | -14.0 | -2239.0 | — | 3 | BEARISH | -80.0 |
| SPBBF Speakeasy Cannabis Club Ltd. | — | -0.0 | -55.1 | -4.0 | -803.2 | 16129.5 | 3 | BEARISH | 0.0 |
| SPBBF Speakeasy Cannabis Club Ltd. | — | -0.0 | -55.1 | -4.0 | -803.2 | 16129.5 | 3 | BEARISH | 0.0 |
| HCANF Halo Collective Inc. | — | -0.0 | -132.7 | -43.7 | -192.0 | -43.0 | 2 | BEARISH | 0.0 |
| HCANF Halo Collective Inc. | — | -0.0 | -132.7 | -43.7 | -192.0 | -43.0 | 2 | BEARISH | 0.0 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -61.2 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -61.2 |
| ALGWF Alliance Growers Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ALGWF Alliance Growers Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PROCF Sofgen Pharma S.A. | — | — | — | — | — | — | — | BEARISH | — |
| PROCF Sofgen Pharma S.A. | — | — | — | — | — | — | — | BEARISH | — |
| VIVXF Avivagen Inc. | — | -0.1 | 63.9 | 92.2 | -2302.1 | -7.9 | 3 | BEARISH | 0.0 |
| VIVXF Avivagen Inc. | — | -0.1 | 63.9 | 92.2 | -2302.1 | -7.9 | 3 | BEARISH | 0.0 |
| GRPS Trans American Aquaculture, Inc. | — | -0.5 | 114.2 | 17.8 | — | -96.0 | 3 | BEARISH | -66.7 |
| GRPS Trans American Aquaculture, Inc. | — | -0.5 | 114.2 | 17.8 | — | -96.0 | 3 | BEARISH | -66.7 |
| KONEF Wellbeing Digital Sciences Inc. | — | — | 10994.4 | -1249.0 | -349.5 | — | 2 | BEARISH | 0.0 |
| KONEF Wellbeing Digital Sciences Inc. | — | — | 10994.4 | -1249.0 | -349.5 | — | 2 | BEARISH | 0.0 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| UPHL UpHealth, Inc. | — | -0.0 | -84.2 | -4.7 | — | -46.7 | 3 | BEARISH | -50.0 |
| UPHL UpHealth, Inc. | — | -0.0 | -84.2 | -4.7 | — | -46.7 | 3 | BEARISH | -50.0 |
| CTVEF Certive Solutions Inc. | — | -0.2 | 13.8 | 16.9 | -129.9 | 8.5 | 4 | BEARISH | 159900.0 |
| CTVEF Certive Solutions Inc. | — | -0.2 | 13.8 | 16.9 | -129.9 | 8.5 | 4 | BEARISH | 159900.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| CBDY Target Group Inc. | — | -0.2 | 23.2 | -10.4 | -17.4 | -30.4 | 2 | BEARISH | -58.8 |
| CBDY Target Group Inc. | — | -0.2 | 23.2 | -10.4 | -17.4 | -30.4 | 2 | BEARISH | -58.8 |
| NIVF NewGenIvf Group Limited | — | 0.0 | 50.6 | -147.7 | -8.5 | — | 2 | BEARISH | -93.3 |
| NIVF NewGenIvf Group Limited | — | 0.0 | 50.6 | -147.7 | -8.5 | — | 2 | BEARISH | -93.3 |
| GBHPF Global Hemp Group Inc. | — | -0.1 | 61.0 | 8.0 | — | — | 2 | BEARISH | -98.6 |
| GBHPF Global Hemp Group Inc. | — | -0.1 | 61.0 | 8.0 | — | — | 2 | BEARISH | -98.6 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| GSRX GSRX Industries Inc. | — | -0.0 | -119.6 | -84.3 | -81.5 | -5.5 | 5 | BEARISH | 0.0 |
| GSRX GSRX Industries Inc. | — | -0.0 | -119.6 | -84.3 | -81.5 | -5.5 | 5 | BEARISH | 0.0 |
| RNUGF ReNeuron Group plc | — | -0.0 | -153.3 | 532.8 | -1809.6 | 194.9 | 3 | BEARISH | 0.0 |
| RNUGF ReNeuron Group plc | — | -0.0 | -153.3 | 532.8 | -1809.6 | 194.9 | 3 | BEARISH | 0.0 |
| LBLTF Lattice Biologics Ltd. | — | -0.0 | 27.4 | -482.6 | — | -28.9 | 4 | BEARISH | 0.0 |
| LBLTF Lattice Biologics Ltd. | — | -0.0 | 27.4 | -482.6 | — | -28.9 | 4 | BEARISH | 0.0 |
| ELLXF Elixinol Wellness Limited | — | -0.7 | -80.4 | -69.0 | -14.9 | 63.8 | 4 | BEARISH | -69.5 |
| ELLXF Elixinol Wellness Limited | — | -0.7 | -80.4 | -69.0 | -14.9 | 63.8 | 4 | BEARISH | -69.5 |
| PLWY Peoplesway.com Inc. | — | -0.0 | -6.5 | -4001.9 | -1.4 | -22.7 | 5 | BEARISH | 0.0 |
| PLWY Peoplesway.com Inc. | — | -0.0 | -6.5 | -4001.9 | -1.4 | -22.7 | 5 | BEARISH | 0.0 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | BEARISH | -98.0 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | BEARISH | -98.0 |
| XCRP Xcorporeal, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| XCRP Xcorporeal, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BSPM Biostar Pharmaceuticals, Inc. | — | -0.0 | 2.7 | 1.9 | — | -91.9 | 5 | BEARISH | 0.0 |
| BSPM Biostar Pharmaceuticals, Inc. | — | -0.0 | 2.7 | 1.9 | — | -91.9 | 5 | BEARISH | 0.0 |
| BNKL Bionik Laboratories Corp. | — | -0.0 | -787.6 | -1107.0 | -282.5 | 41.7 | 3 | BEARISH | 0.0 |
| BNKL Bionik Laboratories Corp. | — | -0.0 | -787.6 | -1107.0 | -282.5 | 41.7 | 3 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| RLLVF Relevium Technologies Inc. | — | -0.3 | 969.5 | 2839.9 | -218.6 | — | 1 | BEARISH | 0.0 |
| RLLVF Relevium Technologies Inc. | — | -0.3 | 969.5 | 2839.9 | -218.6 | — | 1 | BEARISH | 0.0 |
| ZMSPF Zecotek Photonics Inc. | — | -0.0 | 21.5 | 53.8 | 1884.0 | 2081.2 | 3 | BEARISH | 0.0 |
| ZMSPF Zecotek Photonics Inc. | — | -0.0 | 21.5 | 53.8 | 1884.0 | 2081.2 | 3 | BEARISH | 0.0 |
| CNFHF CanaFarma Hemp Products Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CNFHF CanaFarma Hemp Products Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NXGLW NEXGEL, Inc. | — | -0.2 | -128.6 | -35.8 | -98.6 | 3.4 | 1 | BEARISH | -95.4 |
| NXGLW NEXGEL, Inc. | — | -0.2 | -128.6 | -35.8 | -98.6 | 3.4 | 1 | BEARISH | -95.4 |
| CVHIF Ventura Cannabis & Wellness Corporation | — | -0.0 | -24592.2 | -12731.6 | -112.6 | -64.0 | 4 | BEARISH | 0.0 |
| CVHIF Ventura Cannabis & Wellness Corporation | — | -0.0 | -24592.2 | -12731.6 | -112.6 | -64.0 | 4 | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SHMN SOHM, Inc. | — | 9.0 | -15.3 | -2.9 | -130.8 | -3.6 | 4 | BEARISH | -18.2 |
| SHMN SOHM, Inc. | — | 9.0 | -15.3 | -2.9 | -130.8 | -3.6 | 4 | BEARISH | -18.2 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| IYXI Inyx, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| IYXI Inyx, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NVOS Novo Integrated Sciences, Inc. | — | -0.0 | -81.4 | -35.0 | 162.4 | 5.7 | 3 | BEARISH | -88.0 |
| NVOS Novo Integrated Sciences, Inc. | — | -0.0 | -81.4 | -35.0 | 162.4 | 5.7 | 3 | BEARISH | -88.0 |
| HLTHQ Cue Health Inc. | — | -0.0 | -90.3 | -100.6 | -789.6 | -85.3 | 1 | BEARISH | 0.0 |
| HLTHQ Cue Health Inc. | — | -0.0 | -90.3 | -100.6 | -789.6 | -85.3 | 1 | BEARISH | 0.0 |
| AHGIF Alternate Health Corp. | — | -0.0 | -611.4 | -2862.3 | -21.3 | 171.0 | 4 | BEARISH | 0.0 |
| AHGIF Alternate Health Corp. | — | -0.0 | -611.4 | -2862.3 | -21.3 | 171.0 | 4 | BEARISH | 0.0 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -63.0 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -63.0 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.2 | -45.6 | 142.9 | — | — | 2 | BEARISH | -59.2 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.2 | -45.6 | 142.9 | — | — | 2 | BEARISH | -59.2 |
| SOFE SOAFEE, Inc. | — | 0.1 | 12.0 | -337.1 | 21.4 | 1539.1 | 4 | BEARISH | 45.5 |
| SOFE SOAFEE, Inc. | — | 0.1 | 12.0 | -337.1 | 21.4 | 1539.1 | 4 | BEARISH | 45.5 |
| KNBIF Kane Biotech Inc. | — | -2.1 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | BEARISH | -43.7 |
| KNBIF Kane Biotech Inc. | — | -2.1 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | BEARISH | -43.7 |
| ENCW Enchanted World Inc. | — | — | — | — | — | — | — | BEARISH | -99.8 |
| ENCW Enchanted World Inc. | — | — | — | — | — | — | — | BEARISH | -99.8 |
| EVARF Lombard Medical, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| EVARF Lombard Medical, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ARPC Arem Pacific Corporation | — | -9.0 | -104.2 | 50.1 | -12.7 | -7.6 | 5 | BEARISH | 0.0 |
| ARPC Arem Pacific Corporation | — | -9.0 | -104.2 | 50.1 | -12.7 | -7.6 | 5 | BEARISH | 0.0 |
| SNDA Sonida Senior Living, Inc. | $1.8B | -5.4 | -25.2 | -2.9 | -11.8 | 49.4 | 4 | BEARISH | 36.5 |
| SNDA Sonida Senior Living, Inc. | $1.8B | -5.4 | -25.2 | -2.9 | -11.8 | 49.4 | 4 | BEARISH | 36.5 |
| SGRY Surgery Partners, Inc. | $1.7B | -19.3 | -5.2 | 5.9 | -1.8 | 4.0 | 5 | BEARISH | -37.1 |
| SGRY Surgery Partners, Inc. | $1.7B | -19.3 | -5.2 | 5.9 | -1.8 | 4.0 | 5 | BEARISH | -37.1 |
| GDRX GoodRx Holdings, Inc. | $1.1B | 62.4 | 2.5 | 3.5 | 4.3 | -1.8 | 6 | BEARISH | -34.8 |
| GDRX GoodRx Holdings, Inc. | $1.1B | 62.4 | 2.5 | 3.5 | 4.3 | -1.8 | 6 | BEARISH | -34.8 |
| IART Integra LifeSciences Holdings Corporation | $990M | -137.5 | -0.7 | 18.4 | 1.1 | 1.6 | 6 | BEARISH | -13.9 |
| IART Integra LifeSciences Holdings Corporation | $990M | -137.5 | -0.7 | 18.4 | 1.1 | 1.6 | 6 | BEARISH | -13.9 |
| CBIO Crescent Biopharma, Inc. | $530M | -1.9 | -107.7 | 1928.6 | — | — | 5 | BEARISH | 20.3 |
| CBIO Crescent Biopharma, Inc. | $530M | -1.9 | -107.7 | 1928.6 | — | — | 5 | BEARISH | 20.3 |
| CERS Cerus Corporation | $460M | -63.0 | -10.8 | -7.4 | -5.1 | 15.1 | 5 | BEARISH | 50.0 |
| CERS Cerus Corporation | $460M | -63.0 | -10.8 | -7.4 | -5.1 | 15.1 | 5 | BEARISH | 50.0 |
| NRC NRC Health | $460M | 77.5 | 42.0 | 9.9 | -9.3 | -0.2 | 6 | BEARISH | 33.4 |
| NRC NRC Health | $460M | 77.5 | 42.0 | 9.9 | -9.3 | -0.2 | 6 | BEARISH | 33.4 |
| NIKA Nika Pharmaceuticals Inc. | $430M | -5519.3 | 26.8 | 18.5 | — | 100.0 | 3 | BEARISH | 40.6 |
| NIKA Nika Pharmaceuticals Inc. | $430M | -5519.3 | 26.8 | 18.5 | — | 100.0 | 3 | BEARISH | 40.6 |
| EDIT Editas Medicine, Inc. | $400M | -3.5 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BEARISH | -26.2 |
| EDIT Editas Medicine, Inc. | $400M | -3.5 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BEARISH | -26.2 |
| MGNX MacroGenics, Inc. | $230M | -16.3 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 110.6 |
| MGNX MacroGenics, Inc. | $230M | -16.3 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 110.6 |
| NYXH Nyxoah S.A. | $140M | -0.6 | -125.8 | -181.3 | -429.5 | 359.2 | 2 | BEARISH | -72.5 |
| NYXH Nyxoah S.A. | $140M | -0.6 | -125.8 | -181.3 | -429.5 | 359.2 | 2 | BEARISH | -72.5 |
| VANI Vivani Medical, Inc. | $110M | -3.5 | -220.4 | -127.1 | — | — | 4 | BEARISH | -14.6 |
| VANI Vivani Medical, Inc. | $110M | -3.5 | -220.4 | -127.1 | — | — | 4 | BEARISH | -14.6 |
| TLPH Talphera, Inc. | $60M | -3.5 | -143.4 | 436.3 | — | -96.3 | 2 | BEARISH | 21.1 |
| TLPH Talphera, Inc. | $60M | -3.5 | -143.4 | 436.3 | — | -96.3 | 2 | BEARISH | 21.1 |
| NEPH Nephros, Inc. | $40M | 22.8 | 16.1 | 20.0 | 19.9 | 24.2 | 5 | BEARISH | -20.1 |
| NEPH Nephros, Inc. | $40M | 22.8 | 16.1 | 20.0 | 19.9 | 24.2 | 5 | BEARISH | -20.1 |
| ACHFF Arch Biopartners Inc. | $40M | -19.5 | 73.5 | 165.4 | — | 100.0 | 2 | BEARISH | -33.2 |
| ACHFF Arch Biopartners Inc. | $40M | -19.5 | 73.5 | 165.4 | — | 100.0 | 2 | BEARISH | -33.2 |
| PRPO Precipio, Inc. | $40M | -35.6 | -9.0 | -8.1 | -3.1 | 33.5 | 6 | BEARISH | 12.8 |
| PRPO Precipio, Inc. | $40M | -35.6 | -9.0 | -8.1 | -3.1 | 33.5 | 6 | BEARISH | 12.8 |
| ZJYL Jin Medical International Ltd. | $20M | 13.3 | 10.5 | 9.5 | -1.2 | 40.1 | 5 | BEARISH | 250.3 |
| ZJYL Jin Medical International Ltd. | $20M | 13.3 | 10.5 | 9.5 | -1.2 | 40.1 | 5 | BEARISH | 250.3 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.5 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -8.7 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.5 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -8.7 |
| RVP Retractable Technologies, Inc. | $20M | -5.8 | -4.5 | -53.2 | 39.3 | -11.2 | 4 | BEARISH | -16.9 |
| RVP Retractable Technologies, Inc. | $20M | -5.8 | -4.5 | -53.2 | 39.3 | -11.2 | 4 | BEARISH | -16.9 |
| SYBX Synlogic, Inc. | $10M | -20.7 | -5.3 | 306.3 | — | — | 2 | BEARISH | -33.5 |
| SYBX Synlogic, Inc. | $10M | -20.7 | -5.3 | 306.3 | — | — | 2 | BEARISH | -33.5 |
| CMPD CompuMed, Inc. | $10M | -29.7 | -8.7 | -11.2 | 1.1 | 22.4 | 6 | BEARISH | 59.8 |
| CMPD CompuMed, Inc. | $10M | -29.7 | -8.7 | -11.2 | 1.1 | 22.4 | 6 | BEARISH | 59.8 |
| QNCX Quince Therapeutics, Inc. | $10M | -0.4 | -153.8 | 1282.0 | — | — | 4 | BEARISH | 1702.5 |
| QNCX Quince Therapeutics, Inc. | $10M | -0.4 | -153.8 | 1282.0 | — | — | 4 | BEARISH | 1702.5 |
| IMRN Immuron Limited | $10M | -3.1 | -74.6 | -356.5 | -54.4 | 28.7 | 5 | BEARISH | -42.9 |
| IMRN Immuron Limited | $10M | -3.1 | -74.6 | -356.5 | -54.4 | 28.7 | 5 | BEARISH | -42.9 |
| SNOA Sonoma Pharmaceuticals, Inc. | $10M | -1.0 | -84.6 | -126.4 | -10.4 | 36.7 | 2 | BEARISH | -67.9 |
| SNOA Sonoma Pharmaceuticals, Inc. | $10M | -1.0 | -84.6 | -126.4 | -10.4 | 36.7 | 2 | BEARISH | -67.9 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | -66.7 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | -66.7 |
| BUDZ WEED, Inc. | — | -3.6 | 176.9 | 220.9 | — | -100.0 | 1 | BEARISH | -38.5 |
| BUDZ WEED, Inc. | — | -3.6 | 176.9 | 220.9 | — | -100.0 | 1 | BEARISH | -38.5 |
| NCEL NewcelX Ltd. | — | 8.6 | -48.0 | -39.1 | — | — | 2 | BEARISH | — |
| NCEL NewcelX Ltd. | — | 8.6 | -48.0 | -39.1 | — | — | 2 | BEARISH | — |
| ISCO International Stem Cell Corporation | — | -4.6 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | 123.1 |
| ISCO International Stem Cell Corporation | — | -4.6 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | 123.1 |
| PPCB Propanc Biopharma, Inc. | — | -0.0 | -161.9 | -166.7 | — | — | 4 | BEARISH | -70.2 |
| PPCB Propanc Biopharma, Inc. | — | -0.0 | -161.9 | -166.7 | — | — | 4 | BEARISH | -70.2 |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.3 |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.3 |
| RAFA Rafarma Pharmaceuticals, Inc. | — | 13.9 | 2.9 | 3.4 | 26.6 | -66.0 | 3 | BEARISH | -33.3 |
| RAFA Rafarma Pharmaceuticals, Inc. | — | 13.9 | 2.9 | 3.4 | 26.6 | -66.0 | 3 | BEARISH | -33.3 |
| FGHQF Frontage Holdings Corporation | $350M | 28.9 | 4.2 | 4.5 | 4.6 | 2.1 | 6 | BEARISH | 16.8 |
| FGHQF Frontage Holdings Corporation | $350M | 28.9 | 4.2 | 4.5 | 4.6 | 2.1 | 6 | BEARISH | 16.8 |
| SGMT Sagimet Biosciences Inc. | $300M | -7.1 | -24.4 | -231.4 | — | — | 3 | BEARISH | 30.9 |
| SGMT Sagimet Biosciences Inc. | $300M | -7.1 | -24.4 | -231.4 | — | — | 3 | BEARISH | 30.9 |
| IMPZY Implanet S.A. | $230M | -5.3 | -1018.0 | -250.0 | -30.0 | 60.8 | 6 | BEARISH | 0.2 |
| IMPZY Implanet S.A. | $230M | -5.3 | -1018.0 | -250.0 | -30.0 | 60.8 | 6 | BEARISH | 0.2 |
| BRIBF Brii Biosciences Limited | $90M | -3.1 | -16.9 | -94.3 | — | -81.5 | 4 | BEARISH | -46.0 |
| BRIBF Brii Biosciences Limited | $90M | -3.1 | -16.9 | -94.3 | — | -81.5 | 4 | BEARISH | -46.0 |
| NUMIF Numinus Wellness Inc. | $10M | -0.8 | 57.6 | 40.6 | -18.7 | 429.3 | 5 | BEARISH | -36.6 |
| NUMIF Numinus Wellness Inc. | $10M | -0.8 | 57.6 | 40.6 | -18.7 | 429.3 | 5 | BEARISH | -36.6 |
| ANTCF Aion Therapeutic Inc. | — | -0.2 | 365.1 | 64.7 | -53.7 | 563.3 | 3 | BEARISH | 17.6 |
| ANTCF Aion Therapeutic Inc. | — | -0.2 | 365.1 | 64.7 | -53.7 | 563.3 | 3 | BEARISH | 17.6 |
| SYGGF Synairgen plc | — | -0.2 | -114.6 | -853.1 | — | — | 2 | BEARISH | -50.0 |
| SYGGF Synairgen plc | — | -0.2 | -114.6 | -853.1 | — | — | 2 | BEARISH | -50.0 |
| MSIU Medical Supply International USA, Inc. | — | — | — | — | — | — | — | BEARISH | 300.0 |
| MSIU Medical Supply International USA, Inc. | — | — | — | — | — | — | — | BEARISH | 300.0 |
| CHYPF Health Logic Interactive Inc. | — | -3.5 | 20.0 | 14.2 | — | — | 1 | BEARISH | -45.2 |
| CHYPF Health Logic Interactive Inc. | — | -3.5 | 20.0 | 14.2 | — | — | 1 | BEARISH | -45.2 |
| OLMM OneLife Technologies Corp. | — | -0.0 | 454.4 | -594.1 | — | — | 3 | BEARISH | 900.0 |
| OLMM OneLife Technologies Corp. | — | -0.0 | 454.4 | -594.1 | — | — | 3 | BEARISH | 900.0 |
| SYDRF Delota Corp. | — | -3.8 | -52.9 | -6.1 | -4.8 | 7.8 | 6 | BEARISH | 25.0 |
| SYDRF Delota Corp. | — | -3.8 | -52.9 | -6.1 | -4.8 | 7.8 | 6 | BEARISH | 25.0 |
| EPGNF Epigenomics AG | — | -0.0 | -414.0 | -186.5 | 2801.6 | -30.1 | 3 | BEARISH | 0.0 |
| EPGNF Epigenomics AG | — | -0.0 | -414.0 | -186.5 | 2801.6 | -30.1 | 3 | BEARISH | 0.0 |
| SDNI Scandia, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SDNI Scandia, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ACBM Acro Biomedical Co., Ltd. | — | -10.8 | 36.8 | 262.2 | — | 100.0 | 3 | BEARISH | 3614.3 |
| ACBM Acro Biomedical Co., Ltd. | — | -10.8 | 36.8 | 262.2 | — | 100.0 | 3 | BEARISH | 3614.3 |
| IDYLF Imaging Dynamics Company Ltd. | — | -0.3 | 18.7 | 39.1 | -2277.3 | -65.6 | 4 | BEARISH | 152.7 |
| IDYLF Imaging Dynamics Company Ltd. | — | -0.3 | 18.7 | 39.1 | -2277.3 | -65.6 | 4 | BEARISH | 152.7 |
| GHRS GH Research PLC | $1.6B | -22.9 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 69.0 |
| GHRS GH Research PLC | $1.6B | -22.9 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 69.0 |
| LXRX Lexicon Pharmaceuticals, Inc. | $810M | -12.1 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 59.6 |
| LXRX Lexicon Pharmaceuticals, Inc. | $810M | -12.1 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 59.6 |
| ACRS Aclaris Therapeutics, Inc. | $610M | -7.6 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | BEARISH | 134.8 |
| ACRS Aclaris Therapeutics, Inc. | $610M | -7.6 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | BEARISH | 134.8 |
| NVLPF Nova Leap Health Corp. | $30M | 23.1 | 7.0 | 5.6 | 6.9 | 20.3 | 5 | BEARISH | 49.1 |
| NVLPF Nova Leap Health Corp. | $30M | 23.1 | 7.0 | 5.6 | 6.9 | 20.3 | 5 | BEARISH | 49.1 |
| MDBIF TrivarX Limited | $10M | -0.0 | -75.0 | -48.2 | — | 23.6 | 3 | BEARISH | -66.7 |
| MDBIF TrivarX Limited | $10M | -0.0 | -75.0 | -48.2 | — | 23.6 | 3 | BEARISH | -66.7 |
| XBIO Xenetic Biosciences, Inc. | $10M | -1.9 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | BEARISH | -29.0 |
| XBIO Xenetic Biosciences, Inc. | $10M | -1.9 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | BEARISH | -29.0 |
| CANN Trees Corporation | — | -3.1 | 284.2 | -3.9 | -15.1 | -24.7 | 4 | BEARISH | -67.0 |
| CANN Trees Corporation | — | -3.1 | 284.2 | -3.9 | -15.1 | -24.7 | 4 | BEARISH | -67.0 |
| CPMD CannaPharmaRX, Inc. | — | -0.1 | 42.4 | 22.4 | -691.1 | 24.8 | 3 | BEARISH | -33.3 |
| CPMD CannaPharmaRX, Inc. | — | -0.1 | 42.4 | 22.4 | -691.1 | 24.8 | 3 | BEARISH | -33.3 |
| DCGO DocGo Inc. | $40M | -0.2 | -92.4 | -73.3 | -21.5 | -32.4 | 3 | BEARISH | -71.8 |
| DCGO DocGo Inc. | $40M | -0.2 | -92.4 | -73.3 | -21.5 | -32.4 | 3 | BEARISH | -71.8 |
| IRIX IRIDEX Corporation | $10M | -3.2 | -73.1 | -73.9 | -10.1 | 3.7 | 5 | BEARISH | -43.1 |
| IRIX IRIDEX Corporation | $10M | -3.2 | -73.1 | -73.9 | -10.1 | 3.7 | 5 | BEARISH | -43.1 |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| VICA Rafina Innovations Inc. | — | -0.1 | -51.0 | -15.7 | — | 873.6 | 3 | BEARISH | 900.0 |
| VICA Rafina Innovations Inc. | — | -0.1 | -51.0 | -15.7 | — | 873.6 | 3 | BEARISH | 900.0 |
| VTAK Catheter Precision, Inc. | — | -0.0 | -103.3 | -50.5 | -323.4 | 219.2 | 4 | BEARISH | -94.3 |
| VTAK Catheter Precision, Inc. | — | -0.0 | -103.3 | -50.5 | -323.4 | 219.2 | 4 | BEARISH | -94.3 |
| SWNM Southwestern Medical Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | -70.0 |
| SWNM Southwestern Medical Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | -70.0 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | -14.3 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | -14.3 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| EMED Electromedical Technologies, Inc. | — | -0.2 | 44.6 | 29.8 | -8153.1 | -66.6 | 2 | BEARISH | -50.0 |
| EMED Electromedical Technologies, Inc. | — | -0.2 | 44.6 | 29.8 | -8153.1 | -66.6 | 2 | BEARISH | -50.0 |
| BACK IMAC Holdings, Inc. | — | -0.0 | 109.1 | 67.3 | -14505.6 | 100.5 | 2 | BEARISH | -99.1 |
| BACK IMAC Holdings, Inc. | — | -0.0 | 109.1 | 67.3 | -14505.6 | 100.5 | 2 | BEARISH | -99.1 |
| IVF INVO Fertility, Inc. | — | -0.0 | -55.3 | -28.1 | 40.9 | 13.8 | 4 | BEARISH | -97.2 |
| IVF INVO Fertility, Inc. | — | -0.0 | -55.3 | -28.1 | 40.9 | 13.8 | 4 | BEARISH | -97.2 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.6 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | BEARISH | 8.6 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.6 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | BEARISH | 8.6 |
| LFTSF LifeTech Scientific Corporation | $1.0B | 88.0 | 7.3 | 6.9 | -5.7 | 9.2 | 4 | BEARISH | 0.0 |
| LFTSF LifeTech Scientific Corporation | $1.0B | 88.0 | 7.3 | 6.9 | -5.7 | 9.2 | 4 | BEARISH | 0.0 |
| ENOV Enovis Corporation | $1.0B | -0.9 | -54.3 | -13.5 | -0.2 | 4.9 | 4 | BEARISH | -41.7 |
| ENOV Enovis Corporation | $1.0B | -0.9 | -54.3 | -13.5 | -0.2 | 4.9 | 4 | BEARISH | -41.7 |
| IMTX Immatics N.V. | $1.0B | -4.2 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -15.7 |
| IMTX Immatics N.V. | $1.0B | -4.2 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -15.7 |
| ODTX Odyssey Therapeutics, Inc. | $1.0B | — | — | — | — | — | — | BEARISH | — |
| ODTX Odyssey Therapeutics, Inc. | $1.0B | — | — | — | — | — | — | BEARISH | — |
| SVRA Savara Inc. | $990M | -8.3 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 35.9 |
| SVRA Savara Inc. | $990M | -8.3 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 35.9 |
| DSGN Design Therapeutics, Inc. | $770M | -10.5 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 81.7 |
| DSGN Design Therapeutics, Inc. | $770M | -10.5 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 81.7 |
| MTLZF Metall Zug AG | $680M | -36.4 | -5.8 | -4.7 | -5.6 | -60.7 | 4 | BEARISH | 0.0 |
| MTLZF Metall Zug AG | $680M | -36.4 | -5.8 | -4.7 | -5.6 | -60.7 | 4 | BEARISH | 0.0 |
| CRWRF Craneware plc | $620M | 24.1 | 11.2 | 12.9 | 9.7 | 8.7 | 7 | BEARISH | -47.1 |
| CRWRF Craneware plc | $620M | 24.1 | 11.2 | 12.9 | 9.7 | 8.7 | 7 | BEARISH | -47.1 |
| RZLT Rezolute, Inc. | $390M | -5.3 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -57.5 |
| RZLT Rezolute, Inc. | $390M | -5.3 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -57.5 |
| OCGN Ocugen, Inc. | $350M | -4.0 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -39.3 |
| OCGN Ocugen, Inc. | $350M | -4.0 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -39.3 |
| CAMP CAMP4 Therapeutics Corporation | $250M | -1.8 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | BEARISH | 35.6 |
| CAMP CAMP4 Therapeutics Corporation | $250M | -1.8 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | BEARISH | 35.6 |
| RNAC Cartesian Therapeutics, Inc. | $220M | -1.2 | 241.0 | 37.3 | — | 44.0 | 2 | BEARISH | -28.1 |
| RNAC Cartesian Therapeutics, Inc. | $220M | -1.2 | 241.0 | 37.3 | — | 44.0 | 2 | BEARISH | -28.1 |
| APLMW Apollomics, Inc. | $160M | -3.0 | -4655.8 | 1929.8 | 1188.0 | — | 2 | BEARISH | -59.6 |
| APLMW Apollomics, Inc. | $160M | -3.0 | -4655.8 | 1929.8 | 1188.0 | — | 2 | BEARISH | -59.6 |
| ARMP Armata Pharmaceuticals, Inc. | $130M | -0.7 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | BEARISH | 18.9 |
| ARMP Armata Pharmaceuticals, Inc. | $130M | -0.7 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | BEARISH | 18.9 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.6 | -37.2 | -1604.9 | — | -100.0 | 1 | BEARISH | -49.2 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.6 | -37.2 | -1604.9 | — | -100.0 | 1 | BEARISH | -49.2 |
| SKIN SkinHealth Systems Inc. | $80M | -2.8 | -43.8 | -1.6 | -3.7 | -6.5 | 4 | BEARISH | -64.6 |
| SKIN SkinHealth Systems Inc. | $80M | -2.8 | -43.8 | -1.6 | -3.7 | -6.5 | 4 | BEARISH | -64.6 |
| GOSS Gossamer Bio, Inc. | $70M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | BEARISH | -94.6 |
| GOSS Gossamer Bio, Inc. | $70M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | BEARISH | -94.6 |
| OSTX OS Therapies Incorporated | $70M | -1.5 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -18.5 |
| OSTX OS Therapies Incorporated | $70M | -1.5 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -18.5 |
| TDMMF Mach7 Technologies Limited | $40M | -6.1 | -35.0 | -38.2 | -22.3 | 4.2 | 4 | BEARISH | -67.9 |
| TDMMF Mach7 Technologies Limited | $40M | -6.1 | -35.0 | -38.2 | -22.3 | 4.2 | 4 | BEARISH | -67.9 |
| TLTFF Theralase Technologies Inc. | $40M | -12.3 | -93.5 | -173.9 | -646.5 | -24.8 | 4 | BEARISH | -8.2 |
| TLTFF Theralase Technologies Inc. | $40M | -12.3 | -93.5 | -173.9 | -646.5 | -24.8 | 4 | BEARISH | -8.2 |
| INNMF Amplia Therapeutics Limited | $40M | -6.6 | -55.4 | -129.9 | — | -32.9 | 3 | BEARISH | -20.0 |
| INNMF Amplia Therapeutics Limited | $40M | -6.6 | -55.4 | -129.9 | — | -32.9 | 3 | BEARISH | -20.0 |
| OTCFF Ocumetics Technology Corp. | $20M | -6.9 | 174.3 | 2137.7 | — | — | 1 | BEARISH | -67.5 |
| OTCFF Ocumetics Technology Corp. | $20M | -6.9 | 174.3 | 2137.7 | — | — | 1 | BEARISH | -67.5 |
| IPDQF ImpediMed Limited | $20M | -0.5 | -189.0 | 712.6 | -177.9 | 26.1 | 3 | BEARISH | -83.3 |
| RVXCF Resverlogix Corp. | $20M | -1.8 | 11.5 | 25.3 | — | — | 4 | BEARISH | -11.2 |
| RVXCF Resverlogix Corp. | $20M | -1.8 | 11.5 | 25.3 | — | — | 4 | BEARISH | -11.2 |
| IPDQF ImpediMed Limited | $20M | -0.5 | -189.0 | 712.6 | -177.9 | 26.1 | 3 | BEARISH | -83.3 |
| NSCIF Nanalysis Scientific Corp. | $10M | -3.5 | -33.5 | -6.2 | -6.9 | -6.2 | 5 | BEARISH | -41.0 |
| NSCIF Nanalysis Scientific Corp. | $10M | -3.5 | -33.5 | -6.2 | -6.9 | -6.2 | 5 | BEARISH | -41.0 |
| MVMDF The More Life Company Corp. | $10M | -6.2 | -190.3 | 2590.3 | -2792.5 | -82.4 | 1 | BEARISH | 177.6 |
| MVMDF The More Life Company Corp. | $10M | -6.2 | -190.3 | 2590.3 | -2792.5 | -82.4 | 1 | BEARISH | 177.6 |
| OPTH Optimi Health Corp. | $10M | — | — | — | — | — | — | BEARISH | — |
| OPTH Optimi Health Corp. | $10M | — | — | — | — | — | — | BEARISH | — |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -92.8 |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -92.8 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -65.3 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -65.3 |
| BMGL Basel Medical Group Ltd Ordinary Shares | $10M | — | — | — | — | — | — | BEARISH | -84.2 |
| BMGL Basel Medical Group Ltd Ordinary Shares | $10M | — | — | — | — | — | — | BEARISH | -84.2 |
| CNTMF Fluent Corp. | $10M | -0.2 | 119.7 | -49.4 | -65.1 | -34.7 | 4 | BEARISH | -57.4 |
| CNTMF Fluent Corp. | $10M | -0.2 | 119.7 | -49.4 | -65.1 | -34.7 | 4 | BEARISH | -57.4 |
| KALA KALA BIO, Inc. | $10M | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.4 |
| KALA KALA BIO, Inc. | $10M | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.4 |
| PFHO Pacific Health Care Organization, Inc. | $10M | 12.3 | 7.5 | 60.8 | 18.4 | -2.6 | 4 | BEARISH | -19.7 |
| PFHO Pacific Health Care Organization, Inc. | $10M | 12.3 | 7.5 | 60.8 | 18.4 | -2.6 | 4 | BEARISH | -19.7 |
| VPTDF VentriPoint Diagnostics Ltd. | $10M | -6.5 | 58.8 | 122.3 | -3487.7 | 8.8 | 4 | BEARISH | -13.3 |
| VPTDF VentriPoint Diagnostics Ltd. | $10M | -6.5 | 58.8 | 122.3 | -3487.7 | 8.8 | 4 | BEARISH | -13.3 |
| TRUFF Rhelion Life Sciences Corp. | $10M | -2.1 | -41.6 | -142.7 | -288.8 | -15.2 | 4 | BEARISH | -18.0 |
| TRUFF Rhelion Life Sciences Corp. | $10M | -2.1 | -41.6 | -142.7 | -288.8 | -15.2 | 4 | BEARISH | -18.0 |
| NEPTF Neptune Wellness Solutions Inc. | — | -2.7 | 606.5 | 1351.5 | -233.6 | -24.7 | 2 | BEARISH | -100.0 |
| NEXI NexImmune, Inc. | — | -0.0 | -230.1 | 1048.5 | — | — | 4 | BEARISH | -50.0 |
| NEXI NexImmune, Inc. | — | -0.0 | -230.1 | 1048.5 | — | — | 4 | BEARISH | -50.0 |
| NEPTF Neptune Wellness Solutions Inc. | — | -2.7 | 606.5 | 1351.5 | -233.6 | -24.7 | 2 | BEARISH | -100.0 |
| PDMI Paradigm Medical Industries, Inc. | — | -0.0 | 47.4 | -40.4 | -184.3 | -30.7 | 4 | BEARISH | -99.0 |
| PDMI Paradigm Medical Industries, Inc. | — | -0.0 | 47.4 | -40.4 | -184.3 | -30.7 | 4 | BEARISH | -99.0 |
| HKPD Cellyan Biotechnology Co., Ltd | — | -5.0 | -20.8 | -14.1 | -20.5 | — | 2 | BEARISH | -92.4 |
| HKPD Cellyan Biotechnology Co., Ltd | — | -5.0 | -20.8 | -14.1 | -20.5 | — | 2 | BEARISH | -92.4 |
| WPHM Winston Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | -66.7 |
| WPHM Winston Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | -66.7 |
| BIGG Big Tree Group, Inc. | — | 0.0 | 0.4 | -0.6 | -0.6 | 55.4 | 5 | BEARISH | 0.0 |
| BIGG Big Tree Group, Inc. | — | 0.0 | 0.4 | -0.6 | -0.6 | 55.4 | 5 | BEARISH | 0.0 |
| MDCE Medical Care Technologies Inc. | — | 1.0 | 28.0 | 28.7 | 23.9 | 0.6 | 7 | BEARISH | -75.0 |
| MDCE Medical Care Technologies Inc. | — | 1.0 | 28.0 | 28.7 | 23.9 | 0.6 | 7 | BEARISH | -75.0 |
| DECN Decision Diagnostics Corp. | — | -0.0 | -8643.1 | -51.3 | -107.0 | -2.7 | 4 | BEARISH | -99.0 |
| DECN Decision Diagnostics Corp. | — | -0.0 | -8643.1 | -51.3 | -107.0 | -2.7 | 4 | BEARISH | -99.0 |
| ULGX Urologix, Inc. | — | -0.0 | 80.8 | 96.5 | -12.5 | -19.4 | 3 | BEARISH | 0.0 |
| ULGX Urologix, Inc. | — | -0.0 | 80.8 | 96.5 | -12.5 | -19.4 | 3 | BEARISH | 0.0 |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -98.7 |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -98.7 |
| STHZF StateHouse Holdings Inc. | — | -0.1 | 36.1 | 3.8 | 0.8 | -2.6 | 4 | BEARISH | -100.0 |
| STHZF StateHouse Holdings Inc. | — | -0.1 | 36.1 | 3.8 | 0.8 | -2.6 | 4 | BEARISH | -100.0 |
| HPMM Hemp Naturals, Inc. | — | -0.0 | -141.5 | -78.5 | — | 17757.1 | 3 | BEARISH | -99.0 |
| HPMM Hemp Naturals, Inc. | — | -0.0 | -141.5 | -78.5 | — | 17757.1 | 3 | BEARISH | -99.0 |
| EMGE Emergent Health Corp | — | -0.0 | 23.7 | 51.7 | — | -80.0 | 1 | BEARISH | 0.0 |
| EMGE Emergent Health Corp | — | -0.0 | 23.7 | 51.7 | — | -80.0 | 1 | BEARISH | 0.0 |
| SFWJ Software Effective Solutions Corp. | — | -0.9 | -21.8 | -12.6 | -51.5 | 26679.3 | 6 | BEARISH | -33.3 |
| SFWJ Software Effective Solutions Corp. | — | -0.9 | -21.8 | -12.6 | -51.5 | 26679.3 | 6 | BEARISH | -33.3 |
| AKAN Akanda Corp. | — | -0.0 | 679.7 | -257.3 | -17342.7 | -77.1 | 3 | BEARISH | -97.1 |
| AKAN Akanda Corp. | — | -0.0 | 679.7 | -257.3 | -17342.7 | -77.1 | 3 | BEARISH | -97.1 |
| GPFT Grapefruit USA, Inc. | — | -0.2 | 11.4 | 5.9 | — | — | 2 | BEARISH | -80.0 |
| GPFT Grapefruit USA, Inc. | — | -0.2 | 11.4 | 5.9 | — | — | 2 | BEARISH | -80.0 |
| VLXC Veltex Corporation | — | -2.6 | 49.0 | -433.9 | -89.4 | 3.2 | 3 | BEARISH | -37.1 |
| VLXC Veltex Corporation | — | -2.6 | 49.0 | -433.9 | -89.4 | 3.2 | 3 | BEARISH | -37.1 |
| ISPC iSpecimen Inc. | — | -0.0 | -968.5 | 305.3 | -896.9 | -92.1 | 4 | BEARISH | -97.9 |
| ISPC iSpecimen Inc. | — | -0.0 | -968.5 | 305.3 | -896.9 | -92.1 | 4 | BEARISH | -97.9 |
| YCBD cbdMD, Inc. | — | -1.5 | -40.3 | -27.6 | -20.3 | 10.0 | 2 | BEARISH | -60.0 |
| YCBD cbdMD, Inc. | — | -1.5 | -40.3 | -27.6 | -20.3 | 10.0 | 2 | BEARISH | -60.0 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | 0.0 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | 0.0 |
| MRES Institute of Biomedical Research Corp. | — | -4.8 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -71.8 |
| MRES Institute of Biomedical Research Corp. | — | -4.8 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -71.8 |
| LOWLF Lowell Farms Inc. | — | -0.0 | -146.8 | -63.3 | -111.9 | -35.7 | 5 | BEARISH | -100.0 |
| LOWLF Lowell Farms Inc. | — | -0.0 | -146.8 | -63.3 | -111.9 | -35.7 | 5 | BEARISH | -100.0 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | BEARISH | -99.0 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | BEARISH | -99.0 |
| DHBUF Delivra Health Brands Inc. | — | -2.5 | -19.4 | -34.1 | -82.4 | -10.7 | 2 | BEARISH | -67.7 |
| DHBUF Delivra Health Brands Inc. | — | -2.5 | -19.4 | -34.1 | -82.4 | -10.7 | 2 | BEARISH | -67.7 |
| QMDT Quick-Med Technologies, Inc. | — | -0.0 | 8.3 | 3.4 | -78.6 | -6.9 | 5 | BEARISH | 400.0 |
| QMDT Quick-Med Technologies, Inc. | — | -0.0 | 8.3 | 3.4 | -78.6 | -6.9 | 5 | BEARISH | 400.0 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | BEARISH | -90.9 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | BEARISH | -90.9 |
| MEDVF Medivolve Inc. | — | -0.2 | 149.7 | 23.5 | -322.7 | -93.6 | 3 | BEARISH | -95.0 |
| MEDVF Medivolve Inc. | — | -0.2 | 149.7 | 23.5 | -322.7 | -93.6 | 3 | BEARISH | -95.0 |
| CRYM Cryomass Technologies Inc. | — | -0.0 | 137.2 | 57.9 | -22040.0 | -96.0 | 2 | BEARISH | -99.8 |
| CRYM Cryomass Technologies Inc. | — | -0.0 | 137.2 | 57.9 | -22040.0 | -96.0 | 2 | BEARISH | -99.8 |
| GCTK GlucoTrack, Inc. | — | -0.0 | -620.6 | 427.4 | — | — | 2 | BEARISH | -98.7 |
| GCTK GlucoTrack, Inc. | — | -0.0 | -620.6 | 427.4 | — | — | 2 | BEARISH | -98.7 |
| VRSYF VMS Rehab Systems, Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| VRSYF VMS Rehab Systems, Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| CANF Can-Fite BioPharma Ltd. | — | -0.3 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -82.1 |
| CANF Can-Fite BioPharma Ltd. | — | -0.3 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -82.1 |
| MCDA KMA Holding, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MCDA KMA Holding, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BMMJ Body and Mind Inc. | — | -0.1 | 267.1 | 411.6 | -58.9 | -48.9 | 2 | BEARISH | -98.0 |
| BMMJ Body and Mind Inc. | — | -0.1 | 267.1 | 411.6 | -58.9 | -48.9 | 2 | BEARISH | -98.0 |
| DOGP Dogecoin Cash, Inc. | — | -1.9 | 30.1 | 16.3 | -76.3 | 0.2 | 3 | BEARISH | -77.3 |
| DOGP Dogecoin Cash, Inc. | — | -1.9 | 30.1 | 16.3 | -76.3 | 0.2 | 3 | BEARISH | -77.3 |
| SIGO Sunset Island Group, Inc. | — | -0.0 | 185.8 | 85.4 | — | — | 4 | BEARISH | 0.0 |
| SIGO Sunset Island Group, Inc. | — | -0.0 | 185.8 | 85.4 | — | — | 4 | BEARISH | 0.0 |
| VRAYQ ViewRay, Inc. | — | -0.0 | -108.9 | -146.1 | -128.1 | 44.1 | 1 | BEARISH | -90.0 |
| VRAYQ ViewRay, Inc. | — | -0.0 | -108.9 | -146.1 | -128.1 | 44.1 | 1 | BEARISH | -90.0 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -88.0 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -88.0 |
| CDXQ China De Xiao Quan Care Group Co., Ltd | — | 0.0 | -136.1 | -277.5 | — | — | 4 | BEARISH | 300.0 |
| CDXQ China De Xiao Quan Care Group Co., Ltd | — | 0.0 | -136.1 | -277.5 | — | — | 4 | BEARISH | 300.0 |
| APLIF Appili Therapeutics Inc | — | -0.1 | 27.5 | 94.3 | -2486.7 | 159.8 | 2 | BEARISH | -50.0 |
| APLIF Appili Therapeutics Inc | — | -0.1 | 27.5 | 94.3 | -2486.7 | 159.8 | 2 | BEARISH | -50.0 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | BEARISH | -90.0 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | BEARISH | -90.0 |
| ECIA Encision Inc. | — | -0.7 | -21.4 | -7.6 | -17.5 | -3.0 | 3 | BEARISH | -97.0 |
| ECIA Encision Inc. | — | -0.7 | -21.4 | -7.6 | -17.5 | -3.0 | 3 | BEARISH | -97.0 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | BEARISH | -99.8 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | BEARISH | -99.8 |
| PNPL Pineapple, Inc. | — | -6.5 | 63.1 | -28.2 | -276.2 | 943.8 | 7 | BEARISH | -99.6 |
| PNPL Pineapple, Inc. | — | -6.5 | 63.1 | -28.2 | -276.2 | 943.8 | 7 | BEARISH | -99.6 |
| ABTI Alterola Biotech, Inc. | — | -0.1 | -27.4 | 216.7 | — | — | 3 | BEARISH | 0.0 |
| ABTI Alterola Biotech, Inc. | — | -0.1 | -27.4 | 216.7 | — | — | 3 | BEARISH | 0.0 |
| SEPN Septerna Inc | $1.7B | -69.8 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BEARISH | 98.5 |
| SEPN Septerna Inc | $1.7B | -69.8 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BEARISH | 98.5 |
| CRON Cronos Group Inc. | $1.2B | 17.2 | 6.5 | 5.3 | 45.4 | 86.4 | 6 | BEARISH | 21.4 |
| CRON Cronos Group Inc. | $1.2B | 17.2 | 6.5 | 5.3 | 45.4 | 86.4 | 6 | BEARISH | 21.4 |
| SIBN SI-BONE, Inc. | $800M | -53.2 | -8.3 | -32.2 | -7.3 | 15.3 | 6 | BEARISH | 26.7 |
| SIBN SI-BONE, Inc. | $800M | -53.2 | -8.3 | -32.2 | -7.3 | 15.3 | 6 | BEARISH | 26.7 |
| FDMT 4D Molecular Therapeutics, Inc. | $710M | -5.0 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 56.6 |
| FDMT 4D Molecular Therapeutics, Inc. | $710M | -5.0 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 56.6 |
| TMCI Treace Medical Concepts, Inc. | $280M | -4.7 | -72.0 | -44.8 | -35.0 | -4.0 | 2 | BEARISH | -30.5 |
| TMCI Treace Medical Concepts, Inc. | $280M | -4.7 | -72.0 | -44.8 | -35.0 | -4.0 | 2 | BEARISH | -30.5 |
| ANIK Anika Therapeutics, Inc. | $260M | -70.9 | -2.7 | -3.3 | 10.1 | 31.4 | 7 | BEARISH | 106.5 |
| ANIK Anika Therapeutics, Inc. | $260M | -70.9 | -2.7 | -3.3 | 10.1 | 31.4 | 7 | BEARISH | 106.5 |
| EPRX Eupraxia Pharmaceuticals Inc. | $240M | -7.1 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 19.3 |
| EPRX Eupraxia Pharmaceuticals Inc. | $240M | -7.1 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 19.3 |
| NKTX Nkarta, Inc. | $180M | -1.6 | -38.8 | -75.4 | — | — | 1 | BEARISH | 16.7 |
| NKTX Nkarta, Inc. | $180M | -1.6 | -38.8 | -75.4 | — | — | 1 | BEARISH | 16.7 |
| COCH Envoy Medical, Inc. | $50M | -1.0 | 176.2 | 119.9 | -11729.4 | -6.8 | 4 | BEARISH | -12.3 |
| COCH Envoy Medical, Inc. | $50M | -1.0 | 176.2 | 119.9 | -11729.4 | -6.8 | 4 | BEARISH | -12.3 |
| IBO Impact BioMedical Inc. | $50M | -4.5 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -34.5 |
| IBO Impact BioMedical Inc. | $50M | -4.5 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -34.5 |
| IXHL Incannex Healthcare Limited | $40M | -2.9 | -163.9 | 14055.6 | — | 378.7 | 5 | BEARISH | -75.2 |
| IXHL Incannex Healthcare Limited | $40M | -2.9 | -163.9 | 14055.6 | — | 378.7 | 5 | BEARISH | -75.2 |
| CCEL Cryo-Cell International, Inc. | $30M | -13.6 | 14.8 | 0.7 | 7.1 | -2.7 | 5 | BEARISH | -13.9 |
| CCEL Cryo-Cell International, Inc. | $30M | -13.6 | 14.8 | 0.7 | 7.1 | -2.7 | 5 | BEARISH | -13.9 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| JNDOF JINS HOLDINGS Inc. | $900M | 15.6 | 25.4 | 27.3 | 9.4 | 15.5 | 4 | BEARISH | 68.9 |
| JNDOF JINS HOLDINGS Inc. | $900M | 15.6 | 25.4 | 27.3 | 9.4 | 15.5 | 4 | BEARISH | 68.9 |
| AMGXF AnGes, Inc. | $140M | -3.7 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| AMGXF AnGes, Inc. | $140M | -3.7 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| VYND Vynleads, Inc. | $10M | -27.0 | 74.2 | 89.5 | — | — | 4 | BEARISH | -18.0 |
| VYND Vynleads, Inc. | $10M | -27.0 | 74.2 | 89.5 | — | — | 4 | BEARISH | -18.0 |
| IRME IR-Med Inc. | — | -0.1 | 1793.9 | 264.1 | — | -23.5 | 2 | BEARISH | -95.6 |
| IRME IR-Med Inc. | — | -0.1 | 1793.9 | 264.1 | — | -23.5 | 2 | BEARISH | -95.6 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | -99.0 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | -99.0 |
| IHTI Integrative Health Technologies, Inc. | — | 0.0 | -13.8 | -11.8 | 53.8 | 263.8 | 4 | BEARISH | -95.0 |
| IHTI Integrative Health Technologies, Inc. | — | 0.0 | -13.8 | -11.8 | 53.8 | 263.8 | 4 | BEARISH | -95.0 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| SLHPF Skylight Health Group Inc. | — | -0.0 | -109.3 | -44.8 | -21.4 | — | 2 | BEARISH | -90.0 |
| SLHPF Skylight Health Group Inc. | — | -0.0 | -109.3 | -44.8 | -21.4 | — | 2 | BEARISH | -90.0 |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| STLNW Starling Oncology Inc. Wt | — | — | — | — | — | — | — | BEARISH | — |
| STLNW Starling Oncology Inc. Wt | — | — | — | — | — | — | — | BEARISH | — |
| NWPHF Newron Pharmaceuticals S.p.A. | $420M | -6.0 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| NWPHF Newron Pharmaceuticals S.p.A. | $420M | -6.0 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| BLEVF Beleave Inc. | — | -0.0 | -105.9 | -25.1 | -653.1 | 117.7 | 4 | BEARISH | -90.0 |
| BLEVF Beleave Inc. | — | -0.0 | -105.9 | -25.1 | -653.1 | 117.7 | 4 | BEARISH | -90.0 |
| ARCT Arcturus Therapeutics Holdings Inc. | $370M | -3.9 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | BEARISH | -36.4 |
| ARCT Arcturus Therapeutics Holdings Inc. | $370M | -3.9 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | BEARISH | -36.4 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.6 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -52.4 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.6 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -52.4 |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.1 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | BEARISH | -83.7 |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.1 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | BEARISH | -83.7 |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | 300.0 |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | 300.0 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | BEARISH | -99.5 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | BEARISH | -99.5 |
| QDEL QuidelOrtho Corporation | $730M | -0.7 | -45.9 | -13.7 | -14.7 | 0.1 | 4 | BEARISH | -65.5 |
| QDEL QuidelOrtho Corporation | $730M | -0.7 | -45.9 | -13.7 | -14.7 | 0.1 | 4 | BEARISH | -65.5 |
| ROMJF Rubicon Organics Inc. | $20M | -18.5 | -4.1 | -24.0 | 2.2 | 16.7 | 1 | BEARISH | -19.4 |
| ROMJF Rubicon Organics Inc. | $20M | -18.5 | -4.1 | -24.0 | 2.2 | 16.7 | 1 | BEARISH | -19.4 |
| DVHGF Devonian Health Group Inc. | $20M | -3.8 | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| DVHGF Devonian Health Group Inc. | $20M | -3.8 | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| CMHSF Comprehensive Healthcare Systems, Inc. | $10M | -2.0 | 78.3 | 144.6 | -37.9 | -22.6 | 3 | BEARISH | -26.7 |
| CMHSF Comprehensive Healthcare Systems, Inc. | $10M | -2.0 | 78.3 | 144.6 | -37.9 | -22.6 | 3 | BEARISH | -26.7 |
| MDCX Medicus Pharma Ltd. Common Stock | $10M | -0.1 | -3904.0 | -693.1 | — | — | 2 | BEARISH | -92.8 |
| MDCX Medicus Pharma Ltd. Common Stock | $10M | -0.1 | -3904.0 | -693.1 | — | — | 2 | BEARISH | -92.8 |
| APPB Applied Biosciences Corp. | — | -0.0 | -297.6 | -188.8 | -798.1 | 75.3 | 4 | BEARISH | 0.0 |
| APPB Applied Biosciences Corp. | — | -0.0 | -297.6 | -188.8 | -798.1 | 75.3 | 4 | BEARISH | 0.0 |
| FAMDF Futura Medical plc | — | -0.3 | -203.4 | -1029.2 | -72.8 | 1.5 | 3 | BEARISH | -94.4 |
| FAMDF Futura Medical plc | — | -0.3 | -203.4 | -1029.2 | -72.8 | 1.5 | 3 | BEARISH | -94.4 |
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | — | -0.0 | -218.1 | -292.1 | -21.7 | — | 2 | BEARISH | -99.1 |
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | — | -0.0 | -218.1 | -292.1 | -21.7 | — | 2 | BEARISH | -99.1 |
| NMXS Net Medical Xpress Solutions, Inc. | — | -0.0 | -362.8 | -352.4 | -6733.3 | -89.2 | 2 | BEARISH | 600.0 |
| NMXS Net Medical Xpress Solutions, Inc. | — | -0.0 | -362.8 | -352.4 | -6733.3 | -89.2 | 2 | BEARISH | 600.0 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | BEARISH | -83.0 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | BEARISH | -83.0 |
| BHVN Biohaven Ltd. | $1.9B | -2.8 | -799.5 | -1083.0 | — | — | 3 | BEARISH | -13.1 |
| BHVN Biohaven Ltd. | $1.9B | -2.8 | -799.5 | -1083.0 | — | — | 3 | BEARISH | -13.1 |
| RTEZ Rest Ez Inc. | $1.9B | — | — | — | — | — | — | BEARISH | 0.0 |
| RTEZ Rest Ez Inc. | $1.9B | — | — | — | — | — | — | BEARISH | 0.0 |
| PVLA Palvella Therapeutics, Inc. | $1.9B | -27.4 | -46.6 | 137.5 | — | — | 3 | BEARISH | 109.5 |
| PVLA Palvella Therapeutics, Inc. | $1.9B | -27.4 | -46.6 | 137.5 | — | — | 3 | BEARISH | 109.5 |
| NVCR Novocure Ltd | $1.7B | -11.5 | -43.2 | -93.1 | -8.5 | 11.0 | 6 | BEARISH | 6.9 |
| NVCR Novocure Ltd | $1.7B | -11.5 | -43.2 | -93.1 | -8.5 | 11.0 | 6 | BEARISH | 6.9 |
| AGL Agilon Health, Inc. | $1.4B | -5.5 | -78.9 | -273.7 | 1.2 | 0.3 | 6 | BEARISH | 237.0 |
| AGL Agilon Health, Inc. | $1.4B | -5.5 | -78.9 | -273.7 | 1.2 | 0.3 | 6 | BEARISH | 237.0 |
| INNV Innovage Holding Corp. | $1.2B | -432.9 | -1.1 | -89.6 | 3.2 | 16.4 | 6 | BEARISH | 72.6 |
| INNV Innovage Holding Corp. | $1.2B | -432.9 | -1.1 | -89.6 | 3.2 | 16.4 | 6 | BEARISH | 72.6 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -8.5 | -45.3 | -2390.9 | — | — | 2 | BEARISH | 52.2 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -8.5 | -45.3 | -2390.9 | — | — | 2 | BEARISH | 52.2 |
| VOR Vor Biopharma Inc. | $1.0B | -0.1 | -73.6 | 22.2 | — | — | 3 | BEARISH | -52.4 |
| VOR Vor Biopharma Inc. | $1.0B | -0.1 | -73.6 | 22.2 | — | — | 3 | BEARISH | -52.4 |
| ABUS Arbutus Biopharma Corp | $880M | 5.6 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -3.0 |
| ABUS Arbutus Biopharma Corp | $880M | 5.6 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -3.0 |
| SLBT SL Science Holding Ltd | $880M | — | — | — | — | — | — | BEARISH | — |
| SLBT SL Science Holding Ltd | $880M | — | — | — | — | — | — | BEARISH | — |
| AVR Anteris Technologies Global Corp. | $750M | -2.8 | -75.1 | 3136.2 | -2884.3 | 31.1 | 5 | BEARISH | 81.4 |
| AVR Anteris Technologies Global Corp. | $750M | -2.8 | -75.1 | 3136.2 | -2884.3 | 31.1 | 5 | BEARISH | 81.4 |
| IRWD Ironwood Pharmaceuticals, Inc. | $600M | 4.6 | -55.3 | 93.9 | 45.4 | 26.2 | 7 | BEARISH | 149.3 |
| IRWD Ironwood Pharmaceuticals, Inc. | $600M | 4.6 | -55.3 | 93.9 | 45.4 | 26.2 | 7 | BEARISH | 149.3 |
| RSLBF RaySearch Laboratories AB (publ) | $560M | 29.1 | 26.1 | 21.8 | 7.2 | 1.2 | 6 | BEARISH | -40.2 |
| RSLBF RaySearch Laboratories AB (publ) | $560M | 29.1 | 26.1 | 21.8 | 7.2 | 1.2 | 6 | BEARISH | -40.2 |
| EIKN Eikon Therapeutics, Inc. Common Stock | $400M | — | — | — | — | — | — | BEARISH | — |
| EIKN Eikon Therapeutics, Inc. Common Stock | $400M | — | — | — | — | — | — | BEARISH | — |
| VREOF Vireo Growth Inc. | $360M | -4.8 | -4.6 | -0.7 | -0.0 | — | 3 | BEARISH | — |
| VREOF Vireo Growth Inc. | $360M | -4.8 | -4.6 | -0.7 | -0.0 | — | 3 | BEARISH | — |
| CLVLF Clinuvel Pharmaceuticals Limited | $290M | 11.9 | 29.5 | 262.1 | 41.1 | 13.1 | 6 | BEARISH | -28.1 |
| CLVLF Clinuvel Pharmaceuticals Limited | $290M | 11.9 | 29.5 | 262.1 | 41.1 | 13.1 | 6 | BEARISH | -28.1 |
| UPB Upstream Bio, Inc. | $270M | -1.7 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -70.9 |
| UPB Upstream Bio, Inc. | $270M | -1.7 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -70.9 |
| TRDA Entrada Therapeutics, Inc. | $210M | -1.4 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | BEARISH | -8.5 |
| TRDA Entrada Therapeutics, Inc. | $210M | -1.4 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | BEARISH | -8.5 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.5 | -110.7 | 411.1 | — | — | 2 | BEARISH | -6.4 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.5 | -110.7 | 411.1 | — | — | 2 | BEARISH | -6.4 |
| MFCSF Medical Facilities Corporation | $180M | 8.3 | 46.9 | 50.2 | 2.5 | 3.2 | 7 | BEARISH | 2.1 |
| MFCSF Medical Facilities Corporation | $180M | 8.3 | 46.9 | 50.2 | 2.5 | 3.2 | 7 | BEARISH | 2.1 |
| DERM Journey Medical Corporation | $180M | -29.3 | -23.8 | -7.4 | -1.7 | 20.9 | 5 | BEARISH | -8.8 |
| DERM Journey Medical Corporation | $180M | -29.3 | -23.8 | -7.4 | -1.7 | 20.9 | 5 | BEARISH | -8.8 |
| DTIL Precision BioSciences, Inc. | $170M | -2.3 | -135.1 | 203.1 | — | 3473.0 | 5 | BEARISH | 16.0 |
| DTIL Precision BioSciences, Inc. | $170M | -2.3 | -135.1 | 203.1 | — | 3473.0 | 5 | BEARISH | 16.0 |
| BRNHF Broncus Holding Corporation | $160M | -2.5 | -19.0 | -76.7 | -247.3 | -20.6 | 5 | BEARISH | 0.0 |
| BRNHF Broncus Holding Corporation | $160M | -2.5 | -19.0 | -76.7 | -247.3 | -20.6 | 5 | BEARISH | 0.0 |
| NRXP NRx Pharmaceuticals, Inc. | $130M | -3.9 | 131.2 | 61.3 | -1500.5 | — | 5 | BEARISH | -12.9 |
| NRXP NRx Pharmaceuticals, Inc. | $130M | -3.9 | 131.2 | 61.3 | -1500.5 | — | 5 | BEARISH | -12.9 |
| TRIB Trinity Biotech plc | $120M | -0.1 | 69.8 | -14.6 | -157.8 | -28.8 | 2 | BEARISH | 457.8 |
| TRIB Trinity Biotech plc | $120M | -0.1 | 69.8 | -14.6 | -157.8 | -28.8 | 2 | BEARISH | 457.8 |
| HURA TuHURA Biosciences, Inc. | $120M | -3.5 | -161.4 | -137.6 | — | — | 2 | BEARISH | -24.8 |
| HURA TuHURA Biosciences, Inc. | $120M | -3.5 | -161.4 | -137.6 | — | — | 2 | BEARISH | -24.8 |
| ADAG Adagene Inc. | $110M | -6.0 | -72.6 | 324.2 | -1011.1 | 1054.7 | 4 | BEARISH | 42.5 |
| ADAG Adagene Inc. | $110M | -6.0 | -72.6 | 324.2 | -1011.1 | 1054.7 | 4 | BEARISH | 42.5 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $110M | -1.6 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -66.1 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $110M | -1.6 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -66.1 |
| KRRO Korro Bio, Inc. | $100M | -1.0 | -97.7 | -196.6 | — | -62.1 | 2 | BEARISH | -78.0 |
| KRRO Korro Bio, Inc. | $100M | -1.0 | -97.7 | -196.6 | — | -62.1 | 2 | BEARISH | -78.0 |
| HLTRF HLS Therapeutics Inc. | $90M | -10.3 | -14.1 | -4.2 | -7.0 | -0.2 | 5 | BEARISH | -27.6 |
| HLTRF HLS Therapeutics Inc. | $90M | -10.3 | -14.1 | -4.2 | -7.0 | -0.2 | 5 | BEARISH | -27.6 |
| PXMBF Paxman AB (publ) | $80M | -303.4 | -1.2 | -1.7 | 2.4 | 33.5 | 3 | BEARISH | 0.0 |
| PXMBF Paxman AB (publ) | $80M | -303.4 | -1.2 | -1.7 | 2.4 | 33.5 | 3 | BEARISH | 0.0 |
| RNXT RenovoRx, Inc. | $70M | -5.0 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | BEARISH | 17.9 |
| RNXT RenovoRx, Inc. | $70M | -5.0 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | BEARISH | 17.9 |
| BOLD Boundless Bio, Inc. | $60M | -0.9 | -67.9 | 807.9 | — | — | 2 | BEARISH | 113.0 |
| BOLD Boundless Bio, Inc. | $60M | -0.9 | -67.9 | 807.9 | — | — | 2 | BEARISH | 113.0 |
| INMB INmune Bio, Inc. | $50M | -2.8 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -9.4 |
| INMB INmune Bio, Inc. | $50M | -2.8 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -9.4 |
| NNOX Nano-X Imaging Ltd. | $40M | -0.4 | -99.0 | -164.5 | -1335.1 | 31.5 | 2 | BEARISH | -82.8 |
| NNOX Nano-X Imaging Ltd. | $40M | -0.4 | -99.0 | -164.5 | -1335.1 | 31.5 | 2 | BEARISH | -82.8 |
| NDTP NDT Pharmaceuticals Inc. | $40M | -50.0 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -78.2 |
| NDTP NDT Pharmaceuticals Inc. | $40M | -50.0 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -78.2 |
| MDXH MDxHealth S.A. | $30M | -1.0 | 321.7 | -43.8 | -42.4 | 34.4 | 5 | BEARISH | -87.8 |
| MDXH MDxHealth S.A. | $30M | -1.0 | 321.7 | -43.8 | -42.4 | 34.4 | 5 | BEARISH | -87.8 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | BEARISH | — |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | BEARISH | — |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -75.0 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -75.0 |
| TELIF Telescope Innovations Corp. | $20M | -7.2 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | 13.6 |
| TELIF Telescope Innovations Corp. | $20M | -7.2 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | 13.6 |
| TXMD TherapeuticsMD, Inc. | $20M | -109.0 | -0.8 | -12.9 | 17.8 | 27.8 | 6 | BEARISH | 88.7 |
| TXMD TherapeuticsMD, Inc. | $20M | -109.0 | -0.8 | -12.9 | 17.8 | 27.8 | 6 | BEARISH | 88.7 |
| KPTI Karyopharm Therapeutics Inc. | $20M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | BEARISH | -87.1 |
| KPTI Karyopharm Therapeutics Inc. | $20M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | BEARISH | -87.1 |
| ALLR Allarity Therapeutics, Inc. | $20M | -1.3 | -157.1 | -96.5 | — | — | 2 | BEARISH | -35.8 |
| ALLR Allarity Therapeutics, Inc. | $20M | -1.3 | -157.1 | -96.5 | — | — | 2 | BEARISH | -35.8 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.2 | -2011.6 | 159.6 | — | — | 3 | BEARISH | -56.2 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.2 | -2011.6 | 159.6 | — | — | 3 | BEARISH | -56.2 |
| AVTBF Avant Brands Inc. | $10M | -0.5 | -47.1 | -18.4 | -41.2 | 13.3 | 4 | BEARISH | -37.6 |
| AVTBF Avant Brands Inc. | $10M | -0.5 | -47.1 | -18.4 | -41.2 | 13.3 | 4 | BEARISH | -37.6 |
| AVCNF Avicanna Inc. | $10M | -3.1 | -109.4 | -64.5 | -18.1 | -0.2 | 3 | BEARISH | -61.0 |
| AVCNF Avicanna Inc. | $10M | -3.1 | -109.4 | -64.5 | -18.1 | -0.2 | 3 | BEARISH | -61.0 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.3 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | BEARISH | -61.2 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.3 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | BEARISH | -61.2 |
| PLRZ Polyrizon Ltd. | $10M | -2.3 | -30.9 | -68.2 | — | — | 1 | BEARISH | 46.9 |
| PLRZ Polyrizon Ltd. | $10M | -2.3 | -30.9 | -68.2 | — | — | 1 | BEARISH | 46.9 |
| ENGNW enGene Holdings Inc. Warrants | $10M | -6.9 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -69.2 |
| ENGNW enGene Holdings Inc. Warrants | $10M | -6.9 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -69.2 |
| PHYOF IXICO plc | $10M | -3.8 | -32.4 | -40.1 | -28.5 | -1.5 | 2 | BEARISH | 0.0 |
| PHYOF IXICO plc | $10M | -3.8 | -32.4 | -40.1 | -28.5 | -1.5 | 2 | BEARISH | 0.0 |
| NRSN NeuroSense Therapeutics Ltd. | $10M | -0.4 | 779.3 | 571.3 | — | — | 3 | BEARISH | -83.9 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -62.8 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -62.8 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | BEARISH | -88.4 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | BEARISH | -88.4 |
| RVLWF Revitalist Lifestyle and Wellness Ltd. | $10M | -0.1 | 613.5 | -129.3 | -263.6 | — | 2 | BEARISH | 0.0 |
| RVLWF Revitalist Lifestyle and Wellness Ltd. | $10M | -0.1 | 613.5 | -129.3 | -263.6 | — | 2 | BEARISH | 0.0 |
| NRSN NeuroSense Therapeutics Ltd. | $10M | -0.4 | 779.3 | 571.3 | — | — | 3 | BEARISH | -83.9 |
| HTPRF HTC Purenergy Inc. | — | -0.1 | 13.4 | -6.6 | — | 100.0 | 5 | BEARISH | -99.8 |
| HTPRF HTC Purenergy Inc. | — | -0.1 | 13.4 | -6.6 | — | 100.0 | 5 | BEARISH | -99.8 |
| AMBD American Mobile Dental Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AMBD American Mobile Dental Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BTCY Biotricity, Inc. | — | -0.4 | 7.6 | -22.1 | -7.6 | 16.0 | 4 | BEARISH | -88.9 |
| BTCY Biotricity, Inc. | — | -0.4 | 7.6 | -22.1 | -7.6 | 16.0 | 4 | BEARISH | -88.9 |
| AMIX Autonomix Medical, Inc. | — | -0.1 | -238.9 | 1213.5 | — | — | 1 | BEARISH | -84.6 |
| AMIX Autonomix Medical, Inc. | — | -0.1 | -238.9 | 1213.5 | — | — | 1 | BEARISH | -84.6 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | BEARISH | 0.0 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | BEARISH | 0.0 |
| PHMB PharmaCom BioVet, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PHMB PharmaCom BioVet, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VSMD Vasamed, Inc. | — | -0.0 | 54566.1 | 395.4 | -334.5 | 70.0 | 4 | BEARISH | 0.0 |
| VSMD Vasamed, Inc. | — | -0.0 | 54566.1 | 395.4 | -334.5 | 70.0 | 4 | BEARISH | 0.0 |
| CHME China Medicine Corp. | — | -196.6 | 9.7 | 9.7 | 12.7 | -4.3 | 6 | BEARISH | 2483.3 |
| CHME China Medicine Corp. | — | -196.6 | 9.7 | 9.7 | 12.7 | -4.3 | 6 | BEARISH | 2483.3 |
| CNNC Cannonau Corp. | — | 0.0 | -96.5 | -93.3 | — | -100.0 | 2 | BEARISH | -66.7 |
| CNNC Cannonau Corp. | — | 0.0 | -96.5 | -93.3 | — | -100.0 | 2 | BEARISH | -66.7 |
| VRAX Virax Biolabs Group Limited | — | -0.1 | -207.4 | -812.1 | -40439.1 | -87.7 | 4 | BEARISH | 255.2 |
| VRAX Virax Biolabs Group Limited | — | -0.1 | -207.4 | -812.1 | -40439.1 | -87.7 | 4 | BEARISH | 255.2 |
| GSAC GelStat Corporation | — | -2.8 | 25.1 | 80.4 | -124.9 | 62.9 | 6 | BEARISH | -14.3 |
| GSAC GelStat Corporation | — | -2.8 | 25.1 | 80.4 | -124.9 | 62.9 | 6 | BEARISH | -14.3 |
| BRGX BioRegenx, Inc. | — | -2.7 | 0.6 | 1.6 | -6.2 | — | 3 | BEARISH | — |
| BRGX BioRegenx, Inc. | — | -2.7 | 0.6 | 1.6 | -6.2 | — | 3 | BEARISH | — |
| RSCF Reflect Scientific, Inc. | — | 13.2 | 12.1 | 17.0 | 15.2 | 76.0 | 6 | BEARISH | -17.6 |
| RSCF Reflect Scientific, Inc. | — | 13.2 | 12.1 | 17.0 | 15.2 | 76.0 | 6 | BEARISH | -17.6 |
| NTRR Neutra Corp. | — | 1.0 | 1.2 | -42.9 | 632.2 | 1449.2 | 6 | BEARISH | -33.3 |
| NTRR Neutra Corp. | — | 1.0 | 1.2 | -42.9 | 632.2 | 1449.2 | 6 | BEARISH | -33.3 |
| CYIO CYIOS Corporation | — | 1.6 | 60.5 | 46.3 | — | -48.3 | 2 | BEARISH | -79.6 |
| CYIO CYIOS Corporation | — | 1.6 | 60.5 | 46.3 | — | -48.3 | 2 | BEARISH | -79.6 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | -95.0 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | -95.0 |
| OILFF Nextleaf Solutions Ltd. | — | -2.2 | -41.0 | -53.4 | -19.9 | -18.2 | 3 | BEARISH | -61.2 |
| OILFF Nextleaf Solutions Ltd. | — | -2.2 | -41.0 | -53.4 | -19.9 | -18.2 | 3 | BEARISH | -61.2 |
| UNVC Univec, Inc. | — | -3.7 | 6.9 | 5.9 | -1481.4 | 78.3 | 4 | BEARISH | -60.0 |
| UNVC Univec, Inc. | — | -3.7 | 6.9 | 5.9 | -1481.4 | 78.3 | 4 | BEARISH | -60.0 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | BEARISH | 0.0 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | BEARISH | 0.0 |
| OXIHF Oxford Investments Holdings Inc. | — | -0.2 | 19.5 | 9.8 | 6887.8 | -90.6 | 2 | BEARISH | 0.0 |
| OXIHF Oxford Investments Holdings Inc. | — | -0.2 | 19.5 | 9.8 | 6887.8 | -90.6 | 2 | BEARISH | 0.0 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| MPXOF MPX International Corp. | — | -0.0 | -179.4 | -42.1 | -411.8 | 14.3 | 4 | BEARISH | -99.0 |
| MPXOF MPX International Corp. | — | -0.0 | -179.4 | -42.1 | -411.8 | 14.3 | 4 | BEARISH | -99.0 |
| MMTC Micro Imaging Technology, Inc. | — | -0.0 | 83.3 | 72.6 | — | — | 1 | BEARISH | 0.0 |
| MMTC Micro Imaging Technology, Inc. | — | -0.0 | 83.3 | 72.6 | — | — | 1 | BEARISH | 0.0 |
| NXGT Nexteligent Holdings, Inc. | — | -11.6 | 2.7 | -1.5 | 5.3 | -0.2 | 3 | BEARISH | -35.0 |
| NXGT Nexteligent Holdings, Inc. | — | -11.6 | 2.7 | -1.5 | 5.3 | -0.2 | 3 | BEARISH | -35.0 |
| RDHL RedHill Biopharma Ltd. | — | -0.2 | 428.1 | 117.9 | -101.3 | 157.6 | 6 | BEARISH | -80.2 |
| RDHL RedHill Biopharma Ltd. | — | -0.2 | 428.1 | 117.9 | -101.3 | 157.6 | 6 | BEARISH | -80.2 |
| AQQRF Aquarius Surgical Technologies Inc. | — | -0.2 | 10.7 | -42.8 | 91.2 | 0.3 | 5 | BEARISH | 0.0 |
| AQQRF Aquarius Surgical Technologies Inc. | — | -0.2 | 10.7 | -42.8 | 91.2 | 0.3 | 5 | BEARISH | 0.0 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 1115.1 | 183.2 | — | 98.4 | 3 | BEARISH | 0.0 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 1115.1 | 183.2 | — | 98.4 | 3 | BEARISH | 0.0 |
| NHEL Natural Health Farm Holdings Inc. | — | -0.0 | -37.2 | -15.8 | 9.3 | 6892.6 | 4 | BEARISH | 0.0 |
| NHEL Natural Health Farm Holdings Inc. | — | -0.0 | -37.2 | -15.8 | 9.3 | 6892.6 | 4 | BEARISH | 0.0 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.1 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.1 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| CRFTF BC Craft Supply Co. Ltd. | — | -0.0 | 152.6 | 13.1 | — | -82.0 | 2 | BEARISH | -90.0 |
| CRFTF BC Craft Supply Co. Ltd. | — | -0.0 | 152.6 | 13.1 | — | -82.0 | 2 | BEARISH | -90.0 |
| PGNY Progyny, Inc. | $2.0B | 26.0 | 16.2 | 30.2 | 8.0 | 5.5 | 7 | BEARISH | 18.9 |
| PGNY Progyny, Inc. | $2.0B | 26.0 | 16.2 | 30.2 | 8.0 | 5.5 | 7 | BEARISH | 18.9 |
| ESTA Establishment Labs Holdings Inc. | $1.9B | -49.0 | -175.3 | -6.9 | -17.4 | 38.6 | 5 | BEARISH | 56.9 |
| ESTA Establishment Labs Holdings Inc. | $1.9B | -49.0 | -175.3 | -6.9 | -17.4 | 38.6 | 5 | BEARISH | 56.9 |
| ELEAF EL.En. S.p.A. | $1.4B | 14.1 | 13.2 | 29.1 | 6.0 | 25.8 | 8 | BEARISH | 39.8 |
| ELEAF EL.En. S.p.A. | $1.4B | 14.1 | 13.2 | 29.1 | 6.0 | 25.8 | 8 | BEARISH | 39.8 |
| IDRSF Idorsia Ltd | $1.4B | -3.4 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | 17.0 |
| IDRSF Idorsia Ltd | $1.4B | -3.4 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | 17.0 |
| MEDOF Medios AG | $1.3B | 23.5 | 2.1 | 2.8 | 0.6 | 10.0 | 6 | BEARISH | 0.0 |
| MEDOF Medios AG | $1.3B | 23.5 | 2.1 | 2.8 | 0.6 | 10.0 | 6 | BEARISH | 0.0 |
| CGEM Cullinan Therapeutics, Inc. | $950M | -4.6 | -50.3 | 1635.6 | — | — | 1 | BEARISH | 158.5 |
| CGEM Cullinan Therapeutics, Inc. | $950M | -4.6 | -50.3 | 1635.6 | — | — | 1 | BEARISH | 158.5 |
| JBIO Jade Biosciences, Inc. | $860M | -5.1 | -47.8 | 629.9 | — | — | 3 | BEARISH | 55.0 |
| JBIO Jade Biosciences, Inc. | $860M | -5.1 | -47.8 | 629.9 | — | — | 3 | BEARISH | 55.0 |
| INMD InMode Ltd. | $810M | 11.3 | 12.3 | 44.5 | 17.9 | -6.7 | 5 | BEARISH | -7.8 |
| INMD InMode Ltd. | $810M | 11.3 | 12.3 | 44.5 | 17.9 | -6.7 | 5 | BEARISH | -7.8 |
| MNPR Monopar Therapeutics Inc. | $520M | -33.3 | -19.5 | 523.8 | — | — | 2 | BEARISH | -8.0 |
| MNPR Monopar Therapeutics Inc. | $520M | -33.3 | -19.5 | 523.8 | — | — | 2 | BEARISH | -8.0 |
| ASMB Assembly Biosciences, Inc. | $450M | 41.0 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -8.4 |
| ASMB Assembly Biosciences, Inc. | $450M | 41.0 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -8.4 |
| CTEV Claritev Corporation | $400M | -1.4 | 169.3 | 0.9 | -23.0 | 110.3 | 4 | BEARISH | -51.2 |
| CTEV Claritev Corporation | $400M | -1.4 | 169.3 | 0.9 | -23.0 | 110.3 | 4 | BEARISH | -51.2 |
| ABEO Abeona Therapeutics Inc. | $290M | -4.4 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -4.7 |
| ABEO Abeona Therapeutics Inc. | $290M | -4.4 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -4.7 |
| PRQR ProQR Therapeutics N.V. | $170M | -3.7 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -24.1 |
| PRQR ProQR Therapeutics N.V. | $170M | -3.7 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -24.1 |
| STIM Neuronetics, Inc. | $150M | -5.0 | -135.3 | -21.3 | -8.3 | 39.6 | 4 | BEARISH | -20.6 |
| STIM Neuronetics, Inc. | $150M | -5.0 | -135.3 | -21.3 | -8.3 | 39.6 | 4 | BEARISH | -20.6 |
| IMUX Immunic, Inc. | $110M | -1.7 | -138.2 | 345.6 | — | — | 5 | BEARISH | -17.1 |
| IMUX Immunic, Inc. | $110M | -1.7 | -138.2 | 345.6 | — | — | 5 | BEARISH | -17.1 |
| RVRC Revium Recovery Inc. | $90M | -6.4 | -0.0 | 0.0 | — | — | 2 | BEARISH | 175.0 |
| RVRC Revium Recovery Inc. | $90M | -6.4 | -0.0 | 0.0 | — | — | 2 | BEARISH | 175.0 |
| BMEA Biomea Fusion, Inc. | $90M | -2.6 | -164.1 | 210.3 | — | — | 2 | BEARISH | -39.2 |
| BMEA Biomea Fusion, Inc. | $90M | -2.6 | -164.1 | 210.3 | — | — | 2 | BEARISH | -39.2 |
| PMN ProMIS Neurosciences, Inc. | $80M | -0.6 | -172.3 | 844.3 | — | — | 2 | BEARISH | -17.5 |
| PMN ProMIS Neurosciences, Inc. | $80M | -0.6 | -172.3 | 844.3 | — | — | 2 | BEARISH | -17.5 |
| AVEFF Avecho Biotechnology Limited | $20M | -13.3 | -238.0 | 200.0 | -3227.5 | 83.1 | 5 | BEARISH | 0.0 |
| AVEFF Avecho Biotechnology Limited | $20M | -13.3 | -238.0 | 200.0 | -3227.5 | 83.1 | 5 | BEARISH | 0.0 |
| PIII P3 Health Partners Inc. | $20M | -0.2 | -168.8 | -64.8 | 1.9 | 2.8 | 4 | BEARISH | -27.7 |
| PIII P3 Health Partners Inc. | $20M | -0.2 | -168.8 | -64.8 | 1.9 | 2.8 | 4 | BEARISH | -27.7 |
| IBXXF Imagion Biosystems Limited | $10M | -0.6 | 157.2 | 463.1 | -376.2 | -53.1 | 3 | BEARISH | -20.0 |
| IBXXF Imagion Biosystems Limited | $10M | -0.6 | 157.2 | 463.1 | -376.2 | -53.1 | 3 | BEARISH | -20.0 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.4 | -82.7 | -314.7 | — | — | 1 | BEARISH | -45.8 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.4 | -82.7 | -314.7 | — | — | 1 | BEARISH | -45.8 |
| NVNO enVVeno Medical Corporation | $10M | -0.0 | -58.5 | 4255.8 | — | — | 4 | BEARISH | 789.6 |
| NVNO enVVeno Medical Corporation | $10M | -0.0 | -58.5 | 4255.8 | — | — | 4 | BEARISH | 789.6 |
| SILO Silo Pharma, Inc. | — | -0.3 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 113.0 |
| SILO Silo Pharma, Inc. | — | -0.3 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 113.0 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 0.0 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 0.0 |
| TBRIF Therma Bright Inc. | — | -0.6 | 711.8 | 33.4 | -336.3 | 202.0 | 3 | BEARISH | -62.9 |
| TBRIF Therma Bright Inc. | — | -0.6 | 711.8 | 33.4 | -336.3 | 202.0 | 3 | BEARISH | -62.9 |
| IVIXF Invion Limited | — | -0.6 | -106.0 | -133.1 | -537.3 | -89.5 | 1 | BEARISH | 0.0 |
| IVIXF Invion Limited | — | -0.6 | -106.0 | -133.1 | -537.3 | -89.5 | 1 | BEARISH | 0.0 |
| OZYMF Strategic Partners A/S | — | 21.7 | 0.9 | -117.6 | 1019.0 | — | 5 | BEARISH | 0.0 |
| OZYMF Strategic Partners A/S | — | 21.7 | 0.9 | -117.6 | 1019.0 | — | 5 | BEARISH | 0.0 |
| RXEI RxElite, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RXEI RxElite, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -85.1 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -85.1 |
| DPAT Dental Patient Care America, Inc. | — | 419.0 | 117.2 | 10.7 | 26.9 | -3.7 | 5 | BEARISH | 114.9 |
| DPAT Dental Patient Care America, Inc. | — | 419.0 | 117.2 | 10.7 | 26.9 | -3.7 | 5 | BEARISH | 114.9 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| HELP Cybin Inc. Common Stock | $730M | -2.8 | -38.6 | -94.5 | — | — | 2 | BEARISH | — |
| HELP Cybin Inc. Common Stock | $730M | -2.8 | -38.6 | -94.5 | — | — | 2 | BEARISH | — |
| MAJI Nextel Medical Corp. | — | -0.8 | -0.6 | 7.4 | — | — | 1 | BEARISH | — |
| MAJI Nextel Medical Corp. | — | -0.8 | -0.6 | 7.4 | — | — | 1 | BEARISH | — |
| SNDX Syndax Pharmaceuticals, Inc. | $1.6B | -7.0 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | 12.2 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.6B | -7.0 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | 12.2 |
| HBMHF HBM Holdings Limited | $1.3B | 17.0 | 58.2 | 96.1 | 53.0 | 133.3 | 6 | BEARISH | -8.8 |
| HBMHF HBM Holdings Limited | $1.3B | 17.0 | 58.2 | 96.1 | 53.0 | 133.3 | 6 | BEARISH | -8.8 |
| ARDX Ardelyx, Inc. | $830M | -14.8 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -37.7 |
| ARDX Ardelyx, Inc. | $830M | -14.8 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -37.7 |
| PHR Phreesia, Inc. | $620M | 58.5 | 0.8 | -1.4 | 1.0 | 14.5 | 4 | BEARISH | -55.1 |
| PHR Phreesia, Inc. | $620M | 58.5 | 0.8 | -1.4 | 1.0 | 14.5 | 4 | BEARISH | -55.1 |
| SWDCF Swedencare AB (publ) | $370M | 43.2 | 1.1 | 1.6 | 3.5 | 4.5 | 8 | BEARISH | -35.8 |
| SWDCF Swedencare AB (publ) | $370M | 43.2 | 1.1 | 1.6 | 3.5 | 4.5 | 8 | BEARISH | -35.8 |
| MOBI Mobia Medical, Inc. Common Stock | $310M | — | — | — | — | — | — | BEARISH | — |
| MOBI Mobia Medical, Inc. Common Stock | $310M | — | — | — | — | — | — | BEARISH | — |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $280M | -3.1 | -46.8 | -249.1 | — | — | 3 | BEARISH | -46.8 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $280M | -3.1 | -46.8 | -249.1 | — | — | 3 | BEARISH | -46.8 |
| BOVNF BioInvent International AB (publ) | $220M | -3.0 | -88.2 | 20101.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| BOVNF BioInvent International AB (publ) | $220M | -3.0 | -88.2 | 20101.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| EDSA Edesa Biotech, Inc. | $40M | -2.3 | -122.9 | 759.6 | — | — | 1 | BEARISH | 50.2 |
| EDSA Edesa Biotech, Inc. | $40M | -2.3 | -122.9 | 759.6 | — | — | 1 | BEARISH | 50.2 |
| CLCS Cell Source, Inc. | $30M | -4.0 | 27.7 | 34.5 | — | — | 4 | BEARISH | 11.9 |
| CLCS Cell Source, Inc. | $30M | -4.0 | 27.7 | 34.5 | — | — | 4 | BEARISH | 11.9 |
| CNTX Context Therapeutics Inc. | $30M | -0.6 | -76.1 | 841.7 | — | — | 2 | BEARISH | -68.1 |
| CNTX Context Therapeutics Inc. | $30M | -0.6 | -76.1 | 841.7 | — | — | 2 | BEARISH | -68.1 |
| LDDD Longduoduo Company Limited | $20M | -26.6 | 47.5 | -421.7 | -13.8 | -36.8 | 5 | BEARISH | -62.8 |
| LDDD Longduoduo Company Limited | $20M | -26.6 | 47.5 | -421.7 | -13.8 | -36.8 | 5 | BEARISH | -62.8 |
| JMPHF Leveljump Healthcare Corp. | $10M | -1.5 | -21.1 | 0.7 | -9.7 | 5.4 | 3 | BEARISH | 677.3 |
| JMPHF Leveljump Healthcare Corp. | $10M | -1.5 | -21.1 | 0.7 | -9.7 | 5.4 | 3 | BEARISH | 677.3 |
| AIXN AiXin Life International, Inc. | $10M | -3.2 | 37.6 | 39.5 | -191.9 | -61.1 | 4 | BEARISH | -54.9 |
| AIXN AiXin Life International, Inc. | $10M | -3.2 | 37.6 | 39.5 | -191.9 | -61.1 | 4 | BEARISH | -54.9 |
| ADVT Advantis Corp. | — | -0.4 | -8.4 | -3.2 | -1775.1 | — | 1 | BEARISH | 0.0 |
| ADVT Advantis Corp. | — | -0.4 | -8.4 | -3.2 | -1775.1 | — | 1 | BEARISH | 0.0 |
| CGHC Capital Group Holdings, Inc. | — | -0.0 | -44.6 | -14.9 | -24.2 | — | 5 | BEARISH | 0.0 |
| CGHC Capital Group Holdings, Inc. | — | -0.0 | -44.6 | -14.9 | -24.2 | — | 5 | BEARISH | 0.0 |
| WLSS Welsis Corp. | — | -40.5 | 6.2 | 3.3 | — | — | 1 | BEARISH | -82.9 |
| WLSS Welsis Corp. | — | -40.5 | 6.2 | 3.3 | — | — | 1 | BEARISH | -82.9 |
| TSTTF TripSitter Clinic Ltd. | — | -19.2 | -0.1 | 30.7 | — | 100.0 | 4 | BEARISH | -56.2 |
| TSTTF TripSitter Clinic Ltd. | — | -19.2 | -0.1 | 30.7 | — | 100.0 | 4 | BEARISH | -56.2 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -74.7 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -74.7 |
| AYURF Ayurcann Holdings Corp. | — | -0.5 | 315.5 | 53.8 | -13.0 | 47.1 | 4 | BEARISH | -99.0 |
| AYURF Ayurcann Holdings Corp. | — | -0.5 | 315.5 | 53.8 | -13.0 | 47.1 | 4 | BEARISH | -99.0 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 157.7 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 157.7 |
| RSLT Resilient Healthcare Corp | — | — | — | — | — | — | — | BEARISH | — |
| RSLT Resilient Healthcare Corp | — | — | — | — | — | — | — | BEARISH | — |
| HMPQ HempAmericana, Inc | — | -0.5 | 25.6 | 14.8 | — | 184.6 | 2 | BEARISH | 0.0 |
| HMPQ HempAmericana, Inc | — | -0.5 | 25.6 | 14.8 | — | 184.6 | 2 | BEARISH | 0.0 |
| MSGP MedSmart Group Inc. | — | -0.2 | 33.6 | 85.8 | — | -100.0 | 1 | BEARISH | 500.0 |
| MSGP MedSmart Group Inc. | — | -0.2 | 33.6 | 85.8 | — | -100.0 | 1 | BEARISH | 500.0 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | BEARISH | -85.2 |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | BEARISH | -85.2 |
| LTHO Legacy Technology Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LTHO Legacy Technology Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| OMID OMID Holdings, Inc. | — | -10.9 | -127.5 | -314.5 | 40.6 | 57.1 | 5 | BEARISH | -6.0 |
| OMID OMID Holdings, Inc. | — | -10.9 | -127.5 | -314.5 | 40.6 | 57.1 | 5 | BEARISH | -6.0 |
| HSMD Healthcare Solutions Management Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HSMD Healthcare Solutions Management Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| OVIT OncoVista Innovative Therapies, Inc. | — | -0.0 | 61.2 | 43.6 | — | — | 1 | BEARISH | 0.0 |
| OVIT OncoVista Innovative Therapies, Inc. | — | -0.0 | 61.2 | 43.6 | — | — | 1 | BEARISH | 0.0 |
| POAS Phaos Technology Holdings (Caym | — | — | — | — | — | — | — | BEARISH | — |
| POAS Phaos Technology Holdings (Caym | — | — | — | — | — | — | — | BEARISH | — |
| ADXN Addex Therapeutics Ltd | — | -0.5 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | BEARISH | -67.3 |
| ADXN Addex Therapeutics Ltd | — | -0.5 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | BEARISH | -67.3 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | -294.0 | 349.6 | -185107971.7 | -94.8 | 1 | BEARISH | -1.4 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | -294.0 | 349.6 | -185107971.7 | -94.8 | 1 | BEARISH | -1.4 |
| AGTX Agentix Corp. | — | -1.9 | 14.5 | 10.8 | — | — | 3 | BEARISH | -55.6 |
| AGTX Agentix Corp. | — | -1.9 | 14.5 | 10.8 | — | — | 3 | BEARISH | -55.6 |
| NXEN Nexien BioPharma, Inc. | — | -0.0 | 48.5 | 112.0 | — | — | 2 | BEARISH | -99.2 |
| NXEN Nexien BioPharma, Inc. | — | -0.0 | 48.5 | 112.0 | — | — | 2 | BEARISH | -99.2 |
| DOSEF Doseology Sciences Inc. | — | -0.9 | -95.4 | -103.8 | -1609.9 | 161.1 | 1 | BEARISH | -88.9 |
| DOSEF Doseology Sciences Inc. | — | -0.9 | -95.4 | -103.8 | -1609.9 | 161.1 | 1 | BEARISH | -88.9 |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -95.9 |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -95.9 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -99.9 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -99.9 |
| KOAN Resonate Blends, Inc. | — | -0.0 | 46.5 | -991.9 | -399.0 | -32.1 | 4 | BEARISH | -97.4 |
| KOAN Resonate Blends, Inc. | — | -0.0 | 46.5 | -991.9 | -399.0 | -32.1 | 4 | BEARISH | -97.4 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.1 | 9.2 | 4.5 | — | -100.0 | 3 | BEARISH | -50.0 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.1 | 9.2 | 4.5 | — | -100.0 | 3 | BEARISH | -50.0 |
| LNDZF Evome Medical Technologies Inc. | — | -2.2 | -294.8 | -10.4 | -11.5 | -15.9 | 4 | BEARISH | -97.6 |
| LNDZF Evome Medical Technologies Inc. | — | -2.2 | -294.8 | -10.4 | -11.5 | -15.9 | 4 | BEARISH | -97.6 |
| SEPSF Asep Medical Holdings Inc | — | -0.4 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| SEPSF Asep Medical Holdings Inc | — | -0.4 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| ACUT Accustem Sciences Inc. | — | -1.3 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BEARISH | -91.0 |
| ACUT Accustem Sciences Inc. | — | -1.3 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BEARISH | -91.0 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | BEARISH | — |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | BEARISH | — |
| ECGS Eco-Growth Strategies Inc. | — | -2.0 | 19.5 | 55.1 | — | — | 2 | BEARISH | -76.5 |
| ECGS Eco-Growth Strategies Inc. | — | -2.0 | 19.5 | 55.1 | — | — | 2 | BEARISH | -76.5 |
| ARUXF Acrux Limited | — | -7.1 | -276.2 | -405.6 | -26.5 | -56.9 | 3 | BEARISH | -93.4 |
| ARUXF Acrux Limited | — | -7.1 | -276.2 | -405.6 | -26.5 | -56.9 | 3 | BEARISH | -93.4 |
| IPAH Interpharm Holdings, Inc. | — | -0.0 | -342.5 | -47.0 | -67.2 | -5.1 | 1 | BEARISH | -99.8 |
| IPAH Interpharm Holdings, Inc. | — | -0.0 | -342.5 | -47.0 | -67.2 | -5.1 | 1 | BEARISH | -99.8 |
| MICR Micron Solutions, Inc. | — | -0.0 | -32.9 | -10.2 | -16.0 | 19.3 | 3 | BEARISH | 50.0 |
| MICR Micron Solutions, Inc. | — | -0.0 | -32.9 | -10.2 | -16.0 | 19.3 | 3 | BEARISH | 50.0 |
| AGIO Agios Pharmaceuticals, Inc. | $1.9B | -4.5 | -34.3 | -82.5 | -225.1 | 140.6 | 4 | BEARISH | -20.6 |
| AGIO Agios Pharmaceuticals, Inc. | $1.9B | -4.5 | -34.3 | -82.5 | -225.1 | 140.6 | 4 | BEARISH | -20.6 |
| ZYME Zymeworks Inc. | $1.9B | -12.5 | -72.3 | -156.9 | -980.8 | -69.8 | 2 | BEARISH | 48.5 |
| ZYME Zymeworks Inc. | $1.9B | -12.5 | -72.3 | -156.9 | -980.8 | -69.8 | 2 | BEARISH | 48.5 |
| NUVB Nuvation Bio Inc. | $1.8B | -11.8 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | 38.6 |
| NUVB Nuvation Bio Inc. | $1.8B | -11.8 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | 38.6 |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 106.2 |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 106.2 |
| IMCR Immunocore Holdings plc | $1.5B | -164.8 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BEARISH | -17.3 |
| IMCR Immunocore Holdings plc | $1.5B | -164.8 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BEARISH | -17.3 |
| TSHA Taysha Gene Therapies, Inc. | $1.5B | -11.0 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | 45.6 |
| TSHA Taysha Gene Therapies, Inc. | $1.5B | -11.0 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | 45.6 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -10.9 | -1773.6 | 55.8 | — | -100.0 | 4 | BEARISH | 185.4 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -10.9 | -1773.6 | 55.8 | — | -100.0 | 4 | BEARISH | 185.4 |
| NBTX Nanobiotix S.A. | $1.3B | -20.8 | 380.7 | 158.8 | -941.2 | -73.7 | 3 | BEARISH | 37.4 |
| NBTX Nanobiotix S.A. | $1.3B | -20.8 | 380.7 | 158.8 | -941.2 | -73.7 | 3 | BEARISH | 37.4 |
| TDOC Teladoc Health, Inc. | $1.0B | -5.6 | -13.0 | -8.7 | -6.4 | -2.1 | 5 | BEARISH | -29.2 |
| TDOC Teladoc Health, Inc. | $1.0B | -5.6 | -13.0 | -8.7 | -6.4 | -2.1 | 5 | BEARISH | -29.2 |
| KURA Kura Oncology, Inc. | $950M | -3.2 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 15.8 |
| KURA Kura Oncology, Inc. | $950M | -3.2 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 15.8 |
| CADL Candel Therapeutics, Inc. | $750M | -7.2 | -81.8 | 219.4 | — | — | 2 | BEARISH | 83.8 |
| CADL Candel Therapeutics, Inc. | $750M | -7.2 | -81.8 | 219.4 | — | — | 2 | BEARISH | 83.8 |
| ZVRA Zevra Therapeutics, Inc. | $590M | 10.4 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | 5.9 |
| ZVRA Zevra Therapeutics, Inc. | $590M | 10.4 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | 5.9 |
| AQST Aquestive Therapeutics, Inc. | $570M | -7.0 | 121.1 | 43.4 | -165.5 | 22.6 | 5 | BEARISH | -22.6 |
| AQST Aquestive Therapeutics, Inc. | $570M | -7.0 | 121.1 | 43.4 | -165.5 | 22.6 | 5 | BEARISH | -22.6 |
| PRME Prime Medicine, Inc. | $540M | -2.7 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BEARISH | -46.7 |
| PRME Prime Medicine, Inc. | $540M | -2.7 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BEARISH | -46.7 |
| EOLS Evolus, Inc. | $470M | -13.8 | 138.6 | -20.7 | -9.6 | 13.9 | 5 | BEARISH | 16.1 |
| EOLS Evolus, Inc. | $470M | -13.8 | 138.6 | -20.7 | -9.6 | 13.9 | 5 | BEARISH | 16.1 |
| AUTL Autolus Therapeutics plc | $470M | -1.7 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 6.6 |
| AUTL Autolus Therapeutics plc | $470M | -1.7 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 6.6 |
| OVID Ovid Therapeutics Inc. | $440M | -5.0 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 73.7 |
| OVID Ovid Therapeutics Inc. | $440M | -5.0 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 73.7 |
| NGNE Neurogene Inc. | $410M | -4.7 | -45.3 | -111469.0 | — | — | 2 | BEARISH | 42.7 |
| NGNE Neurogene Inc. | $410M | -4.7 | -45.3 | -111469.0 | — | — | 2 | BEARISH | 42.7 |
| CLPT ClearPoint Neuro, Inc. | $330M | -9.2 | -226.5 | -54.1 | -104.2 | 25.9 | 3 | BEARISH | -47.9 |
| CLPT ClearPoint Neuro, Inc. | $330M | -9.2 | -226.5 | -54.1 | -104.2 | 25.9 | 3 | BEARISH | -47.9 |
| CCCC C4 Therapeutics, Inc. | $330M | -3.0 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | BEARISH | 37.2 |
| CCCC C4 Therapeutics, Inc. | $330M | -3.0 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | BEARISH | 37.2 |
| CYDY CytoDyn Inc. | $270M | -5.8 | 41.5 | 21.3 | — | 100.0 | 3 | BEARISH | -23.0 |
| CYDY CytoDyn Inc. | $270M | -5.8 | 41.5 | 21.3 | — | 100.0 | 3 | BEARISH | -23.0 |
| IFRX InflaRx N.V. | $250M | -3.1 | -38.5 | 251.5 | — | -106.2 | 4 | BEARISH | 26.5 |
| IFRX InflaRx N.V. | $250M | -3.1 | -38.5 | 251.5 | — | -106.2 | 4 | BEARISH | 26.5 |
| CGEN Compugen Ltd. | $220M | 6.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 44.4 |
| CGEN Compugen Ltd. | $220M | 6.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 44.4 |
| CUE Cue Biopharma, Inc. | $190M | -0.9 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | 17.8 |
| CUE Cue Biopharma, Inc. | $190M | -0.9 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | 17.8 |
| IPHA Innate Pharma S.A. | $150M | -2.6 | 1600.0 | 254.7 | -630.0 | -91.4 | 2 | BEARISH | -21.2 |
| IPHA Innate Pharma S.A. | $150M | -2.6 | 1600.0 | 254.7 | -630.0 | -91.4 | 2 | BEARISH | -21.2 |
| ABOS Acumen Pharmaceuticals, Inc. | $150M | -1.2 | -120.5 | 389.8 | — | — | 2 | BEARISH | 16.6 |
| ABOS Acumen Pharmaceuticals, Inc. | $150M | -1.2 | -120.5 | 389.8 | — | — | 2 | BEARISH | 16.6 |
| PYXS Pyxis Oncology, Inc. | $140M | -1.5 | -179.1 | 1953.9 | — | 291.4 | 2 | BEARISH | -2.3 |
| PYXS Pyxis Oncology, Inc. | $140M | -1.5 | -179.1 | 1953.9 | — | 291.4 | 2 | BEARISH | -2.3 |
| MEDXF Medexus Pharmaceuticals Inc. | $110M | -43.4 | -4.7 | 7.1 | -10.9 | -8.3 | 5 | BEARISH | 80.5 |
| MEDXF Medexus Pharmaceuticals Inc. | $110M | -43.4 | -4.7 | 7.1 | -10.9 | -8.3 | 5 | BEARISH | 80.5 |
| MXCT MaxCyte, Inc. | $110M | -3.2 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BEARISH | -33.1 |
| MXCT MaxCyte, Inc. | $110M | -3.2 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BEARISH | -33.1 |
| VRCA Verrica Pharmaceuticals Inc. | $80M | -2.5 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -1.4 |
| VRCA Verrica Pharmaceuticals Inc. | $80M | -2.5 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -1.4 |
| PLNH Planet 13 Holdings Inc. | $40M | -0.6 | -90.5 | -50.0 | -24.4 | -21.2 | 2 | BEARISH | -54.1 |
| PLNH Planet 13 Holdings Inc. | $40M | -0.6 | -90.5 | -50.0 | -24.4 | -21.2 | 2 | BEARISH | -54.1 |
| BETRF BetterLife Pharma Inc. | $30M | -12.0 | 14.6 | 14.7 | — | — | 4 | BEARISH | 252.4 |
| BETRF BetterLife Pharma Inc. | $30M | -12.0 | 14.6 | 14.7 | — | — | 4 | BEARISH | 252.4 |
| MLSS Milestone Scientific Inc. | $30M | -7.9 | -121.7 | -160.5 | -37.3 | 3.7 | 4 | BEARISH | -16.1 |
| MLSS Milestone Scientific Inc. | $30M | -7.9 | -121.7 | -160.5 | -37.3 | 3.7 | 4 | BEARISH | -16.1 |
| KZIA Kazia Therapeutics Ltd ADR | $20M | -1.3 | -196.1 | 162.7 | — | 250944.3 | 5 | BEARISH | 35.3 |
| KZIA Kazia Therapeutics Ltd ADR | $20M | -1.3 | -196.1 | 162.7 | — | 250944.3 | 5 | BEARISH | 35.3 |
| LPCN Lipocine Inc. | $20M | -1.1 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -31.0 |
| LPCN Lipocine Inc. | $20M | -1.1 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -31.0 |
| AKTX Akari Therapeutics, Plc | $10M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -77.8 |
| AKTX Akari Therapeutics, Plc | $10M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -77.8 |
| AMS American Shared Hospital Services | $10M | -5.5 | -7.5 | -5.5 | -6.1 | 4.0 | 5 | BEARISH | -43.5 |
| AMS American Shared Hospital Services | $10M | -5.5 | -7.5 | -5.5 | -6.1 | 4.0 | 5 | BEARISH | -43.5 |
| ADIA Adia Med Inc. | $10M | -0.1 | 32.2 | -16.3 | 8.3 | — | 1 | BEARISH | 145.7 |
| UEEC United Health Products, Inc. | $10M | -5.5 | 37.4 | 34.4 | — | — | 4 | BEARISH | -57.9 |
| UEEC United Health Products, Inc. | $10M | -5.5 | 37.4 | 34.4 | — | — | 4 | BEARISH | -57.9 |
| IMNN Imunon, Inc. | $10M | -0.3 | -429.7 | -226.7 | — | — | 2 | BEARISH | -75.6 |
| IMNN Imunon, Inc. | $10M | -0.3 | -429.7 | -226.7 | — | — | 2 | BEARISH | -75.6 |
| ADIA Adia Med Inc. | $10M | -0.1 | 32.2 | -16.3 | 8.3 | — | 1 | BEARISH | 145.7 |
| CCM Concord Medical Services Holdings Limited | — | -0.0 | 7.5 | -26.9 | -13.5 | -22.5 | 2 | BEARISH | -51.0 |
| CCM Concord Medical Services Holdings Limited | — | -0.0 | 7.5 | -26.9 | -13.5 | -22.5 | 2 | BEARISH | -51.0 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -44.8 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -44.8 |
| LMLLF Pharmadrug Inc. | — | -0.9 | 37.6 | 446.5 | — | — | 2 | BEARISH | -57.5 |
| LMLLF Pharmadrug Inc. | — | -0.9 | 37.6 | 446.5 | — | — | 2 | BEARISH | -57.5 |
| EVIO EVIO, Inc. | — | 1.7 | 65.3 | 33.5 | 8.3 | -26.9 | 4 | BEARISH | 0.0 |
| EVIO EVIO, Inc. | — | 1.7 | 65.3 | 33.5 | 8.3 | -26.9 | 4 | BEARISH | 0.0 |
| PAVS Paranovus Entertainment Technology Ltd. | — | -0.0 | -157.0 | -4.3 | -5.5 | -82.4 | 3 | BEARISH | -96.3 |
| PAVS Paranovus Entertainment Technology Ltd. | — | -0.0 | -157.0 | -4.3 | -5.5 | -82.4 | 3 | BEARISH | -96.3 |
| IMNM Immunome, Inc. | $2.0B | -8.2 | -64.0 | -2208.4 | — | -100.0 | 4 | BEARISH | 84.3 |
| IMNM Immunome, Inc. | $2.0B | -8.2 | -64.0 | -2208.4 | — | -100.0 | 4 | BEARISH | 84.3 |
| TRVI Trevi Therapeutics, Inc. | $2.0B | -41.2 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 48.0 |
| TRVI Trevi Therapeutics, Inc. | $2.0B | -41.2 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 48.0 |
| QURE uniQure N.V. | $1.6B | -5.8 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -57.3 |
| QURE uniQure N.V. | $1.6B | -5.8 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -57.3 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.5B | -10.6 | -40.0 | 3981.5 | — | — | 4 | BEARISH | 12.2 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.5B | -10.6 | -40.0 | 3981.5 | — | — | 4 | BEARISH | 12.2 |
| OCUL Ocular Therapeutix, Inc. | $1.5B | -4.9 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -37.0 |
| OCUL Ocular Therapeutix, Inc. | $1.5B | -4.9 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -37.0 |
| ANAB AnaptysBio, Inc. | $1.4B | 7.2 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | BEARISH | 127.7 |
| ANAB AnaptysBio, Inc. | $1.4B | 7.2 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | BEARISH | 127.7 |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 20.8 | 3.0 | 2.6 | -17.0 | 6.0 | 5 | BEARISH | inf |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 20.8 | 3.0 | 2.6 | -17.0 | 6.0 | 5 | BEARISH | inf |
| NKTR Nektar Therapeutics | $1.2B | -6.5 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -25.9 |
| NKTR Nektar Therapeutics | $1.2B | -6.5 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -25.9 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.2B | -5.7 | -41.0 | 583.9 | — | — | 2 | BEARISH | 6.1 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.2B | -5.7 | -41.0 | 583.9 | — | — | 2 | BEARISH | 6.1 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.1B | -12.5 | -25.8 | -768.9 | — | — | 2 | BEARISH | 134.7 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.1B | -12.5 | -25.8 | -768.9 | — | — | 2 | BEARISH | 134.7 |
| MGTX MeiraGTx Holdings plc | $1.0B | 14.2 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 30.5 |
| MGTX MeiraGTx Holdings plc | $1.0B | 14.2 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 30.5 |
| AKTS Aktis Oncology, Inc. | $990M | -17.6 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 18875.4 |
| AKTS Aktis Oncology, Inc. | $990M | -17.6 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 18875.4 |
| ANRO Alto Neuroscience, Inc. | $870M | -10.0 | -49.2 | -201.4 | — | — | 3 | BEARISH | 509.6 |
| ANRO Alto Neuroscience, Inc. | $870M | -10.0 | -49.2 | -201.4 | — | — | 3 | BEARISH | 509.6 |
| AVTX Avalo Therapeutics, Inc. | $790M | -3.2 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | 15.7 |
| AVTX Avalo Therapeutics, Inc. | $790M | -3.2 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | 15.7 |
| XVIPF Xvivo Perfusion AB (publ) | $690M | 76.0 | 7.6 | 35.3 | 6.8 | 8.3 | 6 | BEARISH | 14.4 |
| XVIPF Xvivo Perfusion AB (publ) | $690M | 76.0 | 7.6 | 35.3 | 6.8 | 8.3 | 6 | BEARISH | 14.4 |
| SLDB Solid Biosciences Inc. | $670M | -3.6 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 16.7 |
| SLDB Solid Biosciences Inc. | $670M | -3.6 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 16.7 |
| CLYM Climb Bio, Inc. | $630M | -13.2 | -27.1 | -88.6 | — | — | 2 | BEARISH | 455.3 |
| CLYM Climb Bio, Inc. | $630M | -13.2 | -27.1 | -88.6 | — | — | 2 | BEARISH | 455.3 |
| AURA Aura Biosciences, Inc. | $630M | -3.4 | -53.5 | -1360.0 | — | — | 4 | BEARISH | -1.0 |
| AURA Aura Biosciences, Inc. | $630M | -3.4 | -53.5 | -1360.0 | — | — | 4 | BEARISH | -1.0 |
| IMMX Immix Biopharma, Inc. | $530M | -11.0 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 365.4 |
| IMMX Immix Biopharma, Inc. | $530M | -11.0 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 365.4 |
| BRSYF BrainsWay Ltd. | $510M | 52.6 | 12.9 | 30.9 | 15.8 | 31.5 | 6 | BEARISH | 129.5 |
| BRSYF BrainsWay Ltd. | $510M | 52.6 | 12.9 | 30.9 | 15.8 | 31.5 | 6 | BEARISH | 129.5 |
| TECX Tectonic Therapeutic, Inc. | $430M | -4.9 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 43.9 |
| TECX Tectonic Therapeutic, Inc. | $430M | -4.9 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 43.9 |
| SRTA Strata Critical Medical, Inc. | $410M | 9.5 | 16.0 | -6.2 | -14.5 | 0.6 | 3 | BEARISH | -8.1 |
| SRTA Strata Critical Medical, Inc. | $410M | 9.5 | 16.0 | -6.2 | -14.5 | 0.6 | 3 | BEARISH | -8.1 |
| EVH Evolent Health, Inc. | $390M | -0.8 | -79.0 | -1.8 | -4.3 | -4.5 | 5 | BEARISH | -56.8 |
| EVH Evolent Health, Inc. | $390M | -0.8 | -79.0 | -1.8 | -4.3 | -4.5 | 5 | BEARISH | -56.8 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -78.5 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | BEARISH | 6.4 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -78.5 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | BEARISH | 6.4 |
| ARTV Artiva Biotherapeutics, Inc. | $330M | -2.1 | -36.6 | -954.6 | — | — | 3 | BEARISH | 133.9 |
| ARTV Artiva Biotherapeutics, Inc. | $330M | -2.1 | -36.6 | -954.6 | — | — | 3 | BEARISH | 133.9 |
| SPHDF Santhera Pharmaceuticals Holding AG | $270M | -6.6 | -464.2 | 715.5 | -44.5 | 26.5 | 3 | BEARISH | 37.4 |
| SPHDF Santhera Pharmaceuticals Holding AG | $270M | -6.6 | -464.2 | 715.5 | -44.5 | 26.5 | 3 | BEARISH | 37.4 |
| IKT Inhibikase Therapeutics, Inc. | $260M | -4.2 | -52.0 | 920.5 | — | — | 3 | BEARISH | 24.2 |
| IKT Inhibikase Therapeutics, Inc. | $260M | -4.2 | -52.0 | 920.5 | — | — | 3 | BEARISH | 24.2 |
| QTTB Q32 Bio Inc. | $240M | 2.9 | 72.1 | 435.2 | — | — | 5 | BEARISH | 295.7 |
| QTTB Q32 Bio Inc. | $240M | 2.9 | 72.1 | 435.2 | — | — | 5 | BEARISH | 295.7 |
| CRLBF Cresco Labs Inc. | $230M | -2.2 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -53.6 |
| CRLBF Cresco Labs Inc. | $230M | -2.2 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -53.6 |
| PRLD Prelude Therapeutics Incorporated | $210M | -4.6 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | BEARISH | 143.1 |
| PRLD Prelude Therapeutics Incorporated | $210M | -4.6 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | BEARISH | 143.1 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $180M | -1.0 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 63.6 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $180M | -1.0 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 63.6 |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.1 | -80.6 | -851.1 | — | — | 4 | BEARISH | -32.6 |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.1 | -80.6 | -851.1 | — | — | 4 | BEARISH | -32.6 |
| MAYNF Mayne Pharma Group Limited | $160M | 9.2 | -16.4 | -17.8 | 23.0 | 38.4 | 5 | BEARISH | -41.2 |
| MAYNF Mayne Pharma Group Limited | $160M | 9.2 | -16.4 | -17.8 | 23.0 | 38.4 | 5 | BEARISH | -41.2 |
| CRDL Cardiol Therapeutics Inc. | $160M | -5.9 | -204.6 | 1592.3 | — | — | 4 | BEARISH | 31.8 |
| CRDL Cardiol Therapeutics Inc. | $160M | -5.9 | -204.6 | 1592.3 | — | — | 4 | BEARISH | 31.8 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $110M | -0.9 | -95.6 | 738.2 | — | — | 1 | BEARISH | -53.0 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $110M | -0.9 | -95.6 | 738.2 | — | — | 1 | BEARISH | -53.0 |
| CRDF Cardiff Oncology, Inc. | $90M | -1.9 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -46.1 |
| CRDF Cardiff Oncology, Inc. | $90M | -1.9 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -46.1 |
| RTGN RetinalGenix Technologies Inc. | $80M | -36.0 | 90.4 | -10.3 | — | -100.0 | 4 | BEARISH | 12.7 |
| RTGN RetinalGenix Technologies Inc. | $80M | -36.0 | 90.4 | -10.3 | — | -100.0 | 4 | BEARISH | 12.7 |
| ACET Adicet Bio, Inc. | $60M | -0.6 | -78.1 | -553.5 | — | — | 4 | BEARISH | -50.6 |
| ACET Adicet Bio, Inc. | $60M | -0.6 | -78.1 | -553.5 | — | — | 4 | BEARISH | -50.6 |
| SER Serina Therapeutics, Inc. | $30M | -1.0 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -62.7 |
| SER Serina Therapeutics, Inc. | $30M | -1.0 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -62.7 |
| BFRI Biofrontera Inc. | $10M | -1.7 | -988.4 | -39.2 | -5.0 | 17.8 | 4 | BEARISH | -1.0 |
| BFRI Biofrontera Inc. | $10M | -1.7 | -988.4 | -39.2 | -5.0 | 17.8 | 4 | BEARISH | -1.0 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -82.2 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -82.2 |
| PRMD PrimeMD Inc | — | 0.0 | 42.8 | 34.3 | 159.9 | — | 3 | BEARISH | 200.0 |
| PRMD PrimeMD Inc | — | 0.0 | 42.8 | 34.3 | 159.9 | — | 3 | BEARISH | 200.0 |
| CYDX CYduct Diagnostics, Inc. | — | -11.1 | 15.8 | 13.7 | -394.2 | -16.3 | 3 | BEARISH | 112.9 |
| CYDX CYduct Diagnostics, Inc. | — | -11.1 | 15.8 | 13.7 | -394.2 | -16.3 | 3 | BEARISH | 112.9 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -1.0 | -26.8 | -38.7 | -88.2 | — | 3 | BEARISH | 87.8 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -1.0 | -26.8 | -38.7 | -88.2 | — | 3 | BEARISH | 87.8 |
| VIBEF Vibe Growth Corporation | — | -0.1 | 40.9 | -1.4 | -8.6 | 24.4 | 6 | BEARISH | 486.7 |
| VIBEF Vibe Growth Corporation | — | -0.1 | 40.9 | -1.4 | -8.6 | 24.4 | 6 | BEARISH | 486.7 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| ALUR Allurion Technologies Inc. | — | -0.0 | 45.2 | 39.3 | -206.8 | -55.5 | 3 | BEARISH | -80.2 |
| ALUR Allurion Technologies Inc. | — | -0.0 | 45.2 | 39.3 | -206.8 | -55.5 | 3 | BEARISH | -80.2 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | BEARISH | — |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | BEARISH | — |
| APMD Apnimed, Inc. | $860M | — | — | — | — | — | — | BEARISH | — |
| APMD Apnimed, Inc. | $860M | — | — | — | — | — | — | BEARISH | — |
| GENSF Genus plc | $1.9B | 5.0 | 45.8 | 14.4 | 80.4 | 28.9 | 7 | BEARISH | -17.7 |
| GENSF Genus plc | $1.9B | 5.0 | 45.8 | 14.4 | 80.4 | 28.9 | 7 | BEARISH | -17.7 |
| ADDLF AddLife AB (publ) | $1.9B | 34.7 | 11.4 | 7.4 | 4.8 | 2.5 | 7 | BEARISH | -62.5 |
| ADDLF AddLife AB (publ) | $1.9B | 34.7 | 11.4 | 7.4 | 4.8 | 2.5 | 7 | BEARISH | -62.5 |
| ALHC Alignment Healthcare, Inc. | $1.6B | 39.8 | 20.0 | -54.4 | 2.7 | 37.2 | 8 | BEARISH | -52.8 |
| ALHC Alignment Healthcare, Inc. | $1.6B | 39.8 | 20.0 | -54.4 | 2.7 | 37.2 | 8 | BEARISH | -52.8 |
| MCRPF MicroPort Scientific Corp. | $1.6B | 31.2 | -19.0 | -7.8 | 21.3 | 13.2 | 4 | BEARISH | -54.0 |
| MCRPF MicroPort Scientific Corp. | $1.6B | 31.2 | -19.0 | -7.8 | 21.3 | 13.2 | 4 | BEARISH | -54.0 |
| VIMGF Vimian Group AB (publ) | $1.5B | 44.8 | 5.2 | 5.9 | 6.9 | 10.8 | 6 | BEARISH | -8.0 |
| VIMGF Vimian Group AB (publ) | $1.5B | 44.8 | 5.2 | 5.9 | 6.9 | 10.8 | 6 | BEARISH | -8.0 |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.4B | — | — | — | — | — | — | BEARISH | — |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.4B | — | — | — | — | — | — | BEARISH | — |
| LWSCF Sienna Senior Living Inc. | $1.4B | 38.5 | 6.7 | 3.9 | 4.4 | 16.2 | 7 | BEARISH | 4.2 |
| LWSCF Sienna Senior Living Inc. | $1.4B | 38.5 | 6.7 | 3.9 | 4.4 | 16.2 | 7 | BEARISH | 4.2 |
| KLRA Kailera Therapeutics, Inc. | $1.4B | — | — | — | — | — | — | BEARISH | — |
| KLRA Kailera Therapeutics, Inc. | $1.4B | — | — | — | — | — | — | BEARISH | — |
| KARD Kardigan, Inc. | $1.3B | — | — | — | — | — | — | BEARISH | — |
| KARD Kardigan, Inc. | $1.3B | — | — | — | — | — | — | BEARISH | — |
| VTRLY Vitrolife AB (publ) | $1.3B | -2.5 | -46.5 | -42.3 | 15.1 | -4.6 | 6 | BEARISH | -36.7 |
| VTRLY Vitrolife AB (publ) | $1.3B | -2.5 | -46.5 | -42.3 | 15.1 | -4.6 | 6 | BEARISH | -36.7 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.2B | — | — | — | — | — | — | BEARISH | — |
| AVLN Avalyn Pharma Inc. Common Stock | $1.2B | — | — | — | — | — | — | BEARISH | — |
| RYHTY Ryman Healthcare Limited | $1.2B | -11.0 | -14.4 | -0.6 | -30.8 | 24.7 | 4 | BEARISH | -14.1 |
| RYHTY Ryman Healthcare Limited | $1.2B | -11.0 | -14.4 | -0.6 | -30.8 | 24.7 | 4 | BEARISH | -14.1 |
| TTALF Terveystalo Oyj | $1.1B | 13.7 | 12.6 | 7.6 | 4.7 | -7.9 | 4 | BEARISH | -30.9 |
| TTALF Terveystalo Oyj | $1.1B | 13.7 | 12.6 | 7.6 | 4.7 | -7.9 | 4 | BEARISH | -30.9 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.4 | 4.2 | -0.8 | 19.4 | 33.4 | 7 | BEARISH | 21.7 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.4 | 4.2 | -0.8 | 19.4 | 33.4 | 7 | BEARISH | 21.7 |
| CMOPF Cosmo Pharmaceuticals N.V. | $1.1B | -148.1 | 9.2 | 10.2 | -9.5 | -1.7 | 3 | BEARISH | -22.4 |
| CMOPF Cosmo Pharmaceuticals N.V. | $1.1B | -148.1 | 9.2 | 10.2 | -9.5 | -1.7 | 3 | BEARISH | -22.4 |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | $990M | -27.5 | -3.9 | 0.1 | 1.0 | — | 3 | BEARISH | — |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | $990M | -27.5 | -3.9 | 0.1 | 1.0 | — | 3 | BEARISH | — |
| SPTX Seaport Therapeutics, Inc. Common Stock | $990M | — | — | — | — | — | — | BEARISH | — |
| SPTX Seaport Therapeutics, Inc. Common Stock | $990M | — | — | — | — | — | — | BEARISH | — |
| MLTX MoonLake Immunotherapeutics | $960M | -3.0 | -67.4 | 2902.7 | — | — | 1 | BEARISH | 61.6 |
| MLTX MoonLake Immunotherapeutics | $960M | -3.0 | -67.4 | 2902.7 | — | — | 1 | BEARISH | 61.6 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -5.1 | -5.9 | -0.3 | -14.3 | -30.1 | 5 | BEARISH | -40.7 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -5.1 | -5.9 | -0.3 | -14.3 | -30.1 | 5 | BEARISH | -40.7 |
| AHCO AdaptHealth Corp. | $760M | -3.3 | -15.5 | -0.2 | -18.1 | 22.9 | 6 | BEARISH | -38.5 |
| AHCO AdaptHealth Corp. | $760M | -3.3 | -15.5 | -0.2 | -18.1 | 22.9 | 6 | BEARISH | -38.5 |
| WVE Wave Life Sciences Ltd. | $740M | -3.5 | -68.3 | -2645.3 | -3052.6 | -30.4 | 5 | BEARISH | -46.2 |
| WVE Wave Life Sciences Ltd. | $740M | -3.5 | -68.3 | -2645.3 | -3052.6 | -30.4 | 5 | BEARISH | -46.2 |
| FTH Faeth Therapeutics, Inc. | $730M | — | — | — | — | — | — | BEARISH | — |
| FTH Faeth Therapeutics, Inc. | $730M | — | — | — | — | — | — | BEARISH | — |
| GMRS GMR Solutions Inc. | $530M | — | — | — | — | — | — | BEARISH | — |
| GMRS GMR Solutions Inc. | $530M | — | — | — | — | — | — | BEARISH | — |
| DRUG Bright Minds Biosciences Inc. | $500M | -24.3 | -13.7 | -105758.3 | — | — | 3 | BEARISH | -12.5 |
| DRUG Bright Minds Biosciences Inc. | $500M | -24.3 | -13.7 | -105758.3 | — | — | 3 | BEARISH | -12.5 |
| TCMD Tactile Systems Technology, Inc. | $500M | 20.3 | 11.9 | 13.8 | 9.1 | 17.2 | 8 | BEARISH | 59.8 |
| TCMD Tactile Systems Technology, Inc. | $500M | 20.3 | 11.9 | 13.8 | 9.1 | 17.2 | 8 | BEARISH | 59.8 |
| OCS Oculis Holding AG | $500M | -5.2 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -49.8 |
| OCS Oculis Holding AG | $500M | -5.2 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -49.8 |
| KSRBF Kossan Rubber Industries Bhd | $480M | 15.4 | 5.0 | 8.5 | 11.3 | 1.0 | 5 | BEARISH | -43.2 |
| KSRBF Kossan Rubber Industries Bhd | $480M | 15.4 | 5.0 | 8.5 | 11.3 | 1.0 | 5 | BEARISH | -43.2 |
| PRTA Prothena Corporation plc | $440M | -10.1 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BEARISH | -15.7 |
| PRTA Prothena Corporation plc | $440M | -10.1 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BEARISH | -15.7 |
| MPLT MapLight Therapeutics, Inc. | $420M | -1.9 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| MPLT MapLight Therapeutics, Inc. | $420M | -1.9 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| ZURA Zura Bio Limited | $390M | -3.6 | -54.3 | 910.3 | — | — | 2 | BEARISH | 1.7 |
| ZURA Zura Bio Limited | $390M | -3.6 | -54.3 | 910.3 | — | — | 2 | BEARISH | 1.7 |
| CABA Cabaletta Bio, Inc. | $330M | -1.3 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -13.4 |
| CABA Cabaletta Bio, Inc. | $330M | -1.3 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -13.4 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $310M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -67.7 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $310M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -67.7 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.0 | -32.4 | 2389.1 | — | — | 4 | BEARISH | -60.5 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.0 | -32.4 | 2389.1 | — | — | 4 | BEARISH | -60.5 |
| SABS SAB Biotherapeutics, Inc. | $270M | 0.8 | -11.3 | -48.4 | — | -100.0 | 3 | BEARISH | 50.5 |
| SABS SAB Biotherapeutics, Inc. | $270M | 0.8 | -11.3 | -48.4 | — | -100.0 | 3 | BEARISH | 50.5 |
| PALI Palisade Bio, Inc. | $250M | -2.7 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | 9.9 |
| PALI Palisade Bio, Inc. | $250M | -2.7 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | 9.9 |
| NWBO Northwest Biotherapeutics, Inc. | $250M | -6.0 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | BEARISH | -39.7 |
| NWBO Northwest Biotherapeutics, Inc. | $250M | -6.0 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | BEARISH | -39.7 |
| HLOSF Healios K.K. | $240M | 57.9 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -56.6 |
| HLOSF Healios K.K. | $240M | 57.9 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -56.6 |
| AKBA Akebia Therapeutics, Inc. | $230M | -8.0 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -67.7 |
| AKBA Akebia Therapeutics, Inc. | $230M | -8.0 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -67.7 |
| NAGE Niagen Bioscience Inc | $220M | 14.4 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -64.6 |
| NAGE Niagen Bioscience Inc | $220M | 14.4 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -64.6 |
| YARW Yarrow Bioscience Inc | $210M | — | — | — | — | — | — | BEARISH | — |
| YARW Yarrow Bioscience Inc | $210M | — | — | — | — | — | — | BEARISH | — |
| NBP NovaBridge Biosciences | $160M | -2.4 | -45.7 | -617.8 | — | — | 1 | BEARISH | -64.8 |
| NBP NovaBridge Biosciences | $160M | -2.4 | -45.7 | -617.8 | — | — | 1 | BEARISH | -64.8 |
| VRXA Veraxa Biotech Holding AG | $160M | — | — | — | — | — | — | BEARISH | — |
| VRXA Veraxa Biotech Holding AG | $160M | — | — | — | — | — | — | BEARISH | — |
| IMRX Immuneering Corporation | $150M | -3.9 | -52.1 | -112.8 | — | — | 4 | BEARISH | -36.0 |
| CMPX Compass Therapeutics, Inc. | $150M | -2.1 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -74.5 |
| CMPX Compass Therapeutics, Inc. | $150M | -2.1 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -74.5 |
| IMRX Immuneering Corporation | $150M | -3.9 | -52.1 | -112.8 | — | — | 4 | BEARISH | -36.0 |
| CLLS Cellectis S.A. | $140M | -2.2 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | BEARISH | -56.5 |
| CLLS Cellectis S.A. | $140M | -2.2 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | BEARISH | -56.5 |
| TNXP Tonix Pharmaceuticals Holding Corp. | $140M | -0.7 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -62.8 |
| TNXP Tonix Pharmaceuticals Holding Corp. | $140M | -0.7 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -62.8 |
| AIRS AirSculpt Technologies, Inc. | $120M | -9.7 | -12.0 | -6.0 | -2.6 | -8.7 | 5 | BEARISH | -78.2 |
| AIRS AirSculpt Technologies, Inc. | $120M | -9.7 | -12.0 | -6.0 | -2.6 | -8.7 | 5 | BEARISH | -78.2 |
| ONVVF Oneview Healthcare PLC | $120M | -7.5 | -404.0 | -6454.4 | -100.1 | 40.0 | 4 | BEARISH | -6.2 |
| ONVVF Oneview Healthcare PLC | $120M | -7.5 | -404.0 | -6454.4 | -100.1 | 40.0 | 4 | BEARISH | -6.2 |
| MIST Milestone Pharmaceuticals Inc. | $100M | -1.2 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -52.1 |
| MIST Milestone Pharmaceuticals Inc. | $100M | -1.2 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -52.1 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| HUMA Humacyte, Inc. | $90M | -1.0 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | BEARISH | -70.4 |
| HUMA Humacyte, Inc. | $90M | -1.0 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | BEARISH | -70.4 |
| ABSCF AB Science S.A. | $80M | -13.8 | 49.2 | 32.6 | 549.3 | 16.5 | 5 | BEARISH | -11.1 |
| ABSCF AB Science S.A. | $80M | -13.8 | 49.2 | 32.6 | 549.3 | 16.5 | 5 | BEARISH | -11.1 |
| LNSR LENSAR Inc | $80M | 5.3 | 1231.0 | -218.4 | 21.4 | 3.3 | 5 | BEARISH | -45.0 |
| LNSR LENSAR Inc | $80M | 5.3 | 1231.0 | -218.4 | 21.4 | 3.3 | 5 | BEARISH | -45.0 |
| INO Inovio Pharmaceuticals, Inc. | $80M | -1.0 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -51.0 |
| INO Inovio Pharmaceuticals, Inc. | $80M | -1.0 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -51.0 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.9 | -98.4 | -35.5 | -45.3 | 36.2 | 4 | BEARISH | -58.9 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.9 | -98.4 | -35.5 | -45.3 | 36.2 | 4 | BEARISH | -58.9 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -6.3 | 277.4 | 402.1 | — | 11.3 | 2 | BEARISH | -63.3 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -6.3 | 277.4 | 402.1 | — | 11.3 | 2 | BEARISH | -63.3 |
| GANX Gain Therapeutics, Inc. | $70M | -3.4 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -6.0 |
| GANX Gain Therapeutics, Inc. | $70M | -3.4 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -6.0 |
| THOXF BioPorto A/S | $70M | 81.2 | 12.3 | 43.6 | 520.6 | 3.4 | 4 | BEARISH | -48.3 |
| THOXF BioPorto A/S | $70M | 81.2 | 12.3 | 43.6 | 520.6 | 3.4 | 4 | BEARISH | -48.3 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.9 | -218.7 | 330.4 | — | — | 3 | BEARISH | -28.3 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.9 | -218.7 | 330.4 | — | — | 3 | BEARISH | -28.3 |
| KLRS Kalaris Therapeutics Inc | $60M | -1.3 | -79.9 | 109.5 | — | — | 0 | BEARISH | -55.5 |
| KLRS Kalaris Therapeutics Inc | $60M | -1.3 | -79.9 | 109.5 | — | — | 0 | BEARISH | -55.5 |
| ORXOF Orexo AB (publ) | $50M | -1.5 | -578.7 | -5591.3 | -2868.6 | -78.2 | 4 | BEARISH | -43.5 |
| ORXOF Orexo AB (publ) | $50M | -1.5 | -578.7 | -5591.3 | -2868.6 | -78.2 | 4 | BEARISH | -43.5 |
| IMA ImageneBio Inc | $50M | -0.9 | -40.7 | -594.7 | — | — | 3 | BEARISH | -46.0 |
| IMA ImageneBio Inc | $50M | -0.9 | -40.7 | -594.7 | — | — | 3 | BEARISH | -46.0 |
| DWTX Dogwood Therapeutics, Inc. | $50M | -0.2 | -47.8 | -39.7 | — | — | 2 | BEARISH | -79.3 |
| DWTX Dogwood Therapeutics, Inc. | $50M | -0.2 | -47.8 | -39.7 | — | — | 2 | BEARISH | -79.3 |
| BSEM BioStem Technologies, Inc. | $50M | -1.6 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -45.3 |
| BSEM BioStem Technologies, Inc. | $50M | -1.6 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -45.3 |
| RPID Rapid Micro Biosystems, Inc. | $40M | -0.8 | -141.6 | -183.2 | -160.5 | 16.1 | 2 | BEARISH | -73.4 |
| RPID Rapid Micro Biosystems, Inc. | $40M | -0.8 | -141.6 | -183.2 | -160.5 | 16.1 | 2 | BEARISH | -73.4 |
| MYCOF Noveris Health Sciences Inc. | $40M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 12066.7 |
| MYCOF Noveris Health Sciences Inc. | $40M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 12066.7 |
| SYMQY SymBio Pharmaceuticals Limited | $30M | -0.6 | -334.3 | 639.4 | -515.2 | -54.2 | 1 | BEARISH | -41.5 |
| SYMQY SymBio Pharmaceuticals Limited | $30M | -0.6 | -334.3 | 639.4 | -515.2 | -54.2 | 1 | BEARISH | -41.5 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.6 | -13.8 | -21.9 | — | — | 1 | BEARISH | -32.6 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.6 | -13.8 | -21.9 | — | — | 1 | BEARISH | -32.6 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $20M | -2.1 | -234.4 | -475.2 | -504.1 | 36.6 | 3 | BEARISH | 12.8 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $20M | -2.1 | -234.4 | -475.2 | -504.1 | 36.6 | 3 | BEARISH | 12.8 |
| MODD Modular Medical, Inc. | $20M | -0.2 | -188.1 | -339.7 | — | — | 2 | BEARISH | -90.3 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.2 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | 15.6 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.2 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | 15.6 |
| MODD Modular Medical, Inc. | $20M | -0.2 | -188.1 | -339.7 | — | — | 2 | BEARISH | -90.3 |
| NXTC NextCure, Inc. | $20M | -0.5 | -195.2 | 949.7 | — | — | 2 | BEARISH | -10.5 |
| NXTC NextCure, Inc. | $20M | -0.5 | -195.2 | 949.7 | — | — | 2 | BEARISH | -10.5 |
| ESLA Estrella Immunopharma, Inc. | $20M | -1.9 | 148.1 | 102.1 | — | — | 3 | BEARISH | -65.1 |
| ESLA Estrella Immunopharma, Inc. | $20M | -1.9 | 148.1 | 102.1 | — | — | 3 | BEARISH | -65.1 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.5 | -237.8 | -86.8 | — | — | 4 | BEARISH | -45.0 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.5 | -237.8 | -86.8 | — | — | 4 | BEARISH | -45.0 |
| CRVW CareView Communications, Inc. | $20M | -6.4 | 6.4 | -1.4 | -10.0 | 8.5 | 7 | BEARISH | 71.0 |
| CRVW CareView Communications, Inc. | $20M | -6.4 | 6.4 | -1.4 | -10.0 | 8.5 | 7 | BEARISH | 71.0 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -38.2 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -38.2 |
| FEMY Femasys Inc. | $10M | -0.4 | -443.7 | -188.1 | -1346.8 | 21.9 | 5 | BEARISH | -72.3 |
| FEMY Femasys Inc. | $10M | -0.4 | -443.7 | -188.1 | -1346.8 | 21.9 | 5 | BEARISH | -72.3 |
| CNSY Cerenome, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| CNSY Cerenome, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| BLRX BioLineRx Ltd. | $10M | -1.4 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -38.8 |
| BLRX BioLineRx Ltd. | $10M | -1.4 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -38.8 |
| IUGNF Imugene Limited | $10M | -0.1 | -273.9 | -901.2 | — | -73.7 | 1 | BEARISH | -87.2 |
| IUGNF Imugene Limited | $10M | -0.1 | -273.9 | -901.2 | — | -73.7 | 1 | BEARISH | -87.2 |
| LGVN Longeveron Inc. | $10M | -0.3 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -65.2 |
| LGVN Longeveron Inc. | $10M | -0.3 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -65.2 |
| CKDXF Ceryvyn Therapeutics Limited | $10M | 0.2 | -234.2 | 64023.3 | — | -92.0 | 4 | BEARISH | -97.7 |
| CKDXF Ceryvyn Therapeutics Limited | $10M | 0.2 | -234.2 | 64023.3 | — | -92.0 | 4 | BEARISH | -97.7 |
| XCUR Exicure, Inc. | $10M | -0.9 | -168.4 | 779.8 | — | — | 2 | BEARISH | -72.0 |
| XCUR Exicure, Inc. | $10M | -0.9 | -168.4 | 779.8 | — | — | 2 | BEARISH | -72.0 |
| OPTBF OptiBiotix Health PLC | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| OPTBF OptiBiotix Health PLC | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| MDXHF MedX Health Corp | $10M | -1.9 | 63.5 | 166.6 | -1353.4 | 19.2 | 3 | BEARISH | -49.0 |
| MDXHF MedX Health Corp | $10M | -1.9 | 63.5 | 166.6 | -1353.4 | 19.2 | 3 | BEARISH | -49.0 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -46.6 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -46.6 |
| NMTC NeuroOne Medical Technologies Corporation | $10M | -1.2 | -119.7 | -335.0 | -101.7 | 50.8 | 5 | BEARISH | 29.3 |
| NMTC NeuroOne Medical Technologies Corporation | $10M | -1.2 | -119.7 | -335.0 | -101.7 | 50.8 | 5 | BEARISH | 29.3 |
| CALC CalciMedica, Inc. | $10M | -0.2 | -365.7 | 118.3 | — | — | 4 | BEARISH | -89.5 |
| CALC CalciMedica, Inc. | $10M | -0.2 | -365.7 | 118.3 | — | — | 4 | BEARISH | -89.5 |
| GSGTF GenSight Biologics S.A. | $10M | -1.1 | 104.0 | 107.2 | 848.8 | -139.6 | 2 | BEARISH | -57.9 |
| GSGTF GenSight Biologics S.A. | $10M | -1.1 | 104.0 | 107.2 | 848.8 | -139.6 | 2 | BEARISH | -57.9 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.2 | -140.0 | 105.8 | -5.6 | — | 2 | BEARISH | — |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.2 | -140.0 | 105.8 | -5.6 | — | 2 | BEARISH | — |
| PDRX PD-Rx Pharmaceuticals, Inc. | $10M | — | — | — | — | — | — | BEARISH | 8.8 |
| PDRX PD-Rx Pharmaceuticals, Inc. | $10M | — | — | — | — | — | — | BEARISH | 8.8 |
| PXXLF Poxel S.A. | $10M | -0.4 | 222.8 | 275.8 | -624.6 | -73.2 | 2 | BEARISH | -12.0 |
| PXXLF Poxel S.A. | $10M | -0.4 | 222.8 | 275.8 | -624.6 | -73.2 | 2 | BEARISH | -12.0 |
| PLUR Pluri Inc. | $10M | -0.4 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | BEARISH | -76.8 |
| PLUR Pluri Inc. | $10M | -0.4 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | BEARISH | -76.8 |
| ENLV Enlivex Therapeutics Ltd. | $10M | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -97.4 |
| ENLV Enlivex Therapeutics Ltd. | $10M | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -97.4 |
| VRCDF Verici Dx plc | $10M | -0.6 | -252.0 | -302.5 | -219.5 | 1257.8 | 5 | BEARISH | -60.5 |
| VRCDF Verici Dx plc | $10M | -0.6 | -252.0 | -302.5 | -219.5 | 1257.8 | 5 | BEARISH | -60.5 |
| CTSO Cytosorbents Corporation | $10M | -0.7 | -336.2 | -46.3 | -45.9 | 3.1 | 4 | BEARISH | -79.4 |
| CTSO Cytosorbents Corporation | $10M | -0.7 | -336.2 | -46.3 | -45.9 | 3.1 | 4 | BEARISH | -79.4 |
| LNAI Lunai Bioworks Inc. | $10M | -0.0 | -21.6 | 30.2 | — | — | 2 | BEARISH | -87.0 |
| LNAI Lunai Bioworks Inc. | $10M | -0.0 | -21.6 | 30.2 | — | — | 2 | BEARISH | -87.0 |
| LFWD Lifeward Ltd. | $10M | -0.3 | -225.6 | -129.9 | -173.9 | -10.7 | 4 | BEARISH | -31.3 |
| LFWD Lifeward Ltd. | $10M | -0.3 | -225.6 | -129.9 | -173.9 | -10.7 | 4 | BEARISH | -31.3 |
| INBS Intelligent Bio Solutions Inc. | $10M | -0.2 | -292.3 | -304.3 | -341.0 | 38.1 | 4 | BEARISH | -84.0 |
| INBS Intelligent Bio Solutions Inc. | $10M | -0.2 | -292.3 | -304.3 | -341.0 | 38.1 | 4 | BEARISH | -84.0 |
| FBLG FibroBiologics, Inc. Common Stock | — | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -88.2 |
| FBLG FibroBiologics, Inc. Common Stock | — | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -88.2 |
| PMSNF Proteome Sciences plc | — | -2.0 | 75.0 | -73.3 | -74.6 | -100.0 | 1 | BEARISH | -80.0 |
| PMSNF Proteome Sciences plc | — | -2.0 | 75.0 | -73.3 | -74.6 | -100.0 | 1 | BEARISH | -80.0 |
| AREVF AREV Life Sciences Global Corp | — | -1.9 | 23.9 | 15.1 | — | -96.1 | 2 | BEARISH | -95.0 |
| AREVF AREV Life Sciences Global Corp | — | -1.9 | 23.9 | 15.1 | — | -96.1 | 2 | BEARISH | -95.0 |
| ADGM Adagio Medical Holdings, Inc. | — | -0.1 | -657.8 | -87.8 | — | -100.0 | 2 | BEARISH | -92.3 |
| ADGM Adagio Medical Holdings, Inc. | — | -0.1 | -657.8 | -87.8 | — | -100.0 | 2 | BEARISH | -92.3 |
| RPGLF Regent Pacific Group Limited | — | -16.1 | 119.2 | -279.5 | 10.3 | 1351.3 | 6 | BEARISH | -94.1 |
| RPGLF Regent Pacific Group Limited | — | -16.1 | 119.2 | -279.5 | 10.3 | 1351.3 | 6 | BEARISH | -94.1 |
| USMJ North American Cannabis Holdings, Inc. | — | -3.5 | 40.1 | 1.5 | — | 14.2 | 2 | BEARISH | 0.0 |
| USMJ North American Cannabis Holdings, Inc. | — | -3.5 | 40.1 | 1.5 | — | 14.2 | 2 | BEARISH | 0.0 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| NUNZ Nunzia Pharmaceutical Company | — | -0.0 | 69398.6 | 176728.6 | — | — | 2 | BEARISH | 0.0 |
| NUNZ Nunzia Pharmaceutical Company | — | -0.0 | 69398.6 | 176728.6 | — | — | 2 | BEARISH | 0.0 |
| OVATF Ovation Science Inc. | — | -1.7 | 44.0 | 34.6 | -690.6 | -27.1 | 3 | BEARISH | -70.9 |
| OVATF Ovation Science Inc. | — | -1.7 | 44.0 | 34.6 | -690.6 | -27.1 | 3 | BEARISH | -70.9 |
| RVVQF RavenQuest BioMed Inc. | — | -0.0 | -112.5 | -40.6 | -440.2 | 93.6 | 2 | BEARISH | 0.0 |
| RVVQF RavenQuest BioMed Inc. | — | -0.0 | -112.5 | -40.6 | -440.2 | 93.6 | 2 | BEARISH | 0.0 |
| PTLF Petlife Pharmaceuticals, Inc. | — | -0.0 | 257.0 | 178.4 | — | — | 2 | BEARISH | 0.0 |
| PTLF Petlife Pharmaceuticals, Inc. | — | -0.0 | 257.0 | 178.4 | — | — | 2 | BEARISH | 0.0 |
| BBAL New York Health Care, Inc. | — | -0.0 | -9.2 | -21.4 | -1.7 | 3.5 | 6 | BEARISH | 0.0 |
| BBAL New York Health Care, Inc. | — | -0.0 | -9.2 | -21.4 | -1.7 | 3.5 | 6 | BEARISH | 0.0 |
| TTOO T2 Biosystems, Inc. | — | -0.0 | 277.6 | -638.9 | -509.7 | -30.2 | 3 | BEARISH | -95.1 |
| TTOO T2 Biosystems, Inc. | — | -0.0 | 277.6 | -638.9 | -509.7 | -30.2 | 3 | BEARISH | -95.1 |
| OJSY OJsys, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| OJSY OJsys, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RSHN RushNet, Inc. | — | -1.0 | -1202.9 | -22.5 | — | -43.0 | 2 | BEARISH | -98.0 |
| RSHN RushNet, Inc. | — | -1.0 | -1202.9 | -22.5 | — | -43.0 | 2 | BEARISH | -98.0 |
| SCAL Stem Cell Authority, Ltd. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SCAL Stem Cell Authority, Ltd. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| FCGD First Colombia Gold Corp. | — | -95.6 | 23.1 | 122.7 | — | -93.9 | 2 | BEARISH | 0.0 |
| FCGD First Colombia Gold Corp. | — | -95.6 | 23.1 | 122.7 | — | -93.9 | 2 | BEARISH | 0.0 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.8 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.8 |
| HRTT Heart Tronics, Inc. | — | -0.0 | -1320.1 | -1322.8 | — | — | 1 | BEARISH | 0.0 |
| HRTT Heart Tronics, Inc. | — | -0.0 | -1320.1 | -1322.8 | — | — | 1 | BEARISH | 0.0 |
| PPRG Patient Portal Technologies, Inc. | — | -0.0 | -4.5 | -0.3 | -3.5 | -23.2 | 2 | BEARISH | 0.0 |
| PPRG Patient Portal Technologies, Inc. | — | -0.0 | -4.5 | -0.3 | -3.5 | -23.2 | 2 | BEARISH | 0.0 |
| AVCRF Avricore Health Inc. | — | -3.4 | -131.4 | -548.9 | -354.9 | -93.8 | 2 | BEARISH | -98.3 |
| AVCRF Avricore Health Inc. | — | -3.4 | -131.4 | -548.9 | -354.9 | -93.8 | 2 | BEARISH | -98.3 |
| SMAS Somatic Systems, Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| SMAS Somatic Systems, Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| AXRX Amexdrug Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AXRX Amexdrug Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| TCRT Alaunos Therapeutics, Inc. | — | -0.4 | -185.9 | -607.2 | — | -50.0 | 1 | BEARISH | -66.9 |
| TCRT Alaunos Therapeutics, Inc. | — | -0.4 | -185.9 | -607.2 | — | -50.0 | 1 | BEARISH | -66.9 |
| MCOA Marijuana Company of America, Inc. | — | -0.1 | 295.5 | 51.6 | — | -72.4 | 1 | BEARISH | 0.0 |
| MCOA Marijuana Company of America, Inc. | — | -0.1 | 295.5 | 51.6 | — | -72.4 | 1 | BEARISH | 0.0 |
| PPII Coenzyme-A Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PPII Coenzyme-A Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BBLG Bone Biologics Corporation | — | -0.3 | -55.0 | 2257.6 | — | — | 2 | BEARISH | -83.0 |
| BBLG Bone Biologics Corporation | — | -0.3 | -55.0 | 2257.6 | — | — | 2 | BEARISH | -83.0 |
| CEVE Ceres Ventures, Inc. | — | -0.0 | 175.9 | 280.3 | — | — | 3 | BEARISH | 0.0 |
| CEVE Ceres Ventures, Inc. | — | -0.0 | 175.9 | 280.3 | — | — | 3 | BEARISH | 0.0 |
| IHGP Jun An Kang Group Inc. | — | 2.0 | 0.5 | 0.5 | 1.0 | 64.0 | 6 | BEARISH | -98.2 |
| IHGP Jun An Kang Group Inc. | — | 2.0 | 0.5 | 0.5 | 1.0 | 64.0 | 6 | BEARISH | -98.2 |
| OWPC One World Products, Inc. | — | 0.0 | -124.8 | -16.4 | 10538.7 | 1987.1 | 5 | BEARISH | -99.6 |
| OWPC One World Products, Inc. | — | 0.0 | -124.8 | -16.4 | 10538.7 | 1987.1 | 5 | BEARISH | -99.6 |
| ICCO InterCare DX, Inc. | — | -0.0 | 16.1 | 3053.3 | — | — | 5 | BEARISH | -98.0 |
| ICCO InterCare DX, Inc. | — | -0.0 | 16.1 | 3053.3 | — | — | 5 | BEARISH | -98.0 |
| CBDX Curative Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CBDX Curative Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BKUH Bakhu Holdings, Corp. | — | -0.0 | -7.1 | -30.3 | — | -200.0 | 3 | BEARISH | -95.0 |
| BKUH Bakhu Holdings, Corp. | — | -0.0 | -7.1 | -30.3 | — | -200.0 | 3 | BEARISH | -95.0 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| ISHI Islet Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ISHI Islet Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| STMH Stem Holdings, Inc. | — | -0.0 | -274.8 | 873.4 | 98.5 | -100.0 | 3 | BEARISH | -90.0 |
| STMH Stem Holdings, Inc. | — | -0.0 | -274.8 | 873.4 | 98.5 | -100.0 | 3 | BEARISH | -90.0 |
| AJOY Ayujoy Herbals Ltd. | — | -1.0 | -54.8 | 142.7 | — | -100.0 | 3 | BEARISH | -70.7 |
| AJOY Ayujoy Herbals Ltd. | — | -1.0 | -54.8 | 142.7 | — | -100.0 | 3 | BEARISH | -70.7 |
| AGFAF Digicann Ventures Inc. | — | -0.0 | 30.8 | 63.6 | — | — | 2 | BEARISH | -76.8 |
| AGFAF Digicann Ventures Inc. | — | -0.0 | 30.8 | 63.6 | — | — | 2 | BEARISH | -76.8 |
| GENX Genex Pharmaceutical, Inc. | — | 0.0 | 7.8 | 5.1 | -8.1 | 32.8 | 5 | BEARISH | 0.0 |
| GENX Genex Pharmaceutical, Inc. | — | 0.0 | 7.8 | 5.1 | -8.1 | 32.8 | 5 | BEARISH | 0.0 |
| MDIT Medite Cancer Diagnostics, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MDIT Medite Cancer Diagnostics, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VSBC VitaSpring Biomedical Co. Ltd. | — | -4.8 | 35.7 | 8.9 | — | -100.0 | 3 | BEARISH | -98.9 |
| VSBC VitaSpring Biomedical Co. Ltd. | — | -4.8 | 35.7 | 8.9 | — | -100.0 | 3 | BEARISH | -98.9 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | BEARISH | 400.0 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | BEARISH | 400.0 |
| ACUS Acusphere, Inc. | — | -0.0 | -363.3 | -4565.0 | -3033.3 | -5.2 | 2 | BEARISH | 0.0 |
| ACUS Acusphere, Inc. | — | -0.0 | -363.3 | -4565.0 | -3033.3 | -5.2 | 2 | BEARISH | 0.0 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -87.1 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -87.1 |
| ETAOF Etao International Co., Ltd. | — | -0.0 | -1369.5 | 4843.5 | -1544.0 | — | 5 | BEARISH | -66.7 |
| ETAOF Etao International Co., Ltd. | — | -0.0 | -1369.5 | 4843.5 | -1544.0 | — | 5 | BEARISH | -66.7 |
| MSTH Mystic Holdings, Inc. | — | -0.0 | -35.2 | -19.8 | -27.1 | 24.7 | 5 | BEARISH | -97.7 |
| MSTH Mystic Holdings, Inc. | — | -0.0 | -35.2 | -19.8 | -27.1 | 24.7 | 5 | BEARISH | -97.7 |
| AIDX 20/20 Biolabs Inc. | — | — | — | — | — | — | — | BEARISH | — |
| AIDX 20/20 Biolabs Inc. | — | — | — | — | — | — | — | BEARISH | — |
| ICCM IceCure Medical Ltd | — | -0.2 | -228.3 | 36140.9 | -496.3 | 41.6 | 7 | BEARISH | -94.7 |
| ICCM IceCure Medical Ltd | — | -0.2 | -228.3 | 36140.9 | -496.3 | 41.6 | 7 | BEARISH | -94.7 |
| MBGNF Many Bright Ideas Technologies Inc. | — | -2.2 | 20.4 | 126.7 | — | — | 2 | BEARISH | 0.0 |
| MBGNF Many Bright Ideas Technologies Inc. | — | -2.2 | 20.4 | 126.7 | — | — | 2 | BEARISH | 0.0 |
| GENPF Genix Pharmaceuticals Corporation | — | -5.2 | 19.6 | 11.6 | — | -100.0 | 2 | BEARISH | 0.0 |
| GENPF Genix Pharmaceuticals Corporation | — | -5.2 | 19.6 | 11.6 | — | -100.0 | 2 | BEARISH | 0.0 |
| CHHE China Health Industries Holdings, Inc. | — | -0.0 | -6.9 | -35.0 | -164082.8 | 77.5 | 2 | BEARISH | -100.0 |
| CHHE China Health Industries Holdings, Inc. | — | -0.0 | -6.9 | -35.0 | -164082.8 | 77.5 | 2 | BEARISH | -100.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| LVCE LiveCare, Inc. | — | — | — | — | — | — | — | BEARISH | -76.8 |
| LVCE LiveCare, Inc. | — | — | — | — | — | — | — | BEARISH | -76.8 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| SRUTF Sproutly Canada Inc. | — | -0.0 | 7045.7 | -519.2 | -1194.7 | 28.2 | 4 | BEARISH | 0.0 |
| SRUTF Sproutly Canada Inc. | — | -0.0 | 7045.7 | -519.2 | -1194.7 | 28.2 | 4 | BEARISH | 0.0 |
| OMHE OMNI Health, Inc. | — | 0.0 | 30.4 | -8.8 | -6.1 | 2046.4 | 4 | BEARISH | -95.0 |
| OMHE OMNI Health, Inc. | — | 0.0 | 30.4 | -8.8 | -6.1 | 2046.4 | 4 | BEARISH | -95.0 |
| KAPA Kairos Pharma, Ltd. | — | -0.8 | -114.0 | -301.0 | — | — | 3 | BEARISH | -80.3 |
| KAPA Kairos Pharma, Ltd. | — | -0.8 | -114.0 | -301.0 | — | — | 3 | BEARISH | -80.3 |
| JNHMF Jack Nathan Medical Corp. | — | -0.7 | -152.9 | 25.0 | -471.3 | -108.0 | 4 | BEARISH | -75.0 |
| JNHMF Jack Nathan Medical Corp. | — | -0.7 | -152.9 | 25.0 | -471.3 | -108.0 | 4 | BEARISH | -75.0 |
| PCSA Processa Pharmaceuticals, Inc. | — | -0.3 | -464.2 | 1977.5 | — | — | 2 | BEARISH | -67.5 |
| PCSA Processa Pharmaceuticals, Inc. | — | -0.3 | -464.2 | 1977.5 | — | — | 2 | BEARISH | -67.5 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -93.1 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -93.1 |
| WOWU WOWI, Inc. | — | 0.0 | 51.5 | 49.7 | -38.1 | — | 4 | BEARISH | -50.0 |
| WOWU WOWI, Inc. | — | 0.0 | 51.5 | 49.7 | -38.1 | — | 4 | BEARISH | -50.0 |
| FITY Fifty 1 Labs, Inc. | — | -4.2 | 132.4 | 345.2 | -58137.6 | -75.6 | 4 | BEARISH | -92.9 |
| FITY Fifty 1 Labs, Inc. | — | -4.2 | 132.4 | 345.2 | -58137.6 | -75.6 | 4 | BEARISH | -92.9 |
| IMMVF Immunovia AB | — | -0.5 | -425.5 | 808.2 | -5991.9 | 31.4 | 3 | BEARISH | -80.8 |
| IMMVF Immunovia AB | — | -0.5 | -425.5 | 808.2 | -5991.9 | 31.4 | 3 | BEARISH | -80.8 |
| PMEDF Qscreen Ai Inc. | — | -13.1 | 145.2 | 82.8 | — | — | 3 | BEARISH | -47.3 |
| PMEDF Qscreen Ai Inc. | — | -13.1 | 145.2 | 82.8 | — | — | 3 | BEARISH | -47.3 |
| SZLSF StageZero Life Sciences Ltd. | — | -0.0 | 23.1 | 18.6 | -79.9 | -29.3 | 2 | BEARISH | -80.4 |
| SZLSF StageZero Life Sciences Ltd. | — | -0.0 | 23.1 | 18.6 | -79.9 | -29.3 | 2 | BEARISH | -80.4 |
| TBIO Telesis Bio, Inc. | — | -0.0 | -180.9 | -154.3 | -424.1 | -54.9 | 3 | BEARISH | -99.2 |
| TBIO Telesis Bio, Inc. | — | -0.0 | -180.9 | -154.3 | -424.1 | -54.9 | 3 | BEARISH | -99.2 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | -40.4 | 4 | BEARISH | 0.0 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | -40.4 | 4 | BEARISH | 0.0 |
| PNDHF Pond Technologies Holdings Inc. | — | -0.4 | 43.2 | 90.7 | -114.9 | -47.3 | 2 | BEARISH | 23.1 |
| PNDHF Pond Technologies Holdings Inc. | — | -0.4 | 43.2 | 90.7 | -114.9 | -47.3 | 2 | BEARISH | 23.1 |
| THCT THC Therapeutics, Inc. | — | -0.0 | 16.8 | 16.9 | — | — | 2 | BEARISH | -40.0 |
| THCT THC Therapeutics, Inc. | — | -0.0 | 16.8 | 16.9 | — | — | 2 | BEARISH | -40.0 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | -0.0 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | -0.0 |
| ENZC Enzolytics Inc. | — | -9.3 | 105.9 | 1.4 | — | — | 7 | BEARISH | 100.0 |
| ENZC Enzolytics Inc. | — | -9.3 | 105.9 | 1.4 | — | — | 7 | BEARISH | 100.0 |
| XTXXF Adastra Holdings Ltd. | — | -0.7 | -227.3 | -93.3 | -9.6 | -33.9 | 2 | BEARISH | -44.9 |
| XTXXF Adastra Holdings Ltd. | — | -0.7 | -227.3 | -93.3 | -9.6 | -33.9 | 2 | BEARISH | -44.9 |
| EKGGF CardioComm Solutions, Inc. | — | -4.2 | 92.7 | 515.6 | -152.3 | -41.9 | 2 | BEARISH | 150.0 |
| EKGGF CardioComm Solutions, Inc. | — | -4.2 | 92.7 | 515.6 | -152.3 | -41.9 | 2 | BEARISH | 150.0 |
| NEWUF Newtopia Inc. | — | -0.1 | 75.4 | 107.5 | -166.7 | -36.4 | 2 | BEARISH | -58.3 |
| NEWUF Newtopia Inc. | — | -0.1 | 75.4 | 107.5 | -166.7 | -36.4 | 2 | BEARISH | -58.3 |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| LEXX Lexaria Bioscience Corp. | — | -0.5 | -150.3 | -504.2 | — | -68.5 | 4 | BEARISH | -80.9 |
| LEXX Lexaria Bioscience Corp. | — | -0.5 | -150.3 | -504.2 | — | -68.5 | 4 | BEARISH | -80.9 |
| FWDG FutureWorld Corp. | — | -0.1 | -1.2 | -0.5 | -507.1 | 153.6 | 5 | BEARISH | 0.0 |
| FWDG FutureWorld Corp. | — | -0.1 | -1.2 | -0.5 | -507.1 | 153.6 | 5 | BEARISH | 0.0 |
| NGMDF NuGen Medical Devices Inc. | — | -0.3 | 81.2 | -448.2 | -19565.6 | -86.3 | 2 | BEARISH | -76.2 |
| NGMDF NuGen Medical Devices Inc. | — | -0.3 | 81.2 | -448.2 | -19565.6 | -86.3 | 2 | BEARISH | -76.2 |
| LUDG Ludwig Enterprises, Inc. | — | -0.4 | 43.5 | 103.5 | — | 100.0 | 4 | BEARISH | -94.3 |
| LUDG Ludwig Enterprises, Inc. | — | -0.4 | 43.5 | 103.5 | — | 100.0 | 4 | BEARISH | -94.3 |
| OHCS Optimus Healthcare Services, Inc. | — | -0.0 | 99.2 | 130.3 | -469.4 | 43.7 | 4 | BEARISH | -98.6 |
| OHCS Optimus Healthcare Services, Inc. | — | -0.0 | 99.2 | 130.3 | -469.4 | 43.7 | 4 | BEARISH | -98.6 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| TWSI Tristar Wellness Solutions Inc. | — | -2.0 | 61.9 | 93.6 | -80.6 | -29.1 | 3 | BEARISH | -99.6 |
| TWSI Tristar Wellness Solutions Inc. | — | -2.0 | 61.9 | 93.6 | -80.6 | -29.1 | 3 | BEARISH | -99.6 |
| WEQL WellQuest Medical & Wellness Corporation | — | -0.0 | 16.1 | -19.9 | -36.3 | 126.5 | 3 | BEARISH | 100.0 |
| WEQL WellQuest Medical & Wellness Corporation | — | -0.0 | 16.1 | -19.9 | -36.3 | 126.5 | 3 | BEARISH | 100.0 |
| EVGRF China Evergrande New Energy Vehicle Group Limited | — | -13.0 | 110.9 | 47.6 | -766929.9 | -74.0 | 2 | BEARISH | -71.4 |
| EVGRF China Evergrande New Energy Vehicle Group Limited | — | -13.0 | 110.9 | 47.6 | -766929.9 | -74.0 | 2 | BEARISH | -71.4 |
| TRGM Targeted Medical Pharma, Inc. | — | -0.0 | 26.6 | 20.9 | -45.1 | -26.0 | 4 | BEARISH | -90.0 |
| TRGM Targeted Medical Pharma, Inc. | — | -0.0 | 26.6 | 20.9 | -45.1 | -26.0 | 4 | BEARISH | -90.0 |
| WOK WORK Medical Technology Group Ltd. Class A | — | -0.0 | -27.2 | -22.6 | -63.0 | — | 2 | BEARISH | -78.1 |
| WOK WORK Medical Technology Group Ltd. Class A | — | -0.0 | -27.2 | -22.6 | -63.0 | — | 2 | BEARISH | -78.1 |
| NEUN Neurogenesis, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NEUN Neurogenesis, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| DRMA Dermata Therapeutics, Inc. | — | -0.3 | -183.9 | 734.5 | — | — | 2 | BEARISH | -78.4 |
| DRMA Dermata Therapeutics, Inc. | — | -0.3 | -183.9 | 734.5 | — | — | 2 | BEARISH | -78.4 |
| REFG Medical Cannabis Payment Solutions | — | -3.0 | 1.2 | 1.5 | — | — | 2 | BEARISH | 0.0 |
| REFG Medical Cannabis Payment Solutions | — | -3.0 | 1.2 | 1.5 | — | — | 2 | BEARISH | 0.0 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | BEARISH | -90.0 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | BEARISH | -90.0 |
| USPS Ultimate Sports, Inc. | — | -10.6 | 14.7 | 11.0 | — | — | 1 | BEARISH | 4650.0 |
| USPS Ultimate Sports, Inc. | — | -10.6 | 14.7 | 11.0 | — | — | 1 | BEARISH | 4650.0 |
| GRCU Global Roundtable Corporation | — | -2.9 | 28.1 | 25.5 | -673.8 | 35.7 | 7 | BEARISH | -99.0 |
| GRCU Global Roundtable Corporation | — | -2.9 | 28.1 | 25.5 | -673.8 | 35.7 | 7 | BEARISH | -99.0 |
| GRPI Grupo International Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GRPI Grupo International Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | 1259.6 | 159.9 | -14410.0 | — | 2 | BEARISH | -93.9 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | 1259.6 | 159.9 | -14410.0 | — | 2 | BEARISH | -93.9 |
| EXMT Anything Technologies Media, Inc. | — | -7.0 | 27.0 | -24.5 | — | -100.0 | 2 | BEARISH | -28.6 |
| EXMT Anything Technologies Media, Inc. | — | -7.0 | 27.0 | -24.5 | — | -100.0 | 2 | BEARISH | -28.6 |
| DROR Dror Ortho-Design, Inc. | — | -0.0 | 15.8 | 36.4 | — | — | 1 | BEARISH | — |
| DROR Dror Ortho-Design, Inc. | — | -0.0 | 15.8 | 36.4 | — | — | 1 | BEARISH | — |
| PERCF Percheron Therapeutics Limited | — | — | — | — | — | — | — | BEARISH | — |
| PERCF Percheron Therapeutics Limited | — | — | — | — | — | — | — | BEARISH | — |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| APYI Aspyra Inc. | — | -0.0 | -102.5 | 49.8 | -82.7 | -15.6 | 1 | BEARISH | 0.0 |
| APYI Aspyra Inc. | — | -0.0 | -102.5 | 49.8 | -82.7 | -15.6 | 1 | BEARISH | 0.0 |
| CPYT CarePayment Technologies, Inc. | — | -0.0 | 1607.0 | -66.2 | -585.5 | — | 2 | BEARISH | 0.0 |
| CPYT CarePayment Technologies, Inc. | — | -0.0 | 1607.0 | -66.2 | -585.5 | — | 2 | BEARISH | 0.0 |
| BPTSY Biophytis S.A. | — | -0.0 | 376.0 | 1163.5 | — | — | 2 | BEARISH | -87.5 |
| BPTSY Biophytis S.A. | — | -0.0 | 376.0 | 1163.5 | — | — | 2 | BEARISH | -87.5 |
| AMHD HLK Biotech Holding Group, Inc. | — | — | — | — | — | — | — | BEARISH | -0.0 |
| AMHD HLK Biotech Holding Group, Inc. | — | — | — | — | — | — | — | BEARISH | -0.0 |
| EAPH Parallel Industries Inc. | — | -0.2 | 26.8 | 19.0 | — | 0.0 | 4 | BEARISH | -90.0 |
| EAPH Parallel Industries Inc. | — | -0.2 | 26.8 | 19.0 | — | 0.0 | 4 | BEARISH | -90.0 |
| PAIYY Aesthetic Medical International Holdings Group Limited | — | — | — | — | — | — | — | BEARISH | -93.2 |
| PAIYY Aesthetic Medical International Holdings Group Limited | — | — | — | — | — | — | — | BEARISH | -93.2 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -12.2 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | BEARISH | -9.4 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -12.2 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | BEARISH | -9.4 |
| MESO Mesoblast Limited | $1.8B | -32.0 | -9.9 | -6.3 | -25.2 | 599.2 | 5 | BEARISH | -13.5 |
| MESO Mesoblast Limited | $1.8B | -32.0 | -9.9 | -6.3 | -25.2 | 599.2 | 5 | BEARISH | -13.5 |
| GENB Generate Biomedicines, Inc. | $1.8B | -12.9 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| GENB Generate Biomedicines, Inc. | $1.8B | -12.9 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| XRAY DENTSPLY SIRONA Inc. | $1.7B | -3.2 | -33.0 | 9.9 | 4.1 | -0.8 | 5 | BEARISH | -33.0 |
| XRAY DENTSPLY SIRONA Inc. | $1.7B | -3.2 | -33.0 | 9.9 | 4.1 | -0.8 | 5 | BEARISH | -33.0 |
| GPCR Structure Therapeutics Inc. | $1.6B | -9.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | 6.3 |
| GPCR Structure Therapeutics Inc. | $1.6B | -9.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | 6.3 |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.1 | 12.2 | 8.9 | 7.1 | 3 | BEARISH | inf |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.1 | 12.2 | 8.9 | 7.1 | 3 | BEARISH | inf |
| INVA Innoviva, Inc. | $1.5B | 4.2 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | BEARISH | 12.8 |
| INVA Innoviva, Inc. | $1.5B | 4.2 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | BEARISH | 12.8 |
| ASPHF Ascentage Pharma Group International | $1.4B | -6.4 | -316.9 | -211.0 | -270.2 | -29.1 | 1 | BEARISH | -58.3 |
| ASPHF Ascentage Pharma Group International | $1.4B | -6.4 | -316.9 | -211.0 | -270.2 | -29.1 | 1 | BEARISH | -58.3 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 12.3 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -21.6 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 12.3 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -21.6 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 21.1 | 5.9 | 6.5 | -0.7 | 7.2 | 6 | BEARISH | -1.6 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 21.1 | 5.9 | 6.5 | -0.7 | 7.2 | 6 | BEARISH | -1.6 |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BEARISH | — |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BEARISH | — |
| TRAX First Tracks Biotherapeutics Inc | $1.2B | — | — | — | — | — | — | BEARISH | — |
| TRAX First Tracks Biotherapeutics Inc | $1.2B | — | — | — | — | — | — | BEARISH | — |
| TGLVY Top Glove Corporation Bhd. | $1.2B | 32.3 | 4.0 | 4.2 | 7.4 | 12.8 | 7 | BEARISH | 24.7 |
| TGLVY Top Glove Corporation Bhd. | $1.2B | 32.3 | 4.0 | 4.2 | 7.4 | 12.8 | 7 | BEARISH | 24.7 |
| HROW Harrow Health, Inc. | $1.1B | -30.7 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -37.0 |
| HROW Harrow Health, Inc. | $1.1B | -30.7 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -37.0 |
| ASCLF Ascletis Pharma Inc. | $1.1B | -11.7 | -38.0 | -12387.1 | — | -95.5 | 2 | BEARISH | -14.8 |
| ASCLF Ascletis Pharma Inc. | $1.1B | -11.7 | -38.0 | -12387.1 | — | -95.5 | 2 | BEARISH | -14.8 |
| AORT Artivion, Inc. | $1.1B | -374.3 | -0.7 | -3.4 | -10.7 | 16.4 | 4 | BEARISH | -45.7 |
| AORT Artivion, Inc. | $1.1B | -374.3 | -0.7 | -3.4 | -10.7 | 16.4 | 4 | BEARISH | -45.7 |
| GRRMF Gerresheimer AG | $1.0B | -2.4 | 1.6 | 2.2 | -2.3 | 11.8 | 4 | BEARISH | -43.5 |
| GRRMF Gerresheimer AG | $1.0B | -2.4 | 1.6 | 2.2 | -2.3 | 11.8 | 4 | BEARISH | -43.5 |
| EBOSY EBOS Group Limited | $1.0B | 14.2 | 11.3 | 9.3 | 1.7 | 3.6 | 4 | BEARISH | -53.6 |
| EBOSY EBOS Group Limited | $1.0B | 14.2 | 11.3 | 9.3 | 1.7 | 3.6 | 4 | BEARISH | -53.6 |
| PRCT PROCEPT BioRobotics Corporation | $980M | -8.8 | -30.2 | -47.6 | -28.4 | 22.7 | 2 | BEARISH | -50.6 |
| PRCT PROCEPT BioRobotics Corporation | $980M | -8.8 | -30.2 | -47.6 | -28.4 | 22.7 | 2 | BEARISH | -50.6 |
| LTGO Latigo Biotherapeutics Inc. | $960M | — | — | — | — | — | — | BEARISH | — |
| LTGO Latigo Biotherapeutics Inc. | $960M | — | — | — | — | — | — | BEARISH | — |
| CRVS Corvus Pharmaceuticals, Inc. | $920M | -17.0 | -35.4 | -415.6 | — | — | 4 | BEARISH | 50.1 |
| CRVS Corvus Pharmaceuticals, Inc. | $920M | -17.0 | -35.4 | -415.6 | — | — | 4 | BEARISH | 50.1 |
| GLUE Monte Rosa Therapeutics, Inc. | $890M | -4.8 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | 40.0 |
| GLUE Monte Rosa Therapeutics, Inc. | $890M | -4.8 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | 40.0 |
| ALMS Alumis Inc. | $850M | -1.8 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 68.7 |
| ALMS Alumis Inc. | $850M | -1.8 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 68.7 |
| SANA Sana Biotechnology, Inc. | $800M | -3.8 | -152.9 | -242.3 | — | — | 3 | BEARISH | -21.9 |
| SANA Sana Biotechnology, Inc. | $800M | -3.8 | -152.9 | -242.3 | — | — | 3 | BEARISH | -21.9 |
| GERN Geron Corporation | $770M | -12.0 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -14.9 |
| GERN Geron Corporation | $770M | -12.0 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -14.9 |
| IVEVF Inventiva S.A. | $760M | -5.9 | 5541.6 | 502.1 | -347346.6 | -57.3 | 4 | BEARISH | 41.2 |
| IVEVF Inventiva S.A. | $760M | -5.9 | 5541.6 | 502.1 | -347346.6 | -57.3 | 4 | BEARISH | 41.2 |
| ATTO Attovia Therapeutics, Inc. | $740M | -18.5 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 308.8 |
| ATTO Attovia Therapeutics, Inc. | $740M | -18.5 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 308.8 |
| OLMA Olema Pharmaceuticals, Inc. | $720M | -3.9 | -52.7 | 585.3 | — | — | 2 | BEARISH | -25.4 |
| OLMA Olema Pharmaceuticals, Inc. | $720M | -3.9 | -52.7 | 585.3 | — | — | 2 | BEARISH | -25.4 |
| BLSM BlossomHill Therapeutics, Inc. | $570M | — | — | — | — | — | — | BEARISH | — |
| BLSM BlossomHill Therapeutics, Inc. | $570M | — | — | — | — | — | — | BEARISH | — |
| CRMD CorMedix Inc. | $560M | 3.0 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BEARISH | -34.9 |
| CRMD CorMedix Inc. | $560M | 3.0 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BEARISH | -34.9 |
| CTMX CytomX Therapeutics, Inc. | $560M | -5.7 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -23.6 |
| CTMX CytomX Therapeutics, Inc. | $560M | -5.7 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -23.6 |
| PHAT Phathom Pharmaceuticals, Inc. | $560M | -5.4 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -43.7 |
| PHAT Phathom Pharmaceuticals, Inc. | $560M | -5.4 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -43.7 |
| SSII SS Innovations International, Inc. | $530M | -41.0 | -26.1 | -15.6 | -19.1 | 108.5 | 3 | BEARISH | -62.4 |
| SSII SS Innovations International, Inc. | $530M | -41.0 | -26.1 | -15.6 | -19.1 | 108.5 | 3 | BEARISH | -62.4 |
| ALT Altimmune, Inc. | $530M | -3.5 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -20.4 |
| ALT Altimmune, Inc. | $530M | -3.5 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -20.4 |
| ALLO Allogene Therapeutics, Inc. | $520M | -2.2 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 21.0 |
| ALLO Allogene Therapeutics, Inc. | $520M | -2.2 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 21.0 |
| ARVN Arvinas, Inc. | $480M | 39.0 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -18.8 |
| ARVN Arvinas, Inc. | $480M | 39.0 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -18.8 |
| NPCE NeuroPace, Inc. | $430M | -22.2 | -122.1 | -39.6 | -27.2 | 11.6 | 4 | BEARISH | 25.2 |
| NPCE NeuroPace, Inc. | $430M | -22.2 | -122.1 | -39.6 | -27.2 | 11.6 | 4 | BEARISH | 25.2 |
| CALZF Polynovo Limited | $430M | 85.4 | 25.3 | 19.0 | 10.0 | 60.8 | 7 | BEARISH | -34.7 |
| CALZF Polynovo Limited | $430M | 85.4 | 25.3 | 19.0 | 10.0 | 60.8 | 7 | BEARISH | -34.7 |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $420M | — | — | — | — | — | — | BEARISH | — |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $420M | — | — | — | — | — | — | BEARISH | — |
| GLAS Glass House Brands Inc | $420M | — | — | — | — | — | — | BEARISH | — |
| GLAS Glass House Brands Inc | $420M | — | — | — | — | — | — | BEARISH | — |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.9 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.7 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.9 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.7 |
| TLRY Tilray Brands, Inc. | $400M | -2.7 | -8.1 | -2.7 | -17.6 | 1.2 | 3 | BEARISH | -78.2 |
| TLRY Tilray Brands, Inc. | $400M | -2.7 | -8.1 | -2.7 | -17.6 | 1.2 | 3 | BEARISH | -78.2 |
| VRNO Verano Holdings Corp | $390M | -1.5 | -4.5 | 1.5 | -6.2 | — | 3 | BEARISH | — |
| VRNO Verano Holdings Corp | $390M | -1.5 | -4.5 | 1.5 | -6.2 | — | 3 | BEARISH | — |
| CYH Community Health Systems, Inc. | $380M | -1.2 | 19.9 | -79.1 | 1.7 | 77.2 | 5 | BEARISH | -13.1 |
| CYH Community Health Systems, Inc. | $380M | -1.2 | 19.9 | -79.1 | 1.7 | 77.2 | 5 | BEARISH | -13.1 |
| RGNX REGENXBIO Inc. | $380M | -2.0 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -23.9 |
| RGNX REGENXBIO Inc. | $380M | -2.0 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -23.9 |
| PTCHF PureTech Health plc | $380M | 8.2 | 14.7 | -97.5 | 1890.6 | -3.3 | 5 | BEARISH | -0.7 |
| PTCHF PureTech Health plc | $380M | 8.2 | 14.7 | -97.5 | 1890.6 | -3.3 | 5 | BEARISH | -0.7 |
| RLMD Relmada Therapeutics, Inc. | $380M | -3.9 | -55.7 | 460.5 | — | — | 3 | BEARISH | 66.7 |
| RLMD Relmada Therapeutics, Inc. | $380M | -3.9 | -55.7 | 460.5 | — | — | 3 | BEARISH | 66.7 |
| KYTX Kyverna Therapeutics, Inc. | $380M | -2.1 | -87.2 | 14267.8 | — | — | 2 | BEARISH | 4.2 |
| KYTX Kyverna Therapeutics, Inc. | $380M | -2.1 | -87.2 | 14267.8 | — | — | 2 | BEARISH | 4.2 |
| CGC Canopy Growth Corporation | $370M | -1.9 | -53.8 | -16.5 | -220.5 | 27.6 | 2 | BEARISH | -36.6 |
| CGC Canopy Growth Corporation | $370M | -1.9 | -53.8 | -16.5 | -220.5 | 27.6 | 2 | BEARISH | -36.6 |
| BNTC Benitec Biopharma Inc. | $310M | -9.2 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -29.6 |
| BNTC Benitec Biopharma Inc. | $310M | -9.2 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -29.6 |
| IDGXF Integrated Diagnostics Holdings plc | $310M | 11.0 | 41.4 | 38.4 | 13.8 | 46.8 | 8 | BEARISH | 11.2 |
| IDGXF Integrated Diagnostics Holdings plc | $310M | 11.0 | 41.4 | 38.4 | 13.8 | 46.8 | 8 | BEARISH | 11.2 |
| LRMR Larimar Therapeutics, Inc. | $310M | -1.5 | -139.6 | 590.9 | — | — | 2 | BEARISH | -28.7 |
| LRMR Larimar Therapeutics, Inc. | $310M | -1.5 | -139.6 | 590.9 | — | — | 2 | BEARISH | -28.7 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $300M | — | — | — | — | — | — | BEARISH | — |
| CUVL Clinuvel Pharmaceuticals Ltd. | $300M | — | — | — | — | — | — | BEARISH | — |
| HUMDF Hua Medicine (Shanghai) Ltd. | $290M | -19.6 | 202.2 | -122.6 | -8.0 | 415.7 | 4 | BEARISH | -28.5 |
| HUMDF Hua Medicine (Shanghai) Ltd. | $290M | -19.6 | 202.2 | -122.6 | -8.0 | 415.7 | 4 | BEARISH | -28.5 |
| VNDA Vanda Pharmaceuticals Inc. | $280M | -1.0 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -9.2 |
| VNDA Vanda Pharmaceuticals Inc. | $280M | -1.0 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -9.2 |
| RCKT Rocket Pharmaceuticals, Inc. | $280M | -16.0 | -4.8 | -137.8 | — | — | 3 | BEARISH | -19.0 |
| RCKT Rocket Pharmaceuticals, Inc. | $280M | -16.0 | -4.8 | -137.8 | — | — | 3 | BEARISH | -19.0 |
| IPSC Century Therapeutics, Inc. | $280M | -1.5 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 206.1 |
| IPSC Century Therapeutics, Inc. | $280M | -1.5 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 206.1 |
| EYPT EyePoint Pharmaceuticals, Inc. | $270M | -0.9 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -74.8 |
| EYPT EyePoint Pharmaceuticals, Inc. | $270M | -0.9 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -74.8 |
| XFOR X4 Pharmaceuticals, Inc. | $270M | -2.4 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BEARISH | -21.8 |
| XFOR X4 Pharmaceuticals, Inc. | $270M | -2.4 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BEARISH | -21.8 |
| SCTX Scribe Therapeutics Inc. | $270M | — | — | — | — | — | — | BEARISH | — |
| SCTX Scribe Therapeutics Inc. | $270M | — | — | — | — | — | — | BEARISH | — |
| AMRN Amarin Corporation plc | $260M | -8.6 | -6.0 | -19.6 | -18.1 | -15.1 | 6 | BEARISH | -25.8 |
| AMRN Amarin Corporation plc | $260M | -8.6 | -6.0 | -19.6 | -18.1 | -15.1 | 6 | BEARISH | -25.8 |
| VOGX Vogenx Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| VOGX Vogenx Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| DBVT DBV Technologies S.A. | $250M | -2.7 | -142.6 | -2201.5 | — | -100.0 | 2 | BEARISH | 4.8 |
| DBVT DBV Technologies S.A. | $250M | -2.7 | -142.6 | -2201.5 | — | -100.0 | 2 | BEARISH | 4.8 |
| BIOA BioAge Labs Inc. | $250M | -2.8 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | BEARISH | 11.7 |
| ORYZF Oryzon Genomics S.A. | $250M | -87.6 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -8.3 |
| ORYZF Oryzon Genomics S.A. | $250M | -87.6 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -8.3 |
| BIOA BioAge Labs Inc. | $250M | -2.8 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | BEARISH | 11.7 |
| EVMN Evommune, Inc. | $250M | -2.4 | -29.6 | -82.4 | — | — | 2 | BEARISH | — |
| EVMN Evommune, Inc. | $250M | -2.4 | -29.6 | -82.4 | — | — | 2 | BEARISH | — |
| CPHRF Cipher Pharmaceuticals Inc. | $240M | 8.4 | 23.5 | 24.9 | 33.3 | 3.7 | 6 | BEARISH | -14.2 |
| CPHRF Cipher Pharmaceuticals Inc. | $240M | 8.4 | 23.5 | 24.9 | 33.3 | 3.7 | 6 | BEARISH | -14.2 |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BEARISH | -44.0 |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BEARISH | -44.0 |
| BCYC Bicycle Therapeutics plc | $230M | -1.2 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | BEARISH | -59.4 |
| BCYC Bicycle Therapeutics plc | $230M | -1.2 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | BEARISH | -59.4 |
| LCTX Lineage Cell Therapeutics, Inc. | $230M | -6.6 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | BEARISH | -45.0 |
| LCTX Lineage Cell Therapeutics, Inc. | $230M | -6.6 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | BEARISH | -45.0 |
| SION Sionna Therapeutics, Inc. | $220M | -2.3 | -32.3 | -137.7 | — | — | 0 | BEARISH | -82.8 |
| SION Sionna Therapeutics, Inc. | $220M | -2.3 | -32.3 | -137.7 | — | — | 0 | BEARISH | -82.8 |
| RXST RxSight, Inc. | $190M | -4.1 | -17.3 | -66.9 | -35.9 | -18.8 | 3 | BEARISH | -48.1 |
| RXST RxSight, Inc. | $190M | -4.1 | -17.3 | -66.9 | -35.9 | -18.8 | 3 | BEARISH | -48.1 |
| TSNDF TerrAscend Corp. | $190M | -4.1 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
| TSNDF TerrAscend Corp. | $190M | -4.1 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
| CHRS Coherus Oncology, Inc. | $180M | -1.1 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | BEARISH | -28.4 |
| CHRS Coherus Oncology, Inc. | $180M | -1.1 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | BEARISH | -28.4 |
| AVXL Anavex Life Sciences Corp. | $170M | -7.0 | -23.6 | 411.7 | — | — | 2 | BEARISH | -79.8 |
| AVXL Anavex Life Sciences Corp. | $170M | -7.0 | -23.6 | 411.7 | — | — | 2 | BEARISH | -79.8 |
| ORGO Organogenesis Holdings Inc. | $170M | -1.6 | -27.8 | -7.7 | -227.0 | 6.4 | 3 | BEARISH | -69.0 |
| ORGO Organogenesis Holdings Inc. | $170M | -1.6 | -27.8 | -7.7 | -227.0 | 6.4 | 3 | BEARISH | -69.0 |
| PEPG PepGen Inc. | $160M | -1.5 | -75.5 | -327.5 | — | — | 4 | BEARISH | -51.6 |
| PEPG PepGen Inc. | $160M | -1.5 | -75.5 | -327.5 | — | — | 4 | BEARISH | -51.6 |
| NERV Minerva Neurosciences, Inc. | $150M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | 56.2 |
| NERV Minerva Neurosciences, Inc. | $150M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | 56.2 |
| PHCUF Photocure ASA | $150M | 16.5 | 14.5 | 37.4 | -0.5 | 29.5 | 5 | BEARISH | -3.8 |
| PHCUF Photocure ASA | $150M | 16.5 | 14.5 | 37.4 | -0.5 | 29.5 | 5 | BEARISH | -3.8 |
| TARA Protara Therapeutics, Inc. | $150M | -2.0 | -45.8 | -41.3 | — | — | 2 | BEARISH | -38.8 |
| TARA Protara Therapeutics, Inc. | $150M | -2.0 | -45.8 | -41.3 | — | — | 2 | BEARISH | -38.8 |
| VYGR Voyager Therapeutics, Inc. | $150M | -1.4 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -47.6 |
| VYGR Voyager Therapeutics, Inc. | $150M | -1.4 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -47.6 |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | BEARISH | 413.6 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | BEARISH | 413.6 |
| OGI Organigram Global Inc. | $130M | 2.1 | 18.4 | -1.3 | 99.8 | 38.1 | 5 | BEARISH | -50.1 |
| OGI Organigram Global Inc. | $130M | 2.1 | 18.4 | -1.3 | 99.8 | 38.1 | 5 | BEARISH | -50.1 |
| RNA Atrium Therapeutics, Inc. | $130M | -2.0 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | BEARISH | -82.0 |
| RNA Atrium Therapeutics, Inc. | $130M | -2.0 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | BEARISH | -82.0 |
| LUCD Lucid Diagnostics Inc. | $120M | -1.3 | -556.3 | -1646.4 | -792.9 | 24.9 | 6 | BEARISH | -38.5 |
| LUCD Lucid Diagnostics Inc. | $120M | -1.3 | -556.3 | -1646.4 | -792.9 | 24.9 | 6 | BEARISH | -38.5 |
| STXS Stereotaxis, Inc. | $120M | -4.8 | -184.3 | -142.6 | -58.3 | -5.5 | 5 | BEARISH | -62.4 |
| STXS Stereotaxis, Inc. | $120M | -4.8 | -184.3 | -142.6 | -58.3 | -5.5 | 5 | BEARISH | -62.4 |
| TNYA Tenaya Therapeutics, Inc. | $120M | -1.1 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -66.4 |
| TNYA Tenaya Therapeutics, Inc. | $120M | -1.1 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -66.4 |
| CRBU Caribou Biosciences, Inc. | $120M | -1.1 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -46.0 |
| CRBU Caribou Biosciences, Inc. | $120M | -1.1 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -46.0 |
| LENZ LENZ Therapeutics, Inc. | $110M | -0.9 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -92.7 |
| LENZ LENZ Therapeutics, Inc. | $110M | -0.9 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -92.7 |
| VXRT Vaxart, Inc. | $110M | 2.9 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 15.0 |
| VXRT Vaxart, Inc. | $110M | 2.9 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 15.0 |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.5 | -101.1 | 349.9 | — | — | 4 | BEARISH | -5.4 |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.5 | -101.1 | 349.9 | — | — | 4 | BEARISH | -5.4 |
| APYX Apyx Medical Corporation | $110M | -12.3 | -96.4 | -12.3 | -23.4 | 25.6 | 5 | BEARISH | 18.6 |
| APYX Apyx Medical Corporation | $110M | -12.3 | -96.4 | -12.3 | -23.4 | 25.6 | 5 | BEARISH | 18.6 |
| JYNT The Joint Corp. | $100M | 27.4 | 19.4 | -33.1 | 4.3 | 220.6 | 8 | BEARISH | -21.5 |
| JYNT The Joint Corp. | $100M | 27.4 | 19.4 | -33.1 | 4.3 | 220.6 | 8 | BEARISH | -21.5 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.7 | -46.9 | 1464.5 | — | — | 4 | BEARISH | -4.1 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.7 | -46.9 | 1464.5 | — | — | 4 | BEARISH | -4.1 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $90M | -0.4 | -187.1 | 231.9 | — | — | 2 | BEARISH | -71.3 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $90M | -0.4 | -187.1 | 231.9 | — | — | 2 | BEARISH | -71.3 |
| CCLD CareCloud, Inc. | $90M | 28.9 | 21.8 | 15.7 | 3.5 | 15.1 | 4 | BEARISH | -39.7 |
| CCLD CareCloud, Inc. | $90M | 28.9 | 21.8 | 15.7 | 3.5 | 15.1 | 4 | BEARISH | -39.7 |
| EAPIF Euroapi S.A. | $80M | -0.2 | -57.5 | -10.4 | -39.7 | -14.7 | 6 | BEARISH | -72.7 |
| EAPIF Euroapi S.A. | $80M | -0.2 | -57.5 | -10.4 | -39.7 | -14.7 | 6 | BEARISH | -72.7 |
| CNXU Conexeu Sciences Inc. | $80M | — | — | — | — | — | — | BEARISH | — |
| CNXU Conexeu Sciences Inc. | $80M | — | — | — | — | — | — | BEARISH | — |
| NTHI Neonc Technologies Holdings, Inc. | $80M | — | — | — | — | — | — | BEARISH | -69.7 |
| NTHI Neonc Technologies Holdings, Inc. | $80M | — | — | — | — | — | — | BEARISH | -69.7 |
| CGTX Cognition Therapeutics, Inc. | $80M | -4.8 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -38.7 |
| CGTX Cognition Therapeutics, Inc. | $80M | -4.8 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -38.7 |
| ALDX Aldeyra The | $70M | -3.0 | -49.5 | 269.3 | — | — | 4 | BEARISH | -77.7 |
| ALDX Aldeyra The | $70M | -3.0 | -49.5 | 269.3 | — | — | 4 | BEARISH | -77.7 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.5 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -23.7 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.5 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -23.7 |
| ONCY Oncolytics Biotech Inc. | $60M | -2.6 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -56.1 |
| ONCY Oncolytics Biotech Inc. | $60M | -2.6 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -56.1 |
| GUTS Fractyl Health, Inc. | $60M | -0.4 | 1063.0 | -568.7 | — | -100.0 | 4 | BEARISH | -72.3 |
| GUTS Fractyl Health, Inc. | $60M | -0.4 | 1063.0 | -568.7 | — | -100.0 | 4 | BEARISH | -72.3 |
| PLRX Pliant Therapeutics, Inc. | $60M | -0.7 | -50.3 | -438.3 | — | — | 3 | BEARISH | -29.0 |
| PLRX Pliant Therapeutics, Inc. | $60M | -0.7 | -50.3 | -438.3 | — | — | 3 | BEARISH | -29.0 |
| CING Cingulate Inc. | $60M | -1.0 | -198.7 | -1452.8 | — | — | 4 | BEARISH | 13.6 |
| HBPCF Helix BioPharma Corp. | $60M | -22.3 | -50.8 | -21.5 | — | — | 3 | BEARISH | 28.3 |
| HBPCF Helix BioPharma Corp. | $60M | -22.3 | -50.8 | -21.5 | — | — | 3 | BEARISH | 28.3 |
| CING Cingulate Inc. | $60M | -1.0 | -198.7 | -1452.8 | — | — | 4 | BEARISH | 13.6 |
| SRTS Sensus Healthcare, Inc. | $50M | -3.2 | -34.8 | -47.6 | -382.1 | -53.4 | 3 | BEARISH | -5.7 |
| MBOT Microbot Medical Inc. | $50M | -4.4 | -32.9 | -600.2 | -2334.9 | — | 3 | BEARISH | -63.3 |
| MBOT Microbot Medical Inc. | $50M | -4.4 | -32.9 | -600.2 | -2334.9 | — | 3 | BEARISH | -63.3 |
| BTMD biote Corp. | $50M | 6.8 | -7.8 | 19.7 | -14.8 | -7.8 | 5 | BEARISH | -61.4 |
| BTMD biote Corp. | $50M | 6.8 | -7.8 | 19.7 | -14.8 | -7.8 | 5 | BEARISH | -61.4 |
| SOMNF SomnoMed Limited | $50M | -24.0 | -13.2 | 10.2 | -6.4 | 28.9 | 6 | BEARISH | -45.5 |
| SOMNF SomnoMed Limited | $50M | -24.0 | -13.2 | 10.2 | -6.4 | 28.9 | 6 | BEARISH | -45.5 |
| SRTS Sensus Healthcare, Inc. | $50M | -3.2 | -34.8 | -47.6 | -382.1 | -53.4 | 3 | BEARISH | -5.7 |
| ACH Accendra Health, Inc. | $40M | -0.1 | -1.1 | 4.3 | -14.5 | -99.1 | 3 | BEARISH | -95.6 |
| ACH Accendra Health, Inc. | $40M | -0.1 | -1.1 | 4.3 | -14.5 | -99.1 | 3 | BEARISH | -95.6 |
| CVRX CVRx, Inc. | $40M | -0.8 | -133.4 | -260.4 | -89.4 | 12.0 | 3 | BEARISH | -80.5 |
| CVRX CVRx, Inc. | $40M | -0.8 | -133.4 | -260.4 | -89.4 | 12.0 | 3 | BEARISH | -80.5 |
| MDDVF Medical Developments International Limited | $40M | 75.9 | 1.4 | 12.3 | 4.1 | 24.6 | 8 | BEARISH | -1.0 |
| PRRUF Immutep Ltd | $40M | -0.6 | -96.5 | 2212.5 | -328.8 | 153.6 | 3 | BEARISH | -84.2 |
| PRRUF Immutep Ltd | $40M | -0.6 | -96.5 | 2212.5 | -328.8 | 153.6 | 3 | BEARISH | -84.2 |
| MDDVF Medical Developments International Limited | $40M | 75.9 | 1.4 | 12.3 | 4.1 | 24.6 | 8 | BEARISH | -1.0 |
| VEXTF Vext Science, Inc. | $40M | -2.1 | -23.2 | -8.7 | -2.6 | 14.2 | 5 | BEARISH | -41.4 |
| VEXTF Vext Science, Inc. | $40M | -2.1 | -23.2 | -8.7 | -2.6 | 14.2 | 5 | BEARISH | -41.4 |
| MGX Metagenomi, Inc. Common Stock | $40M | -0.4 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -57.3 |
| MGX Metagenomi, Inc. Common Stock | $40M | -0.4 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -57.3 |
| KYNB Kyntra Bio, Inc. | $30M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| KYNB Kyntra Bio, Inc. | $30M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| BDMD Baird Medical Investment Holdings Limited | $30M | -1.4 | -51.7 | -23.6 | 0.1 | 26.4 | 3 | BEARISH | -64.9 |
| BDMD Baird Medical Investment Holdings Limited | $30M | -1.4 | -51.7 | -23.6 | 0.1 | 26.4 | 3 | BEARISH | -64.9 |
| IDXG Interpace Biosciences, Inc. | $30M | 0.2 | 221.9 | 123.7 | 1.7 | -20.3 | 6 | BEARISH | 46.3 |
| IDXG Interpace Biosciences, Inc. | $30M | 0.2 | 221.9 | 123.7 | 1.7 | -20.3 | 6 | BEARISH | 46.3 |
| MCRB Seres Therapeutics, Inc. | $30M | -1.2 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -85.7 |
| NSPR InspireMD, Inc. | $30M | -1.3 | -148.8 | -1383.2 | -808.8 | 53.4 | 4 | BEARISH | -74.1 |
| NSPR InspireMD, Inc. | $30M | -1.3 | -148.8 | -1383.2 | -808.8 | 53.4 | 4 | BEARISH | -74.1 |
| MCRB Seres Therapeutics, Inc. | $30M | -1.2 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -85.7 |
| ATYR aTyr Pharma, Inc. | $30M | -0.5 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -58.4 |
| ATYR aTyr Pharma, Inc. | $30M | -0.5 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -58.4 |
| SCLX Scilex Holding Company | $30M | -0.1 | 160.5 | 105.7 | -1485.2 | -28.5 | 3 | BEARISH | -80.4 |
| SCLX Scilex Holding Company | $30M | -0.1 | 160.5 | 105.7 | -1485.2 | -28.5 | 3 | BEARISH | -80.4 |
| IMMP Immutep Limited | $30M | -0.6 | -112.5 | 2661.4 | -328.8 | 195.3 | 4 | BEARISH | -88.0 |
| IMMP Immutep Limited | $30M | -0.6 | -112.5 | 2661.4 | -328.8 | 195.3 | 4 | BEARISH | -88.0 |
| PAVM PAVmed Inc. | $20M | -0.2 | -31.9 | -43.6 | -16315.2 | -89.0 | 3 | BEARISH | 552.3 |
| PAVM PAVmed Inc. | $20M | -0.2 | -31.9 | -43.6 | -16315.2 | -89.0 | 3 | BEARISH | 552.3 |
| BCDA BioCardia, Inc. | $20M | -1.4 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -21.8 |
| BCDA BioCardia, Inc. | $20M | -1.4 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -21.8 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.4 | -119.6 | 717.6 | — | — | 3 | BEARISH | -69.2 |
| IGPK Integrated Cannabis Solutions, Inc. | $10M | 9.2 | -3.2 | -5.2 | 0.6 | 2762.5 | 5 | BEARISH | -72.4 |
| IGPK Integrated Cannabis Solutions, Inc. | $10M | 9.2 | -3.2 | -5.2 | 0.6 | 2762.5 | 5 | BEARISH | -72.4 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.4 | -119.6 | 717.6 | — | — | 3 | BEARISH | -69.2 |
| LTRN Lantern Pharma Inc. | $10M | -0.5 | -400.9 | 115.9 | — | — | 2 | BEARISH | -78.5 |
| LTRN Lantern Pharma Inc. | $10M | -0.5 | -400.9 | 115.9 | — | — | 2 | BEARISH | -78.5 |
| SCNX Scienture Holdings, Inc. | $10M | -0.1 | -53.5 | -15.4 | -821.3 | 540.6 | 3 | BEARISH | -82.5 |
| SCNX Scienture Holdings, Inc. | $10M | -0.1 | -53.5 | -15.4 | -821.3 | 540.6 | 3 | BEARISH | -82.5 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 0.0 | -0.0 | 155.3 | — | 5 | BEARISH | -69.5 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 0.0 | -0.0 | 155.3 | — | 5 | BEARISH | -69.5 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.4 | -128.1 | 241.9 | — | — | 3 | BEARISH | -72.4 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.4 | -128.1 | 241.9 | — | — | 3 | BEARISH | -72.4 |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 54.7 | 78.9 | -106.0 | 33.0 | 3 | BEARISH | -49.1 |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 54.7 | 78.9 | -106.0 | 33.0 | 3 | BEARISH | -49.1 |
| INNPF INNOCAN PHARMA Corp | $10M | -7.4 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -80.8 |
| INNPF INNOCAN PHARMA Corp | $10M | -7.4 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -80.8 |
| PASG Passage Bio, Inc. | $10M | -0.4 | -169.1 | 159.0 | — | — | 3 | BEARISH | -49.3 |
| PASG Passage Bio, Inc. | $10M | -0.4 | -169.1 | 159.0 | — | — | 3 | BEARISH | -49.3 |
| HMTXF Hemostemix Inc | $10M | -2.4 | 69.9 | 190.1 | — | — | 1 | BEARISH | -38.1 |
| HMTXF Hemostemix Inc | $10M | -2.4 | 69.9 | 190.1 | — | — | 1 | BEARISH | -38.1 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | BEARISH | -56.2 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | BEARISH | -56.2 |
| JSPR Jasper Therapeutics, Inc. | $10M | -0.4 | -255.0 | 773.9 | — | — | 2 | BEARISH | -76.5 |
| JSPR Jasper Therapeutics, Inc. | $10M | -0.4 | -255.0 | 773.9 | — | — | 2 | BEARISH | -76.5 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.7 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -59.3 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.7 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -59.3 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.4 | -126.2 | 296.9 | — | — | 1 | BEARISH | -97.0 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.4 | -126.2 | 296.9 | — | — | 1 | BEARISH | -97.0 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| CNHC China Health Management Corp. | — | 16.1 | 3.2 | 3.3 | 29.8 | -1.0 | 6 | BEARISH | 100.8 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -542.5 | 1354.9 | — | -40.0 | 2 | BEARISH | -98.8 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -542.5 | 1354.9 | — | -40.0 | 2 | BEARISH | -98.8 |
| CNHC China Health Management Corp. | — | 16.1 | 3.2 | 3.3 | 29.8 | -1.0 | 6 | BEARISH | 100.8 |
| XAGE Longevity Health Holdings Inc. | — | -0.0 | 109.8 | 56.6 | -475.6 | 60.3 | 3 | BEARISH | -79.8 |
| XAGE Longevity Health Holdings Inc. | — | -0.0 | 109.8 | 56.6 | -475.6 | 60.3 | 3 | BEARISH | -79.8 |
| NUMD Nu-Med Plus, Inc. | — | -48.7 | 8.1 | 29.2 | — | -100.0 | 4 | BEARISH | -53.2 |
| NUMD Nu-Med Plus, Inc. | — | -48.7 | 8.1 | 29.2 | — | -100.0 | 4 | BEARISH | -53.2 |
| MEDD Medical Imaging Corp. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| MEDD Medical Imaging Corp. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -92.3 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -92.3 |
| HEWA HealthWarehouse.com, Inc. | — | -3.3 | 24.7 | 44.2 | -6.8 | -42.5 | 3 | BEARISH | -36.4 |
| HEWA HealthWarehouse.com, Inc. | — | -3.3 | 24.7 | 44.2 | -6.8 | -42.5 | 3 | BEARISH | -36.4 |
| YECO EV Biologics, Inc. | — | -0.0 | 4.7 | 15.0 | 18.6 | 347.3 | 6 | BEARISH | -99.9 |
| YECO EV Biologics, Inc. | — | -0.0 | 4.7 | 15.0 | 18.6 | 347.3 | 6 | BEARISH | -99.9 |
| ERNA Ernexa Therapeutics Inc. | — | -0.2 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -89.6 |
| ERNA Ernexa Therapeutics Inc. | — | -0.2 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -89.6 |
| MHTX Manhattan Scientifics, Inc. | — | -0.0 | 45.1 | 23.3 | — | 104.9 | 3 | BEARISH | -90.0 |
| MHTX Manhattan Scientifics, Inc. | — | -0.0 | 45.1 | 23.3 | — | 104.9 | 3 | BEARISH | -90.0 |
| BNYN Banyan Corp. | — | -0.0 | 719.9 | -36.9 | -121.9 | -37.7 | 3 | BEARISH | -99.5 |
| BNYN Banyan Corp. | — | -0.0 | 719.9 | -36.9 | -121.9 | -37.7 | 3 | BEARISH | -99.5 |
| NLVVF New Leaf Ventures Inc | — | -0.2 | -2466.1 | -179.6 | -152.9 | -39.2 | 1 | BEARISH | -99.0 |
| NLVVF New Leaf Ventures Inc | — | -0.2 | -2466.1 | -179.6 | -152.9 | -39.2 | 1 | BEARISH | -99.0 |
| CVSI CV Sciences, Inc. | — | -1.0 | -118.9 | -46.0 | -26.0 | -14.9 | 1 | BEARISH | -74.5 |
| CVSI CV Sciences, Inc. | — | -1.0 | -118.9 | -46.0 | -26.0 | -14.9 | 1 | BEARISH | -74.5 |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| PBIGF Paradigm Biopharmaceuticals Limited | — | -1.6 | -550.4 | 1492.1 | -60158.9 | 17.4 | 3 | BEARISH | -99.2 |
| PBIGF Paradigm Biopharmaceuticals Limited | — | -1.6 | -550.4 | 1492.1 | -60158.9 | 17.4 | 3 | BEARISH | -99.2 |
| EDNEF Eden Empire Inc. | — | — | 64.3 | -88.8 | -1382.1 | — | 2 | BEARISH | -90.9 |
| EDNEF Eden Empire Inc. | — | — | 64.3 | -88.8 | -1382.1 | — | 2 | BEARISH | -90.9 |
| GREH Green Rain Energy Holdings Inc. | — | 0.2 | 28.6 | -43.9 | -94.2 | — | 3 | BEARISH | -56.4 |
| GREH Green Rain Energy Holdings Inc. | — | 0.2 | 28.6 | -43.9 | -94.2 | — | 3 | BEARISH | -56.4 |
| LCDX Caliber Imaging & Diagnostics, Inc. | — | -0.0 | 54.6 | 46.8 | -212.5 | 20.6 | 3 | BEARISH | 0.0 |
| LCDX Caliber Imaging & Diagnostics, Inc. | — | -0.0 | 54.6 | 46.8 | -212.5 | 20.6 | 3 | BEARISH | 0.0 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -97.6 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -97.6 |
| EVAHF EGF Theramed Health Corp. | — | -0.2 | 102.2 | 4.7 | — | — | 2 | BEARISH | -65.1 |
| EVAHF EGF Theramed Health Corp. | — | -0.2 | 102.2 | 4.7 | — | — | 2 | BEARISH | -65.1 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -98.6 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -98.6 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -50.0 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -50.0 |
| MDXL Medixall Group, Inc. | — | -0.1 | 48.8 | 48.2 | 678.9 | 29.4 | 6 | BEARISH | 3200.0 |
| MDXL Medixall Group, Inc. | — | -0.1 | 48.8 | 48.2 | 678.9 | 29.4 | 6 | BEARISH | 3200.0 |
| WUHN Wuhan General Group (China), Inc. | — | -0.0 | 106.5 | 1.0 | -155074.0 | — | 2 | BEARISH | 100.0 |
| WUHN Wuhan General Group (China), Inc. | — | -0.0 | 106.5 | 1.0 | -155074.0 | — | 2 | BEARISH | 100.0 |
| GXXY Galexxy Holdings, Inc. | — | -0.0 | 370.1 | 271.5 | -385.0 | -88.8 | 2 | BEARISH | -98.3 |
| GXXY Galexxy Holdings, Inc. | — | -0.0 | 370.1 | 271.5 | -385.0 | -88.8 | 2 | BEARISH | -98.3 |
| DHAI DIH Holding US, Inc. | — | -0.0 | 24.9 | 14.2 | -34.8 | 262.3 | 3 | BEARISH | -100.0 |
| DHAI DIH Holding US, Inc. | — | -0.0 | 24.9 | 14.2 | -34.8 | 262.3 | 3 | BEARISH | -100.0 |
| MBIO Mustang Bio, Inc. | — | -1.0 | -58.1 | 36.6 | — | — | 2 | BEARISH | -70.0 |
| MBIO Mustang Bio, Inc. | — | -1.0 | -58.1 | 36.6 | — | — | 2 | BEARISH | -70.0 |
| STJO St. Joseph, Inc. | — | 1.1 | 9.1 | 6.7 | 89.6 | -23.9 | 7 | BEARISH | -43.1 |
| STJO St. Joseph, Inc. | — | 1.1 | 9.1 | 6.7 | 89.6 | -23.9 | 7 | BEARISH | -43.1 |
| PPJE PPJ Healthcare Enterprises, Inc. | — | 56.8 | -0.0 | -0.0 | 0.0 | -1.2 | 4 | BEARISH | -99.0 |
| PPJE PPJ Healthcare Enterprises, Inc. | — | 56.8 | -0.0 | -0.0 | 0.0 | -1.2 | 4 | BEARISH | -99.0 |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -38.2 |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -38.2 |
| PKTX ProtoKinetix, Incorporated | — | -0.7 | -117.2 | -115.0 | — | — | 2 | BEARISH | -96.4 |
| PKTX ProtoKinetix, Incorporated | — | -0.7 | -117.2 | -115.0 | — | — | 2 | BEARISH | -96.4 |
| MHUAF Meihua International Medical Technologies Co., Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| MHUAF Meihua International Medical Technologies Co., Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| CDIX Cardiff Lexington Corporation | — | -0.1 | -481.3 | -3.3 | -114.8 | 0.3 | 2 | BEARISH | -99.3 |
| CDIX Cardiff Lexington Corporation | — | -0.1 | -481.3 | -3.3 | -114.8 | 0.3 | 2 | BEARISH | -99.3 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 4 | BEARISH | -81.7 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 4 | BEARISH | -81.7 |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | BEARISH | -50.0 |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | BEARISH | -50.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | BEARISH | -99.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | BEARISH | -99.0 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| HEMP Hemp, Inc | — | -0.2 | -38.7 | -6.0 | -4131.8 | 333.7 | 4 | BEARISH | 0.0 |
| HEMP Hemp, Inc | — | -0.2 | -38.7 | -6.0 | -4131.8 | 333.7 | 4 | BEARISH | 0.0 |
| BLFE BioLife Sciences Inc. | — | -0.0 | 318059.1 | -92210.0 | — | — | 2 | BEARISH | 0.0 |
| BLFE BioLife Sciences Inc. | — | -0.0 | 318059.1 | -92210.0 | — | — | 2 | BEARISH | 0.0 |
| BIMI BIMI International Medical Inc. | — | -0.0 | -159.5 | -56.3 | -124.0 | -65.7 | 4 | BEARISH | 0.0 |
| BIMI BIMI International Medical Inc. | — | -0.0 | -159.5 | -56.3 | -124.0 | -65.7 | 4 | BEARISH | 0.0 |
| CRIS Curis, Inc. | — | -0.1 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -97.6 |
| CRIS Curis, Inc. | — | -0.1 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -97.6 |
| MBRX Moleculin Biotech, Inc. | — | -0.0 | -1371.6 | -494.1 | — | — | 2 | BEARISH | -96.4 |
| MBRX Moleculin Biotech, Inc. | — | -0.0 | -1371.6 | -494.1 | — | — | 2 | BEARISH | -96.4 |
| IGNT Ingen Technologies, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| IGNT Ingen Technologies, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| JRSS JRSIS Health Care Corporation | — | -7.4 | -10.1 | -10.3 | 4.5 | -94.6 | 6 | BEARISH | 7.7 |
| JRSS JRSIS Health Care Corporation | — | -7.4 | -10.1 | -10.3 | 4.5 | -94.6 | 6 | BEARISH | 7.7 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 3 | BEARISH | -47.9 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 3 | BEARISH | -47.9 |
| SBFM Sunshine Biopharma, Inc. | — | -0.1 | -21.9 | -31.4 | -16.9 | -2.7 | 4 | BEARISH | -56.7 |
| SBFM Sunshine Biopharma, Inc. | — | -0.1 | -21.9 | -31.4 | -16.9 | -2.7 | 4 | BEARISH | -56.7 |
| EDVA Endovia Health Sciences, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| EDVA Endovia Health Sciences, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| INLB Item 9 Labs Corp. | — | -0.0 | -47.3 | -18.4 | -117.7 | -17.4 | 2 | BEARISH | -99.0 |
| INLB Item 9 Labs Corp. | — | -0.0 | -47.3 | -18.4 | -117.7 | -17.4 | 2 | BEARISH | -99.0 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -44.1 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -44.1 |
| ATTBF Abattis Bioceuticals Corp. | — | -0.0 | -27.0 | -30.2 | -400.9 | 4163.2 | 4 | BEARISH | -96.7 |
| ATTBF Abattis Bioceuticals Corp. | — | -0.0 | -27.0 | -30.2 | -400.9 | 4163.2 | 4 | BEARISH | -96.7 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
HADV vs Benchmarks
ROIC
P/E Ratio
ROE
Piotroski F